data_2gcx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gcx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.72 0.295 . . . . 2.96 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -108.92 150.05 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 1.3 111.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 85.57 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.562 2.175 . . . . 0.77 112.357 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.6 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 2.69 110.867 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -84.84 164.27 18.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 2.32 110.986 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.7 165.45 11.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.16 111.241 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 61.1 m95 -155.07 174.55 15.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.84 110.832 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -127.6 134.34 49.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 2.52 111.05 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.1 mt -74.52 126.09 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 1.21 111.346 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -139.74 48.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 1.64 110.572 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.72 91.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.866 -0.683 . . . . 0.45 112.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -147.23 96.97 2.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.64 0.257 . . . . 0.93 110.786 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 15.0 m -105.79 -175.79 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 1.26 110.803 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.2 mpt_? -86.31 -21.67 27.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 3.96 111.047 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -147.44 28.19 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.463 -0.335 . . . . 2.48 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 14.6 tt -46.17 122.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.17 111.369 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -72.82 155.43 90.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 2.01 110.929 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 24' ' ' GLN . 37.9 Cg_endo -66.42 -27.71 46.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.503 2.136 . . . . 0.68 112.268 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.64 -45.15 57.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 1.32 110.83 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -85.78 -37.27 19.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 2.53 111.129 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -70.58 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 2.02 111.359 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' PRO . 51.8 tt0 -57.88 -18.64 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 3.29 111.537 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -75.32 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 3.07 111.149 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -50.0 -30.88 11.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 1.94 111.033 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.0 mt -51.57 -34.04 35.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.45 111.013 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.4 p -62.88 -29.47 70.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 2.09 111.092 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.33 -24.43 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 2.13 111.012 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.92 20.63 59.11 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.82 112.465 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.31 91.57 4.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 2.97 110.846 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.5 mp -88.26 160.6 45.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.02 -0.536 . . . . 1.34 110.79 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.37 112.78 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.525 2.15 . . . . 0.51 112.417 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 30.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 0.4 112.454 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.8 t -102.1 174.1 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 1.01 110.878 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -119.06 138.95 52.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.467 . . . . 1.75 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.7 p90 -153.37 159.89 42.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.018 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -114.41 160.76 18.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.426 . . . . 3.83 110.82 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.37 134.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 1.88 111.222 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -94.98 -49.53 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.22 111.08 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.77 138.44 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.53 110.832 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' CG2' ' A' ' 49' ' ' VAL . 19.7 t -146.16 157.97 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 1.79 111.388 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' N ' HG11 ' A' ' 42' ' ' VAL . . . -123.58 147.37 52.82 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 1.25 111.065 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.11 -20.47 19.07 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 1.63 112.663 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.84 -46.41 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.387 -0.37 . . . . 3.06 111.059 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.33 100.3 0.2 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 0.79 112.306 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 1.2 m-20 -139.38 170.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 1.07 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.81 117.19 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.942 2.428 . . . . 0.65 111.647 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 157.17 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.823 -0.626 . . . . 1.15 110.874 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -121.04 136.45 54.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 2.03 110.72 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.08 143.84 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 1.12 111.136 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -106.77 110.58 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 2.13 110.755 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -112.08 -174.33 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 1.28 111.063 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -52.43 94.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 3.43 111.479 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 53.23 38.19 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 4.67 111.691 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -155.44 132.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.713 0.292 . . . . 1.87 111.093 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -112.21 107.83 16.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 1.07 111.148 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.4 tp -101.54 154.07 19.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 2.1 110.55 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.52 139.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 1.11 111.183 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.39 166.18 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 1.56 110.756 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.5 mtt180 -124.63 136.43 53.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 3.81 110.79 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.0 tpmt? -45.96 -29.36 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 5.09 111.253 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -84.41 -31.61 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.937 0.399 . . . . 2.72 110.393 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ARG . 18.5 t70 -69.49 -35.95 76.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 2.3 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -63.0 -23.58 67.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 1.41 110.989 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.17 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.38 . . . . 1.2 111.28 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -83.47 -61.03 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 1.16 111.202 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 pt -65.32 144.52 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 1.12 111.183 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.26 154.44 18.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.847 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.46 148.98 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 2.39 111.05 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -134.43 115.31 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 2.24 110.738 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.39 53.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.34 111.092 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.76 111.234 179.806 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 70' ' ' LEU . 83.1 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.84 0.352 . . . . 2.96 110.802 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -112.03 154.85 44.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.3 111.173 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.527 2.151 . . . . 0.77 112.362 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 177.77 -43.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 2.69 110.794 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.54 149.31 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 2.32 110.788 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.79 146.83 23.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.445 . . . . 1.16 111.18 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 38.8 m95 -133.64 174.06 10.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.84 110.671 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -122.1 138.23 54.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.351 -0.386 . . . . 2.52 111.093 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CD1' ' CE ' ' A' ' 31' ' ' MET . 53.5 mt -77.31 138.9 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.21 111.14 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 17.7 m -142.48 50.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.933 -0.576 . . . . 1.64 110.434 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 91.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.773 -0.648 . . . . 0.45 112.9 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 47.3 t80 -147.25 99.22 3.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.93 110.693 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -101.84 -172.66 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.409 . . . . 1.26 111.075 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.0 mpt_? -77.89 -29.85 50.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 3.96 110.911 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.22 40.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 2.48 110.981 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.21 130.73 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 1.17 111.401 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.3 m -80.64 156.73 72.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 2.01 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.1 Cg_endo -58.39 -33.03 97.47 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.516 2.144 . . . . 0.68 112.166 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.92 -43.52 59.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.104 0.478 . . . . 1.32 110.326 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -85.67 -43.46 13.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 2.53 110.514 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -62.56 -61.67 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 2.02 111.041 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' PRO . 89.8 mt-30 -52.2 -32.21 35.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.453 -0.339 . . . . 3.29 110.833 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -51.04 -40.68 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 3.07 111.021 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 3.4 mm? -84.5 -38.7 19.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 1.94 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.87 -33.45 23.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 1.45 110.99 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -63.12 -50.73 69.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 2.09 110.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.37 -23.82 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 2.13 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.06 18.94 25.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 0.82 112.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.488 ' CE ' ' CD1' ' A' ' 11' ' ' ILE . 65.4 mtp -91.43 94.77 9.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 2.97 110.923 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -103.12 159.7 28.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 1.34 110.857 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.72 111.9 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.569 2.18 . . . . 0.51 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.11 25.64 3.49 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.919 -0.657 . . . . 0.4 112.302 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -93.51 163.47 13.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 1.01 110.709 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -111.01 142.8 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 1.75 110.929 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 24.1 p90 -155.1 162.72 40.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.844 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -114.55 148.04 38.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.83 111.002 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 t -86.88 113.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 1.88 110.868 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.81 -52.38 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 1.22 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -169.25 121.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 3.53 111.107 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -140.32 158.08 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.79 110.944 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -113.94 140.32 24.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 1.25 111.407 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.15 -26.81 83.1 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.554 2.169 . . . . 1.63 112.351 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 45' ' ' LEU . 3.1 mm? -80.41 -65.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 3.06 110.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.27 100.76 0.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.712 -0.756 . . . . 0.79 112.334 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -144.48 171.24 6.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.609 0.242 . . . . 1.07 111.025 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.63 113.64 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.955 2.437 . . . . 0.65 111.677 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.77 140.69 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.625 . . . . 1.15 111.173 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -99.67 137.63 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.905 -0.589 . . . . 2.03 110.611 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -108.67 140.65 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 1.12 111.198 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.29 109.47 21.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 2.13 110.81 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.1 p -107.37 -172.85 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.28 111.087 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -50.93 96.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.43 111.405 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 52.53 26.24 4.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 4.67 111.696 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -146.75 120.68 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.4 . . . . 1.87 111.117 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -104.22 107.93 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 1.07 110.912 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -103.37 160.28 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 2.1 110.669 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.64 138.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.369 . . . . 1.11 111.132 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.15 155.41 50.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.56 110.874 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 64' ' ' ASP . 75.2 mtp180 -122.12 155.62 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 3.81 111.058 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 5.6 mmpt? -44.2 -28.93 0.56 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.078 -0.51 . . . . 5.09 111.486 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -76.43 -36.09 58.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.281 -0.418 . . . . 2.72 110.874 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' ARG . 13.2 m-20 -74.41 -34.47 63.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 2.3 110.825 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 65' ' ' LEU . 7.1 mp -74.58 -26.57 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 1.41 110.937 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.24 -25.33 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 1.2 111.163 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.6 -58.47 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 1.16 111.124 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.0 pt -67.64 154.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 1.12 110.904 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.88 155.74 18.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 2.29 110.974 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.478 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 92.1 mt -128.84 165.66 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.082 -0.508 . . . . 2.39 110.753 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.51 149.08 30.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 2.24 111.023 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -174.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 1.34 110.903 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 1.76 111.023 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.783 0.325 . . . . 2.96 110.957 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -116.23 156.26 47.3 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 1.3 111.381 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.81 141.61 27.77 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.724 2.283 . . . . 0.77 112.396 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.24 21.02 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 2.69 111.518 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.6 p -88.17 159.79 18.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 2.32 110.883 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.19 135.44 53.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.16 111.06 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 54.1 m95 -151.42 157.22 42.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.84 110.572 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -99.52 135.09 41.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 2.52 110.745 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -77.3 132.39 32.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.039 -0.528 . . . . 1.21 111.328 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.2 m -139.51 44.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.009 -0.541 . . . . 1.64 110.391 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.21 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.917 -0.659 . . . . 0.45 112.581 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 89.9 t80 -147.7 94.89 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.93 110.828 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m -100.39 161.86 13.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 1.26 110.857 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -19.15 38.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.96 111.369 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -165.55 42.26 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 2.48 111.401 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.45 139.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.347 -0.388 . . . . 1.17 111.325 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -88.41 156.37 50.98 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 2.01 110.895 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 21.1 Cg_endo -60.45 -30.39 90.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.621 2.214 . . . . 0.68 112.347 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.71 -46.61 50.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.078 0.466 . . . . 1.32 110.665 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -86.45 -43.4 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 2.53 110.806 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -62.09 -58.84 6.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 2.02 111.38 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 61.4 tt0 -46.06 -48.19 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 3.29 111.499 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -51.16 -47.77 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.404 -0.362 . . . . 3.07 111.152 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.95 -57.13 12.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.025 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.7 mt -48.86 -26.48 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.45 111.176 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -66.09 -37.05 84.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 2.09 111.087 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.59 -25.26 38.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.376 -0.375 . . . . 2.13 111.073 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.15 7.67 55.95 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.716 -0.754 . . . . 0.82 113.04 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.401 ' CE ' ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -91.97 103.06 15.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.969 0.385 . . . . 2.97 111.05 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 32' ' ' LEU . 6.6 mp -90.58 160.38 39.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 1.34 110.614 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.23 127.15 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.472 2.115 . . . . 0.51 112.277 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.21 27.39 6.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.727 -0.749 . . . . 0.4 112.323 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -94.31 174.23 7.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.649 0.261 . . . . 1.01 110.788 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -123.97 148.81 46.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 1.75 110.946 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 6.8 p90 -161.43 179.53 8.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.44 110.853 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -132.21 152.22 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 3.83 110.844 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 49' ' ' VAL . 60.5 t -91.23 141.09 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 1.88 111.051 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -95.96 -39.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 1.22 111.342 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 179.73 126.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 3.53 110.982 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 43' ' ' ALA . 9.2 p -148.66 159.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.79 111.153 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -114.15 155.75 45.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 1.25 111.066 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.29 -18.44 23.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.676 2.25 . . . . 1.63 112.586 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 tp -89.65 -65.8 0.98 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 3.06 110.938 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.84 107.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.79 112.434 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -147.72 172.26 5.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.58 0.229 . . . . 1.07 110.712 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 110.87 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.755 2.303 . . . . 0.65 111.526 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 39' ' ' VAL . 3.7 p -106.57 140.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 1.15 111.199 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -101.43 131.03 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.845 -0.616 . . . . 2.03 110.804 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 60' ' ' LEU . 44.2 pt -96.63 139.62 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.12 110.831 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -106.83 97.09 6.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 2.13 110.888 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.2 -172.68 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 1.28 111.002 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 31' ' ' MET . 41.3 mmt180 -51.47 96.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 3.43 111.451 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 51.89 30.08 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 4.67 111.541 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -149.75 117.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 1.87 111.33 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -100.87 107.76 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.07 110.751 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.9 158.17 16.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 2.1 110.988 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -104.55 138.96 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 1.11 110.911 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' CD1' HD13 ' A' ' 51' ' ' ILE . 90.2 mt -144.08 143.13 31.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.931 0.396 . . . . 1.56 111.104 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 32.4 ttm180 -112.12 162.3 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 3.81 110.683 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 mmpt? -47.18 -26.92 1.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 5.09 111.218 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.1 -30.09 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 2.72 110.912 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' ARG . 8.7 m-20 -79.85 -31.93 40.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 2.3 111.027 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.3 mp -81.6 -18.5 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 1.41 111.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.69 -27.03 68.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.766 0.317 . . . . 1.2 111.499 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.67 -57.69 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 1.16 111.119 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.2 pt -66.04 154.81 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 1.12 111.338 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.93 147.78 27.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.186 -0.461 . . . . 2.29 110.475 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.7 mm? -121.43 153.63 37.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 2.39 111.097 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.01 147.08 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 2.24 110.787 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 165.94 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 1.34 111.18 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.76 111.023 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE1' HD21 ' A' ' 70' ' ' LEU . 38.7 m-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.764 0.316 . . . . 2.96 110.715 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.2 p -113.82 156.25 44.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 1.3 111.253 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.92 90.12 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.58 2.187 . . . . 0.77 112.313 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 178.32 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.69 110.828 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 2.32 110.784 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.89 168.68 8.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.93 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.489 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 69.3 m95 -149.75 173.45 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.84 110.872 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -107.06 126.99 53.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 2.52 110.88 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.9 mt -77.21 126.78 38.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 1.21 111.118 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -132.65 56.88 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 1.64 110.393 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' NH1' ' A' ' 23' ' ' ARG . . . -58.59 85.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.971 -0.633 . . . . 0.45 113.004 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -147.11 95.98 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.93 110.632 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -95.05 -174.26 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.082 -0.508 . . . . 1.26 110.985 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -86.18 -26.01 25.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.581 . . . . 3.96 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -150.29 34.23 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 2.48 111.414 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 tt -48.63 143.18 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 1.17 111.253 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -94.63 147.93 34.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 2.01 110.88 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLN . 17.2 Cg_endo -57.29 -32.02 92.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.712 2.274 . . . . 0.68 112.124 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.03 -47.05 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.025 0.44 . . . . 1.32 110.711 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.69 -43.39 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.752 -0.658 . . . . 2.53 110.646 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 13' ' ' GLY . 20.2 tpt180 -60.25 -61.26 2.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 2.02 110.98 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' PRO . 91.5 mt-30 -49.98 -41.71 47.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 3.29 110.843 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -53.69 -25.77 19.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 3.07 110.972 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.29 -46.62 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 1.94 110.594 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -50.77 -33.6 23.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 1.45 111.048 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.9 p -69.23 -42.21 75.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 2.09 110.979 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.3 -25.34 65.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 2.13 110.979 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.14 16.16 39.08 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.82 112.835 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 ptm -104.0 103.94 13.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.983 0.42 . . . . 2.97 110.883 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.4 mp -105.03 159.81 28.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 1.34 110.443 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.11 109.4 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.521 2.147 . . . . 0.51 112.152 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 31.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.4 112.166 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 t -101.35 174.18 6.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.623 0.249 . . . . 1.01 110.57 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -119.99 143.35 48.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 1.75 111.071 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 9' ' ' TRP . 4.0 p90 -150.45 175.36 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.44 110.824 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -130.71 129.03 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 3.83 110.988 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 140.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 1.88 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.06 -35.48 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.22 111.125 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -179.61 139.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 3.53 111.088 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 49' ' ' VAL . 20.5 t -146.92 160.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.122 -0.49 . . . . 1.79 111.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -123.56 132.0 24.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 1.25 110.83 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.46 -21.19 44.24 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 1.63 112.503 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 4.9 mp -89.82 -66.33 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 3.06 111.229 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.96 105.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.79 112.263 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 m-20 -148.12 172.13 5.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.562 0.22 . . . . 1.07 111.056 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.19 119.47 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 0.65 111.487 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.53 148.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 1.15 110.964 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -112.98 135.85 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.779 -0.646 . . . . 2.03 110.745 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' CG2' HD13 ' A' ' 60' ' ' LEU . 47.0 pt -98.55 145.83 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 1.12 111.16 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -109.34 100.81 9.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.742 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 p -103.92 -173.14 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 1.28 111.185 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -50.94 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 3.43 111.531 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 48.62 30.13 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 4.67 111.698 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.0 t -147.8 113.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.981 0.419 . . . . 1.87 111.139 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -100.03 107.74 19.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.07 110.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.13 160.36 14.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 2.1 111.305 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.55 137.01 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 1.11 111.031 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.42 HD13 ' CG2' ' A' ' 51' ' ' ILE . 91.0 mt -130.44 161.43 31.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 1.56 111.059 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.8 mtp180 -130.68 147.7 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 3.81 110.473 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -47.98 -25.9 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 5.09 111.08 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -75.82 -33.43 60.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 2.72 110.7 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.87 -34.86 44.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 2.3 111.044 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.5 mp -67.76 -20.74 65.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.288 -0.415 . . . . 1.41 111.076 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.29 -28.61 68.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.369 -0.378 . . . . 1.2 111.083 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.94 -56.53 3.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 1.16 110.968 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.3 pt -65.09 166.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 1.12 111.005 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -114.47 153.54 29.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 2.29 111.195 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.471 HD21 ' CE1' ' A' ' 3' ' ' PHE . 22.5 tp -129.91 158.09 40.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 2.39 110.664 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.71 147.18 31.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 2.24 110.876 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.53 169.84 2.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 1.34 110.993 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 1.76 111.248 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 42' ' ' VAL . 21.5 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.892 0.377 . . . . 2.96 110.887 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -121.44 156.35 58.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 1.3 111.147 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.65 87.84 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.48 2.12 . . . . 0.77 112.298 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 177.96 -36.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 2.69 110.772 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 t -99.51 170.9 8.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 2.32 110.96 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.26 165.33 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 1.16 110.94 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -154.61 163.5 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.84 110.616 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.77 127.03 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 2.52 111.185 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HD11 ' CE ' ' A' ' 31' ' ' MET . 40.2 mt -74.38 142.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 1.21 111.122 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' GLU . 17.8 m -142.31 52.11 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.688 -0.687 . . . . 1.64 110.155 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.7 95.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.45 112.89 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -147.5 94.74 2.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.378 . . . . 0.93 110.565 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 m -104.19 -174.64 2.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 1.26 110.946 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.2 mpt_? -86.24 -23.27 26.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 3.96 111.002 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.86 32.04 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 2.48 111.504 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tt -47.21 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.974 0.416 . . . . 1.17 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.5 m -66.7 156.67 85.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 2.01 110.735 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.9 -28.66 86.7 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.596 2.198 . . . . 0.68 112.119 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.33 61.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 1.32 110.599 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.74 -40.1 16.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.846 -0.616 . . . . 2.53 110.767 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -65.46 -61.37 2.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 2.02 110.876 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.82 -38.43 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 3.29 110.844 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -53.54 -59.67 4.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 3.07 110.765 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.7 mt -58.56 -44.15 89.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.94 110.718 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -53.53 -29.48 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 1.45 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.3 t -66.79 -38.49 86.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 2.09 110.794 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.02 -24.69 24.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 2.13 110.882 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.31 16.31 18.76 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.848 -0.691 . . . . 0.82 112.732 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.429 ' CE ' HD11 ' A' ' 11' ' ' ILE . 90.7 mmm -91.35 90.52 7.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 2.97 111.048 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.18 161.65 22.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 1.34 110.608 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -42.56 109.77 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.43 2.087 . . . . 0.51 112.068 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.86 2.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.4 112.012 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.2 m -106.87 135.19 48.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.76 0.314 . . . . 1.01 110.904 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.1 m -90.2 148.07 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 1.75 111.199 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.77 179.38 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.892 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.29 153.37 43.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 3.83 110.812 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.0 t -92.55 141.3 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 1.88 111.187 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.75 -44.81 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 1.22 111.303 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -175.71 115.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 3.53 110.975 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG13 ' CD2' ' A' ' 3' ' ' PHE . 14.7 p -135.71 158.81 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.79 111.148 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' OD1' ' A' ' 47' ' ' ASP . . . -106.78 147.61 35.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.985 -0.552 . . . . 1.25 111.085 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 -15.89 34.16 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.586 2.191 . . . . 1.63 112.647 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.32 -73.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 3.06 111.17 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.24 91.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.859 -0.686 . . . . 0.79 112.41 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 7.6 m-20 -137.84 171.38 8.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.646 0.26 . . . . 1.07 110.921 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.57 118.01 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.858 2.372 . . . . 0.65 111.87 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 42' ' ' VAL . 2.4 p -110.13 154.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.569 -0.741 . . . . 1.15 110.942 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 59' ' ' VAL . 76.1 m80 -109.23 133.64 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 2.03 110.688 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 pt -105.02 144.04 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.12 111.051 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.21 110.04 20.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 2.13 110.644 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.8 p -110.58 -171.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 1.28 111.354 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -51.17 95.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 3.43 111.303 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 53.77 24.2 4.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 4.67 111.545 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -146.12 115.3 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.035 0.445 . . . . 1.87 111.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -101.39 108.18 19.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 1.07 110.533 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 46.9 tp -99.61 162.47 13.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.954 0.407 . . . . 2.1 111.262 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 9.3 p -117.01 126.47 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 1.11 110.974 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -119.05 165.95 13.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 1.56 111.158 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.4 ttt180 -139.18 154.59 48.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 3.81 110.657 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -46.48 -27.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 5.09 111.756 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -79.44 -29.21 41.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 2.72 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 61' ' ' ARG . 12.9 t70 -82.12 -33.1 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 2.3 110.984 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 6.7 mp -76.42 -24.51 54.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 1.41 110.968 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.81 62.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 1.2 111.304 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.6 mt -91.53 -60.65 1.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.33 -0.395 . . . . 1.16 110.975 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.7 pt -65.7 151.29 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.12 110.925 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' THR . 7.8 tp10 -101.52 146.21 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 2.29 110.918 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.41 159.44 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 2.39 110.591 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.81 145.29 30.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.393 -0.367 . . . . 2.24 111.084 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.09 163.8 27.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 1.34 111.059 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 1.76 111.308 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.8 0.333 . . . . 2.96 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -122.41 153.83 62.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.241 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.05 83.44 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.77 112.308 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.11 -42.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 2.69 110.641 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.8 m -98.34 165.75 11.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 2.32 110.927 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 160.97 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 1.16 111.101 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.5 m95 -139.97 164.86 28.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.84 110.798 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -104.88 138.28 41.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 2.52 111.106 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.0 mt -88.13 132.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 1.21 110.562 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.9 m -142.27 52.47 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.21 -0.45 . . . . 1.64 110.798 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.22 93.59 0.01 OUTLIER Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.017 -0.611 . . . . 0.45 112.848 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.84 101.41 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.777 0.322 . . . . 0.93 110.88 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 m -110.48 -176.61 3.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 1.26 110.899 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.7 mpt_? -74.85 -23.01 58.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 3.96 111.148 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -169.42 42.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 2.48 110.746 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.97 115.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 1.17 111.266 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -71.0 157.38 90.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.55 . . . . 2.01 110.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -59.83 -27.37 84.78 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.771 2.314 . . . . 0.68 112.141 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.36 -44.09 44.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.509 -0.314 . . . . 1.32 110.713 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -86.15 -39.02 17.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 2.53 111.144 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -67.91 -56.83 7.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 2.02 111.338 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -40.97 -30.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.405 -0.362 . . . . 3.29 111.633 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.48 -54.77 14.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.07 110.376 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.7 mt -54.61 -51.82 64.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 1.94 110.641 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -49.4 -43.57 44.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 1.45 111.006 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -54.26 -50.97 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.474 . . . . 2.09 110.752 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD13 ' HE1' ' A' ' 31' ' ' MET . 85.5 mt -72.96 -23.87 60.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 2.13 110.815 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.12 19.03 31.92 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.82 112.669 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.407 ' HE1' HD13 ' A' ' 29' ' ' LEU . 58.4 mtm -94.33 88.93 5.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.759 0.314 . . . . 2.97 111.01 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.7 mp -92.2 160.61 34.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 1.34 110.531 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.1 104.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.33 2.02 . . . . 0.51 112.197 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 50.33 0.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.4 112.154 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -117.84 170.85 8.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.277 . . . . 1.01 110.746 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.2 p -118.99 139.4 51.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 1.75 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.9 p90 -148.45 163.13 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.041 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 38.0 t60 -108.94 151.45 26.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 3.83 110.983 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' O ' ' CD2' ' A' ' 38' ' ' HIS . 59.4 t -92.5 129.26 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 1.88 111.199 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.03 -36.38 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 1.22 111.115 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -175.03 125.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.361 . . . . 3.53 111.14 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 49' ' ' VAL . 59.0 t -140.86 156.24 22.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.183 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -138.04 128.13 15.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.25 110.845 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.58 -36.73 98.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.427 2.085 . . . . 1.63 112.193 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.9 -45.32 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.925 -0.58 . . . . 3.06 111.167 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.69 99.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.79 112.234 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.26 170.63 7.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.624 0.25 . . . . 1.07 111.14 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.37 121.53 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.856 2.371 . . . . 0.65 111.51 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 42' ' ' VAL . 1.5 p -106.71 156.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.705 -0.68 . . . . 1.15 111.03 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 49' ' ' VAL . 47.8 m-70 -122.96 130.87 53.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 2.03 110.41 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 19.5 pt -103.6 137.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.25 -0.432 . . . . 1.12 111.086 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.01 121.59 44.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 2.13 110.733 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 55' ' ' ARG . 56.5 p -124.12 -172.9 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 1.28 110.99 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -49.63 91.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 3.43 111.351 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' THR . 17.8 mmm180 53.43 33.65 16.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 4.67 111.463 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.6 t -150.97 104.59 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 1.87 111.307 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -97.52 107.84 20.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.07 110.713 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.95 153.64 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 2.1 111.131 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.67 129.88 66.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.025 -0.534 . . . . 1.11 111.052 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.9 135.92 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 1.56 110.906 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.4 mtt180 -103.01 160.36 14.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 3.81 111.041 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -42.51 -37.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 5.09 111.474 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 18.8 ptmt -64.53 -34.43 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 2.72 111.127 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.08 -24.05 35.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 2.3 111.067 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' N ' HD11 ' A' ' 65' ' ' LEU . 7.3 mp -86.18 -21.37 27.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.32 -0.4 . . . . 1.41 111.349 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.5 64.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 1.2 111.377 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.0 mt -91.5 -55.86 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.352 -0.386 . . . . 1.16 111.316 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -65.67 150.56 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 1.12 111.092 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -100.42 143.08 31.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 2.29 110.816 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' N ' HD21 ' A' ' 70' ' ' LEU . 1.9 mm? -116.82 149.5 39.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 2.39 110.779 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -144.21 156.11 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 2.24 110.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.93 164.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.34 111.007 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 1.76 111.196 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 56.7 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.848 0.356 . . . . 2.96 110.787 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -100.26 145.23 29.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.3 111.189 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.34 86.85 0.64 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.608 2.206 . . . . 0.77 112.215 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 177.85 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 2.69 110.847 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -97.82 146.89 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 2.32 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 9' ' ' TRP . . . -79.81 171.14 15.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.955 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' ALA . 57.5 m95 -156.71 160.94 39.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.84 110.78 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.1 134.35 53.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.52 110.801 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.0 mt -70.92 138.65 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 1.21 111.292 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -146.52 43.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.189 0.519 . . . . 1.64 110.484 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.48 90.5 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.45 112.824 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -147.09 95.03 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.93 110.736 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -99.32 -169.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.928 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.1 mpt_? -83.29 -23.49 32.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 3.96 110.93 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.07 37.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.48 110.775 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tt -46.08 116.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 1.17 111.301 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 m -64.25 155.9 77.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 2.01 110.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' GLN . 33.9 Cg_endo -63.37 -26.79 71.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.565 2.176 . . . . 0.68 112.14 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.06 55.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 1.32 110.672 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' OD1' ' A' ' 64' ' ' ASP . 92.8 m-85 -85.84 -39.82 16.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 2.53 110.915 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -65.2 -58.95 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 2.02 111.176 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.0 tt0 -43.8 -28.44 0.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 3.29 111.724 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -65.01 -36.59 84.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 3.07 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.7 mp -79.39 -45.41 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.94 111.038 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -50.47 -25.16 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 1.45 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.8 m -57.41 -47.81 80.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 2.09 111.042 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 4.9 mp -86.18 -25.06 25.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 2.13 110.899 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 27.88 10.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 0.82 112.762 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.2 mmt -95.29 99.45 11.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 2.97 110.7 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.54 159.86 37.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.54 . . . . 1.34 110.826 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -42.24 114.59 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.495 2.13 . . . . 0.51 112.148 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 25.22 2.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.859 -0.686 . . . . 0.4 112.478 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.9 t -94.71 174.09 7.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 1.01 110.57 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.1 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.75 111.097 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -163.84 -173.4 3.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.732 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.11 159.99 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 3.83 110.966 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.57 131.46 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 1.88 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.58 -48.06 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.242 -0.436 . . . . 1.22 111.568 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -171.39 120.8 0.5 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.732 0.301 . . . . 3.53 111.385 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 43' ' ' ALA . 13.2 p -147.77 160.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 1.79 111.088 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -128.84 142.86 46.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 1.25 111.025 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.42 -22.29 65.26 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.474 2.116 . . . . 1.63 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.98 -73.68 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.361 . . . . 3.06 111.242 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.41 91.72 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.779 -0.725 . . . . 0.79 112.354 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.39 171.54 8.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.514 0.197 . . . . 1.07 110.722 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.71 116.45 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.903 2.402 . . . . 0.65 111.95 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 42' ' ' VAL . 2.7 p -111.66 139.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 1.15 111.315 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -101.68 130.79 48.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.604 . . . . 2.03 110.504 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.8 pt -97.26 147.09 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 1.12 111.008 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.73 119.83 40.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 2.13 110.804 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' OG1' ' CG1' ' A' ' 56' ' ' VAL . 17.4 p -127.15 -163.19 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.28 111.205 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -48.31 97.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.079 0.466 . . . . 3.43 111.867 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 43.57 34.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 4.67 112.286 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 12.2 p -159.94 125.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.968 0.413 . . . . 1.87 111.197 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -105.94 112.49 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 1.07 111.271 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.73 171.13 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 2.1 110.553 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -123.32 132.29 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.41 -0.359 . . . . 1.11 111.198 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -135.75 166.39 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.516 . . . . 1.56 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.2 mtt180 -123.54 146.79 47.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 3.81 110.601 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.3 tpmt? -50.01 -25.11 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.368 . . . . 5.09 111.021 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.88 -30.0 40.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 2.72 110.578 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' OD1' ' CD1' ' A' ' 22' ' ' TYR . 21.2 t70 -81.35 -36.63 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 2.3 110.719 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.7 mp -61.69 -22.11 65.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 1.41 110.928 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.13 61.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 1.2 111.192 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.66 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 1.16 110.968 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -65.71 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 1.12 110.78 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -99.04 146.14 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.29 111.109 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.0 mm? -116.52 149.89 38.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 2.39 110.681 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -129.88 150.24 51.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 2.24 110.974 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.97 171.57 12.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 1.34 111.23 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.76 111.022 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 13.5 p90 . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.973 0.416 . . . . 2.96 111.099 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -100.08 154.89 36.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 1.3 110.908 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.72 83.54 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.394 2.063 . . . . 0.77 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.3 t70 178.71 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 2.69 110.897 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 t -90.77 159.35 16.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 2.32 111.11 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.03 169.25 11.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 1.16 111.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 60.6 m95 -151.58 154.82 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.84 111.107 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -95.37 131.33 41.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 2.52 110.982 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.4 mt -83.05 125.33 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.21 111.242 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 p -133.09 58.82 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 1.64 110.534 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.26 91.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.742 -0.663 . . . . 0.45 112.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.05 94.85 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.93 110.344 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -97.89 -172.56 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 1.26 111.247 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -24.31 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 3.96 110.695 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -158.5 37.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.048 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.15 128.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 1.17 111.311 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.3 m -77.61 157.04 80.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 2.01 111.096 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.36 -26.68 24.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.583 2.188 . . . . 0.68 112.491 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.76 -47.11 59.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.351 -0.386 . . . . 1.32 110.724 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -86.22 -38.39 17.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.915 -0.584 . . . . 2.53 110.954 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -66.95 -58.19 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 2.02 111.405 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -44.82 -30.5 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 3.29 111.517 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.36 -40.97 73.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 3.07 111.053 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.24 -50.87 19.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 1.94 110.64 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.33 -35.49 60.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 1.45 110.856 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.2 m -78.25 -27.47 47.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 2.09 111.038 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.39 -25.06 39.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 2.13 110.846 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.07 5.96 43.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.807 -0.711 . . . . 0.82 113.103 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -98.74 96.13 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 2.97 110.931 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -104.96 158.73 31.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 1.34 110.454 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -39.59 105.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.576 2.184 . . . . 0.51 112.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 33.95 0.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.4 112.294 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -106.42 174.44 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.602 0.239 . . . . 1.01 110.525 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 p -129.13 144.98 51.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.866 0.365 . . . . 1.75 111.012 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -152.04 168.41 25.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.021 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -115.56 140.61 49.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 3.83 110.517 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.31 131.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.387 -0.37 . . . . 1.88 111.22 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.07 -39.61 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.428 . . . . 1.22 111.324 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.404 ' O ' ' CG2' ' A' ' 49' ' ' VAL . 37.3 ptt180 -179.73 121.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 3.53 110.801 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -145.02 159.5 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 1.79 111.152 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -112.61 155.45 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 1.25 111.02 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.98 -22.23 15.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.584 2.189 . . . . 1.63 112.367 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.9 -62.21 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 3.06 111.094 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.8 103.13 0.18 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.79 112.208 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -147.97 170.45 7.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.666 0.269 . . . . 1.07 111.039 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.17 119.01 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.848 2.366 . . . . 0.65 111.587 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 41' ' ' ARG . 2.7 p -115.06 149.35 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 1.15 111.406 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -99.55 146.46 26.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 2.03 110.995 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.6 pt -112.08 138.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.12 110.842 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.1 131.44 54.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 2.13 110.91 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 p -137.35 -173.05 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 1.28 110.991 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -52.83 91.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 3.43 111.3 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 54.04 39.11 30.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 4.67 111.57 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -156.86 111.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 1.87 110.976 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -105.32 107.92 19.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 1.07 111.071 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 58.5 tp -98.95 159.96 14.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 2.1 111.022 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 8.6 p -113.89 135.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 1.11 111.009 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.93 141.12 52.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 1.56 110.979 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -106.96 151.61 25.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 3.81 110.97 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -47.38 -29.87 2.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 5.09 111.463 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.34 -25.4 36.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 2.72 110.777 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 12.3 t70 -78.05 -30.69 49.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 2.3 110.48 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 ' N ' HD11 ' A' ' 65' ' ' LEU . 7.8 mp -75.55 -21.91 57.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.142 -0.481 . . . . 1.41 111.124 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.87 71.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 1.2 111.36 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.95 -61.74 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 1.16 111.204 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -65.68 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.287 -0.415 . . . . 1.12 111.031 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -98.49 155.85 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 2.29 110.859 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.1 tp -125.04 157.48 36.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 2.39 110.561 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.42 149.93 33.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.24 110.83 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.29 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 1.34 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 1.76 111.086 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 2.96 110.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 p -102.43 151.46 38.19 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 1.3 111.338 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.87 91.06 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.563 2.176 . . . . 0.77 112.489 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 176.6 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 2.69 110.912 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -106.31 144.14 33.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 2.32 110.984 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.33 165.32 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 1.16 111.128 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -155.2 153.91 31.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.84 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 35' ' ' SER . 49.8 mtmt -113.59 138.68 49.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 2.52 111.25 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.3 mt -79.12 123.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 1.21 111.265 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 p -131.78 59.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 1.64 110.554 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.64 97.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.838 -0.696 . . . . 0.45 112.44 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -145.09 96.92 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.371 . . . . 0.93 111.125 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -114.12 153.57 29.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.26 110.698 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -25.01 9.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 3.96 110.57 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.3 39.72 0.67 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 2.48 110.783 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -42.72 105.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.076 0.465 . . . . 1.17 111.468 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -63.42 146.8 96.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 2.01 110.806 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.3 Cg_endo -58.64 -30.31 91.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.721 2.281 . . . . 0.68 112.131 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -45.33 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 1.32 110.937 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.39 -42.02 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 2.53 111.249 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -60.76 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 2.02 111.269 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.3 mm-40 -54.88 -22.12 13.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.34 -0.391 . . . . 3.29 111.456 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -69.2 -42.93 75.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.331 . . . . 3.07 110.823 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.1 mt -52.14 -34.42 44.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 1.94 110.725 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.83 -27.73 44.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 1.45 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -49.0 -38.11 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 2.09 111.121 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 29' ' ' LEU . 3.1 mm? -107.11 -21.24 13.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.13 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.28 29.63 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.737 -0.744 . . . . 0.82 112.531 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -88.57 92.71 9.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.749 0.309 . . . . 2.97 110.791 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.4 mp -83.04 158.98 63.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 1.34 110.825 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.36 107.27 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.328 2.019 . . . . 0.51 112.112 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.71 32.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.855 -0.688 . . . . 0.4 112.518 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 10' ' ' LYS . 46.7 t -104.76 174.18 5.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.71 0.291 . . . . 1.01 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -116.04 154.54 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.334 -0.394 . . . . 1.75 111.169 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CD2' ' CG2' ' A' ' 51' ' ' ILE . 30.0 p90 -165.04 169.96 15.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.44 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -124.69 134.55 52.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 3.83 111.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 m -83.87 132.32 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.88 111.16 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.69 -49.71 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.22 111.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 3.53 110.892 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' CG2' ' A' ' 49' ' ' VAL . 13.1 t -143.55 159.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.79 111.189 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.416 ' CB ' ' OD1' ' A' ' 47' ' ' ASP . . . -127.26 144.95 52.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 1.25 110.944 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.06 -18.23 31.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.476 2.117 . . . . 1.63 112.596 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.42 -55.17 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 3.06 111.15 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.68 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.79 112.272 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 4.8 m-20 -143.43 170.66 8.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.67 0.271 . . . . 1.07 111.118 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.94 117.14 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.933 2.422 . . . . 0.65 111.924 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 50' ' ' HIS . 2.0 p -106.62 156.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 1.15 110.935 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.436 ' N ' HG21 ' A' ' 49' ' ' VAL . 47.0 m-70 -115.58 131.91 56.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 2.03 110.798 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 37.5 pt -101.73 142.43 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 1.12 111.097 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -107.33 124.53 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 2.13 110.709 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -132.1 -173.52 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 1.28 111.278 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -41.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.105 0.409 . . . . 3.43 112.105 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 44.15 51.0 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.906 -0.588 . . . . 4.67 111.886 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.2 p 179.71 119.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 1.87 111.201 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -102.33 112.57 25.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.07 110.946 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 47.7 tp -92.0 162.77 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 2.1 110.615 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 12.6 p -112.29 145.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 1.11 111.244 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.03 147.06 41.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 1.56 110.847 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.3 mtt180 -107.65 150.51 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.81 110.908 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.89 -25.95 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.919 -0.582 . . . . 5.09 111.226 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -81.08 -27.76 35.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 2.72 110.826 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.5 -31.59 47.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 2.3 110.974 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.3 mp -72.79 -21.17 61.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 1.41 111.008 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.77 71.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 1.2 111.146 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.38 -61.69 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.16 111.042 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 pt -66.08 148.98 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.415 . . . . 1.12 110.962 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -102.35 153.81 19.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 2.29 110.733 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.1 mm? -115.96 149.58 38.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 2.39 110.866 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.32 110.72 9.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 2.24 110.957 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 155.34 1.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 1.34 111.0 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 1.76 111.278 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.941 0.401 . . . . 2.96 110.788 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.4 p -99.88 155.97 35.86 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 1.3 111.143 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.3 87.27 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.502 2.135 . . . . 0.77 112.289 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 t70 177.77 -57.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 2.69 110.965 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -77.32 135.9 38.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 2.32 110.804 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.42 157.65 28.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 1.16 111.327 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 71.9 m95 -141.37 167.62 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.84 110.804 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.1 136.57 51.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 2.52 111.165 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.47 136.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 1.21 110.742 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 14' ' ' PHE . 12.7 m -143.83 46.52 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 1.64 110.825 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.85 90.32 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.881 -0.676 . . . . 0.45 112.657 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' THR . 69.3 t80 -146.68 102.69 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.93 110.732 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -97.94 -179.12 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.26 111.115 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.2 mpt_? -75.25 -24.85 57.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 3.96 110.629 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.95 38.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 2.48 110.63 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -42.88 131.7 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.038 -0.528 . . . . 1.17 111.737 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.8 m -92.47 157.4 40.27 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 2.01 110.784 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 24' ' ' GLN . 11.7 Cg_endo -54.44 -32.75 74.5 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.638 2.225 . . . . 0.68 112.093 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.08 -46.69 34.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.07 0.462 . . . . 1.32 110.771 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -85.95 -49.96 7.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.823 -0.626 . . . . 2.53 110.558 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.48 -61.23 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 2.02 111.064 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.4 tt0 -47.51 -32.42 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 3.29 111.055 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.66 -55.9 28.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.07 110.752 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.5 -45.15 92.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 1.94 110.817 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.45 -53.36 37.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 1.45 111.113 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -49.92 -29.91 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 2.09 111.085 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.88 -25.42 18.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 2.13 110.94 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.06 31.35 9.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.698 -0.763 . . . . 0.82 112.874 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.4 mtt -110.3 87.46 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 2.97 110.623 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.8 mp -86.95 161.21 47.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 1.34 110.746 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.78 115.13 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.508 2.138 . . . . 0.51 112.163 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.4 28.58 2.98 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.786 -0.721 . . . . 0.4 112.188 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -96.36 163.16 13.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.638 0.256 . . . . 1.01 110.634 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -110.67 145.3 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 1.75 111.028 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 19.1 p90 -158.28 170.33 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.848 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -120.81 149.75 42.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.107 -0.497 . . . . 3.83 110.991 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -82.17 132.54 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 1.88 111.072 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.0 -33.51 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 1.22 111.522 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 176.41 130.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 3.53 111.22 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 49' ' ' VAL . 51.0 t -139.87 158.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 1.79 111.04 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 47' ' ' ASP . . . -114.63 134.35 22.39 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 1.25 110.859 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.3 -26.3 76.36 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.455 2.103 . . . . 1.63 112.48 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 5.2 mp -91.26 -65.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.427 -0.351 . . . . 3.06 111.215 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.12 106.94 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.79 112.338 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 2.3 m-20 -148.32 173.21 4.39 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.619 0.247 . . . . 1.07 111.05 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.52 120.23 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.65 111.522 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.55 156.02 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.629 -0.714 . . . . 1.15 111.202 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -120.78 134.26 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 2.03 110.525 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 37.3 pt -101.38 137.88 27.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.198 -0.455 . . . . 1.12 110.916 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.7 101.32 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.445 . . . . 2.13 110.887 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.8 p -99.64 -169.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 1.28 110.838 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -56.18 96.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 3.43 111.584 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.3 26.3 8.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 4.67 111.629 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -148.53 114.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 1.87 111.257 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -103.24 107.86 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 1.07 110.779 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 64.5 mt -94.77 174.78 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 2.1 111.006 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.99 131.26 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.975 0.416 . . . . 1.11 111.181 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.8 mt -124.06 165.11 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 1.56 110.789 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -146.05 162.23 38.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 3.81 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -52.54 -22.33 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 5.09 111.545 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -80.35 -33.67 37.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 2.72 110.624 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.27 -42.55 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 2.3 110.888 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.47 -24.19 65.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 1.41 111.007 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.92 65.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.401 . . . . 1.2 111.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.15 -57.26 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.362 . . . . 1.16 111.072 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.3 pt -65.94 151.19 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 1.12 111.192 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.43 150.51 23.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 2.29 110.722 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.87 142.14 50.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 2.39 111.088 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -124.13 152.72 42.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 2.24 110.906 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.21 -178.51 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 1.34 111.105 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 1.76 111.084 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 9' ' ' TRP . 62.9 m-85 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.832 0.349 . . . . 2.96 110.705 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -114.41 161.09 30.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.97 147.55 14.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.77 112.345 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 66.4 18.27 10.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 2.69 111.647 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.5 p -98.74 173.25 6.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.733 0.301 . . . . 2.32 110.651 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.07 142.81 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 1.16 111.122 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.559 ' CD2' ' CE2' ' A' ' 3' ' ' PHE . 32.1 m95 -154.02 162.83 40.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.84 110.696 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -106.33 138.19 42.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 2.52 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.8 mt -77.79 127.4 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 1.21 111.026 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 m -136.05 48.15 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 1.64 110.571 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -46.59 92.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.45 113.046 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -147.08 94.9 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.93 110.668 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.2 t -98.63 -178.76 4.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.26 110.896 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.9 mpt_? -79.05 -21.49 46.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 3.96 111.001 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.02 37.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.479 -0.328 . . . . 2.48 111.17 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 tt -45.6 126.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.913 0.387 . . . . 1.17 111.396 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -85.36 149.29 51.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 2.01 110.964 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' GLN . 15.6 Cg_endo -56.8 -31.25 87.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.801 2.334 . . . . 0.68 112.257 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.56 -47.11 28.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 1.32 110.858 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -85.79 -43.65 13.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 2.53 110.904 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -60.7 -61.01 2.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 2.02 110.967 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' PRO . 7.7 tp-100 -48.89 -30.35 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 3.29 110.85 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.61 -32.97 73.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 3.07 110.849 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.94 -48.04 26.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 1.94 110.837 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.65 -34.05 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 1.45 111.062 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -53.09 -33.27 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 2.09 110.904 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.3 mp -89.79 -22.95 21.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 2.13 110.823 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.74 23.67 30.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 0.82 112.495 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 39.8 mtm -101.44 91.01 4.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 2.97 110.763 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.6 mp -92.54 159.3 36.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 1.34 110.879 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.04 106.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.637 2.225 . . . . 0.51 112.186 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.18 33.34 0.9 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.798 -0.715 . . . . 0.4 112.454 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.4 t -107.49 171.8 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 1.01 110.829 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -116.05 145.96 42.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 1.75 111.009 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 18.2 p90 -157.62 159.73 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.033 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -109.33 151.62 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 3.83 110.67 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 42' ' ' VAL . 57.6 t -89.37 140.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 1.88 111.221 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.45 -52.22 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 1.22 111.426 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.33 129.13 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 3.53 111.074 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 43' ' ' ALA . 13.3 t -143.2 159.2 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 1.79 111.201 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -129.06 145.17 55.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 1.25 110.98 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 33.3 Cg_endo -64.46 -16.97 57.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.568 2.179 . . . . 1.63 112.468 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -89.88 -69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.872 0.367 . . . . 3.06 110.975 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.52 94.17 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.79 112.347 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.477 ' HB2' ' CD ' ' A' ' 48' ' ' PRO . 4.2 p-10 -131.25 178.01 1.95 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.475 0.179 . . . . 1.07 110.711 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' HB2' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.25 118.36 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.938 2.425 . . . . 0.65 111.557 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 50' ' ' HIS . 2.0 p -106.84 157.53 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 1.15 111.293 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 49' ' ' VAL . 31.8 m-70 -117.57 144.92 44.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.642 -0.708 . . . . 2.03 110.463 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.2 135.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 1.12 111.222 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -106.94 112.49 25.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 2.13 110.651 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -118.13 -174.11 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 1.28 111.128 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -50.71 93.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.43 111.283 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.25 37.71 15.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 4.67 111.578 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -152.71 100.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 1.87 110.887 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -97.77 108.42 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 1.07 111.008 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 56.8 tp -108.01 161.26 15.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 2.1 110.935 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 7.4 p -114.59 141.17 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 1.11 111.023 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -126.77 144.11 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 1.56 110.813 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.401 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 56.9 mtp180 -107.92 152.67 24.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 3.81 111.171 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.81 -33.12 9.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 5.09 111.713 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.98 -22.88 36.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 2.72 111.073 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.96 -23.55 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 2.3 110.931 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 9.6 mp -79.5 -28.93 41.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 1.41 110.965 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -24.27 52.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 1.2 111.071 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.54 -61.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 1.16 110.917 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.403 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 22.4 pt -65.65 151.86 9.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 1.12 110.819 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -105.48 142.54 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 2.29 111.426 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.2 mm? -110.16 125.64 53.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.969 -0.559 . . . . 2.39 110.455 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.44 124.01 45.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.72 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.1 152.44 7.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.028 -0.533 . . . . 1.34 111.199 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 1.76 111.281 179.91 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.475 ' HB2' ' CE2' ' A' ' 9' ' ' TRP . 37.0 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.792 0.33 . . . . 2.96 110.969 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.0 p -81.18 153.1 71.73 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.3 111.194 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HA ' ' CG1' ' A' ' 39' ' ' VAL . 60.4 Cg_endo -72.0 81.7 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.454 2.103 . . . . 0.77 112.013 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -176.58 -42.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 2.69 110.94 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -90.18 154.64 19.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.32 110.884 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.54 170.12 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 1.16 111.034 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 52.0 m95 -155.63 175.69 13.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.84 110.911 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.3 134.02 54.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 2.52 111.094 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 34' ' ' GLY . 58.9 mt -80.74 123.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 1.21 111.028 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 14' ' ' PHE . 19.5 m -133.89 53.46 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.115 0.484 . . . . 1.64 110.509 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.57 88.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.885 -0.598 . . . . 0.45 112.826 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' THR . 19.4 t80 -147.21 107.6 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.93 111.046 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 m -108.66 164.36 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 1.26 110.842 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -22.8 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 3.96 110.976 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -164.1 42.45 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.712 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -44.3 134.17 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 1.17 111.558 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 m -84.6 155.81 62.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 2.01 110.971 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' GLN . 24.9 Cg_endo -62.05 -29.72 81.84 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.605 2.204 . . . . 0.68 112.421 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.08 -45.28 64.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 1.32 110.646 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.38 -41.99 14.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 2.53 110.798 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -65.51 -61.41 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 2.02 110.999 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' PRO . 12.9 mm100 -52.82 -22.95 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 3.29 111.255 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -73.5 -40.41 64.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 3.07 110.796 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.5 -44.04 95.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 1.94 110.895 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.56 -25.79 4.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.45 110.978 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.6 m -53.59 -35.37 60.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 2.09 111.015 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.8 mm? -94.02 -25.21 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 2.13 110.852 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.4 56.16 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.82 112.835 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -88.95 98.51 11.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.923 0.392 . . . . 2.97 110.687 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 32' ' ' LEU . 6.3 mp -83.3 159.66 61.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 1.34 110.544 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.05 149.77 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.47 2.113 . . . . 0.51 111.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . 77.65 17.95 78.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.693 -0.765 . . . . 0.4 112.342 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 t -77.74 174.04 11.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.601 0.239 . . . . 1.01 110.446 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -121.23 136.0 55.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 1.75 110.91 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.8 p90 -151.72 173.65 14.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.085 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -127.75 158.42 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 3.83 110.839 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 5' ' ' PRO . 46.4 t -95.02 128.59 46.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 1.88 111.248 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.2 -38.63 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 1.22 111.05 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -178.74 123.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 3.53 111.003 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.9 p -143.61 160.87 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 1.79 111.218 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -125.16 153.79 71.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 1.25 110.994 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.97 -14.55 9.77 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.592 2.195 . . . . 1.63 112.911 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 46' ' ' GLY . 4.4 pp -85.32 -18.95 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.606 -0.27 . . . . 3.06 111.287 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' N ' HD13 ' A' ' 45' ' ' LEU . . . 114.93 88.45 1.56 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.687 -0.768 . . . . 0.79 112.297 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.432 ' OD2' ' CD1' ' A' ' 45' ' ' LEU . 7.3 m-20 -137.52 171.94 7.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.605 0.24 . . . . 1.07 110.897 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.3 115.94 1.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.832 2.355 . . . . 0.65 111.72 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.54 138.44 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.67 -0.695 . . . . 1.15 111.025 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -95.91 136.01 36.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.919 -0.582 . . . . 2.03 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.62 134.64 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.12 110.962 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.26 120.54 42.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 2.13 111.015 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 74.3 p -124.46 -173.65 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.28 110.657 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -49.57 92.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 3.43 111.328 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 34.0 mmt180 53.09 40.9 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.808 -0.633 . . . . 4.67 111.488 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 55' ' ' ARG . 66.7 t -157.45 105.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 1.87 111.025 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -104.88 107.52 18.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 1.07 110.9 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.7 tp -100.73 160.19 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 2.1 110.644 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.43 142.94 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 1.11 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 65' ' ' LEU . 57.1 tp -137.52 141.92 41.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 1.56 110.82 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -114.84 179.46 3.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 3.81 110.62 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -75.62 -48.85 20.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.521 -0.308 . . . . 5.09 111.513 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -51.57 -34.44 36.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 2.72 110.567 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.52 -25.48 33.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 2.3 110.434 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.422 ' CD2' HD23 ' A' ' 60' ' ' LEU . 10.0 mt -74.86 -25.46 58.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.052 -0.522 . . . . 1.41 111.038 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.89 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 1.2 111.108 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -84.92 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.254 -0.43 . . . . 1.16 110.983 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 20.4 pt -65.97 155.95 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 1.12 111.283 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -107.72 135.37 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 2.29 110.776 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 70' ' ' LEU . 2.8 mm? -105.21 152.32 23.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 2.39 111.11 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.98 121.21 10.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 2.24 110.707 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.75 166.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 1.34 111.22 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 1.76 111.135 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.443 ' CE2' HG23 ' A' ' 42' ' ' VAL . 28.5 p90 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.816 0.341 . . . . 2.96 110.984 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.0 p -79.39 155.35 76.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 1.3 110.954 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HA ' ' CG1' ' A' ' 39' ' ' VAL . 65.5 Cg_endo -74.08 89.64 1.02 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.488 2.125 . . . . 0.77 112.46 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 t70 177.94 -43.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 2.69 111.048 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -87.64 144.24 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 2.32 110.914 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 158.59 32.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 1.16 111.131 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' CZ2' ' CB ' ' A' ' 3' ' ' PHE . 72.5 m95 -145.79 158.11 43.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.84 110.877 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -108.85 138.35 45.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 2.52 110.91 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -80.65 137.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 1.21 111.141 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -141.69 56.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.939 -0.573 . . . . 1.64 110.253 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.22 90.08 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.45 112.875 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -146.43 94.69 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.93 110.433 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -100.85 150.28 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 1.26 111.204 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.55 -22.47 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.616 . . . . 3.96 111.067 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -149.0 34.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.782 0.325 . . . . 2.48 111.151 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -43.94 148.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.389 -0.369 . . . . 1.17 111.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 m -96.01 155.85 37.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 2.01 110.985 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 24' ' ' GLN . 38.8 Cg_endo -66.91 -32.25 36.26 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.461 2.108 . . . . 0.68 112.093 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.98 -44.97 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 1.32 110.433 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.49 -48.17 9.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 2.53 110.325 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -56.98 -61.35 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 2.02 111.022 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -51.47 -34.83 37.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 3.29 111.081 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -60.82 -41.17 95.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.366 -0.379 . . . . 3.07 111.29 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 26' ' ' LEU . 10.8 mp -74.22 -52.69 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 1.94 111.157 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -46.35 -37.1 7.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 1.45 111.513 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -69.31 -23.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 2.09 111.339 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.0 mt -96.87 -24.18 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.438 -0.347 . . . . 2.13 111.055 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.75 7.44 53.35 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.68 -0.771 . . . . 0.82 113.035 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 31' ' ' MET . 1.1 mpt? -89.97 90.67 8.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.891 0.377 . . . . 2.97 110.736 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.7 mp -94.69 160.55 31.15 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.788 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -45.38 122.76 4.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.266 1.977 . . . . 0.51 111.847 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.04 23.8 6.88 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.884 -0.674 . . . . 0.4 112.071 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -87.73 174.05 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 1.01 110.892 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -123.58 144.97 49.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 1.75 111.009 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 51' ' ' ILE . 20.7 p90 -158.98 -177.94 6.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.44 110.891 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -131.8 132.5 43.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.83 111.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 5' ' ' PRO . 7.1 p -78.31 135.62 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 1.88 111.025 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.87 -52.21 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.489 -0.323 . . . . 1.22 111.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -153.84 139.03 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 3.53 111.186 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 HG23 ' CE2' ' A' ' 3' ' ' PHE . 20.6 t -148.59 158.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 1.79 111.108 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -126.11 143.34 45.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.25 111.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 45.2 Cg_endo -68.33 -21.41 41.25 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.647 2.231 . . . . 1.63 112.468 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.8 mm? -89.88 -56.1 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 3.06 111.111 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.12 107.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.79 112.332 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 3.0 m-20 -148.17 170.66 7.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.637 0.256 . . . . 1.07 111.07 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.72 118.12 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.985 2.456 . . . . 0.65 111.77 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.8 p -106.79 160.78 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 1.15 110.881 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 57.4 m80 -123.47 135.74 54.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 2.03 110.98 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 37.1 pt -102.04 139.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.983 -0.553 . . . . 1.12 110.855 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.68 108.88 19.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 2.13 111.014 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 61.9 p -111.14 -175.3 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 1.28 110.703 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -47.68 91.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.43 111.48 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 32.9 mmt180 53.01 36.06 21.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.046 -0.524 . . . . 4.67 111.396 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.87 112.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 1.87 111.052 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -105.07 107.57 18.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.07 110.643 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.72 157.31 17.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.162 -0.472 . . . . 2.1 110.951 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.405 HG22 ' CD2' ' A' ' 50' ' ' HIS . 13.8 p -102.62 143.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 1.11 111.047 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.07 117.58 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 1.56 110.777 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -92.48 169.78 10.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 3.81 110.797 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.94 -27.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 5.09 111.338 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -84.25 -42.43 15.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.38 . . . . 2.72 111.17 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 -34.35 65.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 2.3 110.973 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.7 mp -81.27 -21.14 39.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 1.41 111.134 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.63 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 1.2 111.263 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.65 -65.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 1.16 111.378 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.4 pt -65.08 140.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.482 -0.326 . . . . 1.12 110.967 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.85 154.96 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 2.29 110.697 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -116.43 158.07 24.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 2.39 110.774 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -146.24 154.39 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.24 111.083 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.81 169.17 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 1.34 111.122 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 1.76 110.998 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.475 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 61.9 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.883 0.373 . . . . 2.96 110.836 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -118.54 152.39 51.04 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 1.3 111.209 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.07 84.46 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.663 2.242 . . . . 0.77 112.34 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -179.97 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.293 -0.412 . . . . 2.69 110.901 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.1 t -103.07 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 2.32 110.629 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.93 169.22 8.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 1.16 111.101 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 78.7 m95 -146.41 168.34 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.84 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -124.24 138.05 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 2.52 111.129 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.1 mt -80.2 118.14 27.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.159 -0.473 . . . . 1.21 111.159 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 m -130.37 53.17 1.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.64 110.388 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA3' ' NH2' ' A' ' 23' ' ' ARG . . . -48.83 96.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.45 112.627 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -145.53 95.95 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.93 110.935 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -111.88 158.03 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.013 -0.539 . . . . 1.26 110.778 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -51.78 -24.36 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 3.96 110.729 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -158.29 42.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.789 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -41.07 128.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.219 -0.446 . . . . 1.17 111.802 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.0 t -80.22 147.38 64.68 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 2.01 110.782 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.3 Cg_endo -62.62 -28.43 76.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.625 2.216 . . . . 0.68 112.501 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.02 -43.79 50.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 1.32 111.052 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -85.29 -45.49 11.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 2.53 111.2 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.435 ' NH2' ' HA3' ' A' ' 13' ' ' GLY . 18.3 tpp180 -67.58 -61.46 1.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 2.02 111.43 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 11.1 mm100 -55.93 -19.59 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 3.29 111.629 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -80.25 -36.77 34.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 3.07 110.993 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.74 -32.6 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 1.94 110.982 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -57.24 -33.73 67.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.45 111.254 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.1 m -64.04 -39.63 94.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 2.09 110.997 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 2.6 mm? -78.01 -23.23 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 2.13 111.059 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.79 20.52 10.63 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.771 . . . . 0.82 112.593 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.72 98.24 9.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 2.97 110.988 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -102.51 157.93 32.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.34 110.675 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.46 111.19 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.391 2.061 . . . . 0.51 111.803 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 21.39 4.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 0.4 112.36 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -88.02 166.26 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.303 . . . . 1.01 110.639 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -121.85 156.92 32.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 1.75 111.044 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 51.9 p90 -166.64 178.82 5.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.488 . . . . 0.44 110.831 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -128.3 125.61 39.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 3.83 111.098 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.17 134.59 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 1.88 111.263 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.64 -52.09 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 1.22 111.34 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -148.66 133.71 18.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 3.53 111.083 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 49' ' ' VAL . 41.4 t -146.0 160.39 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.247 -0.433 . . . . 1.79 111.396 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' N ' HG11 ' A' ' 42' ' ' VAL . . . -154.83 124.4 3.18 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.512 . . . . 1.25 110.737 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.05 -24.45 49.12 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.475 2.117 . . . . 1.63 112.491 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -63.45 -22.87 67.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 3.06 111.067 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.06 73.65 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.572 -0.823 . . . . 0.79 112.11 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -122.4 170.11 8.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.731 0.301 . . . . 1.07 111.172 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.93 120.34 2.28 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.975 2.45 . . . . 0.65 111.724 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.6 p -106.74 159.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.783 -0.644 . . . . 1.15 111.123 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 80.8 m80 -123.32 123.53 40.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 2.03 110.804 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.405 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 47.7 pt -97.16 141.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 1.12 111.021 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -106.67 120.89 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.342 -0.39 . . . . 2.13 110.828 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.42 ' OG1' ' CG1' ' A' ' 56' ' ' VAL . 27.1 p -122.63 -163.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.884 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -46.45 93.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.067 0.461 . . . . 3.43 111.732 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' THR . 25.7 mmm180 44.44 28.59 0.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.81 -0.632 . . . . 4.67 112.121 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.42 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 11.9 p -152.55 113.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 1.87 110.838 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -93.84 118.9 32.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 1.07 111.315 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 tp -99.54 150.23 22.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 2.1 110.653 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -104.83 134.32 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.394 . . . . 1.11 111.296 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -143.33 155.62 44.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 1.56 110.721 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 70.4 mtm180 -110.63 160.4 16.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.88 0.371 . . . . 3.81 110.898 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -44.05 -28.2 0.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 5.09 111.585 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 21.8 ptmt -80.73 -35.53 33.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 2.72 110.88 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 7.3 m-20 -68.62 -31.49 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 2.3 111.134 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 65' ' ' LEU . 5.8 mp -86.42 -25.69 25.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 1.41 111.266 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.63 -58.43 6.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 1.2 111.468 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.93 -59.05 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 1.16 111.188 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.22 151.96 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.411 . . . . 1.12 111.47 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -95.78 136.15 36.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.573 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 70' ' ' LEU . 2.5 mm? -110.0 139.71 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 2.39 110.991 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.81 118.01 19.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 2.24 110.817 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.89 148.16 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 1.34 111.073 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 1.76 111.136 -179.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.841 0.353 . . . . 2.96 110.601 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -88.41 154.66 51.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 1.3 111.276 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 92.89 0.78 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.507 2.138 . . . . 0.77 112.354 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 176.29 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.535 . . . . 2.69 110.702 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -104.41 146.4 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 2.32 110.79 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.37 170.21 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.16 111.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 35.2 m95 -155.41 160.4 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.84 110.797 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -114.65 138.62 50.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 2.52 111.125 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.33 129.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 1.21 111.191 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.8 p -134.72 58.73 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 1.64 110.508 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.8 96.39 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.665 -0.698 . . . . 0.45 112.696 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -147.16 98.55 3.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.93 110.875 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.9 m -112.32 161.94 16.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 1.26 110.829 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -22.44 34.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.314 -0.403 . . . . 3.96 110.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -162.7 44.4 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 2.48 110.861 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -45.94 128.67 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 1.17 111.494 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -81.61 154.99 71.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.776 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.9 Cg_endo -63.65 -28.19 69.2 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.615 2.21 . . . . 0.68 112.241 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.34 -45.32 45.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 1.32 110.823 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 95.3 m-85 -85.46 -49.24 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 2.53 110.503 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -57.74 -61.27 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 2.02 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' A' ' 27' ' ' LEU . 27.9 mm-40 -51.02 -34.13 28.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 3.29 110.731 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -51.75 -53.27 41.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 3.07 110.949 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.03 -43.4 95.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 1.94 111.088 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 24' ' ' GLN . 84.0 mt -48.78 -26.51 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 1.45 111.186 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.4 t -69.56 -34.03 73.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 2.09 110.974 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -94.34 -24.53 17.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 2.13 110.921 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.58 9.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.653 -0.784 . . . . 0.82 112.55 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.9 mtt -99.32 91.47 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 2.97 111.018 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.1 mp -92.32 158.02 39.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 1.34 110.561 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.87 118.72 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.481 2.121 . . . . 0.51 112.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.11 31.02 3.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.825 -0.702 . . . . 0.4 112.398 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.6 t -95.57 173.89 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 1.01 110.875 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -121.84 148.94 44.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.75 110.943 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 36.1 p90 -162.22 173.1 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.732 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -128.56 130.33 47.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.956 0.408 . . . . 3.83 111.233 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -80.01 138.38 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.88 110.994 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.62 -40.49 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 1.22 111.426 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -164.67 129.36 2.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.377 -0.374 . . . . 3.53 110.913 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.445 HG22 ' CG2' ' A' ' 49' ' ' VAL . 10.0 t -138.14 159.15 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 1.79 111.159 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.408 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -122.32 146.23 46.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.25 110.995 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.06 -14.85 26.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.573 2.182 . . . . 1.63 112.592 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -93.6 -50.32 5.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 3.06 111.078 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.25 95.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.873 -0.68 . . . . 0.79 112.259 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.52 170.2 11.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.791 0.329 . . . . 1.07 111.151 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.98 116.6 1.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.01 2.473 . . . . 0.65 111.694 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 152.34 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.929 -0.578 . . . . 1.15 110.923 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.422 ' N ' HG22 ' A' ' 49' ' ' VAL . 73.1 m80 -110.44 131.6 54.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 2.03 110.517 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.65 139.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 1.12 111.227 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -108.14 114.46 28.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 2.13 110.639 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.4 p -113.37 -173.82 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 1.28 111.142 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -52.69 99.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 3.43 111.542 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 52.11 29.42 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 4.67 111.651 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.1 t -149.4 128.48 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.87 111.16 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -109.92 107.78 17.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 1.07 110.969 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 tp -105.0 156.71 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.1 111.235 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.99 132.86 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 1.11 111.182 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -118.18 140.32 49.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.56 110.677 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 94.0 mtt180 -107.35 149.21 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 3.81 110.959 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -27.93 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.976 -0.556 . . . . 5.09 111.498 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -82.17 -29.94 31.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 2.72 110.938 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 19.5 t70 -72.47 -30.18 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 2.3 110.863 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.7 mp -79.74 -29.7 40.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 1.41 110.801 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.46 -23.7 10.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 1.2 111.231 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 22' ' ' TYR . 67.7 mt -97.55 -63.75 1.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.438 . . . . 1.16 111.146 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 44.6 pt -65.12 152.99 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 1.12 111.081 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.01 153.27 21.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.954 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 70' ' ' LEU . 3.0 mm? -112.15 148.59 33.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 2.39 110.591 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -131.19 128.67 40.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.331 . . . . 2.24 110.853 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 156.27 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.34 111.288 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.079 -0.51 . . . . 1.76 111.154 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CE1' HD23 ' A' ' 70' ' ' LEU . 51.8 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.745 0.307 . . . . 2.96 110.723 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -113.33 155.21 44.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 1.3 111.642 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.96 89.55 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.564 2.176 . . . . 0.77 112.024 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -179.98 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 2.69 110.631 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -94.07 143.98 25.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 2.32 110.729 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.17 160.18 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 1.16 111.157 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 23.3 m95 -149.37 164.1 35.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.84 110.674 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -114.2 136.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 2.52 111.12 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.4 mt -78.19 134.42 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 1.21 111.045 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 m -136.26 57.88 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 1.64 110.614 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.3 87.42 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.45 112.937 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.07 94.76 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.376 . . . . 0.93 110.713 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.6 m -101.27 -174.93 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 1.26 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -26.67 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 3.96 110.947 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.91 29.6 1.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.078 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 tt -43.69 119.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.401 . . . . 1.17 111.413 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 p -80.64 156.58 72.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.031 -0.532 . . . . 2.01 110.756 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.9 Cg_endo -58.33 -30.83 92.34 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.593 2.195 . . . . 0.68 112.399 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.84 59.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.32 110.758 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -85.75 -37.65 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 2.53 111.118 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.09 -61.56 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 2.02 111.121 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 20' ' ' PRO . 6.3 tp-100 -56.58 -20.59 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 3.29 111.366 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -69.88 -50.43 42.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.842 0.353 . . . . 3.07 110.677 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.16 -37.71 80.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 1.94 110.984 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.6 mt -54.24 -25.73 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.45 111.317 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -52.42 -45.5 65.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 2.09 110.937 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 2.4 mm? -96.91 -22.67 16.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 2.13 111.103 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.34 23.82 8.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.82 112.255 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.4 mtm -84.15 89.81 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 2.97 111.149 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -97.39 158.49 33.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 1.34 110.836 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.89 109.32 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.443 2.095 . . . . 0.51 111.973 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.16 29.15 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.703 -0.761 . . . . 0.4 112.439 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -96.65 174.19 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 1.01 110.614 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.2 p -121.49 143.59 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 1.75 110.93 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 6.8 p90 -156.81 -176.58 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.44 110.946 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -140.09 134.81 31.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 3.83 110.985 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' CG1' HG21 ' A' ' 42' ' ' VAL . 59.0 t -64.81 136.48 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 1.88 111.081 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.5 t -94.26 -40.74 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 1.22 111.221 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -175.57 124.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.038 0.447 . . . . 3.53 111.17 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 49' ' ' VAL . 21.2 t -137.42 157.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.59 . . . . 1.79 111.131 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -116.91 154.51 49.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 1.25 110.988 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.76 -19.34 18.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.565 2.177 . . . . 1.63 112.525 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.47 -67.46 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 3.06 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.08 105.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.809 -0.71 . . . . 0.79 112.365 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.14 171.27 6.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.536 0.207 . . . . 1.07 111.228 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.06 120.06 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.74 2.293 . . . . 0.65 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CB ' HG23 ' A' ' 42' ' ' VAL . 1.8 p -106.26 152.79 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.612 -0.722 . . . . 1.15 111.013 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -109.82 135.86 50.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.605 -0.725 . . . . 2.03 110.398 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 pt -93.82 145.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 1.12 111.039 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -106.84 109.18 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 2.13 110.71 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -114.94 -170.2 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 1.28 111.167 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 25.3 tpp180 -48.96 96.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.43 111.333 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 35.2 ptt180 45.71 33.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 4.67 111.884 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -151.44 116.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 1.87 110.993 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.6 p -103.04 109.99 21.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 1.07 110.907 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.62 170.92 9.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 2.1 111.04 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.76 140.92 33.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.07 -0.514 . . . . 1.11 111.206 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -135.39 120.94 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.362 -0.381 . . . . 1.56 111.181 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -65.83 -168.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.81 110.551 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -81.35 -36.7 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.435 -0.348 . . . . 5.09 111.455 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -86.1 -33.27 20.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.72 111.377 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.74 -24.54 2.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.3 110.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 5.9 mp -85.35 -22.09 28.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 1.41 111.284 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.38 90.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.444 -0.344 . . . . 1.2 111.637 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.1 -59.0 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 1.16 111.127 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 pt -65.6 142.42 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 1.12 111.203 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.06 148.69 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 2.29 110.873 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.9 tp -117.01 159.16 22.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 2.39 111.052 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.36 147.65 43.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 2.24 110.911 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.34 166.85 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 1.34 111.004 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 1.76 111.046 179.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.756 0.312 . . . . 2.96 111.066 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -104.74 155.94 36.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 1.3 111.072 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.51 90.83 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.51 2.14 . . . . 0.77 112.361 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 p30 176.89 -37.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 2.69 110.892 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.0 m -100.96 153.52 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 2.32 110.967 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.52 158.5 15.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 1.16 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 45.2 m95 -139.64 178.05 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.84 110.756 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -125.17 138.1 54.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 2.52 111.279 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.64 125.81 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.21 110.704 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.8 m -139.78 46.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.175 0.512 . . . . 1.64 110.837 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.7 86.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.845 -0.693 . . . . 0.45 112.598 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' THR . 92.0 t80 -143.14 94.89 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.93 110.688 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -97.32 -175.15 3.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 1.26 111.032 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.0 mpt_? -85.49 -28.77 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 3.96 110.788 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -141.03 30.25 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 2.48 110.9 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -41.94 148.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 1.17 111.656 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.0 m -107.31 156.54 37.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.122 -0.49 . . . . 2.01 110.87 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.97 -28.6 66.56 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.601 2.201 . . . . 0.68 112.216 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.08 -46.89 22.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.32 110.863 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CD2' ' OD2' ' A' ' 64' ' ' ASP . 75.6 m-85 -86.57 -46.17 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 2.53 110.561 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -56.4 -58.05 9.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 2.02 111.289 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -43.94 -28.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 3.29 111.703 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.81 -41.08 92.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 3.07 111.004 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 3.7 mm? -72.34 -54.98 7.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.94 111.157 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 mt -50.67 -29.1 10.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 1.45 111.162 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.7 m -77.48 -28.89 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 2.09 111.099 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -25.4 18.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 2.13 111.205 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.69 23.93 19.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.654 -0.784 . . . . 0.82 112.892 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.18 90.48 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 2.97 110.623 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.9 mp -84.47 160.81 55.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.703 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.85 120.3 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.51 112.305 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.52 22.1 5.23 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.873 -0.68 . . . . 0.4 112.489 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -93.56 174.17 7.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 1.01 110.539 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -117.25 158.8 23.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 1.75 111.13 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CD2' ' HB ' ' A' ' 51' ' ' ILE . 28.0 p90 -168.43 168.41 11.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.44 110.626 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -120.53 152.34 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 3.83 110.998 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' HG22 ' A' ' 42' ' ' VAL . 46.0 t -87.75 136.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 1.88 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.5 -40.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.22 111.429 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -169.69 125.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.38 . . . . 3.53 110.886 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 43' ' ' ALA . 60.7 t -137.38 158.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.306 -0.406 . . . . 1.79 111.296 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -145.48 109.78 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 1.25 111.059 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -43.32 -34.1 4.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 1.63 112.745 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.18 -26.59 28.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 3.06 111.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.2 90.09 1.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.79 112.044 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.87 172.01 6.1 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.647 0.26 . . . . 1.07 111.04 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.31 121.77 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.769 2.313 . . . . 0.65 111.687 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.437 HG21 ' N ' ' A' ' 50' ' ' HIS . 1.4 p -106.43 158.96 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.665 -0.698 . . . . 1.15 111.007 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.437 ' N ' HG21 ' A' ' 49' ' ' VAL . 12.5 m-70 -114.83 131.41 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.673 . . . . 2.03 110.605 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.437 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -101.84 141.91 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 1.12 110.987 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.02 108.41 19.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 2.13 111.071 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -108.17 -169.59 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.948 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -55.46 96.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 3.43 111.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 52.39 30.55 8.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 4.67 111.723 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -151.4 112.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.965 0.412 . . . . 1.87 111.388 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -97.15 109.95 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 1.07 110.637 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 74.6 mt -99.79 163.35 12.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.154 -0.475 . . . . 2.1 111.245 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 p -121.76 137.96 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 1.11 110.871 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 68' ' ' ILE . 86.2 mt -127.53 136.27 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 1.56 110.954 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.83 150.83 24.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 3.81 110.915 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -45.64 -30.26 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 5.09 111.454 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -83.17 -39.24 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 2.72 111.191 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' CD2' ' A' ' 22' ' ' TYR . 9.0 t70 -57.96 -29.56 65.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 2.3 111.046 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 65' ' ' LEU . 8.1 mp -76.26 -20.25 57.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 1.41 111.281 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.24 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.557 -0.292 . . . . 1.2 111.441 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.99 -54.32 3.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.747 0.308 . . . . 1.16 111.295 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.415 ' CD1' HD13 ' A' ' 60' ' ' LEU . 36.2 pt -65.61 152.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 1.12 111.035 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -105.02 149.29 25.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 2.29 111.014 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -130.51 139.51 50.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 2.39 110.96 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -116.3 129.97 56.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.792 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.57 20.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 1.34 111.047 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 1.76 111.372 -179.703 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CE2' HG11 ' A' ' 42' ' ' VAL . 6.3 p90 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.894 0.378 . . . . 2.96 110.745 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -86.08 156.22 57.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 1.3 111.259 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 90.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.637 2.224 . . . . 0.77 112.284 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 178.32 -42.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 2.69 110.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.3 m -92.17 141.84 28.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 2.32 110.929 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.98 164.17 25.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 1.16 111.089 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 42.5 m95 -147.84 169.53 19.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.84 110.645 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' SER . 57.8 mttp -114.87 137.03 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 2.52 111.099 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.1 mt -78.34 122.92 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.21 110.955 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -136.16 51.45 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 1.64 110.806 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.42 96.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.957 -0.639 . . . . 0.45 112.638 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -147.29 94.98 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.93 110.813 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 t -105.29 -172.42 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 1.26 110.878 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -21.89 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.009 -0.542 . . . . 3.96 111.188 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -156.5 33.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.455 -0.339 . . . . 2.48 111.159 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tt -46.89 122.61 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 1.17 111.281 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.3 p -76.79 155.58 83.05 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 2.01 110.826 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.77 -29.87 77.41 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.616 2.211 . . . . 0.68 112.488 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.22 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.011 0.434 . . . . 1.32 110.41 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -85.75 -28.93 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 2.53 111.02 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NH1' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -76.04 -61.73 1.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 2.02 111.029 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -53.4 -27.64 25.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.347 -0.388 . . . . 3.29 110.947 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -50.67 -32.1 18.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 3.07 111.153 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.9 mp -84.02 -42.31 16.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 1.94 111.251 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' NH1' ' A' ' 23' ' ' ARG . 73.2 mt -49.03 -25.81 2.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 1.45 111.238 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.426 ' OG ' ' CD1' ' A' ' 29' ' ' LEU . 73.7 p -65.6 -37.54 86.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 2.09 110.935 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -91.07 -24.04 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 2.13 110.898 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.9 16.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.652 -0.785 . . . . 0.82 112.467 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 51.9 mtm -98.43 99.33 10.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 2.97 110.795 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 32' ' ' LEU . 7.7 mp -95.48 160.94 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 1.34 110.816 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.11 114.03 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.601 2.201 . . . . 0.51 112.282 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.17 33.02 1.56 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.4 112.174 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 39.8 t -100.58 174.78 5.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.612 0.244 . . . . 1.01 110.807 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.7 t -120.18 154.7 34.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 1.75 110.876 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.8 p90 -167.62 177.26 5.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.44 110.751 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 76.6 t60 -128.82 155.18 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 3.83 111.033 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.463 ' O ' ' CD2' ' A' ' 38' ' ' HIS . 66.1 t -92.78 134.88 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 1.88 110.906 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.21 -51.44 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 1.22 111.461 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -155.49 123.79 5.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 3.53 111.263 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.441 HG11 ' CE2' ' A' ' 3' ' ' PHE . 46.6 t -135.69 158.79 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 1.79 111.025 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -124.87 152.89 70.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 1.25 111.09 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.25 -30.78 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.8 2.334 . . . . 1.63 112.856 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.11 -26.69 39.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 3.06 111.129 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 104.13 1.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.723 -0.751 . . . . 0.79 112.167 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 4.3 m-20 -147.86 170.67 7.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.673 0.273 . . . . 1.07 111.07 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.5 120.71 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.928 2.419 . . . . 0.65 111.69 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.5 p -106.96 159.12 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.82 -0.627 . . . . 1.15 111.264 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 59' ' ' VAL . 53.2 m-70 -114.35 137.03 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 2.03 110.448 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -102.11 141.18 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 1.12 111.63 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.61 107.75 18.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.942 -0.572 . . . . 2.13 110.507 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.3 p -113.96 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 1.28 111.094 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 39.7 mmt180 -49.61 102.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 3.43 111.428 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 29.4 ptt180 44.81 37.01 2.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 4.67 112.056 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 29' ' ' LEU . 99.1 t -151.52 126.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 1.87 111.118 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.6 t -109.98 107.73 17.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 1.07 110.666 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 77.9 mt -106.95 156.8 18.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 2.1 111.233 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 8.0 p -112.96 134.71 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 1.11 110.992 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.417 ' CB ' HD11 ' A' ' 65' ' ' LEU . 70.5 mt -122.31 134.22 54.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 1.56 110.757 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -97.35 160.68 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.81 110.848 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -51.48 -23.52 4.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 5.09 110.965 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -85.08 -27.88 26.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 2.72 110.815 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.25 -32.75 61.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 2.3 110.823 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 65' ' ' LEU . 7.7 mp -79.44 -21.69 45.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 1.41 111.075 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.18 62.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 1.2 111.589 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.55 -58.94 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.75 0.31 . . . . 1.16 111.353 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.4 pt -65.94 158.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 1.12 111.345 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -111.53 141.74 44.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.29 110.695 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.16 142.27 47.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 2.39 111.086 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -128.02 122.94 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 2.24 110.718 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.27 175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 1.34 111.327 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.76 111.129 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m-85 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.78 0.324 . . . . 2.96 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -112.27 153.86 44.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 1.3 111.203 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.74 89.38 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.56 2.173 . . . . 0.77 112.437 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t70 176.69 -37.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 2.69 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -101.42 144.34 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 2.32 110.934 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.16 167.16 21.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 1.16 110.955 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.6 m95 -151.74 174.78 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.95 0.405 . . . . 0.84 111.198 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -127.23 135.42 50.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 2.52 110.988 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.92 133.17 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 1.21 111.13 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -137.45 48.95 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.64 110.456 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.8 89.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.856 -0.688 . . . . 0.45 112.658 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -147.09 95.42 2.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.93 110.866 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.401 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 15.7 m -102.14 160.4 14.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 1.26 110.943 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -17.75 62.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 3.96 111.232 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -154.06 34.0 0.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.59 0.233 . . . . 2.48 111.415 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 10.2 tt -47.36 128.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.598 -0.274 . . . . 1.17 111.281 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.9 p -87.76 156.55 52.75 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 2.01 110.84 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.44 -28.92 53.93 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.462 2.108 . . . . 0.68 112.482 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.05 -48.35 22.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 1.32 110.772 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 52.5 t80 -86.62 -46.08 10.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 2.53 110.787 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -56.05 -56.19 23.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 2.02 110.919 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -45.73 -34.2 3.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 3.29 111.371 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.73 -27.88 67.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 3.07 111.106 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.81 -55.12 5.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.94 110.912 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -48.2 -30.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 1.45 111.187 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -75.97 -32.04 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 2.09 111.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.0 mt -90.1 -23.09 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 2.13 111.032 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.72 10.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.82 112.358 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.1 mtt -109.01 91.51 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 2.97 110.874 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -104.65 160.24 26.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.34 110.83 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.82 115.26 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.427 2.084 . . . . 0.51 112.094 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.9 19.22 8.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.806 -0.712 . . . . 0.4 112.612 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -92.94 172.36 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 1.01 110.787 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.0 m -116.39 153.56 31.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 1.75 111.182 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.3 p90 -164.76 163.02 21.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.44 110.52 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -115.72 117.48 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 3.83 111.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.66 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 1.88 111.086 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.91 -47.74 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.393 -0.367 . . . . 1.22 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -162.16 138.01 7.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.915 0.388 . . . . 3.53 111.228 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG23 ' CG2' ' A' ' 49' ' ' VAL . 19.5 t -145.78 159.31 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.79 111.078 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 47' ' ' ASP . . . -121.54 155.86 58.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 1.25 111.123 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.42 -26.99 8.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 1.63 112.685 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.9 -52.52 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 3.06 111.02 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.98 111.92 0.3 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.734 -0.746 . . . . 0.79 112.417 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 2.1 m-20 -148.16 172.74 4.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.639 0.257 . . . . 1.07 111.09 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.35 117.24 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.961 2.441 . . . . 0.65 111.654 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 42' ' ' VAL . 2.4 p -106.79 154.12 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.794 -0.639 . . . . 1.15 111.068 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -119.68 142.2 48.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.606 . . . . 2.03 110.805 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 37' ' ' PHE . 38.6 pt -114.72 136.55 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 1.12 111.371 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.08 115.98 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 2.13 110.426 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 55' ' ' ARG . 37.5 p -130.25 -167.76 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 1.28 111.273 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -41.4 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.973 0.416 . . . . 3.43 112.018 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' THR . 79.8 mtm180 41.37 53.15 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 4.67 111.923 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -171.89 116.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.87 111.449 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -104.65 108.11 19.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 1.07 110.515 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.4 tp -100.16 158.44 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 2.1 110.98 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -106.82 153.33 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 1.11 111.118 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.1 mt -144.81 119.45 9.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 1.56 111.023 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -77.51 -173.11 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 3.81 110.91 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -75.1 -28.14 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 5.09 111.153 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.44 -35.33 25.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.348 -0.387 . . . . 2.72 111.036 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.86 -30.93 71.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 2.3 110.754 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.7 mt -76.5 -24.77 53.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.055 -0.521 . . . . 1.41 111.035 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.06 71.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.341 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.81 -58.16 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 1.16 111.361 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.514 ' CG2' ' CE1' ' A' ' 22' ' ' TYR . 31.3 pt -65.52 149.66 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 1.12 111.256 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -109.77 151.56 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 2.29 110.635 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 3.2 mm? -118.91 148.1 43.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 2.39 110.675 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.34 145.19 43.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 2.24 110.852 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.4 172.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.34 110.953 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 1.76 111.233 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 2.96 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -114.17 154.19 46.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 1.3 111.204 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.29 89.73 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.531 2.154 . . . . 0.77 112.432 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 178.24 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 2.69 110.918 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.2 m -106.25 170.21 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 2.32 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.56 169.33 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 1.16 111.044 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 52.1 m95 -151.1 162.08 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.84 110.583 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -107.61 137.85 44.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 2.52 110.987 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.1 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 1.21 111.235 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' GLU . 23.6 m -135.92 56.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 1.64 110.286 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.45 96.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.701 -0.682 . . . . 0.45 112.745 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -147.14 97.38 2.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.341 . . . . 0.93 110.708 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.1 m -108.61 -174.34 2.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.26 110.977 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.3 mpt_? -74.78 -27.26 60.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 3.96 110.881 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.91 42.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.48 110.81 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 tt -45.7 109.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.277 -0.42 . . . . 1.17 111.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.0 p -59.63 155.8 37.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.07 -30.47 89.41 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.68 112.101 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.63 -46.25 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.414 . . . . 1.32 110.897 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.98 -35.3 20.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.51 . . . . 2.53 111.148 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -70.94 -61.04 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.524 . . . . 2.02 111.612 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -42.75 -34.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.506 -0.316 . . . . 3.29 111.839 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.29 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 3.07 111.103 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.21 -53.63 55.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 1.94 111.075 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -48.85 -46.23 41.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 1.45 111.203 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -55.59 -49.25 73.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 2.09 111.05 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.426 ' CD1' HD23 ' A' ' 58' ' ' LEU . 73.5 mt -71.75 -25.17 61.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 2.13 110.885 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 19.54 27.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 0.82 112.774 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.4 mtt -95.03 87.05 4.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.726 0.298 . . . . 2.97 110.792 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.7 mp -92.2 159.65 36.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 1.34 110.499 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.96 132.22 17.43 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.298 1.999 . . . . 0.51 111.757 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.37 38.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.75 -0.738 . . . . 0.4 112.267 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -82.22 174.24 11.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.685 0.278 . . . . 1.01 110.582 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.4 p -125.89 137.83 53.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 1.75 110.733 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 9.6 p90 -150.53 157.64 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.44 111.003 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -108.51 146.87 32.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 3.83 110.855 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.93 128.32 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 1.88 111.144 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.93 -47.54 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 1.22 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -168.28 129.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 3.53 110.814 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 43' ' ' ALA . 39.5 t -141.56 156.56 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.368 . . . . 1.79 111.339 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.88 141.65 41.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 1.25 110.825 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.97 -21.23 37.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.497 2.131 . . . . 1.63 112.658 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 mt -85.74 -48.95 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 3.06 110.882 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.65 105.61 0.37 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.762 -0.732 . . . . 0.79 112.497 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.11 171.06 6.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.619 0.247 . . . . 1.07 110.804 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.48 118.75 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.878 2.385 . . . . 0.65 111.788 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.9 p -106.65 161.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.15 111.123 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.458 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 79.2 m80 -125.07 148.37 48.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 2.03 110.467 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.3 pt -115.56 138.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 1.12 111.446 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.95 112.97 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 2.13 110.612 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.7 p -126.7 -175.98 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.387 . . . . 1.28 111.343 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -41.59 95.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.964 -0.562 . . . . 3.43 112.101 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 43.28 54.79 4.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 4.67 112.089 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -175.78 113.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 1.87 111.29 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -100.49 112.18 24.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 1.07 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 29' ' ' LEU . 38.0 tp -105.73 148.58 27.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 2.1 110.797 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' CD2' ' A' ' 50' ' ' HIS . 8.8 p -99.56 140.71 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.11 111.315 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -140.44 166.12 25.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 1.56 110.881 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 80.7 mtp180 -130.3 152.82 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 3.81 110.896 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.4 tpmt? -50.49 -24.81 3.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.969 -0.56 . . . . 5.09 111.523 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.37 -28.67 34.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.894 0.378 . . . . 2.72 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.28 -33.08 29.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 2.3 111.068 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.8 mp -71.43 -20.7 62.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 1.41 111.267 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.15 84.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.505 -0.316 . . . . 1.2 111.468 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.31 -56.59 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.16 111.257 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -66.96 151.91 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 1.12 111.102 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 12' ' ' THR . 33.0 tt0 -100.49 128.96 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.29 110.59 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.45 136.14 53.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 2.39 111.077 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -130.23 156.53 44.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 2.24 110.755 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 133.43 51.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 1.34 111.113 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.416 HG11 ' CA ' ' A' ' 9' ' ' TRP . 32.7 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.513 . . . . 1.76 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.735 0.302 . . . . 5.58 110.98 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -85.92 163.98 17.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 3.52 111.011 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.43 110.73 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 2.96 110.805 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -108.92 150.05 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 1.3 111.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 85.57 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.562 2.175 . . . . 0.77 112.357 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.6 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 2.69 110.867 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -84.84 164.27 18.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 2.32 110.986 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.7 165.45 11.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.16 111.241 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 61.1 m95 -155.07 174.55 15.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.84 110.832 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -127.6 134.34 49.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 2.52 111.05 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.1 mt -74.52 126.09 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 1.21 111.346 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -139.74 48.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 1.64 110.572 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.72 91.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.866 -0.683 . . . . 0.45 112.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -147.23 96.97 2.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.64 0.257 . . . . 0.93 110.786 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 15.0 m -105.79 -175.79 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 1.26 110.803 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.2 mpt_? -86.31 -21.67 27.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 3.96 111.047 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -147.44 28.19 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.463 -0.335 . . . . 2.48 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 14.6 tt -46.17 122.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.17 111.369 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -72.82 155.43 90.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 2.01 110.929 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 24' ' ' GLN . 37.9 Cg_endo -66.42 -27.71 46.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.503 2.136 . . . . 0.68 112.268 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.64 -45.15 57.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 1.32 110.83 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -85.78 -37.27 19.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 2.53 111.129 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -70.58 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 2.02 111.359 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' PRO . 51.8 tt0 -57.88 -18.64 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 3.29 111.537 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -75.32 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 3.07 111.149 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -50.0 -30.88 11.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 1.94 111.033 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.0 mt -51.57 -34.04 35.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.45 111.013 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.4 p -62.88 -29.47 70.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 2.09 111.092 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.33 -24.43 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 2.13 111.012 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.92 20.63 59.11 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.82 112.465 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.31 91.57 4.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 2.97 110.846 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.5 mp -88.26 160.6 45.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.02 -0.536 . . . . 1.34 110.79 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.37 112.78 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.525 2.15 . . . . 0.51 112.417 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 30.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 0.4 112.454 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.8 t -102.1 174.1 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 1.01 110.878 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -119.06 138.95 52.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.467 . . . . 1.75 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.7 p90 -153.37 159.89 42.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.018 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -114.41 160.76 18.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.426 . . . . 3.83 110.82 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -98.37 134.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 1.88 111.222 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.5 t -94.98 -49.53 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.22 111.08 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.77 138.44 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 3.53 110.832 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' CG2' ' A' ' 49' ' ' VAL . 19.7 t -146.16 157.97 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 1.79 111.388 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' N ' HG11 ' A' ' 42' ' ' VAL . . . -123.58 147.37 52.82 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 1.25 111.065 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.11 -20.47 19.07 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 1.63 112.663 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.84 -46.41 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.387 -0.37 . . . . 3.06 111.059 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.33 100.3 0.2 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 0.79 112.306 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 1.2 m-20 -139.38 170.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 1.07 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.81 117.19 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.942 2.428 . . . . 0.65 111.647 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 157.17 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.823 -0.626 . . . . 1.15 110.874 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -121.04 136.45 54.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 2.03 110.72 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -102.08 143.84 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 1.12 111.136 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -106.77 110.58 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 2.13 110.755 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -112.08 -174.33 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 1.28 111.063 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -52.43 94.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 3.43 111.479 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 53.23 38.19 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 4.67 111.691 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -155.44 132.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.713 0.292 . . . . 1.87 111.093 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -112.21 107.83 16.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 1.07 111.148 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.4 tp -101.54 154.07 19.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 2.1 110.55 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.52 139.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 1.11 111.183 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.39 166.18 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 1.56 110.756 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 64' ' ' ASP . 95.5 mtt180 -124.63 136.43 53.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 3.81 110.79 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.0 tpmt? -45.96 -29.36 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 5.09 111.253 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -84.41 -31.61 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.937 0.399 . . . . 2.72 110.393 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ARG . 18.5 t70 -69.49 -35.95 76.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 2.3 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -63.0 -23.58 67.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 1.41 110.989 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.17 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.38 . . . . 1.2 111.28 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -83.47 -61.03 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 1.16 111.202 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 pt -65.32 144.52 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 1.12 111.183 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.26 154.44 18.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.847 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.46 148.98 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 2.39 111.05 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -134.43 115.31 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 2.24 110.738 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.39 53.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.34 111.092 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.4 -178.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.76 111.234 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.94 101.82 14.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 2.28 111.2 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 5.77 110.856 179.757 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.782 0.325 . . . . 5.58 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -135.62 -176.52 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 3.52 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 70' ' ' LEU . 83.1 m-85 -99.65 105.34 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 2.96 110.802 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -112.03 154.85 44.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.3 111.173 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.527 2.151 . . . . 0.77 112.362 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 177.77 -43.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 2.69 110.794 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.54 149.31 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 2.32 110.788 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.79 146.83 23.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.445 . . . . 1.16 111.18 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 38.8 m95 -133.64 174.06 10.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.84 110.671 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -122.1 138.23 54.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.351 -0.386 . . . . 2.52 111.093 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CD1' ' CE ' ' A' ' 31' ' ' MET . 53.5 mt -77.31 138.9 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.21 111.14 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 17.7 m -142.48 50.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.933 -0.576 . . . . 1.64 110.434 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 91.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.773 -0.648 . . . . 0.45 112.9 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 47.3 t80 -147.25 99.22 3.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.93 110.693 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -101.84 -172.66 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.409 . . . . 1.26 111.075 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.0 mpt_? -77.89 -29.85 50.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 3.96 110.911 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.22 40.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 2.48 110.981 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.21 130.73 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 1.17 111.401 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.3 m -80.64 156.73 72.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 2.01 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.1 Cg_endo -58.39 -33.03 97.47 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.516 2.144 . . . . 0.68 112.166 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.92 -43.52 59.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.104 0.478 . . . . 1.32 110.326 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -85.67 -43.46 13.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 2.53 110.514 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -62.56 -61.67 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 2.02 111.041 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' PRO . 89.8 mt-30 -52.2 -32.21 35.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.453 -0.339 . . . . 3.29 110.833 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -51.04 -40.68 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 3.07 111.021 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 3.4 mm? -84.5 -38.7 19.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 1.94 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.87 -33.45 23.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 1.45 110.99 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -63.12 -50.73 69.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 2.09 110.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.37 -23.82 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 2.13 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.06 18.94 25.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 0.82 112.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.488 ' CE ' ' CD1' ' A' ' 11' ' ' ILE . 65.4 mtp -91.43 94.77 9.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 2.97 110.923 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -103.12 159.7 28.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 1.34 110.857 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.72 111.9 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.569 2.18 . . . . 0.51 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.11 25.64 3.49 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.919 -0.657 . . . . 0.4 112.302 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -93.51 163.47 13.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 1.01 110.709 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -111.01 142.8 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 1.75 110.929 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 24.1 p90 -155.1 162.72 40.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.844 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -114.55 148.04 38.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 3.83 111.002 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 t -86.88 113.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 1.88 110.868 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.81 -52.38 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 1.22 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -169.25 121.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 3.53 111.107 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -140.32 158.08 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.79 110.944 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -113.94 140.32 24.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 1.25 111.407 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.15 -26.81 83.1 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.554 2.169 . . . . 1.63 112.351 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 45' ' ' LEU . 3.1 mm? -80.41 -65.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 3.06 110.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.27 100.76 0.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.712 -0.756 . . . . 0.79 112.334 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -144.48 171.24 6.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.609 0.242 . . . . 1.07 111.025 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.63 113.64 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.955 2.437 . . . . 0.65 111.677 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.77 140.69 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.625 . . . . 1.15 111.173 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -99.67 137.63 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.905 -0.589 . . . . 2.03 110.611 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -108.67 140.65 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 1.12 111.198 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.29 109.47 21.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 2.13 110.81 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.1 p -107.37 -172.85 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.28 111.087 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -50.93 96.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.43 111.405 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 52.53 26.24 4.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 4.67 111.696 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -146.75 120.68 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.4 . . . . 1.87 111.117 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -104.22 107.93 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 1.07 110.912 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -103.37 160.28 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 2.1 110.669 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.64 138.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.369 . . . . 1.11 111.132 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.15 155.41 50.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.56 110.874 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 64' ' ' ASP . 75.2 mtp180 -122.12 155.62 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 3.81 111.058 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 5.6 mmpt? -44.2 -28.93 0.56 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.078 -0.51 . . . . 5.09 111.486 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -76.43 -36.09 58.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.281 -0.418 . . . . 2.72 110.874 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' ARG . 13.2 m-20 -74.41 -34.47 63.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 2.3 110.825 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 65' ' ' LEU . 7.1 mp -74.58 -26.57 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 1.41 110.937 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.24 -25.33 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 1.2 111.163 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.6 -58.47 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 1.16 111.124 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.0 pt -67.64 154.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 1.12 110.904 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -102.88 155.74 18.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 2.29 110.974 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.478 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 92.1 mt -128.84 165.66 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.082 -0.508 . . . . 2.39 110.753 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.51 149.08 30.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 2.24 111.023 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -174.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 1.34 110.903 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.43 -177.78 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 1.76 111.023 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.74 135.64 57.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.28 111.189 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 5.77 110.732 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.862 0.363 . . . . 5.58 110.95 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.7 141.96 56.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 3.52 110.934 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -66.23 106.71 1.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 2.96 110.957 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -116.23 156.26 47.3 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 1.3 111.381 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.81 141.61 27.77 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.724 2.283 . . . . 0.77 112.396 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.24 21.02 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 2.69 111.518 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.6 p -88.17 159.79 18.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 2.32 110.883 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.19 135.44 53.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.16 111.06 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 54.1 m95 -151.42 157.22 42.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.84 110.572 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -99.52 135.09 41.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 2.52 110.745 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -77.3 132.39 32.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.039 -0.528 . . . . 1.21 111.328 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.2 m -139.51 44.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.009 -0.541 . . . . 1.64 110.391 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.21 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.917 -0.659 . . . . 0.45 112.581 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 89.9 t80 -147.7 94.89 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.93 110.828 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m -100.39 161.86 13.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 1.26 110.857 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -19.15 38.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.96 111.369 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -165.55 42.26 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 2.48 111.401 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.45 139.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.347 -0.388 . . . . 1.17 111.325 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -88.41 156.37 50.98 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 2.01 110.895 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 21.1 Cg_endo -60.45 -30.39 90.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.621 2.214 . . . . 0.68 112.347 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.71 -46.61 50.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.078 0.466 . . . . 1.32 110.665 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -86.45 -43.4 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 2.53 110.806 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -62.09 -58.84 6.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 2.02 111.38 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 61.4 tt0 -46.06 -48.19 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 3.29 111.499 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -51.16 -47.77 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.404 -0.362 . . . . 3.07 111.152 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.95 -57.13 12.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.025 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.7 mt -48.86 -26.48 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.45 111.176 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -66.09 -37.05 84.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 2.09 111.087 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.59 -25.26 38.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.376 -0.375 . . . . 2.13 111.073 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.15 7.67 55.95 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.716 -0.754 . . . . 0.82 113.04 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.401 ' CE ' ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -91.97 103.06 15.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.969 0.385 . . . . 2.97 111.05 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 32' ' ' LEU . 6.6 mp -90.58 160.38 39.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 1.34 110.614 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.23 127.15 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.472 2.115 . . . . 0.51 112.277 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.21 27.39 6.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.727 -0.749 . . . . 0.4 112.323 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.5 t -94.31 174.23 7.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.649 0.261 . . . . 1.01 110.788 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -123.97 148.81 46.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 1.75 110.946 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 6.8 p90 -161.43 179.53 8.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.44 110.853 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -132.21 152.22 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 3.83 110.844 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 49' ' ' VAL . 60.5 t -91.23 141.09 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 1.88 111.051 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -95.96 -39.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 1.22 111.342 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 179.73 126.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 3.53 110.982 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 43' ' ' ALA . 9.2 p -148.66 159.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.79 111.153 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' N ' HG21 ' A' ' 42' ' ' VAL . . . -114.15 155.75 45.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 1.25 111.066 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.29 -18.44 23.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.676 2.25 . . . . 1.63 112.586 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 tp -89.65 -65.8 0.98 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 3.06 110.938 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.84 107.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.79 112.434 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -147.72 172.26 5.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.58 0.229 . . . . 1.07 110.712 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.19 110.87 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.755 2.303 . . . . 0.65 111.526 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 39' ' ' VAL . 3.7 p -106.57 140.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 1.15 111.199 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -101.43 131.03 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.845 -0.616 . . . . 2.03 110.804 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 60' ' ' LEU . 44.2 pt -96.63 139.62 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.12 110.831 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -106.83 97.09 6.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 2.13 110.888 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.2 -172.68 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 1.28 111.002 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 31' ' ' MET . 41.3 mmt180 -51.47 96.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 3.43 111.451 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 51.89 30.08 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 4.67 111.541 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.7 t -149.75 117.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 1.87 111.33 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -100.87 107.76 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.07 110.751 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -102.9 158.17 16.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 2.1 110.988 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -104.55 138.96 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 1.11 110.911 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' CD1' HD13 ' A' ' 51' ' ' ILE . 90.2 mt -144.08 143.13 31.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.931 0.396 . . . . 1.56 111.104 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 32.4 ttm180 -112.12 162.3 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 3.81 110.683 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 mmpt? -47.18 -26.92 1.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 5.09 111.218 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.1 -30.09 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 2.72 110.912 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' ARG . 8.7 m-20 -79.85 -31.93 40.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 2.3 111.027 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.3 mp -81.6 -18.5 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 1.41 111.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.69 -27.03 68.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.766 0.317 . . . . 1.2 111.499 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.67 -57.69 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 1.16 111.119 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.2 pt -66.04 154.81 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 1.12 111.338 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.93 147.78 27.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.186 -0.461 . . . . 2.29 110.475 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 70' ' ' LEU . 2.7 mm? -121.43 153.63 37.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 2.39 111.097 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.01 147.08 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 2.24 110.787 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 165.94 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 1.34 111.18 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m -103.03 162.71 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.76 111.023 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.35 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.28 111.122 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.128 -0.487 . . . . 5.77 110.872 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.781 0.324 . . . . 5.58 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.53 167.35 10.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.774 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE1' HD21 ' A' ' 70' ' ' LEU . 38.7 m-85 -72.06 92.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 2.96 110.715 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.2 p -113.82 156.25 44.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 1.3 111.253 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.92 90.12 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.58 2.187 . . . . 0.77 112.313 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 178.32 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.69 110.828 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 2.32 110.784 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.89 168.68 8.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.93 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.489 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 69.3 m95 -149.75 173.45 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.84 110.872 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -107.06 126.99 53.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 2.52 110.88 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.9 mt -77.21 126.78 38.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 1.21 111.118 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 m -132.65 56.88 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 1.64 110.393 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' NH1' ' A' ' 23' ' ' ARG . . . -58.59 85.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.971 -0.633 . . . . 0.45 113.004 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -147.11 95.98 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.93 110.632 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -95.05 -174.26 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.082 -0.508 . . . . 1.26 110.985 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -86.18 -26.01 25.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.581 . . . . 3.96 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -150.29 34.23 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 2.48 111.414 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 tt -48.63 143.18 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 1.17 111.253 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -94.63 147.93 34.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 2.01 110.88 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLN . 17.2 Cg_endo -57.29 -32.02 92.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.712 2.274 . . . . 0.68 112.124 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.03 -47.05 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.025 0.44 . . . . 1.32 110.711 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.69 -43.39 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.752 -0.658 . . . . 2.53 110.646 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.405 ' NH1' ' O ' ' A' ' 13' ' ' GLY . 20.2 tpt180 -60.25 -61.26 2.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 2.02 110.98 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' PRO . 91.5 mt-30 -49.98 -41.71 47.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 3.29 110.843 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -53.69 -25.77 19.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 3.07 110.972 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.29 -46.62 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 1.94 110.594 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -50.77 -33.6 23.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 1.45 111.048 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.9 p -69.23 -42.21 75.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 2.09 110.979 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.3 -25.34 65.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 2.13 110.979 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.14 16.16 39.08 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.82 112.835 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 ptm -104.0 103.94 13.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.983 0.42 . . . . 2.97 110.883 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.4 mp -105.03 159.81 28.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 1.34 110.443 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.11 109.4 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.521 2.147 . . . . 0.51 112.152 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 31.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.4 112.166 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 t -101.35 174.18 6.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.623 0.249 . . . . 1.01 110.57 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -119.99 143.35 48.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 1.75 111.071 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.489 ' CE1' ' HB2' ' A' ' 9' ' ' TRP . 4.0 p90 -150.45 175.36 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.44 110.824 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -130.71 129.03 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 3.83 110.988 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 140.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 1.88 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.06 -35.48 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.22 111.125 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -179.61 139.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 3.53 111.088 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 49' ' ' VAL . 20.5 t -146.92 160.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.122 -0.49 . . . . 1.79 111.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -123.56 132.0 24.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 1.25 110.83 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.46 -21.19 44.24 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 1.63 112.503 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 4.9 mp -89.82 -66.33 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 3.06 111.229 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.96 105.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.79 112.263 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 m-20 -148.12 172.13 5.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.562 0.22 . . . . 1.07 111.056 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.19 119.47 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 0.65 111.487 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.53 148.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 1.15 110.964 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -112.98 135.85 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.779 -0.646 . . . . 2.03 110.745 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' CG2' HD13 ' A' ' 60' ' ' LEU . 47.0 pt -98.55 145.83 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 1.12 111.16 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -109.34 100.81 9.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.742 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 p -103.92 -173.14 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 1.28 111.185 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -50.94 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 3.43 111.531 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 48.62 30.13 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 4.67 111.698 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.0 t -147.8 113.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.981 0.419 . . . . 1.87 111.139 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -100.03 107.74 19.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 1.07 110.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.13 160.36 14.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 2.1 111.305 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.55 137.01 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 1.11 111.031 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.42 HD13 ' CG2' ' A' ' 51' ' ' ILE . 91.0 mt -130.44 161.43 31.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 1.56 111.059 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.8 mtp180 -130.68 147.7 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 3.81 110.473 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -47.98 -25.9 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 5.09 111.08 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -75.82 -33.43 60.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 2.72 110.7 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.87 -34.86 44.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 2.3 111.044 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.5 mp -67.76 -20.74 65.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.288 -0.415 . . . . 1.41 111.076 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.29 -28.61 68.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.369 -0.378 . . . . 1.2 111.083 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.94 -56.53 3.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 1.16 110.968 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.3 pt -65.09 166.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 1.12 111.005 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -114.47 153.54 29.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 2.29 111.195 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 HD21 ' CE1' ' A' ' 3' ' ' PHE . 22.5 tp -129.91 158.09 40.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 2.39 110.664 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.71 147.18 31.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 2.24 110.876 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.53 169.84 2.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 1.34 110.993 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.7 m -89.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 1.76 111.248 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.59 134.52 44.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 2.28 111.094 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 5.77 110.876 179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.821 0.343 . . . . 5.58 110.851 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -120.36 135.99 54.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 3.52 110.922 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 42' ' ' VAL . 21.5 p90 -113.27 140.23 48.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.96 110.887 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -121.44 156.35 58.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 1.3 111.147 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.65 87.84 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.48 2.12 . . . . 0.77 112.298 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 177.96 -36.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 2.69 110.772 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 t -99.51 170.9 8.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 2.32 110.96 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.26 165.33 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 1.16 110.94 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.0 m95 -154.61 163.5 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.84 110.616 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.77 127.03 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 2.52 111.185 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HD11 ' CE ' ' A' ' 31' ' ' MET . 40.2 mt -74.38 142.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 1.21 111.122 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' GLU . 17.8 m -142.31 52.11 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.688 -0.687 . . . . 1.64 110.155 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.7 95.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.45 112.89 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -147.5 94.74 2.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.378 . . . . 0.93 110.565 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 m -104.19 -174.64 2.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 1.26 110.946 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.2 mpt_? -86.24 -23.27 26.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 3.96 111.002 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.86 32.04 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 2.48 111.504 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tt -47.21 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.974 0.416 . . . . 1.17 111.058 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.5 m -66.7 156.67 85.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 2.01 110.735 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.9 -28.66 86.7 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.596 2.198 . . . . 0.68 112.119 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.33 61.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 1.32 110.599 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.74 -40.1 16.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.846 -0.616 . . . . 2.53 110.767 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -65.46 -61.37 2.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 2.02 110.876 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.82 -38.43 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 3.29 110.844 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -53.54 -59.67 4.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 3.07 110.765 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.7 mt -58.56 -44.15 89.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.94 110.718 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -53.53 -29.48 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 1.45 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.3 t -66.79 -38.49 86.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 2.09 110.794 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.02 -24.69 24.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 2.13 110.882 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.31 16.31 18.76 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.848 -0.691 . . . . 0.82 112.732 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.429 ' CE ' HD11 ' A' ' 11' ' ' ILE . 90.7 mmm -91.35 90.52 7.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 2.97 111.048 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -108.18 161.65 22.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 1.34 110.608 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -42.56 109.77 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.43 2.087 . . . . 0.51 112.068 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.86 2.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.4 112.012 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.2 m -106.87 135.19 48.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.76 0.314 . . . . 1.01 110.904 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.1 m -90.2 148.07 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 1.75 111.199 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -162.77 179.38 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.892 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.29 153.37 43.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 3.83 110.812 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.0 t -92.55 141.3 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 1.88 111.187 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.75 -44.81 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 1.22 111.303 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -175.71 115.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 3.53 110.975 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG13 ' CD2' ' A' ' 3' ' ' PHE . 14.7 p -135.71 158.81 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.79 111.148 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' ' OD1' ' A' ' 47' ' ' ASP . . . -106.78 147.61 35.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.985 -0.552 . . . . 1.25 111.085 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 -15.89 34.16 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.586 2.191 . . . . 1.63 112.647 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.32 -73.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 3.06 111.17 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.24 91.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.859 -0.686 . . . . 0.79 112.41 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 7.6 m-20 -137.84 171.38 8.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.646 0.26 . . . . 1.07 110.921 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.57 118.01 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.858 2.372 . . . . 0.65 111.87 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 42' ' ' VAL . 2.4 p -110.13 154.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.569 -0.741 . . . . 1.15 110.942 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 59' ' ' VAL . 76.1 m80 -109.23 133.64 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 2.03 110.688 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 pt -105.02 144.04 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.12 111.051 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.21 110.04 20.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 2.13 110.644 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.8 p -110.58 -171.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 1.28 111.354 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -51.17 95.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 3.43 111.303 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 53.77 24.2 4.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 4.67 111.545 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -146.12 115.3 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.035 0.445 . . . . 1.87 111.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -101.39 108.18 19.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 1.07 110.533 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 46.9 tp -99.61 162.47 13.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.954 0.407 . . . . 2.1 111.262 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 9.3 p -117.01 126.47 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 1.11 110.974 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -119.05 165.95 13.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 1.56 111.158 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.4 ttt180 -139.18 154.59 48.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 3.81 110.657 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -46.48 -27.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 5.09 111.756 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -79.44 -29.21 41.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 2.72 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 61' ' ' ARG . 12.9 t70 -82.12 -33.1 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 2.3 110.984 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 6.7 mp -76.42 -24.51 54.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 1.41 110.968 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.81 62.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 1.2 111.304 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.6 mt -91.53 -60.65 1.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.33 -0.395 . . . . 1.16 110.975 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.7 pt -65.7 151.29 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.12 110.925 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' THR . 7.8 tp10 -101.52 146.21 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 2.29 110.918 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.41 159.44 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 2.39 110.591 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.81 145.29 30.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.393 -0.367 . . . . 2.24 111.084 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.09 163.8 27.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 1.34 111.059 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m -109.82 161.82 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 1.76 111.308 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.35 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 2.28 111.09 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 5.77 110.924 179.914 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.925 0.393 . . . . 5.58 111.052 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -138.18 171.28 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.52 . . . . 3.52 110.86 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -59.11 99.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 2.96 110.873 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -122.41 153.83 62.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.241 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.05 83.44 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.77 112.308 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.11 -42.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 2.69 110.641 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.8 m -98.34 165.75 11.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 2.32 110.927 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 160.97 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 1.16 111.101 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.5 m95 -139.97 164.86 28.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.84 110.798 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -104.88 138.28 41.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 2.52 111.106 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.0 mt -88.13 132.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 1.21 110.562 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.9 m -142.27 52.47 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.21 -0.45 . . . . 1.64 110.798 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.22 93.59 0.01 OUTLIER Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.017 -0.611 . . . . 0.45 112.848 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.84 101.41 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.777 0.322 . . . . 0.93 110.88 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 m -110.48 -176.61 3.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 1.26 110.899 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.7 mpt_? -74.85 -23.01 58.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 3.96 111.148 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -169.42 42.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 2.48 110.746 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.97 115.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 1.17 111.266 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -71.0 157.38 90.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.55 . . . . 2.01 110.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -59.83 -27.37 84.78 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.771 2.314 . . . . 0.68 112.141 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.36 -44.09 44.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.509 -0.314 . . . . 1.32 110.713 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -86.15 -39.02 17.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 2.53 111.144 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -67.91 -56.83 7.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 2.02 111.338 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -40.97 -30.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.405 -0.362 . . . . 3.29 111.633 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.48 -54.77 14.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.07 110.376 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.7 mt -54.61 -51.82 64.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 1.94 110.641 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -49.4 -43.57 44.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 1.45 111.006 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -54.26 -50.97 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.474 . . . . 2.09 110.752 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD13 ' HE1' ' A' ' 31' ' ' MET . 85.5 mt -72.96 -23.87 60.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 2.13 110.815 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.12 19.03 31.92 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.82 112.669 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.407 ' HE1' HD13 ' A' ' 29' ' ' LEU . 58.4 mtm -94.33 88.93 5.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.759 0.314 . . . . 2.97 111.01 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.7 mp -92.2 160.61 34.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 1.34 110.531 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.1 104.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.33 2.02 . . . . 0.51 112.197 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 50.33 0.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.4 112.154 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 t -117.84 170.85 8.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.277 . . . . 1.01 110.746 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.2 p -118.99 139.4 51.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 1.75 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.9 p90 -148.45 163.13 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.041 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 38.0 t60 -108.94 151.45 26.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 3.83 110.983 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' O ' ' CD2' ' A' ' 38' ' ' HIS . 59.4 t -92.5 129.26 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 1.88 111.199 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.5 t -99.03 -36.38 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 1.22 111.115 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -175.03 125.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.361 . . . . 3.53 111.14 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 49' ' ' VAL . 59.0 t -140.86 156.24 22.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.183 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -138.04 128.13 15.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.25 110.845 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.58 -36.73 98.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.427 2.085 . . . . 1.63 112.193 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.9 -45.32 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.925 -0.58 . . . . 3.06 111.167 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.69 99.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.79 112.234 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.26 170.63 7.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.624 0.25 . . . . 1.07 111.14 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.37 121.53 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.856 2.371 . . . . 0.65 111.51 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 42' ' ' VAL . 1.5 p -106.71 156.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.705 -0.68 . . . . 1.15 111.03 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 49' ' ' VAL . 47.8 m-70 -122.96 130.87 53.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 2.03 110.41 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 19.5 pt -103.6 137.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.25 -0.432 . . . . 1.12 111.086 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.01 121.59 44.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 2.13 110.733 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 55' ' ' ARG . 56.5 p -124.12 -172.9 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 1.28 110.99 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -49.63 91.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 3.43 111.351 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' THR . 17.8 mmm180 53.43 33.65 16.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 4.67 111.463 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.6 t -150.97 104.59 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 1.87 111.307 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -97.52 107.84 20.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 1.07 110.713 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.95 153.64 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 2.1 111.131 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.67 129.88 66.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.025 -0.534 . . . . 1.11 111.052 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.9 135.92 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 1.56 110.906 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.4 mtt180 -103.01 160.36 14.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 3.81 111.041 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -42.51 -37.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 5.09 111.474 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 18.8 ptmt -64.53 -34.43 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 2.72 111.127 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.08 -24.05 35.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 2.3 111.067 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' N ' HD11 ' A' ' 65' ' ' LEU . 7.3 mp -86.18 -21.37 27.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.32 -0.4 . . . . 1.41 111.349 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.5 64.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 1.2 111.377 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.0 mt -91.5 -55.86 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.352 -0.386 . . . . 1.16 111.316 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 pt -65.67 150.56 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 1.12 111.092 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -100.42 143.08 31.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 2.29 110.816 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' N ' HD21 ' A' ' 70' ' ' LEU . 1.9 mm? -116.82 149.5 39.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 2.39 110.779 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -144.21 156.11 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 2.24 110.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.93 164.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.34 111.007 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -95.45 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 1.76 111.196 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.7 146.4 40.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 2.28 110.754 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 5.77 111.061 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.769 0.318 . . . . 5.58 110.966 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.48 106.06 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 3.52 111.014 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 56.7 m-85 -61.58 99.39 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.475 . . . . 2.96 110.787 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -100.26 145.23 29.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 1.3 111.189 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.34 86.85 0.64 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.608 2.206 . . . . 0.77 112.215 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 177.85 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 2.69 110.847 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -97.82 146.89 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 2.32 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 9' ' ' TRP . . . -79.81 171.14 15.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.955 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' ALA . 57.5 m95 -156.71 160.94 39.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.84 110.78 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -112.1 134.35 53.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.52 110.801 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.0 mt -70.92 138.65 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 1.21 111.292 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -146.52 43.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.189 0.519 . . . . 1.64 110.484 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.48 90.5 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.45 112.824 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -147.09 95.03 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.93 110.736 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -99.32 -169.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.928 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.1 mpt_? -83.29 -23.49 32.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 3.96 110.93 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.07 37.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.48 110.775 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tt -46.08 116.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 1.17 111.301 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 m -64.25 155.9 77.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 2.01 110.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 24' ' ' GLN . 33.9 Cg_endo -63.37 -26.79 71.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.565 2.176 . . . . 0.68 112.14 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.06 55.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 1.32 110.672 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' OD1' ' A' ' 64' ' ' ASP . 92.8 m-85 -85.84 -39.82 16.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 2.53 110.915 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -65.2 -58.95 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 2.02 111.176 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.0 tt0 -43.8 -28.44 0.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 3.29 111.724 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -65.01 -36.59 84.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 3.07 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.7 mp -79.39 -45.41 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.94 111.038 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -50.47 -25.16 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 1.45 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.8 m -57.41 -47.81 80.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 2.09 111.042 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 4.9 mp -86.18 -25.06 25.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 2.13 110.899 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 27.88 10.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 0.82 112.762 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.2 mmt -95.29 99.45 11.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 2.97 110.7 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.54 159.86 37.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.54 . . . . 1.34 110.826 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -42.24 114.59 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.495 2.13 . . . . 0.51 112.148 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 25.22 2.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.859 -0.686 . . . . 0.4 112.478 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.9 t -94.71 174.09 7.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 1.01 110.57 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.1 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.75 111.097 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -163.84 -173.4 3.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.732 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.11 159.99 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 3.83 110.966 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.57 131.46 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 1.88 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.58 -48.06 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.242 -0.436 . . . . 1.22 111.568 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -171.39 120.8 0.5 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.732 0.301 . . . . 3.53 111.385 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 43' ' ' ALA . 13.2 p -147.77 160.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 1.79 111.088 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -128.84 142.86 46.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 1.25 111.025 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.42 -22.29 65.26 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.474 2.116 . . . . 1.63 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.98 -73.68 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.361 . . . . 3.06 111.242 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.41 91.72 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.779 -0.725 . . . . 0.79 112.354 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.39 171.54 8.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.514 0.197 . . . . 1.07 110.722 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.71 116.45 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.903 2.402 . . . . 0.65 111.95 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 42' ' ' VAL . 2.7 p -111.66 139.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 1.15 111.315 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -101.68 130.79 48.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.604 . . . . 2.03 110.504 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.8 pt -97.26 147.09 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 1.12 111.008 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.73 119.83 40.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 2.13 110.804 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' OG1' ' CG1' ' A' ' 56' ' ' VAL . 17.4 p -127.15 -163.19 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.28 111.205 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -48.31 97.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.079 0.466 . . . . 3.43 111.867 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 43.57 34.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 4.67 112.286 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 12.2 p -159.94 125.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.968 0.413 . . . . 1.87 111.197 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -105.94 112.49 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 1.07 111.271 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.73 171.13 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 2.1 110.553 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -123.32 132.29 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.41 -0.359 . . . . 1.11 111.198 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -135.75 166.39 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.516 . . . . 1.56 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.2 mtt180 -123.54 146.79 47.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 3.81 110.601 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.3 tpmt? -50.01 -25.11 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.368 . . . . 5.09 111.021 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.88 -30.0 40.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 2.72 110.578 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' OD1' ' CD1' ' A' ' 22' ' ' TYR . 21.2 t70 -81.35 -36.63 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 2.3 110.719 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.7 mp -61.69 -22.11 65.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 1.41 110.928 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.13 61.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 1.2 111.192 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.66 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 1.16 110.968 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -65.71 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 1.12 110.78 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -99.04 146.14 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.29 111.109 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.0 mm? -116.52 149.89 38.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 2.39 110.681 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -129.88 150.24 51.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 2.24 110.974 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.97 171.57 12.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 1.34 111.23 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.4 m -77.57 176.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.76 111.022 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 -52.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 2.28 111.034 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 5.77 110.916 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.779 0.324 . . . . 5.58 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -171.79 -179.05 2.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 3.52 110.995 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 13.5 p90 -118.86 128.29 54.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 2.96 111.099 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -100.08 154.89 36.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 1.3 110.908 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.72 83.54 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.394 2.063 . . . . 0.77 112.484 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.3 t70 178.71 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 2.69 110.897 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 t -90.77 159.35 16.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 2.32 111.11 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.03 169.25 11.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 1.16 111.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 60.6 m95 -151.58 154.82 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.84 111.107 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -95.37 131.33 41.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 2.52 110.982 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.4 mt -83.05 125.33 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.21 111.242 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 p -133.09 58.82 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 1.64 110.534 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.26 91.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.742 -0.663 . . . . 0.45 112.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.05 94.85 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.93 110.344 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -97.89 -172.56 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 1.26 111.247 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -24.31 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 3.96 110.695 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -158.5 37.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.048 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.15 128.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 1.17 111.311 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.3 m -77.61 157.04 80.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 2.01 111.096 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.36 -26.68 24.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.583 2.188 . . . . 0.68 112.491 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.76 -47.11 59.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.351 -0.386 . . . . 1.32 110.724 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -86.22 -38.39 17.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.915 -0.584 . . . . 2.53 110.954 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -66.95 -58.19 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 2.02 111.405 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -44.82 -30.5 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 3.29 111.517 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.36 -40.97 73.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 3.07 111.053 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.24 -50.87 19.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 1.94 110.64 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.33 -35.49 60.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 1.45 110.856 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.2 m -78.25 -27.47 47.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 2.09 111.038 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.39 -25.06 39.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 2.13 110.846 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.07 5.96 43.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.807 -0.711 . . . . 0.82 113.103 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -98.74 96.13 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 2.97 110.931 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -104.96 158.73 31.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 1.34 110.454 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -39.59 105.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.576 2.184 . . . . 0.51 112.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 33.95 0.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.4 112.294 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -106.42 174.44 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.602 0.239 . . . . 1.01 110.525 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 p -129.13 144.98 51.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.866 0.365 . . . . 1.75 111.012 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -152.04 168.41 25.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.021 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -115.56 140.61 49.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 3.83 110.517 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.31 131.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.387 -0.37 . . . . 1.88 111.22 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.07 -39.61 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.428 . . . . 1.22 111.324 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.404 ' O ' ' CG2' ' A' ' 49' ' ' VAL . 37.3 ptt180 -179.73 121.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 3.53 110.801 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -145.02 159.5 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 1.79 111.152 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -112.61 155.45 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 1.25 111.02 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.98 -22.23 15.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.584 2.189 . . . . 1.63 112.367 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.9 -62.21 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 3.06 111.094 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.8 103.13 0.18 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.79 112.208 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -147.97 170.45 7.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.666 0.269 . . . . 1.07 111.039 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.17 119.01 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.848 2.366 . . . . 0.65 111.587 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 41' ' ' ARG . 2.7 p -115.06 149.35 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 1.15 111.406 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -99.55 146.46 26.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 2.03 110.995 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.6 pt -112.08 138.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.12 110.842 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.1 131.44 54.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 2.13 110.91 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 p -137.35 -173.05 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 1.28 110.991 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -52.83 91.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 3.43 111.3 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 54.04 39.11 30.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 4.67 111.57 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -156.86 111.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 1.87 110.976 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -105.32 107.92 19.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 1.07 111.071 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 58.5 tp -98.95 159.96 14.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 2.1 111.022 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 8.6 p -113.89 135.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 1.11 111.009 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.93 141.12 52.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 1.56 110.979 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -106.96 151.61 25.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 3.81 110.97 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -47.38 -29.87 2.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 5.09 111.463 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.34 -25.4 36.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 2.72 110.777 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' ARG . 12.3 t70 -78.05 -30.69 49.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 2.3 110.48 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' N ' HD11 ' A' ' 65' ' ' LEU . 7.8 mp -75.55 -21.91 57.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.142 -0.481 . . . . 1.41 111.124 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.87 71.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 1.2 111.36 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.95 -61.74 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 1.16 111.204 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -65.68 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.287 -0.415 . . . . 1.12 111.031 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -98.49 155.85 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 2.29 110.859 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.1 tp -125.04 157.48 36.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 2.39 110.561 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.42 149.93 33.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.24 110.83 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.29 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 1.34 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.35 -174.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 1.76 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.79 113.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 2.28 111.298 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 5.77 110.639 179.669 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ptp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.828 0.347 . . . . 5.58 110.844 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -148.29 117.3 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 3.52 110.909 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.44 99.11 12.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 2.96 110.721 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 p -102.43 151.46 38.19 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 1.3 111.338 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.87 91.06 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.563 2.176 . . . . 0.77 112.489 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 176.6 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 2.69 110.912 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -106.31 144.14 33.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 2.32 110.984 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.33 165.32 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 1.16 111.128 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -155.2 153.91 31.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.84 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 35' ' ' SER . 49.8 mtmt -113.59 138.68 49.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 2.52 111.25 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.3 mt -79.12 123.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 1.21 111.265 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 p -131.78 59.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 1.64 110.554 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.64 97.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.838 -0.696 . . . . 0.45 112.44 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -145.09 96.92 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.371 . . . . 0.93 111.125 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -114.12 153.57 29.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.26 110.698 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -25.01 9.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 3.96 110.57 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.3 39.72 0.67 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 2.48 110.783 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -42.72 105.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.076 0.465 . . . . 1.17 111.468 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -63.42 146.8 96.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 2.01 110.806 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.3 Cg_endo -58.64 -30.31 91.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.721 2.281 . . . . 0.68 112.131 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -45.33 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 1.32 110.937 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.39 -42.02 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 2.53 111.249 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -60.76 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 2.02 111.269 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.3 mm-40 -54.88 -22.12 13.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.34 -0.391 . . . . 3.29 111.456 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -69.2 -42.93 75.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.331 . . . . 3.07 110.823 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.1 mt -52.14 -34.42 44.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 1.94 110.725 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.83 -27.73 44.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 1.45 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -49.0 -38.11 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 2.09 111.121 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 29' ' ' LEU . 3.1 mm? -107.11 -21.24 13.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.13 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.28 29.63 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.737 -0.744 . . . . 0.82 112.531 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -88.57 92.71 9.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.749 0.309 . . . . 2.97 110.791 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.4 mp -83.04 158.98 63.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 1.34 110.825 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.36 107.27 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.328 2.019 . . . . 0.51 112.112 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.71 32.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.855 -0.688 . . . . 0.4 112.518 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 10' ' ' LYS . 46.7 t -104.76 174.18 5.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.71 0.291 . . . . 1.01 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -116.04 154.54 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.334 -0.394 . . . . 1.75 111.169 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CD2' ' CG2' ' A' ' 51' ' ' ILE . 30.0 p90 -165.04 169.96 15.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.44 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -124.69 134.55 52.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 3.83 111.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.0 m -83.87 132.32 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.88 111.16 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.69 -49.71 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.22 111.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 3.53 110.892 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' CG2' ' A' ' 49' ' ' VAL . 13.1 t -143.55 159.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.79 111.189 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.416 ' CB ' ' OD1' ' A' ' 47' ' ' ASP . . . -127.26 144.95 52.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 1.25 110.944 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.06 -18.23 31.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.476 2.117 . . . . 1.63 112.596 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.42 -55.17 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 3.06 111.15 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.68 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.79 112.272 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 4.8 m-20 -143.43 170.66 8.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.67 0.271 . . . . 1.07 111.118 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.94 117.14 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.933 2.422 . . . . 0.65 111.924 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 50' ' ' HIS . 2.0 p -106.62 156.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 1.15 110.935 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.436 ' N ' HG21 ' A' ' 49' ' ' VAL . 47.0 m-70 -115.58 131.91 56.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 2.03 110.798 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 37.5 pt -101.73 142.43 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 1.12 111.097 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -107.33 124.53 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 2.13 110.709 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.6 p -132.1 -173.52 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 1.28 111.278 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -41.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.105 0.409 . . . . 3.43 112.105 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 44.15 51.0 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.906 -0.588 . . . . 4.67 111.886 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.2 p 179.71 119.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 1.87 111.201 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -102.33 112.57 25.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.07 110.946 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 47.7 tp -92.0 162.77 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 2.1 110.615 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 12.6 p -112.29 145.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 1.11 111.244 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.03 147.06 41.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 1.56 110.847 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.3 mtt180 -107.65 150.51 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.81 110.908 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.89 -25.95 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.919 -0.582 . . . . 5.09 111.226 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -81.08 -27.76 35.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 2.72 110.826 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.5 -31.59 47.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 2.3 110.974 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.3 mp -72.79 -21.17 61.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 1.41 111.008 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.77 71.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 1.2 111.146 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.38 -61.69 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.16 111.042 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 pt -66.08 148.98 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.415 . . . . 1.12 110.962 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -102.35 153.81 19.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 2.29 110.733 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.1 mm? -115.96 149.58 38.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 2.39 110.866 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.32 110.72 9.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 2.24 110.957 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 155.34 1.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 1.34 111.0 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.81 163.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 1.76 111.278 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.17 128.91 35.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 2.28 110.908 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 5.77 110.956 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.4 mtp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.866 0.365 . . . . 5.58 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.47 167.45 18.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 3.52 110.902 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.15 104.84 12.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 2.96 110.788 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.4 p -99.88 155.97 35.86 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 1.3 111.143 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.3 87.27 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.502 2.135 . . . . 0.77 112.289 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 t70 177.77 -57.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 2.69 110.965 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -77.32 135.9 38.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 2.32 110.804 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.42 157.65 28.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 1.16 111.327 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 71.9 m95 -141.37 167.62 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.84 110.804 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.1 136.57 51.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 2.52 111.165 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.47 136.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 1.21 110.742 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 14' ' ' PHE . 12.7 m -143.83 46.52 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 1.64 110.825 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.85 90.32 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.881 -0.676 . . . . 0.45 112.657 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' THR . 69.3 t80 -146.68 102.69 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.93 110.732 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -97.94 -179.12 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.26 111.115 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.2 mpt_? -75.25 -24.85 57.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 3.96 110.629 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.95 38.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 2.48 110.63 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -42.88 131.7 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.038 -0.528 . . . . 1.17 111.737 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.8 m -92.47 157.4 40.27 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 2.01 110.784 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 24' ' ' GLN . 11.7 Cg_endo -54.44 -32.75 74.5 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.638 2.225 . . . . 0.68 112.093 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.08 -46.69 34.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.07 0.462 . . . . 1.32 110.771 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -85.95 -49.96 7.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.823 -0.626 . . . . 2.53 110.558 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.48 -61.23 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 2.02 111.064 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.4 tt0 -47.51 -32.42 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 3.29 111.055 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.66 -55.9 28.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.07 110.752 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.5 -45.15 92.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 1.94 110.817 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.45 -53.36 37.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 1.45 111.113 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -49.92 -29.91 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 2.09 111.085 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -91.88 -25.42 18.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 2.13 110.94 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.06 31.35 9.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.698 -0.763 . . . . 0.82 112.874 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.4 mtt -110.3 87.46 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 2.97 110.623 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.8 mp -86.95 161.21 47.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 1.34 110.746 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.78 115.13 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.508 2.138 . . . . 0.51 112.163 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.4 28.58 2.98 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.786 -0.721 . . . . 0.4 112.188 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -96.36 163.16 13.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.638 0.256 . . . . 1.01 110.634 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -110.67 145.3 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 1.75 111.028 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 19.1 p90 -158.28 170.33 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.848 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -120.81 149.75 42.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.107 -0.497 . . . . 3.83 110.991 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -82.17 132.54 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 1.88 111.072 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.0 -33.51 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 1.22 111.522 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 176.41 130.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 3.53 111.22 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 49' ' ' VAL . 51.0 t -139.87 158.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 1.79 111.04 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 47' ' ' ASP . . . -114.63 134.35 22.39 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 1.25 110.859 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.3 -26.3 76.36 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.455 2.103 . . . . 1.63 112.48 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 5.2 mp -91.26 -65.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.427 -0.351 . . . . 3.06 111.215 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.12 106.94 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.79 112.338 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 2.3 m-20 -148.32 173.21 4.39 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.619 0.247 . . . . 1.07 111.05 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.52 120.23 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.65 111.522 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.55 156.02 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.629 -0.714 . . . . 1.15 111.202 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -120.78 134.26 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 2.03 110.525 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 37.3 pt -101.38 137.88 27.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.198 -0.455 . . . . 1.12 110.916 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.7 101.32 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.445 . . . . 2.13 110.887 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.8 p -99.64 -169.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 1.28 110.838 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -56.18 96.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 3.43 111.584 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.3 26.3 8.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 4.67 111.629 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -148.53 114.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 1.87 111.257 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -103.24 107.86 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 1.07 110.779 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 64.5 mt -94.77 174.78 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 2.1 111.006 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.99 131.26 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.975 0.416 . . . . 1.11 111.181 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.8 mt -124.06 165.11 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 1.56 110.789 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -146.05 162.23 38.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 3.81 111.066 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -52.54 -22.33 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 5.09 111.545 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -80.35 -33.67 37.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 2.72 110.624 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.27 -42.55 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 2.3 110.888 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.9 mp -60.47 -24.19 65.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 1.41 111.007 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.92 65.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.401 . . . . 1.2 111.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.15 -57.26 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.362 . . . . 1.16 111.072 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.3 pt -65.94 151.19 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 1.12 111.192 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -103.43 150.51 23.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 2.29 110.722 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.87 142.14 50.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 2.39 111.088 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -124.13 152.72 42.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 2.24 110.906 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.21 -178.51 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 1.34 111.105 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.9 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 1.76 111.084 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.19 -43.21 14.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 2.28 111.065 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 5.77 110.85 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' N ' ' HA ' ' A' ' 44' ' ' PRO . 24.5 mmt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.774 0.321 . . . . 5.58 110.96 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.89 144.9 28.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 3.52 110.832 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 9' ' ' TRP . 62.9 m-85 57.41 96.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 2.96 110.705 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -114.41 161.09 30.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.97 147.55 14.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.77 112.345 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 66.4 18.27 10.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 2.69 111.647 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.5 p -98.74 173.25 6.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.733 0.301 . . . . 2.32 110.651 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.07 142.81 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 1.16 111.122 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.559 ' CD2' ' CE2' ' A' ' 3' ' ' PHE . 32.1 m95 -154.02 162.83 40.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.84 110.696 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -106.33 138.19 42.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 2.52 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.8 mt -77.79 127.4 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 1.21 111.026 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 m -136.05 48.15 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 1.64 110.571 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -46.59 92.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.45 113.046 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -147.08 94.9 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.93 110.668 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.2 t -98.63 -178.76 4.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.26 110.896 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 8.9 mpt_? -79.05 -21.49 46.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 3.96 111.001 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.02 37.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.479 -0.328 . . . . 2.48 111.17 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.8 tt -45.6 126.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.913 0.387 . . . . 1.17 111.396 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -85.36 149.29 51.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 2.01 110.964 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 24' ' ' GLN . 15.6 Cg_endo -56.8 -31.25 87.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.801 2.334 . . . . 0.68 112.257 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.56 -47.11 28.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 1.32 110.858 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -85.79 -43.65 13.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 2.53 110.904 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -60.7 -61.01 2.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 2.02 110.967 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' PRO . 7.7 tp-100 -48.89 -30.35 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 3.29 110.85 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.61 -32.97 73.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 3.07 110.849 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.94 -48.04 26.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 1.94 110.837 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.65 -34.05 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 1.45 111.062 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -53.09 -33.27 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 2.09 110.904 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.3 mp -89.79 -22.95 21.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 2.13 110.823 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.74 23.67 30.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 0.82 112.495 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 39.8 mtm -101.44 91.01 4.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 2.97 110.763 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.6 mp -92.54 159.3 36.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 1.34 110.879 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.04 106.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.637 2.225 . . . . 0.51 112.186 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.18 33.34 0.9 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.798 -0.715 . . . . 0.4 112.454 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.4 t -107.49 171.8 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 1.01 110.829 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -116.05 145.96 42.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 1.75 111.009 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 18.2 p90 -157.62 159.73 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.033 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -109.33 151.62 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 3.83 110.67 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 42' ' ' VAL . 57.6 t -89.37 140.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 1.88 111.221 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.45 -52.22 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 1.22 111.426 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.33 129.13 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 3.53 111.074 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 43' ' ' ALA . 13.3 t -143.2 159.2 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 1.79 111.201 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' ' OD1' ' A' ' 47' ' ' ASP . . . -129.06 145.17 55.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 1.25 110.98 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 33.3 Cg_endo -64.46 -16.97 57.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.568 2.179 . . . . 1.63 112.468 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.0 mm? -89.88 -69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.872 0.367 . . . . 3.06 110.975 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.52 94.17 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.79 112.347 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.477 ' HB2' ' CD ' ' A' ' 48' ' ' PRO . 4.2 p-10 -131.25 178.01 1.95 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.475 0.179 . . . . 1.07 110.711 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' HB2' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.25 118.36 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.938 2.425 . . . . 0.65 111.557 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 50' ' ' HIS . 2.0 p -106.84 157.53 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 1.15 111.293 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 49' ' ' VAL . 31.8 m-70 -117.57 144.92 44.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.642 -0.708 . . . . 2.03 110.463 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.2 135.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 1.12 111.222 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -106.94 112.49 25.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 2.13 110.651 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -118.13 -174.11 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 1.28 111.128 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -50.71 93.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.43 111.283 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.25 37.71 15.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 4.67 111.578 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 89.2 t -152.71 100.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 1.87 110.887 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -97.77 108.42 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 1.07 111.008 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 56.8 tp -108.01 161.26 15.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 2.1 110.935 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 7.4 p -114.59 141.17 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 1.11 111.023 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -126.77 144.11 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 1.56 110.813 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.401 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 56.9 mtp180 -107.92 152.67 24.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 3.81 111.171 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.81 -33.12 9.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 5.09 111.713 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.98 -22.88 36.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 2.72 111.073 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.96 -23.55 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 2.3 110.931 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 9.6 mp -79.5 -28.93 41.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 1.41 110.965 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -24.27 52.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 1.2 111.071 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.54 -61.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 1.16 110.917 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.403 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 22.4 pt -65.65 151.86 9.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 1.12 110.819 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -105.48 142.54 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 2.29 111.426 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.2 mm? -110.16 125.64 53.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.969 -0.559 . . . . 2.39 110.455 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.44 124.01 45.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.72 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.1 152.44 7.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.028 -0.533 . . . . 1.34 111.199 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.78 177.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 1.76 111.281 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.39 -50.55 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 2.28 110.993 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 5.77 110.854 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.885 0.374 . . . . 5.58 110.968 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -132.72 139.52 47.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 3.52 110.852 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' HB2' ' CE2' ' A' ' 9' ' ' TRP . 37.0 p90 -121.6 112.74 18.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 2.96 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.0 p -81.18 153.1 71.73 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 1.3 111.194 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HA ' ' CG1' ' A' ' 39' ' ' VAL . 60.4 Cg_endo -72.0 81.7 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.454 2.103 . . . . 0.77 112.013 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -176.58 -42.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 2.69 110.94 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -90.18 154.64 19.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 2.32 110.884 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.54 170.12 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 1.16 111.034 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 52.0 m95 -155.63 175.69 13.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.84 110.911 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.3 134.02 54.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 2.52 111.094 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 34' ' ' GLY . 58.9 mt -80.74 123.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 1.21 111.028 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 14' ' ' PHE . 19.5 m -133.89 53.46 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.115 0.484 . . . . 1.64 110.509 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.57 88.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.885 -0.598 . . . . 0.45 112.826 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' THR . 19.4 t80 -147.21 107.6 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.93 111.046 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 m -108.66 164.36 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 1.26 110.842 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -22.8 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 3.96 110.976 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -164.1 42.45 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.712 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -44.3 134.17 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 1.17 111.558 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 m -84.6 155.81 62.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 2.01 110.971 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' GLN . 24.9 Cg_endo -62.05 -29.72 81.84 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.605 2.204 . . . . 0.68 112.421 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.08 -45.28 64.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 1.32 110.646 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.38 -41.99 14.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 2.53 110.798 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -65.51 -61.41 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 2.02 110.999 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' PRO . 12.9 mm100 -52.82 -22.95 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 3.29 111.255 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -73.5 -40.41 64.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 3.07 110.796 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.5 -44.04 95.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 1.94 110.895 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.56 -25.79 4.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 1.45 110.978 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.6 m -53.59 -35.37 60.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 2.09 111.015 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.8 mm? -94.02 -25.21 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 2.13 110.852 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.4 56.16 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.82 112.835 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -88.95 98.51 11.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.923 0.392 . . . . 2.97 110.687 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 32' ' ' LEU . 6.3 mp -83.3 159.66 61.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 1.34 110.544 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.05 149.77 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.47 2.113 . . . . 0.51 111.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . 77.65 17.95 78.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.693 -0.765 . . . . 0.4 112.342 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 t -77.74 174.04 11.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.601 0.239 . . . . 1.01 110.446 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -121.23 136.0 55.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 1.75 110.91 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.8 p90 -151.72 173.65 14.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.085 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -127.75 158.42 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 3.83 110.839 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 5' ' ' PRO . 46.4 t -95.02 128.59 46.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 1.88 111.248 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.2 -38.63 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 1.22 111.05 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -178.74 123.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 3.53 111.003 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.9 p -143.61 160.87 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 1.79 111.218 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -125.16 153.79 71.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 1.25 110.994 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.97 -14.55 9.77 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.592 2.195 . . . . 1.63 112.911 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 46' ' ' GLY . 4.4 pp -85.32 -18.95 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.606 -0.27 . . . . 3.06 111.287 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' N ' HD13 ' A' ' 45' ' ' LEU . . . 114.93 88.45 1.56 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.687 -0.768 . . . . 0.79 112.297 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.432 ' OD2' ' CD1' ' A' ' 45' ' ' LEU . 7.3 m-20 -137.52 171.94 7.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.605 0.24 . . . . 1.07 110.897 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.3 115.94 1.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.832 2.355 . . . . 0.65 111.72 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.54 138.44 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.67 -0.695 . . . . 1.15 111.025 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -95.91 136.01 36.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.919 -0.582 . . . . 2.03 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.62 134.64 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.12 110.962 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.26 120.54 42.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 2.13 111.015 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 74.3 p -124.46 -173.65 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.28 110.657 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -49.57 92.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 3.43 111.328 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 34.0 mmt180 53.09 40.9 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.808 -0.633 . . . . 4.67 111.488 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 55' ' ' ARG . 66.7 t -157.45 105.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 1.87 111.025 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -104.88 107.52 18.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 1.07 110.9 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.7 tp -100.73 160.19 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 2.1 110.644 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.43 142.94 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 1.11 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 65' ' ' LEU . 57.1 tp -137.52 141.92 41.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 1.56 110.82 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -114.84 179.46 3.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 3.81 110.62 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -75.62 -48.85 20.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.521 -0.308 . . . . 5.09 111.513 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -51.57 -34.44 36.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 2.72 110.567 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.52 -25.48 33.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 2.3 110.434 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.422 ' CD2' HD23 ' A' ' 60' ' ' LEU . 10.0 mt -74.86 -25.46 58.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.052 -0.522 . . . . 1.41 111.038 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.89 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 1.2 111.108 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -84.92 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.254 -0.43 . . . . 1.16 110.983 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 20.4 pt -65.97 155.95 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 1.12 111.283 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -107.72 135.37 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 2.29 110.776 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 70' ' ' LEU . 2.8 mm? -105.21 152.32 23.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 2.39 111.11 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.98 121.21 10.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 2.24 110.707 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.75 166.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 1.34 111.22 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.28 148.64 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 1.76 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.83 171.24 7.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 2.28 111.122 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.437 ' N ' ' NE2' ' A' ' 75' ' ' GLN . 1.3 mp0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 5.77 110.961 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.96 0.41 . . . . 5.58 110.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -139.26 164.8 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 3.52 110.757 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.443 ' CE2' HG23 ' A' ' 42' ' ' VAL . 28.5 p90 -147.93 111.76 5.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 2.96 110.984 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.0 p -79.39 155.35 76.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 1.3 110.954 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HA ' ' CG1' ' A' ' 39' ' ' VAL . 65.5 Cg_endo -74.08 89.64 1.02 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.488 2.125 . . . . 0.77 112.46 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 t70 177.94 -43.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 2.69 111.048 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -87.64 144.24 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 2.32 110.914 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 158.59 32.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 1.16 111.131 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' CZ2' ' CB ' ' A' ' 3' ' ' PHE . 72.5 m95 -145.79 158.11 43.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.84 110.877 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -108.85 138.35 45.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 2.52 110.91 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -80.65 137.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 1.21 111.141 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -141.69 56.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.939 -0.573 . . . . 1.64 110.253 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.22 90.08 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.45 112.875 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -146.43 94.69 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.93 110.433 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -100.85 150.28 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 1.26 111.204 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.55 -22.47 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.616 . . . . 3.96 111.067 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -149.0 34.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.782 0.325 . . . . 2.48 111.151 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -43.94 148.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.389 -0.369 . . . . 1.17 111.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 m -96.01 155.85 37.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 2.01 110.985 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 24' ' ' GLN . 38.8 Cg_endo -66.91 -32.25 36.26 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.461 2.108 . . . . 0.68 112.093 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.98 -44.97 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 1.32 110.433 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.49 -48.17 9.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 2.53 110.325 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -56.98 -61.35 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 2.02 111.022 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -51.47 -34.83 37.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 3.29 111.081 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -60.82 -41.17 95.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.366 -0.379 . . . . 3.07 111.29 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 26' ' ' LEU . 10.8 mp -74.22 -52.69 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 1.94 111.157 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -46.35 -37.1 7.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 1.45 111.513 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -69.31 -23.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 2.09 111.339 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.0 mt -96.87 -24.18 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.438 -0.347 . . . . 2.13 111.055 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.75 7.44 53.35 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.68 -0.771 . . . . 0.82 113.035 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 31' ' ' MET . 1.1 mpt? -89.97 90.67 8.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.891 0.377 . . . . 2.97 110.736 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.7 mp -94.69 160.55 31.15 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.788 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -45.38 122.76 4.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.266 1.977 . . . . 0.51 111.847 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.04 23.8 6.88 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.884 -0.674 . . . . 0.4 112.071 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 t -87.73 174.05 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 1.01 110.892 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -123.58 144.97 49.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 1.75 111.009 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' ' 51' ' ' ILE . 20.7 p90 -158.98 -177.94 6.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.44 110.891 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -131.8 132.5 43.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 3.83 111.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 5' ' ' PRO . 7.1 p -78.31 135.62 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 1.88 111.025 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.87 -52.21 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.489 -0.323 . . . . 1.22 111.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -153.84 139.03 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 3.53 111.186 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 HG23 ' CE2' ' A' ' 3' ' ' PHE . 20.6 t -148.59 158.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 1.79 111.108 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -126.11 143.34 45.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.25 111.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 45.2 Cg_endo -68.33 -21.41 41.25 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.647 2.231 . . . . 1.63 112.468 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.8 mm? -89.88 -56.1 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 3.06 111.111 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.12 107.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.79 112.332 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 3.0 m-20 -148.17 170.66 7.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.637 0.256 . . . . 1.07 111.07 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.72 118.12 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.985 2.456 . . . . 0.65 111.77 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.8 p -106.79 160.78 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 1.15 110.881 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 57.4 m80 -123.47 135.74 54.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 2.03 110.98 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 37.1 pt -102.04 139.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.983 -0.553 . . . . 1.12 110.855 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.68 108.88 19.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 2.13 111.014 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 61.9 p -111.14 -175.3 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 1.28 110.703 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -47.68 91.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.43 111.48 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 32.9 mmt180 53.01 36.06 21.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.046 -0.524 . . . . 4.67 111.396 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.87 112.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 1.87 111.052 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -105.07 107.57 18.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.07 110.643 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.72 157.31 17.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.162 -0.472 . . . . 2.1 110.951 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.405 HG22 ' CD2' ' A' ' 50' ' ' HIS . 13.8 p -102.62 143.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 1.11 111.047 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -139.07 117.58 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 1.56 110.777 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -92.48 169.78 10.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 3.81 110.797 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.94 -27.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 5.09 111.338 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -84.25 -42.43 15.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.38 . . . . 2.72 111.17 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 -34.35 65.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 2.3 110.973 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.7 mp -81.27 -21.14 39.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 1.41 111.134 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.63 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 1.2 111.263 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.65 -65.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 1.16 111.378 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.4 pt -65.08 140.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.482 -0.326 . . . . 1.12 110.967 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.85 154.96 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 2.29 110.697 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -116.43 158.07 24.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 2.39 110.774 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -146.24 154.39 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.24 111.083 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.81 169.17 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 1.34 111.122 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 m -98.99 -178.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 1.76 110.998 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' CB ' ' OE1' ' A' ' 75' ' ' GLN . . . -133.97 -58.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 2.28 111.176 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.424 ' OE1' ' CB ' ' A' ' 74' ' ' ALA . 5.0 pm0 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.359 -0.382 . . . . 5.77 110.923 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.898 0.38 . . . . 5.58 110.841 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -81.47 171.04 15.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.051 -0.522 . . . . 3.52 110.731 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 61.9 m-85 -76.89 106.73 8.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.337 -0.392 . . . . 2.96 110.836 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -118.54 152.39 51.04 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 1.3 111.209 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.07 84.46 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.663 2.242 . . . . 0.77 112.34 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -179.97 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.293 -0.412 . . . . 2.69 110.901 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.1 t -103.07 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 2.32 110.629 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.93 169.22 8.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 1.16 111.101 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.475 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 78.7 m95 -146.41 168.34 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.84 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -124.24 138.05 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 2.52 111.129 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.1 mt -80.2 118.14 27.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.159 -0.473 . . . . 1.21 111.159 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 m -130.37 53.17 1.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 1.64 110.388 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA3' ' NH2' ' A' ' 23' ' ' ARG . . . -48.83 96.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.45 112.627 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -145.53 95.95 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.93 110.935 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -111.88 158.03 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.013 -0.539 . . . . 1.26 110.778 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -51.78 -24.36 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 3.96 110.729 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -158.29 42.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.789 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -41.07 128.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.219 -0.446 . . . . 1.17 111.802 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.0 t -80.22 147.38 64.68 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 2.01 110.782 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.3 Cg_endo -62.62 -28.43 76.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.625 2.216 . . . . 0.68 112.501 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.02 -43.79 50.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 1.32 111.052 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -85.29 -45.49 11.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 2.53 111.2 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.435 ' NH2' ' HA3' ' A' ' 13' ' ' GLY . 18.3 tpp180 -67.58 -61.46 1.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 2.02 111.43 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 11.1 mm100 -55.93 -19.59 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 3.29 111.629 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -80.25 -36.77 34.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 3.07 110.993 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.74 -32.6 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 1.94 110.982 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -57.24 -33.73 67.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.45 111.254 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.1 m -64.04 -39.63 94.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 2.09 110.997 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 2.6 mm? -78.01 -23.23 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 2.13 111.059 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.79 20.52 10.63 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.771 . . . . 0.82 112.593 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.72 98.24 9.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 2.97 110.988 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -102.51 157.93 32.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 1.34 110.675 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.46 111.19 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.391 2.061 . . . . 0.51 111.803 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 21.39 4.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 0.4 112.36 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -88.02 166.26 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.303 . . . . 1.01 110.639 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -121.85 156.92 32.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 1.75 111.044 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 51.9 p90 -166.64 178.82 5.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.488 . . . . 0.44 110.831 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -128.3 125.61 39.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 3.83 111.098 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.17 134.59 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 1.88 111.263 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.64 -52.09 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 1.22 111.34 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -148.66 133.71 18.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 3.53 111.083 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 49' ' ' VAL . 41.4 t -146.0 160.39 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.247 -0.433 . . . . 1.79 111.396 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' N ' HG11 ' A' ' 42' ' ' VAL . . . -154.83 124.4 3.18 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.512 . . . . 1.25 110.737 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.05 -24.45 49.12 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.475 2.117 . . . . 1.63 112.491 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -63.45 -22.87 67.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 3.06 111.067 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.06 73.65 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.572 -0.823 . . . . 0.79 112.11 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -122.4 170.11 8.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.731 0.301 . . . . 1.07 111.172 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.93 120.34 2.28 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.975 2.45 . . . . 0.65 111.724 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.6 p -106.74 159.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.783 -0.644 . . . . 1.15 111.123 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 80.8 m80 -123.32 123.53 40.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 2.03 110.804 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.405 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 47.7 pt -97.16 141.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 1.12 111.021 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -106.67 120.89 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.342 -0.39 . . . . 2.13 110.828 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.42 ' OG1' ' CG1' ' A' ' 56' ' ' VAL . 27.1 p -122.63 -163.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.884 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -46.45 93.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.067 0.461 . . . . 3.43 111.732 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' THR . 25.7 mmm180 44.44 28.59 0.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.81 -0.632 . . . . 4.67 112.121 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.42 ' CG1' ' OG1' ' A' ' 53' ' ' THR . 11.9 p -152.55 113.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 1.87 110.838 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -93.84 118.9 32.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 1.07 111.315 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 tp -99.54 150.23 22.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 2.1 110.653 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -104.83 134.32 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.394 . . . . 1.11 111.296 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -143.33 155.62 44.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 1.56 110.721 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 70.4 mtm180 -110.63 160.4 16.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.88 0.371 . . . . 3.81 110.898 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -44.05 -28.2 0.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 5.09 111.585 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 21.8 ptmt -80.73 -35.53 33.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 2.72 110.88 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 7.3 m-20 -68.62 -31.49 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 2.3 111.134 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 65' ' ' LEU . 5.8 mp -86.42 -25.69 25.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 1.41 111.266 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.63 -58.43 6.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 1.2 111.468 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.93 -59.05 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 1.16 111.188 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.22 151.96 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.411 . . . . 1.12 111.47 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -95.78 136.15 36.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.573 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 70' ' ' LEU . 2.5 mm? -110.0 139.71 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 2.39 110.991 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.81 118.01 19.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 2.24 110.817 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.89 148.16 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 1.34 111.073 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.0 -176.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 1.76 111.136 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.19 116.89 8.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 2.28 111.187 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 5.77 110.882 179.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 tpp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.817 0.341 . . . . 5.58 110.997 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -76.36 142.36 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 3.52 111.046 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -98.44 92.44 5.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 2.96 110.601 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -88.41 154.66 51.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 1.3 111.276 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.85 92.89 0.78 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.507 2.138 . . . . 0.77 112.354 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 176.29 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.535 . . . . 2.69 110.702 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -104.41 146.4 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 2.32 110.79 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.37 170.21 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.16 111.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 35.2 m95 -155.41 160.4 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.84 110.797 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -114.65 138.62 50.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 2.52 111.125 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -79.33 129.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 1.21 111.191 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.8 p -134.72 58.73 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 1.64 110.508 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.8 96.39 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.665 -0.698 . . . . 0.45 112.696 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -147.16 98.55 3.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.93 110.875 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.9 m -112.32 161.94 16.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 1.26 110.829 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -22.44 34.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.314 -0.403 . . . . 3.96 110.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -162.7 44.4 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 2.48 110.861 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -45.94 128.67 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 1.17 111.494 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -81.61 154.99 71.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.01 110.776 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.9 Cg_endo -63.65 -28.19 69.2 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.615 2.21 . . . . 0.68 112.241 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.34 -45.32 45.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 1.32 110.823 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 95.3 m-85 -85.46 -49.24 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 2.53 110.503 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -57.74 -61.27 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 2.02 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' A' ' 27' ' ' LEU . 27.9 mm-40 -51.02 -34.13 28.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 3.29 110.731 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -51.75 -53.27 41.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 3.07 110.949 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.03 -43.4 95.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 1.94 111.088 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' A' ' 24' ' ' GLN . 84.0 mt -48.78 -26.51 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 1.45 111.186 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.4 t -69.56 -34.03 73.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 2.09 110.974 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -94.34 -24.53 17.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 2.13 110.921 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.58 9.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.653 -0.784 . . . . 0.82 112.55 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.9 mtt -99.32 91.47 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 2.97 111.018 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.1 mp -92.32 158.02 39.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 1.34 110.561 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.87 118.72 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.481 2.121 . . . . 0.51 112.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.11 31.02 3.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.825 -0.702 . . . . 0.4 112.398 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.6 t -95.57 173.89 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 1.01 110.875 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -121.84 148.94 44.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.75 110.943 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 36.1 p90 -162.22 173.1 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.732 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -128.56 130.33 47.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.956 0.408 . . . . 3.83 111.233 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 m -80.01 138.38 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.88 110.994 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.62 -40.49 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 1.22 111.426 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -164.67 129.36 2.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.377 -0.374 . . . . 3.53 110.913 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.445 HG22 ' CG2' ' A' ' 49' ' ' VAL . 10.0 t -138.14 159.15 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 1.79 111.159 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.408 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -122.32 146.23 46.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.25 110.995 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.06 -14.85 26.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.573 2.182 . . . . 1.63 112.592 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -93.6 -50.32 5.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 3.06 111.078 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.25 95.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.873 -0.68 . . . . 0.79 112.259 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.52 170.2 11.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.791 0.329 . . . . 1.07 111.151 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.98 116.6 1.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.01 2.473 . . . . 0.65 111.694 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 152.34 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.929 -0.578 . . . . 1.15 110.923 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.422 ' N ' HG22 ' A' ' 49' ' ' VAL . 73.1 m80 -110.44 131.6 54.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 2.03 110.517 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.65 139.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 1.12 111.227 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -108.14 114.46 28.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 2.13 110.639 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.4 p -113.37 -173.82 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 1.28 111.142 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -52.69 99.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 3.43 111.542 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 52.11 29.42 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 4.67 111.651 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.1 t -149.4 128.48 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.87 111.16 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -109.92 107.78 17.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 1.07 110.969 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 tp -105.0 156.71 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.1 111.235 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.99 132.86 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 1.11 111.182 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.2 mt -118.18 140.32 49.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 1.56 110.677 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 94.0 mtt180 -107.35 149.21 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 3.81 110.959 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -27.93 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.976 -0.556 . . . . 5.09 111.498 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -82.17 -29.94 31.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 2.72 110.938 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 19.5 t70 -72.47 -30.18 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 2.3 110.863 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.7 mp -79.74 -29.7 40.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 1.41 110.801 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.46 -23.7 10.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 1.2 111.231 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 22' ' ' TYR . 67.7 mt -97.55 -63.75 1.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.438 . . . . 1.16 111.146 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.413 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 44.6 pt -65.12 152.99 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 1.12 111.081 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.01 153.27 21.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.954 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 70' ' ' LEU . 3.0 mm? -112.15 148.59 33.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 2.39 110.591 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -131.19 128.67 40.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.331 . . . . 2.24 110.853 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 156.27 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 1.34 111.288 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -61.81 178.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.079 -0.51 . . . . 1.76 111.154 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.69 125.31 49.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 2.28 111.28 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 5.77 110.824 179.877 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mmm . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.755 0.312 . . . . 5.58 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -77.78 -179.44 5.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 3.52 110.974 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CE1' HD23 ' A' ' 70' ' ' LEU . 51.8 m-85 -112.66 112.16 23.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 2.96 110.723 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -113.33 155.21 44.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 1.3 111.642 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.96 89.55 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.564 2.176 . . . . 0.77 112.024 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -179.98 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 2.69 110.631 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -94.07 143.98 25.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 2.32 110.729 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.17 160.18 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 1.16 111.157 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 23.3 m95 -149.37 164.1 35.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.84 110.674 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -114.2 136.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 2.52 111.12 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.4 mt -78.19 134.42 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 1.21 111.045 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 m -136.26 57.88 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 1.64 110.614 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.3 87.42 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.45 112.937 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.07 94.76 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.376 . . . . 0.93 110.713 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.6 m -101.27 -174.93 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 1.26 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -26.67 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 3.96 110.947 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.91 29.6 1.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.078 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 tt -43.69 119.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.401 . . . . 1.17 111.413 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 p -80.64 156.58 72.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.031 -0.532 . . . . 2.01 110.756 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.9 Cg_endo -58.33 -30.83 92.34 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.593 2.195 . . . . 0.68 112.399 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.84 59.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 1.32 110.758 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -85.75 -37.65 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 2.53 111.118 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.09 -61.56 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 2.02 111.121 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 20' ' ' PRO . 6.3 tp-100 -56.58 -20.59 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 3.29 111.366 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -69.88 -50.43 42.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.842 0.353 . . . . 3.07 110.677 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.16 -37.71 80.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 1.94 110.984 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.6 mt -54.24 -25.73 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.45 111.317 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -52.42 -45.5 65.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 2.09 110.937 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 2.4 mm? -96.91 -22.67 16.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 2.13 111.103 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.34 23.82 8.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.82 112.255 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 50.4 mtm -84.15 89.81 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 2.97 111.149 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -97.39 158.49 33.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 1.34 110.836 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.89 109.32 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.443 2.095 . . . . 0.51 111.973 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.16 29.15 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.703 -0.761 . . . . 0.4 112.439 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -96.65 174.19 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 1.01 110.614 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.2 p -121.49 143.59 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 1.75 110.93 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 6.8 p90 -156.81 -176.58 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.44 110.946 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -140.09 134.81 31.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 3.83 110.985 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' CG1' HG21 ' A' ' 42' ' ' VAL . 59.0 t -64.81 136.48 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 1.88 111.081 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.5 t -94.26 -40.74 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 1.22 111.221 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -175.57 124.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.038 0.447 . . . . 3.53 111.17 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 49' ' ' VAL . 21.2 t -137.42 157.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.59 . . . . 1.79 111.131 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -116.91 154.51 49.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 1.25 110.988 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.76 -19.34 18.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.565 2.177 . . . . 1.63 112.525 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.47 -67.46 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 3.06 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.08 105.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.809 -0.71 . . . . 0.79 112.365 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -148.14 171.27 6.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.536 0.207 . . . . 1.07 111.228 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.06 120.06 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.74 2.293 . . . . 0.65 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CB ' HG23 ' A' ' 42' ' ' VAL . 1.8 p -106.26 152.79 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.612 -0.722 . . . . 1.15 111.013 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -109.82 135.86 50.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.605 -0.725 . . . . 2.03 110.398 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.9 pt -93.82 145.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 1.12 111.039 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -106.84 109.18 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 2.13 110.71 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -114.94 -170.2 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 1.28 111.167 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 25.3 tpp180 -48.96 96.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.43 111.333 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 35.2 ptt180 45.71 33.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 4.67 111.884 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -151.44 116.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 1.87 110.993 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.6 p -103.04 109.99 21.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 1.07 110.907 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.62 170.92 9.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 2.1 111.04 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.76 140.92 33.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.07 -0.514 . . . . 1.11 111.206 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -135.39 120.94 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.362 -0.381 . . . . 1.56 111.181 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -65.83 -168.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.81 110.551 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -81.35 -36.7 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.435 -0.348 . . . . 5.09 111.455 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -86.1 -33.27 20.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.72 111.377 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.74 -24.54 2.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.3 110.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 5.9 mp -85.35 -22.09 28.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 1.41 111.284 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.38 90.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.444 -0.344 . . . . 1.2 111.637 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.1 -59.0 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 1.16 111.127 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 pt -65.6 142.42 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 1.12 111.203 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.06 148.69 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 2.29 110.873 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.9 tp -117.01 159.16 22.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 2.39 111.052 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.36 147.65 43.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 2.24 110.911 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.34 166.85 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 1.34 111.004 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -76.78 -176.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 1.76 111.046 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.2 173.46 7.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.28 111.033 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 5.77 110.946 179.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.588 0.232 . . . . 5.58 111.542 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -171.54 126.29 0.62 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.761 0.315 . . . . 3.52 110.616 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -121.24 105.7 10.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 2.96 111.066 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -104.74 155.94 36.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 1.3 111.072 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.51 90.83 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.51 2.14 . . . . 0.77 112.361 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 p30 176.89 -37.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 2.69 110.892 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.0 m -100.96 153.52 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 2.32 110.967 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.52 158.5 15.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 1.16 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 45.2 m95 -139.64 178.05 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.84 110.756 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -125.17 138.1 54.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 2.52 111.279 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.64 125.81 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.21 110.704 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.8 m -139.78 46.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.175 0.512 . . . . 1.64 110.837 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.7 86.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.845 -0.693 . . . . 0.45 112.598 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' THR . 92.0 t80 -143.14 94.89 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.93 110.688 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -97.32 -175.15 3.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 1.26 111.032 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.0 mpt_? -85.49 -28.77 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 3.96 110.788 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -141.03 30.25 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 2.48 110.9 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -41.94 148.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 1.17 111.656 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.0 m -107.31 156.54 37.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.122 -0.49 . . . . 2.01 110.87 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.97 -28.6 66.56 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.601 2.201 . . . . 0.68 112.216 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.08 -46.89 22.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.32 110.863 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CD2' ' OD2' ' A' ' 64' ' ' ASP . 75.6 m-85 -86.57 -46.17 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 2.53 110.561 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -56.4 -58.05 9.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 2.02 111.289 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -43.94 -28.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 3.29 111.703 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.81 -41.08 92.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 3.07 111.004 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 3.7 mm? -72.34 -54.98 7.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.94 111.157 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 mt -50.67 -29.1 10.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 1.45 111.162 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.7 m -77.48 -28.89 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 2.09 111.099 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -25.4 18.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 2.13 111.205 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.69 23.93 19.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.654 -0.784 . . . . 0.82 112.892 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.18 90.48 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 2.97 110.623 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.9 mp -84.47 160.81 55.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 1.34 110.703 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.85 120.3 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.51 112.305 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.52 22.1 5.23 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.873 -0.68 . . . . 0.4 112.489 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -93.56 174.17 7.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 1.01 110.539 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -117.25 158.8 23.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 1.75 111.13 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CD2' ' HB ' ' A' ' 51' ' ' ILE . 28.0 p90 -168.43 168.41 11.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.44 110.626 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -120.53 152.34 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 3.83 110.998 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' CG1' HG22 ' A' ' 42' ' ' VAL . 46.0 t -87.75 136.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 1.88 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.5 -40.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.22 111.429 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -169.69 125.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.38 . . . . 3.53 110.886 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 43' ' ' ALA . 60.7 t -137.38 158.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.306 -0.406 . . . . 1.79 111.296 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -145.48 109.78 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 1.25 111.059 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -43.32 -34.1 4.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 1.63 112.745 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.18 -26.59 28.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 3.06 111.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.2 90.09 1.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.79 112.044 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.87 172.01 6.1 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.647 0.26 . . . . 1.07 111.04 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.31 121.77 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.769 2.313 . . . . 0.65 111.687 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.437 HG21 ' N ' ' A' ' 50' ' ' HIS . 1.4 p -106.43 158.96 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.665 -0.698 . . . . 1.15 111.007 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.437 ' N ' HG21 ' A' ' 49' ' ' VAL . 12.5 m-70 -114.83 131.41 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.673 . . . . 2.03 110.605 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.437 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -101.84 141.91 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 1.12 110.987 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.02 108.41 19.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 2.13 111.071 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -108.17 -169.59 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.28 110.948 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -55.46 96.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 3.43 111.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 52.39 30.55 8.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 4.67 111.723 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -151.4 112.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.965 0.412 . . . . 1.87 111.388 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -97.15 109.95 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 1.07 110.637 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 74.6 mt -99.79 163.35 12.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.154 -0.475 . . . . 2.1 111.245 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 p -121.76 137.96 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 1.11 110.871 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 68' ' ' ILE . 86.2 mt -127.53 136.27 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 1.56 110.954 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -85.83 150.83 24.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 3.81 110.915 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -45.64 -30.26 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 5.09 111.454 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -83.17 -39.24 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 2.72 111.191 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' CD2' ' A' ' 22' ' ' TYR . 9.0 t70 -57.96 -29.56 65.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 2.3 111.046 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 65' ' ' LEU . 8.1 mp -76.26 -20.25 57.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 1.41 111.281 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.24 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.557 -0.292 . . . . 1.2 111.441 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.99 -54.32 3.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.747 0.308 . . . . 1.16 111.295 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.415 ' CD1' HD13 ' A' ' 60' ' ' LEU . 36.2 pt -65.61 152.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 1.12 111.035 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -105.02 149.29 25.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 2.29 111.014 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -130.51 139.51 50.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 2.39 110.96 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -116.3 129.97 56.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.792 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.57 20.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 1.34 111.047 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.85 175.99 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 1.76 111.372 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 -177.83 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 2.28 111.026 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 5.77 110.843 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.854 0.359 . . . . 5.58 111.042 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -52.15 150.19 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 3.52 111.147 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' CE2' HG11 ' A' ' 42' ' ' VAL . 6.3 p90 -141.36 104.03 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 2.96 110.745 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -86.08 156.22 57.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 1.3 111.259 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 90.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.637 2.224 . . . . 0.77 112.284 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 178.32 -42.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 2.69 110.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.3 m -92.17 141.84 28.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 2.32 110.929 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.98 164.17 25.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 1.16 111.089 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 42.5 m95 -147.84 169.53 19.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.84 110.645 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' SER . 57.8 mttp -114.87 137.03 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 2.52 111.099 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.1 mt -78.34 122.92 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.21 110.955 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -136.16 51.45 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 1.64 110.806 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.42 96.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.957 -0.639 . . . . 0.45 112.638 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -147.29 94.98 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.93 110.813 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.6 t -105.29 -172.42 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 1.26 110.878 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -21.89 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.009 -0.542 . . . . 3.96 111.188 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -156.5 33.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.455 -0.339 . . . . 2.48 111.159 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tt -46.89 122.61 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 1.17 111.281 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.3 p -76.79 155.58 83.05 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 2.01 110.826 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.77 -29.87 77.41 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.616 2.211 . . . . 0.68 112.488 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.22 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.011 0.434 . . . . 1.32 110.41 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -85.75 -28.93 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 2.53 111.02 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NH1' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -76.04 -61.73 1.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 2.02 111.029 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -53.4 -27.64 25.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.347 -0.388 . . . . 3.29 110.947 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -50.67 -32.1 18.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 3.07 111.153 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.9 mp -84.02 -42.31 16.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 1.94 111.251 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' NH1' ' A' ' 23' ' ' ARG . 73.2 mt -49.03 -25.81 2.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 1.45 111.238 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.426 ' OG ' ' CD1' ' A' ' 29' ' ' LEU . 73.7 p -65.6 -37.54 86.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 2.09 110.935 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -91.07 -24.04 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 2.13 110.898 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.9 16.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.652 -0.785 . . . . 0.82 112.467 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 51.9 mtm -98.43 99.33 10.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 2.97 110.795 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 32' ' ' LEU . 7.7 mp -95.48 160.94 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 1.34 110.816 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.11 114.03 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.601 2.201 . . . . 0.51 112.282 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.17 33.02 1.56 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.4 112.174 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 39.8 t -100.58 174.78 5.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.612 0.244 . . . . 1.01 110.807 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.7 t -120.18 154.7 34.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 1.75 110.876 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.8 p90 -167.62 177.26 5.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.44 110.751 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 76.6 t60 -128.82 155.18 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 3.83 111.033 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' O ' ' CD2' ' A' ' 38' ' ' HIS . 66.1 t -92.78 134.88 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 1.88 110.906 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.21 -51.44 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 1.22 111.461 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -155.49 123.79 5.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 3.53 111.263 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.441 HG11 ' CE2' ' A' ' 3' ' ' PHE . 46.6 t -135.69 158.79 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 1.79 111.025 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -124.87 152.89 70.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 1.25 111.09 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.25 -30.78 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.8 2.334 . . . . 1.63 112.856 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.11 -26.69 39.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 3.06 111.129 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 104.13 1.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.723 -0.751 . . . . 0.79 112.167 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 4.3 m-20 -147.86 170.67 7.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.673 0.273 . . . . 1.07 111.07 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.5 120.71 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.928 2.419 . . . . 0.65 111.69 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.5 p -106.96 159.12 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.82 -0.627 . . . . 1.15 111.264 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 59' ' ' VAL . 53.2 m-70 -114.35 137.03 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 2.03 110.448 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -102.11 141.18 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 1.12 111.63 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.61 107.75 18.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.942 -0.572 . . . . 2.13 110.507 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.3 p -113.96 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 1.28 111.094 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 39.7 mmt180 -49.61 102.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 3.43 111.428 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 29.4 ptt180 44.81 37.01 2.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 4.67 112.056 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 29' ' ' LEU . 99.1 t -151.52 126.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 1.87 111.118 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.6 t -109.98 107.73 17.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 1.07 110.666 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 77.9 mt -106.95 156.8 18.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 2.1 111.233 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 8.0 p -112.96 134.71 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 1.11 110.992 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 ' CB ' HD11 ' A' ' 65' ' ' LEU . 70.5 mt -122.31 134.22 54.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 1.56 110.757 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -97.35 160.68 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.81 110.848 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -51.48 -23.52 4.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 5.09 110.965 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -85.08 -27.88 26.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 2.72 110.815 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.25 -32.75 61.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 2.3 110.823 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 65' ' ' LEU . 7.7 mp -79.44 -21.69 45.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 1.41 111.075 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.18 62.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 1.2 111.589 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.55 -58.94 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.75 0.31 . . . . 1.16 111.353 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.4 pt -65.94 158.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 1.12 111.345 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -111.53 141.74 44.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.29 110.695 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.16 142.27 47.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 2.39 111.086 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -128.02 122.94 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 2.24 110.718 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.27 175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 1.34 111.327 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.61 -176.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.76 111.129 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.96 114.77 1.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 2.28 111.088 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 5.77 110.804 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.727 0.299 . . . . 5.58 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -175.38 -175.2 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 3.52 110.804 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m-85 -101.9 117.74 35.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 2.96 110.897 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -112.27 153.86 44.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 1.3 111.203 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.74 89.38 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.56 2.173 . . . . 0.77 112.437 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t70 176.69 -37.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 2.69 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -101.42 144.34 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 2.32 110.934 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.16 167.16 21.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 1.16 110.955 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.6 m95 -151.74 174.78 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.95 0.405 . . . . 0.84 111.198 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -127.23 135.42 50.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 2.52 110.988 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.0 mt -72.92 133.17 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 1.21 111.13 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -137.45 48.95 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.64 110.456 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.8 89.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.856 -0.688 . . . . 0.45 112.658 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -147.09 95.42 2.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.93 110.866 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.401 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 15.7 m -102.14 160.4 14.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 1.26 110.943 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -17.75 62.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 3.96 111.232 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -154.06 34.0 0.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.59 0.233 . . . . 2.48 111.415 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 10.2 tt -47.36 128.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.598 -0.274 . . . . 1.17 111.281 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.9 p -87.76 156.55 52.75 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 2.01 110.84 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.44 -28.92 53.93 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.462 2.108 . . . . 0.68 112.482 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.05 -48.35 22.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 1.32 110.772 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 52.5 t80 -86.62 -46.08 10.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 2.53 110.787 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -56.05 -56.19 23.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 2.02 110.919 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -45.73 -34.2 3.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 3.29 111.371 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.73 -27.88 67.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 3.07 111.106 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.81 -55.12 5.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.94 110.912 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -48.2 -30.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 1.45 111.187 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -75.97 -32.04 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 2.09 111.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.0 mt -90.1 -23.09 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 2.13 111.032 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.72 10.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.82 112.358 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.1 mtt -109.01 91.51 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 2.97 110.874 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -104.65 160.24 26.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 1.34 110.83 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.82 115.26 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.427 2.084 . . . . 0.51 112.094 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.9 19.22 8.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.806 -0.712 . . . . 0.4 112.612 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -92.94 172.36 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 1.01 110.787 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.0 m -116.39 153.56 31.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 1.75 111.182 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.3 p90 -164.76 163.02 21.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.44 110.52 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -115.72 117.48 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 3.83 111.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.66 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 1.88 111.086 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.91 -47.74 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.393 -0.367 . . . . 1.22 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -162.16 138.01 7.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.915 0.388 . . . . 3.53 111.228 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG23 ' CG2' ' A' ' 49' ' ' VAL . 19.5 t -145.78 159.31 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.79 111.078 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 47' ' ' ASP . . . -121.54 155.86 58.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 1.25 111.123 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.42 -26.99 8.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 1.63 112.685 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.9 -52.52 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 3.06 111.02 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.98 111.92 0.3 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.734 -0.746 . . . . 0.79 112.417 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 43' ' ' ALA . 2.1 m-20 -148.16 172.74 4.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.639 0.257 . . . . 1.07 111.09 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.35 117.24 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.961 2.441 . . . . 0.65 111.654 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 42' ' ' VAL . 2.4 p -106.79 154.12 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.794 -0.639 . . . . 1.15 111.068 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -119.68 142.2 48.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.606 . . . . 2.03 110.805 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.433 HG21 ' CD2' ' A' ' 37' ' ' PHE . 38.6 pt -114.72 136.55 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 1.12 111.371 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.08 115.98 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 2.13 110.426 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 55' ' ' ARG . 37.5 p -130.25 -167.76 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 1.28 111.273 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -41.4 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.973 0.416 . . . . 3.43 112.018 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' THR . 79.8 mtm180 41.37 53.15 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 4.67 111.923 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.1 p -171.89 116.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.87 111.449 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -104.65 108.11 19.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 1.07 110.515 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.4 tp -100.16 158.44 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 2.1 110.98 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.3 p -106.82 153.33 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 1.11 111.118 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.1 mt -144.81 119.45 9.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 1.56 111.023 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -77.51 -173.11 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 3.81 110.91 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -75.1 -28.14 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 5.09 111.153 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.44 -35.33 25.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.348 -0.387 . . . . 2.72 111.036 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.86 -30.93 71.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 2.3 110.754 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.7 mt -76.5 -24.77 53.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.055 -0.521 . . . . 1.41 111.035 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.06 71.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 1.2 111.341 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.81 -58.16 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 1.16 111.361 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.514 ' CG2' ' CE1' ' A' ' 22' ' ' TYR . 31.3 pt -65.52 149.66 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 1.12 111.256 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -109.77 151.56 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 2.29 110.635 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 3.2 mm? -118.91 148.1 43.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 2.39 110.675 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.34 145.19 43.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 2.24 110.852 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.4 172.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.34 110.953 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.6 m -97.03 167.14 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 1.76 111.233 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.42 95.62 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 2.28 110.878 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 5.77 110.939 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.756 0.312 . . . . 5.58 110.993 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -104.76 134.37 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 3.52 111.047 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -85.91 108.23 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 2.96 110.898 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -114.17 154.19 46.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 1.3 111.204 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.29 89.73 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.531 2.154 . . . . 0.77 112.432 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 178.24 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 2.69 110.918 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.2 m -106.25 170.21 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 2.32 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.56 169.33 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 1.16 111.044 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 52.1 m95 -151.1 162.08 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.84 110.583 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -107.61 137.85 44.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 2.52 110.987 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.1 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 1.21 111.235 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' GLU . 23.6 m -135.92 56.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 1.64 110.286 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.45 96.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.701 -0.682 . . . . 0.45 112.745 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -147.14 97.38 2.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.341 . . . . 0.93 110.708 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.1 m -108.61 -174.34 2.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.26 110.977 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 10.3 mpt_? -74.78 -27.26 60.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 3.96 110.881 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.91 42.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.48 110.81 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 tt -45.7 109.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.277 -0.42 . . . . 1.17 111.172 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.0 p -59.63 155.8 37.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.07 -30.47 89.41 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.68 112.101 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.63 -46.25 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.414 . . . . 1.32 110.897 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.98 -35.3 20.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.51 . . . . 2.53 111.148 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -70.94 -61.04 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.524 . . . . 2.02 111.612 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -42.75 -34.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.506 -0.316 . . . . 3.29 111.839 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.29 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 3.07 111.103 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.21 -53.63 55.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 1.94 111.075 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -48.85 -46.23 41.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 1.45 111.203 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -55.59 -49.25 73.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 2.09 111.05 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.426 ' CD1' HD23 ' A' ' 58' ' ' LEU . 73.5 mt -71.75 -25.17 61.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 2.13 110.885 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 19.54 27.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 0.82 112.774 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.4 mtt -95.03 87.05 4.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.726 0.298 . . . . 2.97 110.792 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.7 mp -92.2 159.65 36.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 1.34 110.499 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.96 132.22 17.43 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.298 1.999 . . . . 0.51 111.757 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.37 38.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.75 -0.738 . . . . 0.4 112.267 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -82.22 174.24 11.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.685 0.278 . . . . 1.01 110.582 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.4 p -125.89 137.83 53.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 1.75 110.733 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 9' ' ' TRP . 9.6 p90 -150.53 157.64 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.44 111.003 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -108.51 146.87 32.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 3.83 110.855 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.93 128.32 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 1.88 111.144 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.93 -47.54 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 1.22 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -168.28 129.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 3.53 110.814 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 43' ' ' ALA . 39.5 t -141.56 156.56 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.368 . . . . 1.79 111.339 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.88 141.65 41.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 1.25 110.825 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.97 -21.23 37.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.497 2.131 . . . . 1.63 112.658 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 mt -85.74 -48.95 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 3.06 110.882 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.65 105.61 0.37 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.762 -0.732 . . . . 0.79 112.497 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.11 171.06 6.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.619 0.247 . . . . 1.07 110.804 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.48 118.75 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.878 2.385 . . . . 0.65 111.788 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.9 p -106.65 161.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.15 111.123 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.458 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 79.2 m80 -125.07 148.37 48.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 2.03 110.467 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.3 pt -115.56 138.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 1.12 111.446 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.95 112.97 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 2.13 110.612 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.7 p -126.7 -175.98 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.387 . . . . 1.28 111.343 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -41.59 95.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.964 -0.562 . . . . 3.43 112.101 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 43.28 54.79 4.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 4.67 112.089 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -175.78 113.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 1.87 111.29 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -100.49 112.18 24.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 1.07 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' CD1' ' A' ' 29' ' ' LEU . 38.0 tp -105.73 148.58 27.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 2.1 110.797 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' CD2' ' A' ' 50' ' ' HIS . 8.8 p -99.56 140.71 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 1.11 111.315 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.8 mt -140.44 166.12 25.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 1.56 110.881 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 80.7 mtp180 -130.3 152.82 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 3.81 110.896 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' CE ' ' HA ' ' A' ' 62' ' ' LYS . 2.4 tpmt? -50.49 -24.81 3.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.969 -0.56 . . . . 5.09 111.523 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.37 -28.67 34.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.894 0.378 . . . . 2.72 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.28 -33.08 29.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 2.3 111.068 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.8 mp -71.43 -20.7 62.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 1.41 111.267 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.15 84.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.505 -0.316 . . . . 1.2 111.468 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.31 -56.59 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.16 111.257 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -66.96 151.91 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 1.12 111.102 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 12' ' ' THR . 33.0 tt0 -100.49 128.96 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.29 110.59 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.45 136.14 53.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 2.39 111.077 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -130.23 156.53 44.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 2.24 110.755 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 133.43 51.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 1.34 111.113 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.416 HG11 ' CA ' ' A' ' 9' ' ' TRP . 32.7 m -60.25 167.66 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.513 . . . . 1.76 111.208 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.08 134.48 50.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 2.28 110.98 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 5.77 110.816 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.72 0.295 . . . . 2.25 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -108.92 150.05 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.66000000000000003 111.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 85.57 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.562 2.175 . . . . 0.65000000000000002 112.357 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.6 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 2.6899999999999999 110.867 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -84.84 164.27 18.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 1.8899999999999999 110.986 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.7 165.45 11.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.46999999999999997 111.241 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 61.1 m95 -155.07 174.55 15.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.68999999999999995 110.832 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -127.6 134.34 49.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 2.04 111.05 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.451 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.1 mt -74.52 126.09 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.56000000000000005 111.346 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -139.74 48.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.96999999999999997 110.572 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.72 91.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.866 -0.683 . . . . 0.45000000000000001 112.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -147.23 96.97 2.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.64 0.257 . . . . 0.81000000000000005 110.786 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -105.79 -175.79 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.76000000000000001 110.803 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.2 mpt_? -86.31 -21.67 27.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 3.5800000000000001 111.047 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -147.44 28.19 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.463 -0.335 . . . . 2.48 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 18' ' ' ILE . 14.6 tt -46.17 122.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 0.56999999999999995 111.369 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -72.82 155.43 90.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 1.5 110.929 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 24' ' ' GLN . 37.9 Cg_endo -66.42 -27.71 46.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.503 2.136 . . . . 0.60999999999999999 112.268 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.64 -45.15 57.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.70999999999999996 110.83 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -85.78 -37.27 19.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 2.1699999999999999 111.129 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -70.58 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 1.5700000000000001 111.359 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' PRO . 51.8 tt0 -57.88 -18.64 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 2.6899999999999999 111.537 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -75.32 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 2.5899999999999999 111.149 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -50.0 -30.88 11.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.033 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.0 mt -51.57 -34.04 35.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.94999999999999996 111.013 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.4 p -62.88 -29.47 70.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.6399999999999999 111.092 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.33 -24.43 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 1.6399999999999999 111.012 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.92 20.63 59.11 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.81999999999999995 112.465 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.31 91.57 4.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 2.5499999999999998 110.846 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -88.26 160.6 45.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 110.79 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 87.7 Cg_exo -42.37 112.78 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.525 2.15 . . . . 0.51000000000000001 112.417 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 30.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 0.40000000000000002 112.454 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.8 t -102.1 174.1 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.62 110.878 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -119.06 138.95 52.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.467 . . . . 1.3 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.451 ' CD1' HG13 ' A' ' 11' ' ' ILE . 23.7 p90 -153.37 159.89 42.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.35999999999999999 111.018 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 73.3 m80 -114.41 160.76 18.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.426 . . . . 2.9399999999999999 110.82 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.8 t -98.37 134.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 1.28 111.222 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.5 t -94.98 -49.53 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.54000000000000004 111.08 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.77 138.44 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 2.7999999999999998 110.832 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG22 ' CG2' ' A' ' 49' ' ' VAL . 19.7 t -146.16 157.97 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 1.2 111.388 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.58 147.37 52.82 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.81000000000000005 111.065 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.11 -20.47 19.07 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 1.3400000000000001 112.663 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.84 -46.41 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.387 -0.37 . . . . 2.5099999999999998 111.059 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.33 100.3 0.2 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 0.77000000000000002 112.306 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.2 m-20 -139.38 170.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 1.0700000000000001 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.81 117.19 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.942 2.428 . . . . 0.60999999999999999 111.647 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 157.17 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.823 -0.626 . . . . 0.39000000000000001 110.874 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.5 m-70 -121.04 136.45 54.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 1.1299999999999999 110.72 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 58' ' ' LEU . 31.8 pt -102.08 143.84 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.35999999999999999 111.136 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' HIS . 7.7 mm-40 -106.77 110.58 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 2.1299999999999999 110.755 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -112.08 -174.33 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.64000000000000001 111.063 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -52.43 94.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 3.04 111.479 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 53.23 38.19 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 4.1100000000000003 111.691 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -155.44 132.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.713 0.292 . . . . 1.23 111.093 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -112.21 107.83 16.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.64000000000000001 111.148 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 50.4 tp -101.54 154.07 19.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 1.54 110.55 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.52 139.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 0.5 111.183 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.39 166.18 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.96999999999999997 110.756 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HD3' ' NZ ' ' A' ' 63' ' ' LYS . 95.5 mtt180 -124.63 136.43 53.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.79 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.0 tpmt? -45.96 -29.36 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 4.7000000000000002 111.253 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' NZ ' ' HD3' ' A' ' 61' ' ' ARG . 21.3 pttm -84.41 -31.61 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.937 0.399 . . . . 2.2799999999999998 110.393 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ARG . 18.5 t70 -69.49 -35.95 76.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 2.2999999999999998 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -63.0 -23.58 67.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.69999999999999996 110.989 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.17 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.38 . . . . 0.66000000000000003 111.28 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -83.47 -61.03 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.47999999999999998 111.202 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 pt -65.32 144.52 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.42999999999999999 111.183 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.26 154.44 18.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.847 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.46 148.98 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.8500000000000001 111.05 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -134.43 115.31 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 2.2400000000000002 110.738 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.39 53.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.76000000000000001 111.092 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.1599999999999999 111.234 179.806 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 70' ' ' LEU . 83.1 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.84 0.352 . . . . 2.25 110.802 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -112.03 154.85 44.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.66000000000000003 111.173 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.362 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 177.77 -43.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 110.794 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.54 149.31 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.8899999999999999 110.788 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.79 146.83 23.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.445 . . . . 0.46999999999999997 111.18 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 38.8 m95 -133.64 174.06 10.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.68999999999999995 110.671 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -122.1 138.23 54.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.351 -0.386 . . . . 2.04 111.093 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CD1' ' CE ' ' A' ' 31' ' ' MET . 53.5 mt -77.31 138.9 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.56000000000000005 111.14 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 17.7 m -142.48 50.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 110.434 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 91.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.773 -0.648 . . . . 0.45000000000000001 112.9 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 47.3 t80 -147.25 99.22 3.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.81000000000000005 110.693 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -101.84 -172.66 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.409 . . . . 0.76000000000000001 111.075 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.0 mpt_? -77.89 -29.85 50.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 3.5800000000000001 110.911 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.22 40.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 2.48 110.981 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.21 130.73 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.56999999999999995 111.401 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.3 m -80.64 156.73 72.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 1.5 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 18.1 Cg_endo -58.39 -33.03 97.47 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.516 2.144 . . . . 0.60999999999999999 112.166 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.92 -43.52 59.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.70999999999999996 110.326 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -85.67 -43.46 13.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 2.1699999999999999 110.514 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.4 tpt180 -62.56 -61.67 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.5700000000000001 111.041 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' PRO . 89.8 mt-30 -52.2 -32.21 35.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.453 -0.339 . . . . 2.6899999999999999 110.833 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -51.04 -40.68 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 2.5899999999999999 111.021 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.4 mm? -84.5 -38.7 19.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 1.3 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.87 -33.45 23.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.94999999999999996 110.99 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -63.12 -50.73 69.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 1.6399999999999999 110.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.37 -23.82 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 1.6399999999999999 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.06 18.94 25.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 0.81999999999999995 112.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.488 ' CE ' ' CD1' ' A' ' 11' ' ' ILE . 65.4 mtp -91.43 94.77 9.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 2.5499999999999998 110.923 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -103.12 159.7 28.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.857 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.72 111.9 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.569 2.18 . . . . 0.51000000000000001 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.11 25.64 3.49 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.919 -0.657 . . . . 0.40000000000000002 112.302 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.2 t -93.51 163.47 13.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.62 110.709 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -111.01 142.8 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.929 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 11' ' ' ILE . 24.1 p90 -155.1 162.72 40.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.35999999999999999 110.844 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -114.55 148.04 38.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 2.9399999999999999 111.002 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 t -86.88 113.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 1.28 110.868 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.9 t -78.81 -52.38 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.54000000000000004 111.398 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -169.25 121.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 2.7999999999999998 111.107 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -140.32 158.08 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.944 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -113.94 140.32 24.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.81000000000000005 111.407 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.15 -26.81 83.1 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.554 2.169 . . . . 1.3400000000000001 112.351 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -80.41 -65.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 2.5099999999999998 110.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 169.27 100.76 0.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.712 -0.756 . . . . 0.77000000000000002 112.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.3 m-20 -144.48 171.24 6.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.609 0.242 . . . . 1.0700000000000001 111.025 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.63 113.64 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.955 2.437 . . . . 0.60999999999999999 111.677 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.77 140.69 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 111.173 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 44.5 m-70 -99.67 137.63 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.905 -0.589 . . . . 1.1299999999999999 110.611 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -108.67 140.65 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.35999999999999999 111.198 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.29 109.47 21.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 2.1299999999999999 110.81 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.1 p -107.37 -172.85 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.64000000000000001 111.087 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -50.93 96.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.04 111.405 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 52.53 26.24 4.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 4.1100000000000003 111.696 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -146.75 120.68 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.4 . . . . 1.23 111.117 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -104.22 107.93 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.64000000000000001 110.912 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -103.37 160.28 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 1.54 110.669 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.64 138.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.369 . . . . 0.5 111.132 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.15 155.41 50.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.96999999999999997 110.874 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 64' ' ' ASP . 75.2 mtp180 -122.12 155.62 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 3.3199999999999998 111.058 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 5.6 mmpt? -44.2 -28.93 0.56 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.078 -0.51 . . . . 4.7000000000000002 111.486 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 pttt -76.43 -36.09 58.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.281 -0.418 . . . . 2.2799999999999998 110.874 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' ARG . 13.2 m-20 -74.41 -34.47 63.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.825 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.1 mp -74.58 -26.57 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.69999999999999996 110.937 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.24 -25.33 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.66000000000000003 111.163 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.6 -58.47 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.47999999999999998 111.124 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.0 pt -67.64 154.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.42999999999999999 110.904 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 8.3 tp10 -102.88 155.74 18.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 2.29 110.974 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 92.1 mt -128.84 165.66 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.082 -0.508 . . . . 1.8500000000000001 110.753 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.51 149.08 30.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 2.2400000000000002 111.023 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -174.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 110.903 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 1.1599999999999999 111.023 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.783 0.325 . . . . 2.25 110.957 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -116.23 156.26 47.3 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.66000000000000003 111.381 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.81 141.61 27.77 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.724 2.283 . . . . 0.65000000000000002 112.396 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.24 21.02 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 2.6899999999999999 111.518 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.6 p -88.17 159.79 18.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.8899999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.19 135.44 53.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.46999999999999997 111.06 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 54.1 m95 -151.42 157.22 42.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.68999999999999995 110.572 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' SER . 62.7 mttp -99.52 135.09 41.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 2.04 110.745 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.496 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.9 mt -77.3 132.39 32.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.039 -0.528 . . . . 0.56000000000000005 111.328 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.2 m -139.51 44.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.009 -0.541 . . . . 0.96999999999999997 110.391 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.21 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.917 -0.659 . . . . 0.45000000000000001 112.581 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 89.9 t80 -147.7 94.89 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.81000000000000005 110.828 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m -100.39 161.86 13.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.857 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -58.77 -19.15 38.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.5800000000000001 111.369 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -165.55 42.26 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 2.48 111.401 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.45 139.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.347 -0.388 . . . . 0.56999999999999995 111.325 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -88.41 156.37 50.98 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 1.5 110.895 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.45 -30.39 90.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.621 2.214 . . . . 0.60999999999999999 112.347 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.71 -46.61 50.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.078 0.466 . . . . 0.70999999999999996 110.665 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -86.45 -43.4 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 2.1699999999999999 110.806 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -62.09 -58.84 6.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 1.5700000000000001 111.38 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.06 -48.19 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.499 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 28' ' ' SER . 61.1 mttp -51.16 -47.77 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.404 -0.362 . . . . 2.5899999999999999 111.152 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.95 -57.13 12.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 1.3 111.025 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.7 mt -48.86 -26.48 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.94999999999999996 111.176 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 38.5 t -66.09 -37.05 84.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 1.6399999999999999 111.087 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.59 -25.26 38.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.376 -0.375 . . . . 1.6399999999999999 111.073 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.15 7.67 55.95 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.716 -0.754 . . . . 0.81999999999999995 113.04 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -91.97 103.06 15.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.969 0.385 . . . . 2.5499999999999998 111.05 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -90.58 160.38 39.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.614 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.23 127.15 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.277 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.21 27.39 6.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.727 -0.749 . . . . 0.40000000000000002 112.323 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 46.5 t -94.31 174.23 7.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.649 0.261 . . . . 0.62 110.788 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -123.97 148.81 46.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 1.3 110.946 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' A' ' 11' ' ' ILE . 6.8 p90 -161.43 179.53 8.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.35999999999999999 110.853 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -132.21 152.22 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 2.9399999999999999 110.844 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 49' ' ' VAL . 60.5 t -91.23 141.09 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 1.28 111.051 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -95.96 -39.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 111.342 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.8 ptm180 179.73 126.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 2.7999999999999998 110.982 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 43' ' ' ALA . 9.2 p -148.66 159.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.2 111.153 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.505 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -114.15 155.75 45.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.81000000000000005 111.066 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.29 -18.44 23.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.676 2.25 . . . . 1.3400000000000001 112.586 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 tp -89.65 -65.8 0.98 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 2.5099999999999998 110.938 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 170.84 107.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.77000000000000002 112.434 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.0 m-20 -147.72 172.26 5.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.58 0.229 . . . . 1.0700000000000001 110.712 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.19 110.87 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.755 2.303 . . . . 0.60999999999999999 111.526 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' CG2' HG13 ' A' ' 39' ' ' VAL . 3.7 p -106.57 140.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 111.199 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 97.0 m-70 -101.43 131.03 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.845 -0.616 . . . . 1.1299999999999999 110.804 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 60' ' ' LEU . 44.2 pt -96.63 139.62 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 110.831 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -106.83 97.09 6.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 2.1299999999999999 110.888 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.2 -172.68 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.64000000000000001 111.002 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HB2' ' CE ' ' A' ' 31' ' ' MET . 41.3 mmt180 -51.47 96.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 3.04 111.451 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 51.89 30.08 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 4.1100000000000003 111.541 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 54' ' ' ARG . 79.7 t -149.75 117.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 1.23 111.33 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -100.87 107.76 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.64000000000000001 110.751 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' A' ' 51' ' ' ILE . 32.0 tp -102.9 158.17 16.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.988 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -104.55 138.96 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.5 110.911 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD1' HD13 ' A' ' 51' ' ' ILE . 90.2 mt -144.08 143.13 31.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.931 0.396 . . . . 0.96999999999999997 111.104 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 32.4 ttm180 -112.12 162.3 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 3.3199999999999998 110.683 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 mmpt? -47.18 -26.92 1.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 4.7000000000000002 111.218 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.1 -30.09 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 2.2799999999999998 110.912 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.85 -31.93 40.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 2.2999999999999998 111.027 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.3 mp -81.6 -18.5 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.69 -27.03 68.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.766 0.317 . . . . 0.66000000000000003 111.499 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.67 -57.69 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.47999999999999998 111.119 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.2 pt -66.04 154.81 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.42999999999999999 111.338 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 12' ' ' THR . 9.0 tp10 -104.93 147.78 27.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.186 -0.461 . . . . 2.29 110.475 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.7 mm? -121.43 153.63 37.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 1.8500000000000001 111.097 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.01 147.08 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 2.2400000000000002 110.787 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 165.94 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.76000000000000001 111.18 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.1599999999999999 111.023 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CE1' HD23 ' A' ' 70' ' ' LEU . 38.7 m-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.764 0.316 . . . . 2.25 110.715 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 41.2 p -113.82 156.25 44.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.66000000000000003 111.253 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 62.0 Cg_endo -72.92 90.12 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.58 2.187 . . . . 0.65000000000000002 112.313 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 178.32 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 110.828 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 1.8899999999999999 110.784 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.89 168.68 8.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 110.93 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.512 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 69.3 m95 -149.75 173.45 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.68999999999999995 110.872 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.435 ' O ' HD12 ' A' ' 70' ' ' LEU . 31.2 mmmt -107.06 126.99 53.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.88 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.9 mt -77.21 126.78 38.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.56000000000000005 111.118 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 23.0 m -132.65 56.88 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.393 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' NH1' ' A' ' 23' ' ' ARG . . . -58.59 85.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.971 -0.633 . . . . 0.45000000000000001 113.004 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -147.11 95.98 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.81000000000000005 110.632 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -95.05 -174.26 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.985 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -86.18 -26.01 25.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.581 . . . . 3.5800000000000001 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -150.29 34.23 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 2.48 111.414 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 tt -48.63 143.18 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 111.253 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -94.63 147.93 34.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.5 110.88 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 17.2 Cg_endo -57.29 -32.02 92.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.712 2.274 . . . . 0.60999999999999999 112.124 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.03 -47.05 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.025 0.44 . . . . 0.70999999999999996 110.711 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.69 -43.39 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.646 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.2 tpt180 -60.25 -61.26 2.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 1.5700000000000001 110.98 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' PRO . 91.5 mt-30 -49.98 -41.71 47.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 2.6899999999999999 110.843 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -53.69 -25.77 19.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 2.5899999999999999 110.972 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.29 -46.62 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 1.3 110.594 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -50.77 -33.6 23.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.94999999999999996 111.048 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.9 p -69.23 -42.21 75.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.979 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.3 -25.34 65.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 1.6399999999999999 110.979 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.14 16.16 39.08 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.81999999999999995 112.835 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 ptm -104.0 103.94 13.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.983 0.42 . . . . 2.5499999999999998 110.883 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -105.03 159.81 28.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.443 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.0 Cg_exo -42.11 109.4 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.521 2.147 . . . . 0.51000000000000001 112.152 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 31.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.40000000000000002 112.166 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 t -101.35 174.18 6.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.623 0.249 . . . . 0.62 110.57 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -119.99 143.35 48.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 1.3 111.071 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' TRP . 4.0 p90 -150.45 175.36 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.35999999999999999 110.824 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -130.71 129.03 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 2.9399999999999999 110.988 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 140.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 1.28 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.4 t -99.06 -35.48 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54000000000000004 111.125 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -179.61 139.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 2.7999999999999998 111.088 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.5 t -146.92 160.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.122 -0.49 . . . . 1.2 111.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.56 132.0 24.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.81000000000000005 110.83 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.46 -21.19 44.24 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 1.3400000000000001 112.503 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -89.82 -66.33 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 2.5099999999999998 111.229 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.96 105.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.77000000000000002 112.263 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.455 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.0 m-20 -148.12 172.13 5.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.562 0.22 . . . . 1.0700000000000001 111.056 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.19 119.47 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 0.60999999999999999 111.487 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.53 148.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.39000000000000001 110.964 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' VAL . 36.4 m-70 -112.98 135.85 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.779 -0.646 . . . . 1.1299999999999999 110.745 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 60' ' ' LEU . 47.0 pt -98.55 145.83 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.35999999999999999 111.16 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -109.34 100.81 9.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 2.1299999999999999 110.742 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 p -103.92 -173.14 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.64000000000000001 111.185 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.0 mmt180 -50.94 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 3.04 111.531 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 48.62 30.13 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 4.1100000000000003 111.698 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' ARG . 89.0 t -147.8 113.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.981 0.419 . . . . 1.23 111.139 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -100.03 107.74 19.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.64000000000000001 110.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.13 160.36 14.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.54 111.305 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.55 137.01 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.031 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' CG2' ' A' ' 51' ' ' ILE . 91.0 mt -130.44 161.43 31.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.96999999999999997 111.059 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.8 mtp180 -130.68 147.7 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 3.3199999999999998 110.473 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -47.98 -25.9 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 4.7000000000000002 111.08 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -75.82 -33.43 60.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 2.2799999999999998 110.7 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.87 -34.86 44.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 2.2999999999999998 111.044 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.5 mp -67.76 -20.74 65.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.288 -0.415 . . . . 0.69999999999999996 111.076 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.29 -28.61 68.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.369 -0.378 . . . . 0.66000000000000003 111.083 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.94 -56.53 3.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.47999999999999998 110.968 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.3 pt -65.09 166.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.005 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 12' ' ' THR . 12.3 tt0 -114.47 153.54 29.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 2.29 111.195 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.469 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.5 tp -129.91 158.09 40.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 110.664 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.71 147.18 31.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 2.2400000000000002 110.876 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.53 169.84 2.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.76000000000000001 110.993 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 1.1599999999999999 111.248 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CD2' HG11 ' A' ' 42' ' ' VAL . 21.5 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.892 0.377 . . . . 2.25 110.887 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -121.44 156.35 58.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.66000000000000003 111.147 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.65 87.84 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.48 2.12 . . . . 0.65000000000000002 112.298 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 177.96 -36.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 2.6899999999999999 110.772 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 t -99.51 170.9 8.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 1.8899999999999999 110.96 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.26 165.33 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.46999999999999997 110.94 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 3' ' ' PHE . 54.0 m95 -154.61 163.5 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.68999999999999995 110.616 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.77 127.03 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 2.04 111.185 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.2 mt -74.38 142.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.56000000000000005 111.122 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -142.31 52.11 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.688 -0.687 . . . . 0.96999999999999997 110.155 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -50.7 95.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.45000000000000001 112.89 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -147.5 94.74 2.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.378 . . . . 0.81000000000000005 110.565 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 m -104.19 -174.64 2.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.76000000000000001 110.946 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 9.2 mpt_? -86.24 -23.27 26.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 3.5800000000000001 111.002 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.86 32.04 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 2.48 111.504 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.8 tt -47.21 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.974 0.416 . . . . 0.56999999999999995 111.058 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.5 m -66.7 156.67 85.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 1.5 110.735 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 25.8 Cg_endo -60.9 -28.66 86.7 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.596 2.198 . . . . 0.60999999999999999 112.119 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.33 61.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.70999999999999996 110.599 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.74 -40.1 16.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.846 -0.616 . . . . 2.1699999999999999 110.767 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.7 tpt180 -65.46 -61.37 2.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.5700000000000001 110.876 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.82 -38.43 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 2.6899999999999999 110.844 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -53.54 -59.67 4.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 2.5899999999999999 110.765 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.7 mt -58.56 -44.15 89.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.3 110.718 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -53.53 -29.48 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.94999999999999996 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.3 t -66.79 -38.49 86.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 1.6399999999999999 110.794 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.02 -24.69 24.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 1.6399999999999999 110.882 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.31 16.31 18.76 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.848 -0.691 . . . . 0.81999999999999995 112.732 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.453 ' CE ' HD12 ' A' ' 11' ' ' ILE . 90.7 mmm -91.35 90.52 7.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 2.5499999999999998 111.048 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.6 mp -108.18 161.65 22.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.68999999999999995 110.608 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 91.5 Cg_exo -42.56 109.77 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.43 2.087 . . . . 0.51000000000000001 112.068 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.86 2.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.40000000000000002 112.012 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.2 m -106.87 135.19 48.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.76 0.314 . . . . 0.62 110.904 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.1 m -90.2 148.07 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 1.3 111.199 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.7 p90 -162.77 179.38 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.35999999999999999 110.892 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.29 153.37 43.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 2.9399999999999999 110.812 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.0 t -92.55 141.3 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 1.28 111.187 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 60.6 t -101.75 -44.81 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.54000000000000004 111.303 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -175.71 115.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 2.7999999999999998 110.975 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.7 p -135.71 158.81 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.2 111.148 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -106.78 147.61 35.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.985 -0.552 . . . . 0.81000000000000005 111.085 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 -15.89 34.16 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.586 2.191 . . . . 1.3400000000000001 112.647 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.32 -73.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 2.5099999999999998 111.17 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.24 91.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.859 -0.686 . . . . 0.77000000000000002 112.41 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 7.6 m-20 -137.84 171.38 8.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.646 0.26 . . . . 1.0700000000000001 110.921 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.57 118.01 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.858 2.372 . . . . 0.60999999999999999 111.87 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.416 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.4 p -110.13 154.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.569 -0.741 . . . . 0.39000000000000001 110.942 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' VAL . 72.1 m-70 -109.23 133.64 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.688 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 pt -105.02 144.04 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.35999999999999999 111.051 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.21 110.04 20.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 2.1299999999999999 110.644 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 31' ' ' MET . 30.8 p -110.58 -171.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.64000000000000001 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -51.17 95.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 3.04 111.303 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 53.77 24.2 4.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 4.1100000000000003 111.545 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -146.12 115.3 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.035 0.445 . . . . 1.23 111.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -101.39 108.18 19.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.64000000000000001 110.533 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 46.9 tp -99.61 162.47 13.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.954 0.407 . . . . 1.54 111.262 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 9.3 p -117.01 126.47 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.5 110.974 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 65' ' ' LEU . 88.2 mt -119.05 165.95 13.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.96999999999999997 111.158 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.4 ttt180 -139.18 154.59 48.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 3.3199999999999998 110.657 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -46.48 -27.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 4.7000000000000002 111.756 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -79.44 -29.21 41.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 2.2799999999999998 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.12 -33.1 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 2.2999999999999998 110.984 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -76.42 -24.51 54.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.69999999999999996 110.968 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.81 62.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.66000000000000003 111.304 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.6 mt -91.53 -60.65 1.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.33 -0.395 . . . . 0.47999999999999998 110.975 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.405 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 23.7 pt -65.7 151.29 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.42999999999999999 110.925 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.52 146.21 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 2.29 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.41 159.44 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.8500000000000001 110.591 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.81 145.29 30.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.393 -0.367 . . . . 2.2400000000000002 111.084 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.09 163.8 27.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.76000000000000001 111.059 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 1.1599999999999999 111.308 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.8 0.333 . . . . 2.25 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -122.41 153.83 62.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.66000000000000003 111.241 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.05 83.44 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.65000000000000002 112.308 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.11 -42.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 2.6899999999999999 110.641 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.8 m -98.34 165.75 11.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 1.8899999999999999 110.927 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 160.97 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.46999999999999997 111.101 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.5 m95 -139.97 164.86 28.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.68999999999999995 110.798 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' SER . 39.9 ttmt -104.88 138.28 41.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 2.04 111.106 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.0 mt -88.13 132.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.56000000000000005 110.562 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 15.9 m -142.27 52.47 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.21 -0.45 . . . . 0.96999999999999997 110.798 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.22 93.59 0.01 OUTLIER Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.017 -0.611 . . . . 0.45000000000000001 112.848 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.84 101.41 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.777 0.322 . . . . 0.81000000000000005 110.88 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 m -110.48 -176.61 3.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.76000000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.7 mpt_? -74.85 -23.01 58.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -169.42 42.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 2.48 110.746 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.7 tt -46.97 115.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.56999999999999995 111.266 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -71.0 157.38 90.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.55 . . . . 1.5 110.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 24.9 Cg_endo -59.83 -27.37 84.78 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.771 2.314 . . . . 0.60999999999999999 112.141 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -49.36 -44.09 44.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.509 -0.314 . . . . 0.70999999999999996 110.713 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -86.15 -39.02 17.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 2.1699999999999999 111.144 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 17.9 tpp180 -67.91 -56.83 7.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 1.5700000000000001 111.338 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -40.97 -30.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.405 -0.362 . . . . 2.6899999999999999 111.633 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 14.2 mmmm -68.48 -54.77 14.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 2.5899999999999999 110.376 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.7 mt -54.61 -51.82 64.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 1.3 110.641 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -49.4 -43.57 44.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.94999999999999996 111.006 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -54.26 -50.97 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.474 . . . . 1.6399999999999999 110.752 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.96 -23.87 60.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 1.6399999999999999 110.815 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.12 19.03 31.92 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.81999999999999995 112.669 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 mtm -94.33 88.93 5.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.759 0.314 . . . . 2.5499999999999998 111.01 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -92.2 160.61 34.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.68999999999999995 110.531 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.1 104.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.33 2.02 . . . . 0.51000000000000001 112.197 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 50.33 0.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.40000000000000002 112.154 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 48.0 t -117.84 170.85 8.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.277 . . . . 0.62 110.746 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.2 p -118.99 139.4 51.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 1.3 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.9 p90 -148.45 163.13 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.35999999999999999 111.041 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -108.94 151.45 26.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 2.9399999999999999 110.983 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.5 129.26 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.199 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.5 t -99.03 -36.38 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.54000000000000004 111.115 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -175.03 125.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.361 . . . . 2.7999999999999998 111.14 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' CG2' ' A' ' 49' ' ' VAL . 59.0 t -140.86 156.24 22.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 1.2 111.183 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -138.04 128.13 15.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.81000000000000005 110.845 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.6 Cg_exo -57.58 -36.73 98.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.427 2.085 . . . . 1.3400000000000001 112.193 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.9 -45.32 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.925 -0.58 . . . . 2.5099999999999998 111.167 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.69 99.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.77000000000000002 112.234 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 8.9 m-20 -148.26 170.63 7.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.624 0.25 . . . . 1.0700000000000001 111.14 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.37 121.53 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.856 2.371 . . . . 0.60999999999999999 111.51 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.71 156.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.705 -0.68 . . . . 0.39000000000000001 111.03 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.8 m-70 -122.96 130.87 53.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 1.1299999999999999 110.41 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 19.5 pt -103.6 137.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.086 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.01 121.59 44.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 2.1299999999999999 110.733 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 55' ' ' ARG . 56.5 p -124.12 -172.9 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.99 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -49.63 91.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 3.04 111.351 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' THR . 17.8 mmm180 53.43 33.65 16.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 4.1100000000000003 111.463 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.6 t -150.97 104.59 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 1.23 111.307 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -97.52 107.84 20.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.64000000000000001 110.713 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.95 153.64 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 1.54 111.131 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 7.1 p -111.67 129.88 66.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.5 111.052 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.9 135.92 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.96999999999999997 110.906 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.4 mtt180 -103.01 160.36 14.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 3.3199999999999998 111.041 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -42.51 -37.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 4.7000000000000002 111.474 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 18.8 ptmt -64.53 -34.43 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 2.2799999999999998 111.127 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.08 -24.05 35.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 2.2999999999999998 111.067 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -86.18 -21.37 27.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.349 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.5 64.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.66000000000000003 111.377 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.0 mt -91.5 -55.86 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.352 -0.386 . . . . 0.47999999999999998 111.316 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 65' ' ' LEU . 25.7 pt -65.67 150.56 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.42999999999999999 111.092 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -100.42 143.08 31.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 2.29 110.816 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.6 ' N ' HD22 ' A' ' 70' ' ' LEU . 1.9 mm? -116.82 149.5 39.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.8500000000000001 110.779 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -144.21 156.11 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 2.2400000000000002 110.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.93 164.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 0.76000000000000001 111.007 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 1.1599999999999999 111.196 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 56.7 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.848 0.356 . . . . 2.25 110.787 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -100.26 145.23 29.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.66000000000000003 111.189 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' HG23 ' A' ' 39' ' ' VAL . 57.3 Cg_endo -70.34 86.85 0.64 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 112.215 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 177.85 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 2.6899999999999999 110.847 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -97.82 146.89 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 9' ' ' TRP . . . -79.81 171.14 15.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.46999999999999997 110.955 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' ALA . 57.5 m95 -156.71 160.94 39.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.68999999999999995 110.78 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 71' ' ' GLU . 59.0 mttp -112.1 134.35 53.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.04 110.801 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.477 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.0 mt -70.92 138.65 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.56000000000000005 111.292 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 9.2 m -146.52 43.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.189 0.519 . . . . 0.96999999999999997 110.484 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.48 90.5 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.45000000000000001 112.824 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -147.09 95.03 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.81000000000000005 110.736 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -99.32 -169.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.76000000000000001 110.928 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.1 mpt_? -83.29 -23.49 32.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 3.5800000000000001 110.93 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.07 37.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.48 110.775 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tt -46.08 116.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.301 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 m -64.25 155.9 77.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 1.5 110.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 33.9 Cg_endo -63.37 -26.79 71.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.565 2.176 . . . . 0.60999999999999999 112.14 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.06 55.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.70999999999999996 110.672 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' OD1' ' A' ' 64' ' ' ASP . 92.8 m-85 -85.84 -39.82 16.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 2.1699999999999999 110.915 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 22.5 tpt180 -65.2 -58.95 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.176 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.0 tt0 -43.8 -28.44 0.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 2.6899999999999999 111.724 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -65.01 -36.59 84.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 2.5899999999999999 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.7 mp -79.39 -45.41 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.3 111.038 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -50.47 -25.16 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.94999999999999996 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.8 m -57.41 -47.81 80.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.6399999999999999 111.042 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.9 mp -86.18 -25.06 25.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 1.6399999999999999 110.899 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 27.88 10.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 0.81999999999999995 112.762 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.2 mmt -95.29 99.45 11.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.7 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.54 159.86 37.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.54 . . . . 0.68999999999999995 110.826 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -42.24 114.59 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.495 2.13 . . . . 0.51000000000000001 112.148 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 25.22 2.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.859 -0.686 . . . . 0.40000000000000002 112.478 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 44.9 t -94.71 174.09 7.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.62 110.57 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.1 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.3 111.097 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.6 p90 -163.84 -173.4 3.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.076 -0.511 . . . . 0.35999999999999999 110.732 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -137.11 159.99 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 2.9399999999999999 110.966 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -100.57 131.46 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 1.28 110.883 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -89.58 -48.06 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.242 -0.436 . . . . 0.54000000000000004 111.568 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -171.39 120.8 0.5 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.732 0.301 . . . . 2.7999999999999998 111.385 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 43' ' ' ALA . 13.2 p -147.77 160.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 1.2 111.088 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -128.84 142.86 46.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 111.025 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 33.9 Cg_exo -59.42 -22.29 65.26 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.474 2.116 . . . . 1.3400000000000001 112.514 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.98 -73.68 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.361 . . . . 2.5099999999999998 111.242 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.41 91.72 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.779 -0.725 . . . . 0.77000000000000002 112.354 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.464 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.8 m-20 -138.39 171.54 8.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.514 0.197 . . . . 1.0700000000000001 110.722 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.71 116.45 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.903 2.402 . . . . 0.60999999999999999 111.95 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 42' ' ' VAL . 2.7 p -111.66 139.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.39000000000000001 111.315 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' VAL . 35.0 m-70 -101.68 130.79 48.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.604 . . . . 1.1299999999999999 110.504 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 57' ' ' SER . 37.8 pt -97.26 147.09 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.35999999999999999 111.008 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.73 119.83 40.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 2.1299999999999999 110.804 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.477 ' HG1' HG13 ' A' ' 56' ' ' VAL . 17.4 p -127.15 -163.19 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.64000000000000001 111.205 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 56' ' ' VAL . 34.5 mmt180 -48.31 97.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.079 0.466 . . . . 3.04 111.867 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 43.57 34.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 4.1100000000000003 112.286 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HG1' ' A' ' 53' ' ' THR . 12.2 p -159.94 125.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.968 0.413 . . . . 1.23 111.197 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 47.0 t -105.94 112.49 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 111.271 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.73 171.13 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.553 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -123.32 132.29 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.41 -0.359 . . . . 0.5 111.198 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -135.75 166.39 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.516 . . . . 0.96999999999999997 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.2 mtt180 -123.54 146.79 47.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 3.3199999999999998 110.601 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.453 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.3 tpmt? -50.01 -25.11 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.368 . . . . 4.7000000000000002 111.021 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.88 -30.0 40.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 2.2799999999999998 110.578 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' OD1' ' CD1' ' A' ' 22' ' ' TYR . 21.2 t70 -81.35 -36.63 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 2.2999999999999998 110.719 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.7 mp -61.69 -22.11 65.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.69999999999999996 110.928 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.13 61.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 111.192 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.66 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.47999999999999998 110.968 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 65' ' ' LEU . 27.6 pt -65.71 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.42999999999999999 110.78 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.8 tt0 -99.04 146.14 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.29 111.109 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -116.52 149.89 38.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 1.8500000000000001 110.681 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.4 tp10 -129.88 150.24 51.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 2.2400000000000002 110.974 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.97 171.57 12.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.76000000000000001 111.23 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.1599999999999999 111.022 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 13.5 p90 . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.973 0.416 . . . . 2.25 111.099 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -100.08 154.89 36.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.66000000000000003 110.908 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 58.0 Cg_endo -71.72 83.54 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.394 2.063 . . . . 0.65000000000000002 112.484 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 13.3 t70 178.71 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 2.6899999999999999 110.897 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 t -90.77 159.35 16.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.8899999999999999 111.11 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.03 169.25 11.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.46999999999999997 111.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 60.6 m95 -151.58 154.82 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.68999999999999995 111.107 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' SER . 31.7 mmmt -95.37 131.33 41.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.982 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 32.4 mt -83.05 125.33 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.56000000000000005 111.242 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 35.7 p -133.09 58.82 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.96999999999999997 110.534 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.26 91.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.742 -0.663 . . . . 0.45000000000000001 112.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.05 94.85 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.81000000000000005 110.344 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -97.89 -172.56 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.76000000000000001 111.247 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -85.73 -24.31 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 3.5800000000000001 110.695 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -158.5 37.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.048 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.15 128.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 0.56999999999999995 111.311 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.3 m -77.61 157.04 80.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 1.5 111.096 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 55.8 Cg_endo -70.36 -26.68 24.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.583 2.188 . . . . 0.60999999999999999 112.491 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.76 -47.11 59.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.351 -0.386 . . . . 0.70999999999999996 110.724 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -86.22 -38.39 17.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.915 -0.584 . . . . 2.1699999999999999 110.954 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 24.1 tpt180 -66.95 -58.19 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 1.5700000000000001 111.405 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -44.82 -30.5 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 2.6899999999999999 111.517 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.36 -40.97 73.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 2.5899999999999999 111.053 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.24 -50.87 19.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 1.3 110.64 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.33 -35.49 60.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.94999999999999996 110.856 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.2 m -78.25 -27.47 47.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 1.6399999999999999 111.038 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.39 -25.06 39.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 1.6399999999999999 110.846 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.07 5.96 43.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.807 -0.711 . . . . 0.81999999999999995 113.103 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -98.74 96.13 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 2.5499999999999998 110.931 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -104.96 158.73 31.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.454 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -39.59 105.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.576 2.184 . . . . 0.51000000000000001 112.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 33.95 0.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.40000000000000002 112.294 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.5 t -106.42 174.44 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.602 0.239 . . . . 0.62 110.525 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 p -129.13 144.98 51.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.866 0.365 . . . . 1.3 111.012 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CE2' HG22 ' A' ' 51' ' ' ILE . 13.5 p90 -152.04 168.41 25.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.35999999999999999 111.021 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -115.56 140.61 49.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 2.9399999999999999 110.517 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 49' ' ' VAL . 48.0 t -80.31 131.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.387 -0.37 . . . . 1.28 111.22 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.07 -39.61 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.428 . . . . 0.54000000000000004 111.324 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 49' ' ' VAL . 37.3 ptt180 -179.73 121.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 2.7999999999999998 110.801 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -145.02 159.5 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 1.2 111.152 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -112.61 155.45 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.81000000000000005 111.02 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.98 -22.23 15.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.584 2.189 . . . . 1.3400000000000001 112.367 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.9 -62.21 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 111.094 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.8 103.13 0.18 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.77000000000000002 112.208 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.457 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.9 m-20 -147.97 170.45 7.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.666 0.269 . . . . 1.0700000000000001 111.039 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -85.17 119.01 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.848 2.366 . . . . 0.60999999999999999 111.587 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' ARG . 2.7 p -115.06 149.35 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.39000000000000001 111.406 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -99.55 146.46 26.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 1.1299999999999999 110.995 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 58' ' ' LEU . 33.6 pt -112.08 138.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.35999999999999999 110.842 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.1 131.44 54.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 2.1299999999999999 110.91 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 p -137.35 -173.05 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.64000000000000001 110.991 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -52.83 91.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 3.04 111.3 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 54.04 39.11 30.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 4.1100000000000003 111.57 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -156.86 111.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 1.23 110.976 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -105.32 107.92 19.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.64000000000000001 111.071 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 58.5 tp -98.95 159.96 14.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.54 111.022 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 8.6 p -113.89 135.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.5 111.009 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.93 141.12 52.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.96999999999999997 110.979 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -106.96 151.61 25.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 3.3199999999999998 110.97 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -47.38 -29.87 2.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 4.7000000000000002 111.463 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 21.1 ptmt -81.34 -25.4 36.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 2.2799999999999998 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 61' ' ' ARG . 12.3 t70 -78.05 -30.69 49.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.48 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.8 mp -75.55 -21.91 57.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.142 -0.481 . . . . 0.69999999999999996 111.124 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.87 71.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.66000000000000003 111.36 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.95 -61.74 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.47999999999999998 111.204 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -65.68 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.031 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 5.8 tp10 -98.49 155.85 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 2.29 110.859 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.1 tp -125.04 157.48 36.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 1.8500000000000001 110.561 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 35.3 tt0 -147.42 149.93 33.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 110.83 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.29 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 111.086 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 2.25 110.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 p -102.43 151.46 38.19 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.66000000000000003 111.338 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.681 ' HA ' HG23 ' A' ' 39' ' ' VAL . 59.0 Cg_endo -71.87 91.06 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.563 2.176 . . . . 0.65000000000000002 112.489 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 176.6 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 2.6899999999999999 110.912 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -106.31 144.14 33.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 1.8899999999999999 110.984 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.33 165.32 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 111.128 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -155.2 153.91 31.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.68999999999999995 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 35' ' ' SER . 49.8 mtmt -113.59 138.68 49.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 2.04 111.25 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' CD1' ' A' ' 37' ' ' PHE . 47.3 mt -79.12 123.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.56000000000000005 111.265 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 57.7 p -131.78 59.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.96999999999999997 110.554 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -51.64 97.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.838 -0.696 . . . . 0.45000000000000001 112.44 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -145.09 96.92 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.371 . . . . 0.81000000000000005 111.125 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -114.12 153.57 29.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.76000000000000001 110.698 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -52.55 -25.01 9.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 3.5800000000000001 110.57 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.3 39.72 0.67 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 2.48 110.783 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.3 tt -42.72 105.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.076 0.465 . . . . 0.56999999999999995 111.468 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -63.42 146.8 96.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.5 110.806 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.3 Cg_endo -58.64 -30.31 91.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.721 2.281 . . . . 0.60999999999999999 112.131 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -45.33 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.70999999999999996 110.937 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 54.0 m-85 -85.39 -42.02 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 2.1699999999999999 111.249 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -60.76 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 1.5700000000000001 111.269 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.3 mm-40 -54.88 -22.12 13.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.34 -0.391 . . . . 2.6899999999999999 111.456 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 22' ' ' TYR . 23.1 ttpp -69.2 -42.93 75.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.331 . . . . 2.5899999999999999 110.823 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.1 mt -52.14 -34.42 44.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.725 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.83 -27.73 44.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.94999999999999996 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -49.0 -38.11 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 1.6399999999999999 111.121 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.1 mm? -107.11 -21.24 13.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.6399999999999999 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.28 29.63 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.737 -0.744 . . . . 0.81999999999999995 112.531 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -88.57 92.71 9.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.749 0.309 . . . . 2.5499999999999998 110.791 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.4 mp -83.04 158.98 63.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.68999999999999995 110.825 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.36 107.27 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.328 2.019 . . . . 0.51000000000000001 112.112 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.71 32.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.855 -0.688 . . . . 0.40000000000000002 112.518 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 10' ' ' LYS . 46.7 t -104.76 174.18 5.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.71 0.291 . . . . 0.62 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -116.04 154.54 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.334 -0.394 . . . . 1.3 111.169 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 11' ' ' ILE . 30.0 p90 -165.04 169.96 15.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.35999999999999999 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 29.3 m80 -124.69 134.55 52.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 2.9399999999999999 111.014 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 5' ' ' PRO . 7.0 m -83.87 132.32 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.28 111.16 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.69 -49.71 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.54000000000000004 111.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 2.7999999999999998 110.892 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.1 t -143.55 159.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.2 111.189 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.26 144.95 52.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.81000000000000005 110.944 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.06 -18.23 31.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.476 2.117 . . . . 1.3400000000000001 112.596 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.42 -55.17 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 2.5099999999999998 111.15 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.68 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.77000000000000002 112.272 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.8 m-20 -143.43 170.66 8.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.67 0.271 . . . . 1.0700000000000001 111.118 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.94 117.14 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.933 2.422 . . . . 0.60999999999999999 111.924 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.62 156.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.39000000000000001 110.935 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -115.58 131.91 56.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 37.5 pt -101.73 142.43 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.097 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 38.0 tt0 -107.33 124.53 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 2.1299999999999999 110.709 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 56' ' ' VAL . 69.6 p -132.1 -173.52 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.64000000000000001 111.278 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 56' ' ' VAL . 38.1 mmt180 -41.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.105 0.409 . . . . 3.04 112.105 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 44.15 51.0 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.906 -0.588 . . . . 4.1100000000000003 111.886 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 56' ' ' VAL . 14.2 p 179.71 119.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 1.23 111.201 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -102.33 112.57 25.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 110.946 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 47.7 tp -92.0 162.77 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 1.54 110.615 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 12.6 p -112.29 145.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.5 111.244 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.03 147.06 41.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.847 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.3 mtt180 -107.65 150.51 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.3199999999999998 110.908 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.89 -25.95 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.919 -0.582 . . . . 4.7000000000000002 111.226 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -81.08 -27.76 35.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 2.2799999999999998 110.826 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.5 -31.59 47.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 2.2999999999999998 110.974 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -72.79 -21.17 61.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.69999999999999996 111.008 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.77 71.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.66000000000000003 111.146 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.38 -61.69 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.47999999999999998 111.042 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.403 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 25.8 pt -66.08 148.98 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.415 . . . . 0.42999999999999999 110.962 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.4 tt0 -102.35 153.81 19.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 2.29 110.733 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -115.96 149.58 38.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.8500000000000001 110.866 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.32 110.72 9.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 2.2400000000000002 110.957 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 155.34 1.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.76000000000000001 111.0 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 1.1599999999999999 111.278 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.941 0.401 . . . . 2.25 110.788 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.4 p -99.88 155.97 35.86 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.66000000000000003 111.143 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 58.6 Cg_endo -72.3 87.27 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.502 2.135 . . . . 0.65000000000000002 112.289 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 t70 177.77 -57.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 2.6899999999999999 110.965 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -77.32 135.9 38.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 1.8899999999999999 110.804 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.42 157.65 28.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.46999999999999997 111.327 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 71.9 m95 -141.37 167.62 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.68999999999999995 110.804 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.1 136.57 51.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 2.04 111.165 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' CD1' ' A' ' 37' ' ' PHE . 50.5 mt -79.47 136.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.56000000000000005 110.742 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 12' ' ' THR . 12.7 m -143.83 46.52 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.96999999999999997 110.825 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.85 90.32 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.881 -0.676 . . . . 0.45000000000000001 112.657 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' THR . 69.3 t80 -146.68 102.69 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.81000000000000005 110.732 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -97.94 -179.12 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.76000000000000001 111.115 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.2 mpt_? -75.25 -24.85 57.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 3.5800000000000001 110.629 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.95 38.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 2.48 110.63 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -42.88 131.7 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.038 -0.528 . . . . 0.56999999999999995 111.737 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.8 m -92.47 157.4 40.27 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.5 110.784 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 24' ' ' GLN . 11.7 Cg_endo -54.44 -32.75 74.5 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.638 2.225 . . . . 0.60999999999999999 112.093 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.08 -46.69 34.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.07 0.462 . . . . 0.70999999999999996 110.771 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -85.95 -49.96 7.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.558 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.48 -61.23 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 1.5700000000000001 111.064 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.4 tt0 -47.51 -32.42 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 2.6899999999999999 111.055 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.66 -55.9 28.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 2.5899999999999999 110.752 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.5 -45.15 92.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 1.3 110.817 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.45 -53.36 37.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.94999999999999996 111.113 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -49.92 -29.91 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 1.6399999999999999 111.085 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HD11 ' A' ' 58' ' ' LEU . 84.2 mt -91.88 -25.42 18.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 1.6399999999999999 110.94 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.06 31.35 9.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.698 -0.763 . . . . 0.81999999999999995 112.874 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.4 mtt -110.3 87.46 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 2.5499999999999998 110.623 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.8 mp -86.95 161.21 47.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.68999999999999995 110.746 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.78 115.13 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.508 2.138 . . . . 0.51000000000000001 112.163 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.4 28.58 2.98 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.786 -0.721 . . . . 0.40000000000000002 112.188 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 37.3 t -96.36 163.16 13.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.638 0.256 . . . . 0.62 110.634 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -110.67 145.3 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 1.3 111.028 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 11' ' ' ILE . 19.1 p90 -158.28 170.33 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.35999999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -120.81 149.75 42.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.107 -0.497 . . . . 2.9399999999999999 110.991 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 5' ' ' PRO . 54.2 t -82.17 132.54 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.072 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.0 -33.51 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.54000000000000004 111.522 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 176.41 130.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 2.7999999999999998 111.22 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 43' ' ' ALA . 51.0 t -139.87 158.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 1.2 111.04 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -114.63 134.35 22.39 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.81000000000000005 110.859 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.3 -26.3 76.36 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.455 2.103 . . . . 1.3400000000000001 112.48 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.2 mp -91.26 -65.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.427 -0.351 . . . . 2.5099999999999998 111.215 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.12 106.94 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.77000000000000002 112.338 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.3 m-20 -148.32 173.21 4.39 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 111.05 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.467 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 2.3 Cg_endo -83.52 120.23 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.60999999999999999 111.522 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.486 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.55 156.02 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.629 -0.714 . . . . 0.39000000000000001 111.202 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -120.78 134.26 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 1.1299999999999999 110.525 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 37.3 pt -101.38 137.88 27.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.198 -0.455 . . . . 0.35999999999999999 110.916 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.7 101.32 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.445 . . . . 2.1299999999999999 110.887 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.8 p -99.64 -169.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 110.838 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -56.18 96.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 3.04 111.584 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.3 26.3 8.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 4.1100000000000003 111.629 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -148.53 114.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 1.23 111.257 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -103.24 107.86 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.64000000000000001 110.779 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 64.5 mt -94.77 174.78 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 1.54 111.006 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.99 131.26 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.975 0.416 . . . . 0.5 111.181 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.8 mt -124.06 165.11 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.789 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' HD13 ' A' ' 65' ' ' LEU . 97.5 mtt180 -146.05 162.23 38.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 3.3199999999999998 111.066 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -52.54 -22.33 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 4.7000000000000002 111.545 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE3' ' HD2' ' A' ' 61' ' ' ARG . 23.0 pttp -80.35 -33.67 37.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 2.2799999999999998 110.624 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.27 -42.55 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 2.2999999999999998 110.888 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -60.47 -24.19 65.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.69999999999999996 111.007 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.92 65.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.401 . . . . 0.66000000000000003 111.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.15 -57.26 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.362 . . . . 0.47999999999999998 111.072 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.3 pt -65.94 151.19 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.42999999999999999 111.192 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -103.43 150.51 23.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 2.29 110.722 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.87 142.14 50.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.8500000000000001 111.088 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -124.13 152.72 42.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 2.2400000000000002 110.906 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.21 -178.51 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 111.105 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 1.1599999999999999 111.084 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 9' ' ' TRP . 62.9 m-85 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.832 0.349 . . . . 2.25 110.705 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -114.41 161.09 30.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.66000000000000003 111.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.97 147.55 14.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.65000000000000002 112.345 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 66.4 18.27 10.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 2.6899999999999999 111.647 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.493 ' OG ' HG21 ' A' ' 39' ' ' VAL . 84.5 p -98.74 173.25 6.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.733 0.301 . . . . 1.8899999999999999 110.651 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.07 142.81 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.46999999999999997 111.122 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.559 ' CD2' ' CE2' ' A' ' 3' ' ' PHE . 32.1 m95 -154.02 162.83 40.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.68999999999999995 110.696 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -106.33 138.19 42.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 2.04 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 44.8 mt -77.79 127.4 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.56000000000000005 111.026 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 m -136.05 48.15 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.96999999999999997 110.571 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -46.59 92.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.45000000000000001 113.046 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -147.08 94.9 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.81000000000000005 110.668 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 32.2 t -98.63 -178.76 4.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.896 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.9 mpt_? -79.05 -21.49 46.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 3.5800000000000001 111.001 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.02 37.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.479 -0.328 . . . . 2.48 111.17 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 10.8 tt -45.6 126.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.56999999999999995 111.396 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -85.36 149.29 51.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 1.5 110.964 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 15.6 Cg_endo -56.8 -31.25 87.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.801 2.334 . . . . 0.60999999999999999 112.257 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.56 -47.11 28.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.70999999999999996 110.858 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -85.79 -43.65 13.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 2.1699999999999999 110.904 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.4 tpt180 -60.7 -61.01 2.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 1.5700000000000001 110.967 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' PRO . 52.8 tp60 -48.89 -30.35 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 2.6899999999999999 110.85 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.61 -32.97 73.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 2.5899999999999999 110.849 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.94 -48.04 26.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.837 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.65 -34.05 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.94999999999999996 111.062 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -53.09 -33.27 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.6399999999999999 110.904 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -89.79 -22.95 21.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 1.6399999999999999 110.823 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.74 23.67 30.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 0.81999999999999995 112.495 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 39.8 mtm -101.44 91.01 4.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 2.5499999999999998 110.763 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -92.54 159.3 36.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.68999999999999995 110.879 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.04 106.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.637 2.225 . . . . 0.51000000000000001 112.186 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.18 33.34 0.9 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.798 -0.715 . . . . 0.40000000000000002 112.454 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.4 t -107.49 171.8 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.62 110.829 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -116.05 145.96 42.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 1.3 111.009 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 18.2 p90 -157.62 159.73 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.317 -0.401 . . . . 0.35999999999999999 111.033 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -109.33 151.62 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 2.9399999999999999 110.67 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.493 HG21 ' OG ' ' A' ' 7' ' ' SER . 57.6 t -89.37 140.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 1.28 111.221 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.9 t -103.45 -52.22 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.54000000000000004 111.426 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.33 129.13 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 2.7999999999999998 111.074 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.3 t -143.2 159.2 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.201 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -129.06 145.17 55.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.98 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 33.3 Cg_endo -64.46 -16.97 57.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.568 2.179 . . . . 1.3400000000000001 112.468 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -89.88 -69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.872 0.367 . . . . 2.5099999999999998 110.975 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.52 94.17 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.77000000000000002 112.347 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB2' ' CD ' ' A' ' 48' ' ' PRO . 4.2 p-10 -131.25 178.01 1.95 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.475 0.179 . . . . 1.0700000000000001 110.711 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' CD ' ' HB2' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.25 118.36 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.938 2.425 . . . . 0.60999999999999999 111.557 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.84 157.53 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.39000000000000001 111.293 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.43 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.8 m-70 -117.57 144.92 44.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.642 -0.708 . . . . 1.1299999999999999 110.463 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.2 135.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.35999999999999999 111.222 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -106.94 112.49 25.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 2.1299999999999999 110.651 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -118.13 -174.11 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.64000000000000001 111.128 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -50.71 93.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.04 111.283 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.25 37.71 15.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 4.1100000000000003 111.578 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG11 HD23 ' A' ' 29' ' ' LEU . 89.2 t -152.71 100.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 1.23 110.887 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -97.77 108.42 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.64000000000000001 111.008 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 56.8 tp -108.01 161.26 15.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 1.54 110.935 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 7.4 p -114.59 141.17 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.023 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -126.77 144.11 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.96999999999999997 110.813 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.45 ' O ' HD13 ' A' ' 65' ' ' LEU . 56.9 mtp180 -107.92 152.67 24.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 3.3199999999999998 111.171 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.81 -33.12 9.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 4.7000000000000002 111.713 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.98 -22.88 36.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 2.2799999999999998 111.073 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.96 -23.55 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 2.2999999999999998 110.931 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 61' ' ' ARG . 9.6 mp -79.5 -28.93 41.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.69999999999999996 110.965 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -24.27 52.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.66000000000000003 111.071 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.54 -61.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.47999999999999998 110.917 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 22.4 pt -65.65 151.86 9.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.42999999999999999 110.819 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -105.48 142.54 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 2.29 111.426 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -110.16 125.64 53.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.969 -0.559 . . . . 1.8500000000000001 110.455 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.44 124.01 45.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.2400000000000002 110.72 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.1 152.44 7.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.028 -0.533 . . . . 0.76000000000000001 111.199 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 1.1599999999999999 111.281 179.91 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.5 ' HB2' ' CE2' ' A' ' 9' ' ' TRP . 37.0 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.792 0.33 . . . . 2.25 110.969 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.0 p -81.18 153.1 71.73 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.66000000000000003 111.194 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.0 81.7 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.454 2.103 . . . . 0.65000000000000002 112.013 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -176.58 -42.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 2.6899999999999999 110.94 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -90.18 154.64 19.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.8899999999999999 110.884 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.54 170.12 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.46999999999999997 111.034 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 52.0 m95 -155.63 175.69 13.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.68999999999999995 110.911 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.3 134.02 54.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 2.04 111.094 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.501 HG13 ' CD1' ' A' ' 37' ' ' PHE . 58.9 mt -80.74 123.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.56000000000000005 111.028 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 19.5 m -133.89 53.46 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.115 0.484 . . . . 0.96999999999999997 110.509 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.57 88.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.885 -0.598 . . . . 0.45000000000000001 112.826 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' THR . 19.4 t80 -147.21 107.6 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.81000000000000005 111.046 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 m -108.66 164.36 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.76000000000000001 110.842 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.448 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -55.17 -22.8 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 3.5800000000000001 110.976 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -164.1 42.45 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.712 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -44.3 134.17 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.56999999999999995 111.558 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 m -84.6 155.81 62.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.5 110.971 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' GLN . 24.9 Cg_endo -62.05 -29.72 81.84 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.605 2.204 . . . . 0.60999999999999999 112.421 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.08 -45.28 64.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.70999999999999996 110.646 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.38 -41.99 14.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 110.798 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -65.51 -61.41 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.5700000000000001 110.999 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' PRO . 12.9 mm100 -52.82 -22.95 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 2.6899999999999999 111.255 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -73.5 -40.41 64.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 2.5899999999999999 110.796 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.5 -44.04 95.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 1.3 110.895 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.56 -25.79 4.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.94999999999999996 110.978 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.6 m -53.59 -35.37 60.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.6399999999999999 111.015 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.8 mm? -94.02 -25.21 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 1.6399999999999999 110.852 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.4 56.16 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.81999999999999995 112.835 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -88.95 98.51 11.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.923 0.392 . . . . 2.5499999999999998 110.687 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.3 mp -83.3 159.66 61.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.544 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.05 149.77 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.47 2.113 . . . . 0.51000000000000001 111.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . 77.65 17.95 78.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.693 -0.765 . . . . 0.40000000000000002 112.342 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.6 t -77.74 174.04 11.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.601 0.239 . . . . 0.62 110.446 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -121.23 136.0 55.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 1.3 110.91 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CD1' HG13 ' A' ' 11' ' ' ILE . 12.8 p90 -151.72 173.65 14.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.35999999999999999 111.085 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -127.75 158.42 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 2.9399999999999999 110.839 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.02 128.59 46.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 1.28 111.248 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.2 -38.63 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.54000000000000004 111.05 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -178.74 123.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 2.7999999999999998 111.003 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.9 p -143.61 160.87 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 1.2 111.218 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -125.16 153.79 71.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.81000000000000005 110.994 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.97 -14.55 9.77 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.592 2.195 . . . . 1.3400000000000001 112.911 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD11 ' OD2' ' A' ' 47' ' ' ASP . 4.4 pp -85.32 -18.95 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.606 -0.27 . . . . 2.5099999999999998 111.287 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 45' ' ' LEU . . . 114.93 88.45 1.56 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.687 -0.768 . . . . 0.77000000000000002 112.297 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.639 ' OD2' HD11 ' A' ' 45' ' ' LEU . 7.3 m-20 -137.52 171.94 7.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.605 0.24 . . . . 1.0700000000000001 110.897 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.4 Cg_endo -84.3 115.94 1.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.832 2.355 . . . . 0.60999999999999999 111.72 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.54 138.44 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.39000000000000001 111.025 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -95.91 136.01 36.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.919 -0.582 . . . . 1.1299999999999999 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.62 134.64 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.35999999999999999 110.962 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.26 120.54 42.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 2.1299999999999999 111.015 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 74.3 p -124.46 -173.65 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.64000000000000001 110.657 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -49.57 92.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 3.04 111.328 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 34.0 mmt180 53.09 40.9 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.808 -0.633 . . . . 4.1100000000000003 111.488 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 55' ' ' ARG . 66.7 t -157.45 105.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 1.23 111.025 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -104.88 107.52 18.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.64000000000000001 110.9 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.7 tp -100.73 160.19 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.644 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.43 142.94 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.5 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' CD2' ' A' ' 65' ' ' LEU . 57.1 tp -137.52 141.92 41.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.96999999999999997 110.82 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.433 ' CZ ' ' HD3' ' A' ' 63' ' ' LYS . 31.3 ptt180 -114.84 179.46 3.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 3.3199999999999998 110.62 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -75.62 -48.85 20.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.521 -0.308 . . . . 4.7000000000000002 111.513 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 61' ' ' ARG . 21.0 ptmt -51.57 -34.44 36.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 2.2799999999999998 110.567 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.52 -25.48 33.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 2.2999999999999998 110.434 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.536 ' CD2' HD21 ' A' ' 60' ' ' LEU . 10.0 mt -74.86 -25.46 58.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.052 -0.522 . . . . 0.69999999999999996 111.038 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.89 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.66000000000000003 111.108 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -84.92 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.254 -0.43 . . . . 0.47999999999999998 110.983 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.97 155.95 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.283 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.7 tp10 -107.72 135.37 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 2.29 110.776 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.8 mm? -105.21 152.32 23.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 1.8500000000000001 111.11 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.98 121.21 10.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 2.2400000000000002 110.707 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.75 166.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.76000000000000001 111.22 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 1.1599999999999999 111.135 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' A' ' 42' ' ' VAL . 28.5 p90 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.816 0.341 . . . . 2.25 110.984 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.0 p -79.39 155.35 76.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.66000000000000003 110.954 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 65.5 Cg_endo -74.08 89.64 1.02 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.488 2.125 . . . . 0.65000000000000002 112.46 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 t70 177.94 -43.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 2.6899999999999999 111.048 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -87.64 144.24 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.8899999999999999 110.914 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 158.59 32.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 111.131 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.435 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 72.5 m95 -145.79 158.11 43.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.68999999999999995 110.877 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -108.85 138.35 45.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 2.04 110.91 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 60.8 mt -80.65 137.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.56000000000000005 111.141 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -141.69 56.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.96999999999999997 110.253 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.22 90.08 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.45000000000000001 112.875 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -146.43 94.69 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.81000000000000005 110.433 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -100.85 150.28 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.76000000000000001 111.204 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' OD2' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -53.55 -22.47 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.616 . . . . 3.5800000000000001 111.067 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 48.5 m-20 -149.0 34.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.782 0.325 . . . . 2.48 111.151 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -43.94 148.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.389 -0.369 . . . . 0.56999999999999995 111.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 m -96.01 155.85 37.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 1.5 110.985 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 38.8 Cg_endo -66.91 -32.25 36.26 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.461 2.108 . . . . 0.60999999999999999 112.093 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.98 -44.97 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 110.433 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 26' ' ' LEU . 96.1 m-85 -85.49 -48.17 9.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 2.1699999999999999 110.325 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 25.6 tpt180 -56.98 -61.35 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 1.5700000000000001 111.022 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.517 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER -51.47 -34.83 37.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.081 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -60.82 -41.17 95.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.366 -0.379 . . . . 2.5899999999999999 111.29 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 22' ' ' TYR . 10.8 mp -74.22 -52.69 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 1.3 111.157 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -46.35 -37.1 7.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.94999999999999996 111.513 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -69.31 -23.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 1.6399999999999999 111.339 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.0 mt -96.87 -24.18 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.438 -0.347 . . . . 1.6399999999999999 111.055 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.75 7.44 53.35 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.68 -0.771 . . . . 0.81999999999999995 113.035 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 31' ' ' MET . 1.1 mpt? -89.97 90.67 8.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.891 0.377 . . . . 2.5499999999999998 110.736 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -94.69 160.55 31.15 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.788 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.5 Cg_exo -45.38 122.76 4.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.266 1.977 . . . . 0.51000000000000001 111.847 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.04 23.8 6.88 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.884 -0.674 . . . . 0.40000000000000002 112.071 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.8 t -87.73 174.05 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.62 110.892 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -123.58 144.97 49.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.009 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' HG22 ' A' ' 51' ' ' ILE . 20.7 p90 -158.98 -177.94 6.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.35999999999999999 110.891 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -131.8 132.5 43.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 2.9399999999999999 111.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 5' ' ' PRO . 7.1 p -78.31 135.62 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 1.28 111.025 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.87 -52.21 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.489 -0.323 . . . . 0.54000000000000004 111.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 20.9 ptp180 -153.84 139.03 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 2.7999999999999998 111.186 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.6 t -148.59 158.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 1.2 111.108 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -126.11 143.34 45.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.81000000000000005 111.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 45.2 Cg_endo -68.33 -21.41 41.25 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.647 2.231 . . . . 1.3400000000000001 112.468 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.8 mm? -89.88 -56.1 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 2.5099999999999998 111.111 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.12 107.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.77000000000000002 112.332 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.0 m-20 -148.17 170.66 7.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.637 0.256 . . . . 1.0700000000000001 111.07 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.72 118.12 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.985 2.456 . . . . 0.60999999999999999 111.77 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.8 p -106.79 160.78 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 0.39000000000000001 110.881 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.494 ' CE1' HG23 ' A' ' 59' ' ' VAL . 93.3 m-70 -123.47 135.74 54.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 1.1299999999999999 110.98 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 37' ' ' PHE . 37.1 pt -102.04 139.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.983 -0.553 . . . . 0.35999999999999999 110.855 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.68 108.88 19.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 2.1299999999999999 111.014 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 61.9 p -111.14 -175.3 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.64000000000000001 110.703 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.7 mmt180 -47.68 91.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.04 111.48 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 32.9 mmt180 53.01 36.06 21.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.046 -0.524 . . . . 4.1100000000000003 111.396 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 54' ' ' ARG . 85.9 t -150.87 112.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 1.23 111.052 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -105.07 107.57 18.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.64000000000000001 110.643 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.72 157.31 17.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.162 -0.472 . . . . 1.54 110.951 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.494 HG23 ' CE1' ' A' ' 50' ' ' HIS . 13.8 p -102.62 143.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.047 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 51' ' ' ILE . 96.5 mt -139.07 117.58 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.96999999999999997 110.777 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -92.48 169.78 10.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 3.3199999999999998 110.797 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -46.94 -27.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 4.7000000000000002 111.338 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -84.25 -42.43 15.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.38 . . . . 2.2799999999999998 111.17 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 -34.35 65.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 2.2999999999999998 110.973 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -81.27 -21.14 39.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.69999999999999996 111.134 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.63 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.66000000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.65 -65.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.47999999999999998 111.378 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.4 pt -65.08 140.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.482 -0.326 . . . . 0.42999999999999999 110.967 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.85 154.96 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 2.29 110.697 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -116.43 158.07 24.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 1.8500000000000001 110.774 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -146.24 154.39 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.2400000000000002 111.083 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.81 169.17 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.76000000000000001 111.122 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 1.1599999999999999 110.998 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 61.9 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.883 0.373 . . . . 2.25 110.836 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -118.54 152.39 51.04 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.66000000000000003 111.209 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.07 84.46 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.663 2.242 . . . . 0.65000000000000002 112.34 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -179.97 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.293 -0.412 . . . . 2.6899999999999999 110.901 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 42.1 t -103.07 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 1.8899999999999999 110.629 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.93 169.22 8.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.46999999999999997 111.101 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 78.7 m95 -146.41 168.34 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.68999999999999995 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 54.9 mtpt -124.24 138.05 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 2.04 111.129 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.478 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.1 mt -80.2 118.14 27.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.159 -0.473 . . . . 0.56000000000000005 111.159 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 18.9 m -130.37 53.17 1.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.96999999999999997 110.388 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' HA3' ' NH2' ' A' ' 23' ' ' ARG . . . -48.83 96.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.45000000000000001 112.627 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -145.53 95.95 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.81000000000000005 110.935 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -111.88 158.03 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.013 -0.539 . . . . 0.76000000000000001 110.778 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -51.78 -24.36 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 3.5800000000000001 110.729 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -158.29 42.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.789 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -41.07 128.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.802 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.0 t -80.22 147.38 64.68 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 1.5 110.782 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.3 Cg_endo -62.62 -28.43 76.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.625 2.216 . . . . 0.60999999999999999 112.501 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.02 -43.79 50.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.70999999999999996 111.052 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -85.29 -45.49 11.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 2.1699999999999999 111.2 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' NH2' ' HA3' ' A' ' 13' ' ' GLY . 18.3 tpp180 -67.58 -61.46 1.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.5700000000000001 111.43 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 11.1 mm100 -55.93 -19.59 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 111.629 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -80.25 -36.77 34.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 2.5899999999999999 110.993 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.74 -32.6 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 1.3 110.982 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -57.24 -33.73 67.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.94999999999999996 111.254 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.1 m -64.04 -39.63 94.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 1.6399999999999999 110.997 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.6 mm? -78.01 -23.23 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 1.6399999999999999 111.059 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.79 20.52 10.63 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.771 . . . . 0.81999999999999995 112.593 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.402 ' C ' HD12 ' A' ' 32' ' ' LEU . 1.1 mpt? -98.72 98.24 9.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 2.5499999999999998 110.988 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -102.51 157.93 32.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.68999999999999995 110.675 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' NH1' ' A' ' 23' ' ' ARG . 71.2 Cg_exo -47.46 111.19 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.391 2.061 . . . . 0.51000000000000001 111.803 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 21.39 4.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 0.40000000000000002 112.36 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -88.02 166.26 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.303 . . . . 0.62 110.639 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 49.7 m -121.85 156.92 32.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 1.3 111.044 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 51.9 p90 -166.64 178.82 5.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.488 . . . . 0.35999999999999999 110.831 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -128.3 125.61 39.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 2.9399999999999999 111.098 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' SER . 18.9 m -75.17 134.59 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.263 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.64 -52.09 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.54000000000000004 111.34 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -148.66 133.71 18.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 2.7999999999999998 111.083 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 43' ' ' ALA . 41.4 t -146.0 160.39 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.396 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -154.83 124.4 3.18 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.512 . . . . 0.81000000000000005 110.737 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.05 -24.45 49.12 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.475 2.117 . . . . 1.3400000000000001 112.491 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -63.45 -22.87 67.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 2.5099999999999998 111.067 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.06 73.65 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.572 -0.823 . . . . 0.77000000000000002 112.11 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.1 m-20 -122.4 170.11 8.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.731 0.301 . . . . 1.0700000000000001 111.172 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.93 120.34 2.28 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.975 2.45 . . . . 0.60999999999999999 111.724 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.6 p -106.74 159.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.783 -0.644 . . . . 0.39000000000000001 111.123 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 80.8 m80 -123.32 123.53 40.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 1.1299999999999999 110.804 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 47.7 pt -97.16 141.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.35999999999999999 111.021 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -106.67 120.89 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.342 -0.39 . . . . 2.1299999999999999 110.828 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.549 ' OG1' HG13 ' A' ' 56' ' ' VAL . 27.1 p -122.63 -163.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.884 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -46.45 93.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.067 0.461 . . . . 3.04 111.732 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' THR . 25.7 mmm180 44.44 28.59 0.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.81 -0.632 . . . . 4.1100000000000003 112.121 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -152.55 113.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 1.23 110.838 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -93.84 118.9 32.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.64000000000000001 111.315 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 tp -99.54 150.23 22.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 1.54 110.653 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' HD23 ' A' ' 60' ' ' LEU . 11.4 p -104.83 134.32 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.394 . . . . 0.5 111.296 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB2' HD11 ' A' ' 65' ' ' LEU . 83.7 mt -143.33 155.62 44.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 110.721 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' NH2' ' HD3' ' A' ' 63' ' ' LYS . 70.4 mtm180 -110.63 160.4 16.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.88 0.371 . . . . 3.3199999999999998 110.898 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -44.05 -28.2 0.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 4.7000000000000002 111.585 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 21.8 ptmt -80.73 -35.53 33.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 2.2799999999999998 110.88 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 7.3 m-20 -68.62 -31.49 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 2.2999999999999998 111.134 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 65' ' ' LEU . 5.8 mp -86.42 -25.69 25.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.69999999999999996 111.266 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.63 -58.43 6.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.66000000000000003 111.468 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.93 -59.05 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.47999999999999998 111.188 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.22 151.96 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.411 . . . . 0.42999999999999999 111.47 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 12' ' ' THR . 9.1 tp10 -95.78 136.15 36.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.573 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.5 mm? -110.0 139.71 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 1.8500000000000001 110.991 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.81 118.01 19.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 2.2400000000000002 110.817 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.89 148.16 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.76000000000000001 111.073 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 1.1599999999999999 111.136 -179.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.841 0.353 . . . . 2.25 110.601 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -88.41 154.66 51.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.66000000000000003 111.276 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.567 ' HA ' HG23 ' A' ' 39' ' ' VAL . 60.7 Cg_endo -72.85 92.89 0.78 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.507 2.138 . . . . 0.65000000000000002 112.354 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 176.29 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.535 . . . . 2.6899999999999999 110.702 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -104.41 146.4 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 1.8899999999999999 110.79 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.37 170.21 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.46999999999999997 111.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 35.2 m95 -155.41 160.4 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.68999999999999995 110.797 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -114.65 138.62 50.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 2.04 111.125 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 37' ' ' PHE . 57.3 mt -79.33 129.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.56000000000000005 111.191 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 62.8 p -134.72 58.73 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.96999999999999997 110.508 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.8 96.39 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.665 -0.698 . . . . 0.45000000000000001 112.696 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -147.16 98.55 3.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.81000000000000005 110.875 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.9 m -112.32 161.94 16.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.76000000000000001 110.829 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -22.44 34.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.314 -0.403 . . . . 3.5800000000000001 110.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -162.7 44.4 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 2.48 110.861 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -45.94 128.67 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.494 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -81.61 154.99 71.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 1.5 110.776 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.65 -28.19 69.2 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.615 2.21 . . . . 0.60999999999999999 112.241 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.34 -45.32 45.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.823 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 95.3 m-85 -85.46 -49.24 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 2.1699999999999999 110.503 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -57.74 -61.27 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.5700000000000001 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 27' ' ' LEU . 13.4 mm100 -51.02 -34.13 28.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 2.6899999999999999 110.731 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -51.75 -53.27 41.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 2.5899999999999999 110.949 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.03 -43.4 95.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 1.3 111.088 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 24' ' ' GLN . 84.0 mt -48.78 -26.51 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.94999999999999996 111.186 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.4 t -69.56 -34.03 73.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 1.6399999999999999 110.974 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -94.34 -24.53 17.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.6399999999999999 110.921 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.58 9.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.653 -0.784 . . . . 0.81999999999999995 112.55 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.9 mtt -99.32 91.47 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 111.018 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -92.32 158.02 39.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.561 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.87 118.72 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.481 2.121 . . . . 0.51000000000000001 112.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.11 31.02 3.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.825 -0.702 . . . . 0.40000000000000002 112.398 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.6 t -95.57 173.89 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.62 110.875 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -121.84 148.94 44.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.3 110.943 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 36.1 p90 -162.22 173.1 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.35999999999999999 110.732 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 47.9 m-70 -128.56 130.33 47.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.956 0.408 . . . . 2.9399999999999999 111.233 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 5' ' ' PRO . 19.4 m -80.01 138.38 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.28 110.994 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 48.1 t -99.62 -40.49 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.54000000000000004 111.426 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 38.8 ptt180 -164.67 129.36 2.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.377 -0.374 . . . . 2.7999999999999998 110.913 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG21 ' A' ' 49' ' ' VAL . 10.0 t -138.14 159.15 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 1.2 111.159 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -122.32 146.23 46.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.995 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.06 -14.85 26.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.573 2.182 . . . . 1.3400000000000001 112.592 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -93.6 -50.32 5.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 2.5099999999999998 111.078 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.25 95.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.873 -0.68 . . . . 0.77000000000000002 112.259 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.9 m-20 -136.52 170.2 11.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.791 0.329 . . . . 1.0700000000000001 111.151 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.98 116.6 1.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.01 2.473 . . . . 0.60999999999999999 111.694 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 152.34 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 110.923 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 91.8 m-70 -110.44 131.6 54.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 1.1299999999999999 110.517 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.489 HD11 HD23 ' A' ' 58' ' ' LEU . 30.9 pt -104.65 139.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.35999999999999999 111.227 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 39.3 tt0 -108.14 114.46 28.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.639 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.4 p -113.37 -173.82 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.64000000000000001 111.142 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -52.69 99.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 3.04 111.542 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 52.11 29.42 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 4.1100000000000003 111.651 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.1 t -149.4 128.48 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.23 111.16 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -109.92 107.78 17.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.64000000000000001 110.969 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 HD11 ' A' ' 51' ' ' ILE . 58.6 tp -105.0 156.71 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 1.54 111.235 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.99 132.86 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.182 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 65' ' ' LEU . 74.2 mt -118.18 140.32 49.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.96999999999999997 110.677 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 94.0 mtt180 -107.35 149.21 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 3.3199999999999998 110.959 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -27.93 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.976 -0.556 . . . . 4.7000000000000002 111.498 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -82.17 -29.94 31.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 2.2799999999999998 110.938 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 19.5 t70 -72.47 -30.18 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 2.2999999999999998 110.863 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -79.74 -29.7 40.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.69999999999999996 110.801 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.46 -23.7 10.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.66000000000000003 111.231 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 22' ' ' TYR . 67.7 mt -97.55 -63.75 1.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.438 . . . . 0.47999999999999998 111.146 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 44.6 pt -65.12 152.99 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.42999999999999999 111.081 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.2 tt0 -104.01 153.27 21.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.954 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -112.15 148.59 33.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 1.8500000000000001 110.591 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -131.19 128.67 40.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.331 . . . . 2.2400000000000002 110.853 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 156.27 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 111.288 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.079 -0.51 . . . . 1.1599999999999999 111.154 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CE1' HD23 ' A' ' 70' ' ' LEU . 51.8 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.745 0.307 . . . . 2.25 110.723 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -113.33 155.21 44.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.66000000000000003 111.642 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.96 89.55 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.564 2.176 . . . . 0.65000000000000002 112.024 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -179.98 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 2.6899999999999999 110.631 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -94.07 143.98 25.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 1.8899999999999999 110.729 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.17 160.18 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.46999999999999997 111.157 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 23.3 m95 -149.37 164.1 35.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.68999999999999995 110.674 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -114.2 136.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 2.04 111.12 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.4 mt -78.19 134.42 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 0.56000000000000005 111.045 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 12' ' ' THR . 24.4 m -136.26 57.88 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.96999999999999997 110.614 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.3 87.42 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.45000000000000001 112.937 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.07 94.76 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.376 . . . . 0.81000000000000005 110.713 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.6 m -101.27 -174.93 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -26.67 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 3.5800000000000001 110.947 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.91 29.6 1.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.078 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 18' ' ' ILE . 10.2 tt -43.69 119.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.401 . . . . 0.56999999999999995 111.413 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 p -80.64 156.58 72.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.031 -0.532 . . . . 1.5 110.756 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.9 Cg_endo -58.33 -30.83 92.34 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.593 2.195 . . . . 0.60999999999999999 112.399 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.84 59.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.70999999999999996 110.758 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -85.75 -37.65 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 2.1699999999999999 111.118 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.09 -61.56 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 1.5700000000000001 111.121 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 20' ' ' PRO . 6.3 tp-100 -56.58 -20.59 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.6899999999999999 111.366 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -69.88 -50.43 42.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.842 0.353 . . . . 2.5899999999999999 110.677 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.16 -37.71 80.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 1.3 110.984 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.6 mt -54.24 -25.73 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.94999999999999996 111.317 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -52.42 -45.5 65.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.937 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.4 mm? -96.91 -22.67 16.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 1.6399999999999999 111.103 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.34 23.82 8.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.81999999999999995 112.255 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.446 ' HE3' ' HB2' ' A' ' 31' ' ' MET . 50.4 mtm -84.15 89.81 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 2.5499999999999998 111.149 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -97.39 158.49 33.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.68999999999999995 110.836 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.89 109.32 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.443 2.095 . . . . 0.51000000000000001 111.973 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.16 29.15 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.703 -0.761 . . . . 0.40000000000000002 112.439 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -96.65 174.19 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.62 110.614 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.2 p -121.49 143.59 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 1.3 110.93 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 6.8 p90 -156.81 -176.58 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.35999999999999999 110.946 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -140.09 134.81 31.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 2.9399999999999999 110.985 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 42' ' ' VAL . 59.0 t -64.81 136.48 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 1.28 111.081 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -94.26 -40.74 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.54000000000000004 111.221 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -175.57 124.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.038 0.447 . . . . 2.7999999999999998 111.17 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.619 HG23 ' CG1' ' A' ' 39' ' ' VAL . 21.2 t -137.42 157.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.59 . . . . 1.2 111.131 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -116.91 154.51 49.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.81000000000000005 110.988 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.76 -19.34 18.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.565 2.177 . . . . 1.3400000000000001 112.525 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.47 -67.46 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 2.5099999999999998 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.08 105.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.809 -0.71 . . . . 0.77000000000000002 112.365 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 6.2 m-20 -148.14 171.27 6.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.536 0.207 . . . . 1.0700000000000001 111.228 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.06 120.06 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.74 2.293 . . . . 0.60999999999999999 111.486 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.26 152.79 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.612 -0.722 . . . . 0.39000000000000001 111.013 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.5 m-70 -109.82 135.86 50.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.605 -0.725 . . . . 1.1299999999999999 110.398 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 60' ' ' LEU . 36.9 pt -93.82 145.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.35999999999999999 111.039 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -106.84 109.18 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 2.1299999999999999 110.71 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -114.94 -170.2 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 111.167 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 25.3 tpp180 -48.96 96.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.333 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 35.2 ptt180 45.71 33.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 4.1100000000000003 111.884 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -151.44 116.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 1.23 110.993 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.6 p -103.04 109.99 21.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.64000000000000001 110.907 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.62 170.92 9.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 1.54 111.04 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 7.6 p -114.76 140.92 33.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.07 -0.514 . . . . 0.5 111.206 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 65' ' ' LEU . 91.4 mt -135.39 120.94 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.362 -0.381 . . . . 0.96999999999999997 111.181 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.657 ' O ' HD13 ' A' ' 65' ' ' LEU . 33.6 mmt180 -65.83 -168.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.3199999999999998 110.551 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 2.6 mppt? -81.35 -36.7 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.435 -0.348 . . . . 4.7000000000000002 111.455 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -86.1 -33.27 20.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.2799999999999998 111.377 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.74 -24.54 2.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.2999999999999998 110.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.9 mp -85.35 -22.09 28.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.284 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.38 90.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.444 -0.344 . . . . 0.66000000000000003 111.637 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.1 -59.0 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.47999999999999998 111.127 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 pt -65.6 142.42 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.42999999999999999 111.203 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.06 148.69 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 2.29 110.873 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.9 tp -117.01 159.16 22.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 1.8500000000000001 111.052 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.36 147.65 43.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.34 166.85 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.76000000000000001 111.004 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 1.1599999999999999 111.046 179.893 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.756 0.312 . . . . 2.25 111.066 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -104.74 155.94 36.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.66000000000000003 111.072 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.51 90.83 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.51 2.14 . . . . 0.65000000000000002 112.361 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 p30 176.89 -37.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 2.6899999999999999 110.892 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.0 m -100.96 153.52 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 1.8899999999999999 110.967 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.52 158.5 15.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.46999999999999997 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 45.2 m95 -139.64 178.05 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.68999999999999995 110.756 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -125.17 138.1 54.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 2.04 111.279 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 49.9 mt -75.64 125.81 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.56000000000000005 110.704 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 12' ' ' THR . 9.8 m -139.78 46.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.175 0.512 . . . . 0.96999999999999997 110.837 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.7 86.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.845 -0.693 . . . . 0.45000000000000001 112.598 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' THR . 92.0 t80 -143.14 94.89 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.81000000000000005 110.688 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -97.32 -175.15 3.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.76000000000000001 111.032 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -85.49 -28.77 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 3.5800000000000001 110.788 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -141.03 30.25 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 2.48 110.9 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -41.94 148.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 111.656 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.0 m -107.31 156.54 37.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.122 -0.49 . . . . 1.5 110.87 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 32.9 Cg_endo -63.97 -28.6 66.56 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.216 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -47.08 -46.89 22.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.70999999999999996 110.863 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CD2' ' OD2' ' A' ' 64' ' ' ASP . 75.6 m-85 -86.57 -46.17 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 2.1699999999999999 110.561 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.5 tpt180 -56.4 -58.05 9.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 1.5700000000000001 111.289 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -43.94 -28.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 2.6899999999999999 111.703 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 30.9 mmmt -65.81 -41.08 92.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 2.5899999999999999 111.004 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.7 mm? -72.34 -54.98 7.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.157 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 mt -50.67 -29.1 10.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.94999999999999996 111.162 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.7 m -77.48 -28.89 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 1.6399999999999999 111.099 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -25.4 18.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.6399999999999999 111.205 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.69 23.93 19.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.654 -0.784 . . . . 0.81999999999999995 112.892 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.18 90.48 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 2.5499999999999998 110.623 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -84.47 160.81 55.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.703 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 85.7 Cg_exo -44.85 120.3 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.305 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.52 22.1 5.23 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.873 -0.68 . . . . 0.40000000000000002 112.489 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.8 t -93.56 174.17 7.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.62 110.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -117.25 158.8 23.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 1.3 111.13 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 28.0 p90 -168.43 168.41 11.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.35999999999999999 110.626 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -120.53 152.34 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 2.9399999999999999 110.998 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' CG1' HG23 ' A' ' 42' ' ' VAL . 46.0 t -87.75 136.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 1.28 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.5 -40.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.54000000000000004 111.429 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -169.69 125.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.38 . . . . 2.7999999999999998 110.886 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG23 ' CG1' ' A' ' 39' ' ' VAL . 60.7 t -137.38 158.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.296 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.506 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -145.48 109.78 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.81000000000000005 111.059 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -43.32 -34.1 4.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 1.3400000000000001 112.745 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.18 -26.59 28.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 2.5099999999999998 111.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.2 90.09 1.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.77000000000000002 112.044 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.6 m-20 -143.87 172.01 6.1 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.647 0.26 . . . . 1.0700000000000001 111.04 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.31 121.77 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.769 2.313 . . . . 0.60999999999999999 111.687 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.4 p -106.43 158.96 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.665 -0.698 . . . . 0.39000000000000001 111.007 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 5.3 m80 -114.83 131.41 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.673 . . . . 1.1299999999999999 110.605 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -101.84 141.91 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 110.987 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.02 108.41 19.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.071 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -108.17 -169.59 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.948 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -55.46 96.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 3.04 111.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 52.39 30.55 8.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 4.1100000000000003 111.723 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -151.4 112.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.965 0.412 . . . . 1.23 111.388 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -97.15 109.95 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.637 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 74.6 mt -99.79 163.35 12.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.154 -0.475 . . . . 1.54 111.245 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 12.0 p -121.76 137.96 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.5 110.871 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD13 ' CD1' ' A' ' 68' ' ' ILE . 86.2 mt -127.53 136.27 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.96999999999999997 110.954 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . 99.4 mtt180 -85.83 150.83 24.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 3.3199999999999998 110.915 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -45.64 -30.26 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 4.7000000000000002 111.454 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -83.17 -39.24 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 2.2799999999999998 111.191 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' CD2' ' A' ' 22' ' ' TYR . 9.0 t70 -57.96 -29.56 65.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 2.2999999999999998 111.046 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.1 mp -76.26 -20.25 57.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.69999999999999996 111.281 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.24 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.557 -0.292 . . . . 0.66000000000000003 111.441 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.99 -54.32 3.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.747 0.308 . . . . 0.47999999999999998 111.295 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' CD1' HD13 ' A' ' 60' ' ' LEU . 36.2 pt -65.61 152.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.42999999999999999 111.035 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 7.6 tp10 -105.02 149.29 25.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 2.29 111.014 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -130.51 139.51 50.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.8500000000000001 110.96 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -116.3 129.97 56.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 2.2400000000000002 110.792 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.57 20.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.76000000000000001 111.047 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 1.1599999999999999 111.372 -179.703 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.3 p90 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.894 0.378 . . . . 2.25 110.745 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 46.2 p -86.08 156.22 57.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.66000000000000003 111.259 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 73.2 Cg_endo -74.27 90.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.637 2.224 . . . . 0.65000000000000002 112.284 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 178.32 -42.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 110.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.3 m -92.17 141.84 28.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 110.929 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.98 164.17 25.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.46999999999999997 111.089 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 42.5 m95 -147.84 169.53 19.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.68999999999999995 110.645 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' SER . 57.8 mttp -114.87 137.03 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 2.04 111.099 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 42.1 mt -78.34 122.92 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 110.955 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 12' ' ' THR . 32.1 m -136.16 51.45 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.96999999999999997 110.806 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.42 96.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.957 -0.639 . . . . 0.45000000000000001 112.638 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -147.29 94.98 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.81000000000000005 110.813 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 25.6 t -105.29 -172.42 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.76000000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -21.89 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.009 -0.542 . . . . 3.5800000000000001 111.188 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -156.5 33.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.455 -0.339 . . . . 2.48 111.159 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 5.6 tt -46.89 122.61 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.56999999999999995 111.281 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.3 p -76.79 155.58 83.05 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 1.5 110.826 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.77 -29.87 77.41 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.616 2.211 . . . . 0.60999999999999999 112.488 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.22 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.011 0.434 . . . . 0.70999999999999996 110.41 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -85.75 -28.93 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 111.02 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NH1' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -76.04 -61.73 1.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 1.5700000000000001 111.029 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -53.4 -27.64 25.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.347 -0.388 . . . . 2.6899999999999999 110.947 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -50.67 -32.1 18.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 2.5899999999999999 111.153 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.9 mp -84.02 -42.31 16.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 1.3 111.251 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' NH1' ' A' ' 23' ' ' ARG . 73.2 mt -49.03 -25.81 2.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.94999999999999996 111.238 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 29' ' ' LEU . 73.7 p -65.6 -37.54 86.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 1.6399999999999999 110.935 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -91.07 -24.04 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 1.6399999999999999 110.898 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.9 16.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.652 -0.785 . . . . 0.81999999999999995 112.467 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 51.9 mtm -98.43 99.33 10.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 2.5499999999999998 110.795 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.7 mp -95.48 160.94 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.68999999999999995 110.816 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 80.2 Cg_exo -41.11 114.03 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.601 2.201 . . . . 0.51000000000000001 112.282 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.17 33.02 1.56 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.40000000000000002 112.174 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 39.8 t -100.58 174.78 5.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.612 0.244 . . . . 0.62 110.807 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.7 t -120.18 154.7 34.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 1.3 110.876 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.8 p90 -167.62 177.26 5.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.35999999999999999 110.751 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -128.82 155.18 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 2.9399999999999999 111.033 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 42' ' ' VAL . 66.1 t -92.78 134.88 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 1.28 110.906 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.21 -51.44 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.54000000000000004 111.461 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 16.9 ptm180 -155.49 123.79 5.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 2.7999999999999998 111.263 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 49' ' ' VAL . 46.6 t -135.69 158.79 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 1.2 111.025 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.498 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -124.87 152.89 70.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.81000000000000005 111.09 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.25 -30.78 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.8 2.334 . . . . 1.3400000000000001 112.856 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.11 -26.69 39.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 2.5099999999999998 111.129 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 104.13 1.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.723 -0.751 . . . . 0.77000000000000002 112.167 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.3 m-20 -147.86 170.67 7.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.07 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.5 120.71 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.928 2.419 . . . . 0.60999999999999999 111.69 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.96 159.12 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.82 -0.627 . . . . 0.39000000000000001 111.264 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 59' ' ' VAL . 53.2 m-70 -114.35 137.03 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 1.1299999999999999 110.448 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -102.11 141.18 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.35999999999999999 111.63 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.61 107.75 18.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.942 -0.572 . . . . 2.1299999999999999 110.507 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.3 p -113.96 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.64000000000000001 111.094 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.7 mmt180 -49.61 102.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 3.04 111.428 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 29.4 ptt180 44.81 37.01 2.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 4.1100000000000003 112.056 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 54' ' ' ARG . 99.1 t -151.52 126.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 1.23 111.118 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.6 t -109.98 107.73 17.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.64000000000000001 110.666 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 77.9 mt -106.95 156.8 18.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 1.54 111.233 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 8.0 p -112.96 134.71 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.5 110.992 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CB ' HD11 ' A' ' 65' ' ' LEU . 70.5 mt -122.31 134.22 54.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.96999999999999997 110.757 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -97.35 160.68 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.3199999999999998 110.848 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -51.48 -23.52 4.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 4.7000000000000002 110.965 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -85.08 -27.88 26.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 2.2799999999999998 110.815 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.25 -32.75 61.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 2.2999999999999998 110.823 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.7 mp -79.44 -21.69 45.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.69999999999999996 111.075 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.18 62.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.66000000000000003 111.589 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.55 -58.94 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.75 0.31 . . . . 0.47999999999999998 111.353 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.4 pt -65.94 158.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.42999999999999999 111.345 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.4 tp10 -111.53 141.74 44.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.29 110.695 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -117.16 142.27 47.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 1.8500000000000001 111.086 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -128.02 122.94 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 2.2400000000000002 110.718 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.27 175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.76000000000000001 111.327 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.1599999999999999 111.129 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m-85 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.78 0.324 . . . . 2.25 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -112.27 153.86 44.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.66000000000000003 111.203 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . 59.2 Cg_endo -71.74 89.38 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.56 2.173 . . . . 0.65000000000000002 112.437 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t70 176.69 -37.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 2.6899999999999999 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -101.42 144.34 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 1.8899999999999999 110.934 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.16 167.16 21.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.46999999999999997 110.955 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.6 m95 -151.74 174.78 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.95 0.405 . . . . 0.68999999999999995 111.198 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -127.23 135.42 50.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 2.04 110.988 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 64.0 mt -72.92 133.17 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.56000000000000005 111.13 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 12' ' ' THR . 13.9 m -137.45 48.95 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.456 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.8 89.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.856 -0.688 . . . . 0.45000000000000001 112.658 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -147.09 95.42 2.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.81000000000000005 110.866 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -102.14 160.4 14.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.943 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -17.75 62.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 3.5800000000000001 111.232 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -154.06 34.0 0.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.59 0.233 . . . . 2.48 111.415 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 tt -47.36 128.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.598 -0.274 . . . . 0.56999999999999995 111.281 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.9 p -87.76 156.55 52.75 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 1.5 110.84 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -65.44 -28.92 53.93 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.462 2.108 . . . . 0.60999999999999999 112.482 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.05 -48.35 22.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.70999999999999996 110.772 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 52.5 t80 -86.62 -46.08 10.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 2.1699999999999999 110.787 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 18.2 tpt180 -56.05 -56.19 23.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 1.5700000000000001 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -45.73 -34.2 3.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 2.6899999999999999 111.371 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.73 -27.88 67.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 2.5899999999999999 111.106 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.81 -55.12 5.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.3 110.912 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -48.2 -30.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.94999999999999996 111.187 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -75.97 -32.04 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.6399999999999999 111.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CD1' HD22 ' A' ' 58' ' ' LEU . 80.0 mt -90.1 -23.09 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.6399999999999999 111.032 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.72 10.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.81999999999999995 112.358 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.401 ' C ' HD12 ' A' ' 32' ' ' LEU . 65.1 mtt -109.01 91.51 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 2.5499999999999998 110.874 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -104.65 160.24 26.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.68999999999999995 110.83 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 71.1 Cg_exo -46.82 115.26 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.427 2.084 . . . . 0.51000000000000001 112.094 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.9 19.22 8.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.806 -0.712 . . . . 0.40000000000000002 112.612 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 43.7 t -92.94 172.36 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.62 110.787 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.0 m -116.39 153.56 31.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 1.3 111.182 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.3 p90 -164.76 163.02 21.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.35999999999999999 110.52 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -115.72 117.48 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 2.9399999999999999 111.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.66 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.086 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.91 -47.74 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.393 -0.367 . . . . 0.54000000000000004 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 36.9 ptt180 -162.16 138.01 7.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.915 0.388 . . . . 2.7999999999999998 111.228 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' ALA . 19.5 t -145.78 159.31 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.2 111.078 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -121.54 155.86 58.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.81000000000000005 111.123 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.42 -26.99 8.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 1.3400000000000001 112.685 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.9 -52.52 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 2.5099999999999998 111.02 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.98 111.92 0.3 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.734 -0.746 . . . . 0.77000000000000002 112.417 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.1 m-20 -148.16 172.74 4.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.639 0.257 . . . . 1.0700000000000001 111.09 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.9 Cg_endo -84.35 117.24 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.961 2.441 . . . . 0.60999999999999999 111.654 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.4 p -106.79 154.12 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.39000000000000001 111.068 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -119.68 142.2 48.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.606 . . . . 1.1299999999999999 110.805 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 37' ' ' PHE . 38.6 pt -114.72 136.55 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.35999999999999999 111.371 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.08 115.98 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 2.1299999999999999 110.426 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.471 ' OG1' HG13 ' A' ' 56' ' ' VAL . 37.5 p -130.25 -167.76 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.64000000000000001 111.273 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HG12 ' A' ' 56' ' ' VAL . 40.0 mmt180 -41.4 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.973 0.416 . . . . 3.04 112.018 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' THR . 79.8 mtm180 41.37 53.15 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 4.1100000000000003 111.923 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.1 p -171.89 116.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.23 111.449 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -104.65 108.11 19.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 0.64000000000000001 110.515 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' A' ' 29' ' ' LEU . 48.4 tp -100.16 158.44 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 1.54 110.98 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 60' ' ' LEU . 13.3 p -106.82 153.33 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.5 111.118 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 59' ' ' VAL . 97.1 mt -144.81 119.45 9.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.96999999999999997 111.023 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -77.51 -173.11 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 3.3199999999999998 110.91 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -75.1 -28.14 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 4.7000000000000002 111.153 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.44 -35.33 25.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.348 -0.387 . . . . 2.2799999999999998 111.036 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.86 -30.93 71.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 2.2999999999999998 110.754 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 68' ' ' ILE . 26.7 mt -76.5 -24.77 53.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.69999999999999996 111.035 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.06 71.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.66000000000000003 111.341 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.81 -58.16 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.47999999999999998 111.361 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.514 ' CG2' ' CE1' ' A' ' 22' ' ' TYR . 31.3 pt -65.52 149.66 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.42999999999999999 111.256 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' C ' HD22 ' A' ' 70' ' ' LEU . 6.3 tp10 -109.77 151.56 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 2.29 110.635 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -118.91 148.1 43.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 110.675 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.34 145.19 43.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 2.2400000000000002 110.852 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.4 172.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.76000000000000001 110.953 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 1.1599999999999999 111.233 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 2.25 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -114.17 154.19 46.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.66000000000000003 111.204 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.29 89.73 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.531 2.154 . . . . 0.65000000000000002 112.432 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 178.24 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 2.6899999999999999 110.918 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.2 m -106.25 170.21 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.56 169.33 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.46999999999999997 111.044 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CA ' HG13 ' A' ' 73' ' ' VAL . 52.1 m95 -151.1 162.08 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.68999999999999995 110.583 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 5.8 ptpp? -107.61 137.85 44.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 2.04 110.987 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.8 mt -83.1 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.56000000000000005 111.235 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' GLU . 23.6 m -135.92 56.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.96999999999999997 110.286 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.45 96.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.701 -0.682 . . . . 0.45000000000000001 112.745 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -147.14 97.38 2.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.341 . . . . 0.81000000000000005 110.708 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.1 m -108.61 -174.34 2.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.76000000000000001 110.977 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.3 mpt_? -74.78 -27.26 60.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 3.5800000000000001 110.881 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.91 42.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.48 110.81 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 18' ' ' ILE . 5.7 tt -45.7 109.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.277 -0.42 . . . . 0.56999999999999995 111.172 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.0 p -59.63 155.8 37.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 1.5 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 21.8 Cg_endo -61.07 -30.47 89.41 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.60999999999999999 112.101 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.63 -46.25 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.414 . . . . 0.70999999999999996 110.897 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.98 -35.3 20.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.51 . . . . 2.1699999999999999 111.148 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.1 tpt180 -70.94 -61.04 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.524 . . . . 1.5700000000000001 111.612 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -42.75 -34.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.506 -0.316 . . . . 2.6899999999999999 111.839 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.29 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 2.5899999999999999 111.103 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.21 -53.63 55.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 1.3 111.075 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -48.85 -46.23 41.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 0.94999999999999996 111.203 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -55.59 -49.25 73.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 1.6399999999999999 111.05 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 58' ' ' LEU . 73.5 mt -71.75 -25.17 61.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 1.6399999999999999 110.885 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 19.54 27.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 0.81999999999999995 112.774 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.4 mtt -95.03 87.05 4.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.726 0.298 . . . . 2.5499999999999998 110.792 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.7 mp -92.2 159.65 36.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.68999999999999995 110.499 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.96 132.22 17.43 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.298 1.999 . . . . 0.51000000000000001 111.757 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.37 38.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.75 -0.738 . . . . 0.40000000000000002 112.267 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -82.22 174.24 11.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.685 0.278 . . . . 0.62 110.582 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.4 p -125.89 137.83 53.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 1.3 110.733 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 9.6 p90 -150.53 157.64 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 111.003 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -108.51 146.87 32.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.9399999999999999 110.855 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.0 t -84.93 128.32 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 1.28 111.144 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.93 -47.54 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.54000000000000004 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -168.28 129.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 2.7999999999999998 110.814 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG22 ' HB ' ' A' ' 49' ' ' VAL . 39.5 t -141.56 156.56 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.368 . . . . 1.2 111.339 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.88 141.65 41.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.81000000000000005 110.825 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.97 -21.23 37.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.497 2.131 . . . . 1.3400000000000001 112.658 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 mt -85.74 -48.95 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 2.5099999999999998 110.882 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.65 105.61 0.37 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.762 -0.732 . . . . 0.77000000000000002 112.497 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.9 m-20 -148.11 171.06 6.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 110.804 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.48 118.75 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.878 2.385 . . . . 0.60999999999999999 111.788 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.65 161.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 0.39000000000000001 111.123 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.458 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 82.1 m-70 -125.07 148.37 48.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 1.1299999999999999 110.467 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.3 pt -115.56 138.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.35999999999999999 111.446 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.95 112.97 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 2.1299999999999999 110.612 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.533 ' OG1' HG13 ' A' ' 56' ' ' VAL . 41.7 p -126.7 -175.98 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.387 . . . . 0.64000000000000001 111.343 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -41.59 95.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.964 -0.562 . . . . 3.04 112.101 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 43.28 54.79 4.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 4.1100000000000003 112.089 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.4 p -175.78 113.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 1.23 111.29 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -100.49 112.18 24.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 0.64000000000000001 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 29' ' ' LEU . 38.0 tp -105.73 148.58 27.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.797 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.56 140.71 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.315 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' HD11 ' A' ' 65' ' ' LEU . 95.8 mt -140.44 166.12 25.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.96999999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 80.7 mtp180 -130.3 152.82 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 3.3199999999999998 110.896 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.4 tpmt? -50.49 -24.81 3.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.969 -0.56 . . . . 4.7000000000000002 111.523 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.37 -28.67 34.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.894 0.378 . . . . 2.2799999999999998 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.28 -33.08 29.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 2.2999999999999998 111.068 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.8 mp -71.43 -20.7 62.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.69999999999999996 111.267 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.15 84.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.505 -0.316 . . . . 0.66000000000000003 111.468 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.31 -56.59 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.47999999999999998 111.257 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 65' ' ' LEU . 28.7 pt -66.96 151.91 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.42999999999999999 111.102 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 70' ' ' LEU . 33.0 tt0 -100.49 128.96 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.29 110.59 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 69' ' ' GLU . 5.3 mp -118.45 136.14 53.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 1.8500000000000001 111.077 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 38.4 tt0 -130.23 156.53 44.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 2.2400000000000002 110.755 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 133.43 51.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.113 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 9' ' ' TRP . 32.7 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.735 0.302 . . . . 5.1699999999999999 110.98 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -85.92 163.98 17.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 2.9399999999999999 111.011 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.43 110.73 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 2.25 110.805 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -108.92 150.05 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.66000000000000003 111.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 85.57 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.562 2.175 . . . . 0.65000000000000002 112.357 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.6 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 2.6899999999999999 110.867 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -84.84 164.27 18.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 1.8899999999999999 110.986 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.7 165.45 11.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.46999999999999997 111.241 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 61.1 m95 -155.07 174.55 15.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.68999999999999995 110.832 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -127.6 134.34 49.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 2.04 111.05 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.451 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.1 mt -74.52 126.09 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.56000000000000005 111.346 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -139.74 48.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.96999999999999997 110.572 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.72 91.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.866 -0.683 . . . . 0.45000000000000001 112.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -147.23 96.97 2.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.64 0.257 . . . . 0.81000000000000005 110.786 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -105.79 -175.79 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.76000000000000001 110.803 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.2 mpt_? -86.31 -21.67 27.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 3.5800000000000001 111.047 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -147.44 28.19 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.463 -0.335 . . . . 2.48 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 18' ' ' ILE . 14.6 tt -46.17 122.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 0.56999999999999995 111.369 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -72.82 155.43 90.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 1.5 110.929 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 24' ' ' GLN . 37.9 Cg_endo -66.42 -27.71 46.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.503 2.136 . . . . 0.60999999999999999 112.268 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.64 -45.15 57.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.70999999999999996 110.83 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -85.78 -37.27 19.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 2.1699999999999999 111.129 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -70.58 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 1.5700000000000001 111.359 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' PRO . 51.8 tt0 -57.88 -18.64 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 2.6899999999999999 111.537 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -75.32 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 2.5899999999999999 111.149 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -50.0 -30.88 11.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.033 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.0 mt -51.57 -34.04 35.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.94999999999999996 111.013 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.4 p -62.88 -29.47 70.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.6399999999999999 111.092 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.33 -24.43 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 1.6399999999999999 111.012 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.92 20.63 59.11 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.81999999999999995 112.465 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.31 91.57 4.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 2.5499999999999998 110.846 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -88.26 160.6 45.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 110.79 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 87.7 Cg_exo -42.37 112.78 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.525 2.15 . . . . 0.51000000000000001 112.417 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 30.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 0.40000000000000002 112.454 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.8 t -102.1 174.1 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.62 110.878 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -119.06 138.95 52.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.467 . . . . 1.3 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.451 ' CD1' HG13 ' A' ' 11' ' ' ILE . 23.7 p90 -153.37 159.89 42.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.35999999999999999 111.018 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 73.3 m80 -114.41 160.76 18.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.426 . . . . 2.9399999999999999 110.82 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.8 t -98.37 134.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 1.28 111.222 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.5 t -94.98 -49.53 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.54000000000000004 111.08 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.77 138.44 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 2.7999999999999998 110.832 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.474 HG22 ' CG2' ' A' ' 49' ' ' VAL . 19.7 t -146.16 157.97 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 1.2 111.388 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.58 147.37 52.82 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.81000000000000005 111.065 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.11 -20.47 19.07 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 1.3400000000000001 112.663 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.84 -46.41 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.387 -0.37 . . . . 2.5099999999999998 111.059 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.33 100.3 0.2 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 0.77000000000000002 112.306 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.2 m-20 -139.38 170.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 1.0700000000000001 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.81 117.19 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.942 2.428 . . . . 0.60999999999999999 111.647 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 157.17 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.823 -0.626 . . . . 0.39000000000000001 110.874 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.5 m-70 -121.04 136.45 54.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 1.1299999999999999 110.72 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 58' ' ' LEU . 31.8 pt -102.08 143.84 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.35999999999999999 111.136 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' HIS . 7.7 mm-40 -106.77 110.58 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 2.1299999999999999 110.755 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -112.08 -174.33 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.64000000000000001 111.063 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -52.43 94.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 3.04 111.479 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 53.23 38.19 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 4.1100000000000003 111.691 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -155.44 132.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.713 0.292 . . . . 1.23 111.093 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -112.21 107.83 16.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.64000000000000001 111.148 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 50.4 tp -101.54 154.07 19.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 1.54 110.55 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.52 139.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 0.5 111.183 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.39 166.18 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.96999999999999997 110.756 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HD3' ' NZ ' ' A' ' 63' ' ' LYS . 95.5 mtt180 -124.63 136.43 53.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.79 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.0 tpmt? -45.96 -29.36 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 4.7000000000000002 111.253 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' NZ ' ' HD3' ' A' ' 61' ' ' ARG . 21.3 pttm -84.41 -31.61 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.937 0.399 . . . . 2.2799999999999998 110.393 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ARG . 18.5 t70 -69.49 -35.95 76.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 2.2999999999999998 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -63.0 -23.58 67.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.69999999999999996 110.989 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.17 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.38 . . . . 0.66000000000000003 111.28 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -83.47 -61.03 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.47999999999999998 111.202 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 pt -65.32 144.52 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.42999999999999999 111.183 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.26 154.44 18.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.847 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.46 148.98 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.8500000000000001 111.05 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -134.43 115.31 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 2.2400000000000002 110.738 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.39 53.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.76000000000000001 111.092 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.4 -178.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.1599999999999999 111.234 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.94 101.82 14.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 2.2799999999999998 111.2 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 5.1299999999999999 110.856 179.757 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.782 0.325 . . . . 5.1699999999999999 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -135.62 -176.52 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 2.9399999999999999 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 70' ' ' LEU . 83.1 m-85 -99.65 105.34 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 2.25 110.802 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -112.03 154.85 44.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.66000000000000003 111.173 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.362 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 177.77 -43.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 110.794 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.54 149.31 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.8899999999999999 110.788 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.79 146.83 23.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.445 . . . . 0.46999999999999997 111.18 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 38.8 m95 -133.64 174.06 10.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.68999999999999995 110.671 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -122.1 138.23 54.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.351 -0.386 . . . . 2.04 111.093 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CD1' ' CE ' ' A' ' 31' ' ' MET . 53.5 mt -77.31 138.9 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.56000000000000005 111.14 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 17.7 m -142.48 50.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 110.434 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 91.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.773 -0.648 . . . . 0.45000000000000001 112.9 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 47.3 t80 -147.25 99.22 3.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.81000000000000005 110.693 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -101.84 -172.66 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.409 . . . . 0.76000000000000001 111.075 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.0 mpt_? -77.89 -29.85 50.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 3.5800000000000001 110.911 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.22 40.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 2.48 110.981 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.21 130.73 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.56999999999999995 111.401 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.3 m -80.64 156.73 72.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 1.5 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 18.1 Cg_endo -58.39 -33.03 97.47 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.516 2.144 . . . . 0.60999999999999999 112.166 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.92 -43.52 59.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.70999999999999996 110.326 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -85.67 -43.46 13.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 2.1699999999999999 110.514 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.4 tpt180 -62.56 -61.67 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.5700000000000001 111.041 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' PRO . 89.8 mt-30 -52.2 -32.21 35.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.453 -0.339 . . . . 2.6899999999999999 110.833 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -51.04 -40.68 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 2.5899999999999999 111.021 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.4 mm? -84.5 -38.7 19.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 1.3 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.87 -33.45 23.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.94999999999999996 110.99 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -63.12 -50.73 69.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 1.6399999999999999 110.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.37 -23.82 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 1.6399999999999999 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.06 18.94 25.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 0.81999999999999995 112.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.488 ' CE ' ' CD1' ' A' ' 11' ' ' ILE . 65.4 mtp -91.43 94.77 9.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 2.5499999999999998 110.923 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -103.12 159.7 28.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.857 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.72 111.9 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.569 2.18 . . . . 0.51000000000000001 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.11 25.64 3.49 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.919 -0.657 . . . . 0.40000000000000002 112.302 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.2 t -93.51 163.47 13.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.62 110.709 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -111.01 142.8 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.929 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 11' ' ' ILE . 24.1 p90 -155.1 162.72 40.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.35999999999999999 110.844 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -114.55 148.04 38.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 2.9399999999999999 111.002 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 t -86.88 113.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 1.28 110.868 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.9 t -78.81 -52.38 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.54000000000000004 111.398 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -169.25 121.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 2.7999999999999998 111.107 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -140.32 158.08 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.944 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -113.94 140.32 24.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.81000000000000005 111.407 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.15 -26.81 83.1 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.554 2.169 . . . . 1.3400000000000001 112.351 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -80.41 -65.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 2.5099999999999998 110.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 169.27 100.76 0.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.712 -0.756 . . . . 0.77000000000000002 112.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.3 m-20 -144.48 171.24 6.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.609 0.242 . . . . 1.0700000000000001 111.025 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.63 113.64 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.955 2.437 . . . . 0.60999999999999999 111.677 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.77 140.69 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 111.173 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 44.5 m-70 -99.67 137.63 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.905 -0.589 . . . . 1.1299999999999999 110.611 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -108.67 140.65 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.35999999999999999 111.198 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.29 109.47 21.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 2.1299999999999999 110.81 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.1 p -107.37 -172.85 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.64000000000000001 111.087 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -50.93 96.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.04 111.405 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 52.53 26.24 4.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 4.1100000000000003 111.696 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -146.75 120.68 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.4 . . . . 1.23 111.117 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -104.22 107.93 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.64000000000000001 110.912 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -103.37 160.28 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 1.54 110.669 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.64 138.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.369 . . . . 0.5 111.132 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.15 155.41 50.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.96999999999999997 110.874 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 64' ' ' ASP . 75.2 mtp180 -122.12 155.62 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 3.3199999999999998 111.058 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 5.6 mmpt? -44.2 -28.93 0.56 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.078 -0.51 . . . . 4.7000000000000002 111.486 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 pttt -76.43 -36.09 58.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.281 -0.418 . . . . 2.2799999999999998 110.874 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' ARG . 13.2 m-20 -74.41 -34.47 63.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.825 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.1 mp -74.58 -26.57 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.69999999999999996 110.937 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.24 -25.33 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.66000000000000003 111.163 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.6 -58.47 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.47999999999999998 111.124 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.0 pt -67.64 154.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.42999999999999999 110.904 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 8.3 tp10 -102.88 155.74 18.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 2.29 110.974 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 92.1 mt -128.84 165.66 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.082 -0.508 . . . . 1.8500000000000001 110.753 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.51 149.08 30.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 2.2400000000000002 111.023 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -174.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 110.903 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.43 -177.78 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 1.1599999999999999 111.023 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.74 135.64 57.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.2799999999999998 111.189 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 5.1299999999999999 110.732 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.862 0.363 . . . . 5.1699999999999999 110.95 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.7 141.96 56.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 2.9399999999999999 110.934 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -66.23 106.71 1.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 2.25 110.957 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -116.23 156.26 47.3 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.66000000000000003 111.381 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.81 141.61 27.77 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.724 2.283 . . . . 0.65000000000000002 112.396 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.24 21.02 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 2.6899999999999999 111.518 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.6 p -88.17 159.79 18.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.8899999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.19 135.44 53.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.46999999999999997 111.06 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 54.1 m95 -151.42 157.22 42.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.68999999999999995 110.572 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' SER . 62.7 mttp -99.52 135.09 41.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 2.04 110.745 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.496 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.9 mt -77.3 132.39 32.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.039 -0.528 . . . . 0.56000000000000005 111.328 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.2 m -139.51 44.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.009 -0.541 . . . . 0.96999999999999997 110.391 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.21 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.917 -0.659 . . . . 0.45000000000000001 112.581 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 89.9 t80 -147.7 94.89 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.81000000000000005 110.828 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m -100.39 161.86 13.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.857 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -58.77 -19.15 38.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.5800000000000001 111.369 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -165.55 42.26 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 2.48 111.401 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.45 139.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.347 -0.388 . . . . 0.56999999999999995 111.325 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -88.41 156.37 50.98 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 1.5 110.895 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.45 -30.39 90.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.621 2.214 . . . . 0.60999999999999999 112.347 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.71 -46.61 50.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.078 0.466 . . . . 0.70999999999999996 110.665 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -86.45 -43.4 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 2.1699999999999999 110.806 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -62.09 -58.84 6.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 1.5700000000000001 111.38 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.06 -48.19 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.499 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 28' ' ' SER . 61.1 mttp -51.16 -47.77 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.404 -0.362 . . . . 2.5899999999999999 111.152 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.95 -57.13 12.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 1.3 111.025 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.7 mt -48.86 -26.48 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.94999999999999996 111.176 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 38.5 t -66.09 -37.05 84.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 1.6399999999999999 111.087 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.59 -25.26 38.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.376 -0.375 . . . . 1.6399999999999999 111.073 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.15 7.67 55.95 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.716 -0.754 . . . . 0.81999999999999995 113.04 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -91.97 103.06 15.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.969 0.385 . . . . 2.5499999999999998 111.05 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -90.58 160.38 39.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.614 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.23 127.15 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.277 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.21 27.39 6.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.727 -0.749 . . . . 0.40000000000000002 112.323 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 46.5 t -94.31 174.23 7.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.649 0.261 . . . . 0.62 110.788 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -123.97 148.81 46.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 1.3 110.946 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' A' ' 11' ' ' ILE . 6.8 p90 -161.43 179.53 8.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.35999999999999999 110.853 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -132.21 152.22 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 2.9399999999999999 110.844 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 49' ' ' VAL . 60.5 t -91.23 141.09 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 1.28 111.051 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -95.96 -39.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 111.342 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.8 ptm180 179.73 126.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 2.7999999999999998 110.982 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 43' ' ' ALA . 9.2 p -148.66 159.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.2 111.153 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.505 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -114.15 155.75 45.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.81000000000000005 111.066 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.29 -18.44 23.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.676 2.25 . . . . 1.3400000000000001 112.586 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 tp -89.65 -65.8 0.98 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 2.5099999999999998 110.938 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 170.84 107.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.77000000000000002 112.434 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.0 m-20 -147.72 172.26 5.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.58 0.229 . . . . 1.0700000000000001 110.712 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.19 110.87 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.755 2.303 . . . . 0.60999999999999999 111.526 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' CG2' HG13 ' A' ' 39' ' ' VAL . 3.7 p -106.57 140.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 111.199 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 97.0 m-70 -101.43 131.03 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.845 -0.616 . . . . 1.1299999999999999 110.804 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 60' ' ' LEU . 44.2 pt -96.63 139.62 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 110.831 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -106.83 97.09 6.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 2.1299999999999999 110.888 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.2 -172.68 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.64000000000000001 111.002 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HB2' ' CE ' ' A' ' 31' ' ' MET . 41.3 mmt180 -51.47 96.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 3.04 111.451 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 51.89 30.08 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 4.1100000000000003 111.541 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 54' ' ' ARG . 79.7 t -149.75 117.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 1.23 111.33 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -100.87 107.76 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.64000000000000001 110.751 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' A' ' 51' ' ' ILE . 32.0 tp -102.9 158.17 16.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.988 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -104.55 138.96 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.5 110.911 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD1' HD13 ' A' ' 51' ' ' ILE . 90.2 mt -144.08 143.13 31.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.931 0.396 . . . . 0.96999999999999997 111.104 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 32.4 ttm180 -112.12 162.3 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 3.3199999999999998 110.683 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 mmpt? -47.18 -26.92 1.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 4.7000000000000002 111.218 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.1 -30.09 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 2.2799999999999998 110.912 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.85 -31.93 40.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 2.2999999999999998 111.027 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.3 mp -81.6 -18.5 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.69 -27.03 68.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.766 0.317 . . . . 0.66000000000000003 111.499 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.67 -57.69 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.47999999999999998 111.119 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.2 pt -66.04 154.81 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.42999999999999999 111.338 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 12' ' ' THR . 9.0 tp10 -104.93 147.78 27.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.186 -0.461 . . . . 2.29 110.475 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.7 mm? -121.43 153.63 37.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 1.8500000000000001 111.097 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.01 147.08 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 2.2400000000000002 110.787 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 165.94 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.76000000000000001 111.18 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m -103.03 162.71 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.1599999999999999 111.023 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.35 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.2799999999999998 111.122 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.128 -0.487 . . . . 5.1299999999999999 110.872 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.781 0.324 . . . . 5.1699999999999999 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.53 167.35 10.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 2.9399999999999999 110.774 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CE1' HD23 ' A' ' 70' ' ' LEU . 38.7 m-85 -72.06 92.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 2.25 110.715 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 41.2 p -113.82 156.25 44.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.66000000000000003 111.253 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 62.0 Cg_endo -72.92 90.12 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.58 2.187 . . . . 0.65000000000000002 112.313 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 178.32 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 110.828 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 1.8899999999999999 110.784 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.89 168.68 8.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 110.93 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.512 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 69.3 m95 -149.75 173.45 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.68999999999999995 110.872 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' O ' HD12 ' A' ' 70' ' ' LEU . 31.2 mmmt -107.06 126.99 53.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.88 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.9 mt -77.21 126.78 38.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.56000000000000005 111.118 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 23.0 m -132.65 56.88 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.393 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' NH1' ' A' ' 23' ' ' ARG . . . -58.59 85.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.971 -0.633 . . . . 0.45000000000000001 113.004 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -147.11 95.98 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.81000000000000005 110.632 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -95.05 -174.26 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.985 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -86.18 -26.01 25.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.581 . . . . 3.5800000000000001 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -150.29 34.23 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 2.48 111.414 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 tt -48.63 143.18 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 111.253 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -94.63 147.93 34.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.5 110.88 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 17.2 Cg_endo -57.29 -32.02 92.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.712 2.274 . . . . 0.60999999999999999 112.124 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.03 -47.05 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.025 0.44 . . . . 0.70999999999999996 110.711 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.69 -43.39 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.646 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.2 tpt180 -60.25 -61.26 2.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 1.5700000000000001 110.98 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' PRO . 91.5 mt-30 -49.98 -41.71 47.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 2.6899999999999999 110.843 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -53.69 -25.77 19.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 2.5899999999999999 110.972 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.29 -46.62 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 1.3 110.594 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -50.77 -33.6 23.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.94999999999999996 111.048 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.9 p -69.23 -42.21 75.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.979 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.3 -25.34 65.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 1.6399999999999999 110.979 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.14 16.16 39.08 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.81999999999999995 112.835 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 ptm -104.0 103.94 13.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.983 0.42 . . . . 2.5499999999999998 110.883 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -105.03 159.81 28.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.443 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.0 Cg_exo -42.11 109.4 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.521 2.147 . . . . 0.51000000000000001 112.152 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 31.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.40000000000000002 112.166 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 t -101.35 174.18 6.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.623 0.249 . . . . 0.62 110.57 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -119.99 143.35 48.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 1.3 111.071 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' TRP . 4.0 p90 -150.45 175.36 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.35999999999999999 110.824 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -130.71 129.03 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 2.9399999999999999 110.988 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 140.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 1.28 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.4 t -99.06 -35.48 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54000000000000004 111.125 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -179.61 139.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 2.7999999999999998 111.088 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.5 t -146.92 160.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.122 -0.49 . . . . 1.2 111.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.56 132.0 24.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.81000000000000005 110.83 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.46 -21.19 44.24 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 1.3400000000000001 112.503 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -89.82 -66.33 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 2.5099999999999998 111.229 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.96 105.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.77000000000000002 112.263 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.455 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.0 m-20 -148.12 172.13 5.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.562 0.22 . . . . 1.0700000000000001 111.056 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.19 119.47 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 0.60999999999999999 111.487 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.53 148.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.39000000000000001 110.964 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' VAL . 36.4 m-70 -112.98 135.85 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.779 -0.646 . . . . 1.1299999999999999 110.745 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 60' ' ' LEU . 47.0 pt -98.55 145.83 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.35999999999999999 111.16 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -109.34 100.81 9.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 2.1299999999999999 110.742 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 p -103.92 -173.14 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.64000000000000001 111.185 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.0 mmt180 -50.94 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 3.04 111.531 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 48.62 30.13 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 4.1100000000000003 111.698 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' ARG . 89.0 t -147.8 113.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.981 0.419 . . . . 1.23 111.139 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -100.03 107.74 19.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.64000000000000001 110.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.13 160.36 14.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.54 111.305 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.55 137.01 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.031 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' CG2' ' A' ' 51' ' ' ILE . 91.0 mt -130.44 161.43 31.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.96999999999999997 111.059 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.8 mtp180 -130.68 147.7 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 3.3199999999999998 110.473 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -47.98 -25.9 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 4.7000000000000002 111.08 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -75.82 -33.43 60.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 2.2799999999999998 110.7 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.87 -34.86 44.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 2.2999999999999998 111.044 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.5 mp -67.76 -20.74 65.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.288 -0.415 . . . . 0.69999999999999996 111.076 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.29 -28.61 68.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.369 -0.378 . . . . 0.66000000000000003 111.083 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.94 -56.53 3.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.47999999999999998 110.968 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.3 pt -65.09 166.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.005 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 12' ' ' THR . 12.3 tt0 -114.47 153.54 29.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 2.29 111.195 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.469 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.5 tp -129.91 158.09 40.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 110.664 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.71 147.18 31.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 2.2400000000000002 110.876 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.53 169.84 2.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.76000000000000001 110.993 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.7 m -89.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 1.1599999999999999 111.248 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.59 134.52 44.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 2.2799999999999998 111.094 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 5.1299999999999999 110.876 179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.821 0.343 . . . . 5.1699999999999999 110.851 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -120.36 135.99 54.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 2.9399999999999999 110.922 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CD2' HG11 ' A' ' 42' ' ' VAL . 21.5 p90 -113.27 140.23 48.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.25 110.887 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -121.44 156.35 58.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.66000000000000003 111.147 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.65 87.84 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.48 2.12 . . . . 0.65000000000000002 112.298 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 177.96 -36.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 2.6899999999999999 110.772 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 t -99.51 170.9 8.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 1.8899999999999999 110.96 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.26 165.33 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.46999999999999997 110.94 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 3' ' ' PHE . 54.0 m95 -154.61 163.5 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.68999999999999995 110.616 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.77 127.03 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 2.04 111.185 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.2 mt -74.38 142.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.56000000000000005 111.122 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -142.31 52.11 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.688 -0.687 . . . . 0.96999999999999997 110.155 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -50.7 95.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.45000000000000001 112.89 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -147.5 94.74 2.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.378 . . . . 0.81000000000000005 110.565 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 m -104.19 -174.64 2.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.76000000000000001 110.946 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 9.2 mpt_? -86.24 -23.27 26.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 3.5800000000000001 111.002 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.86 32.04 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 2.48 111.504 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.8 tt -47.21 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.974 0.416 . . . . 0.56999999999999995 111.058 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.5 m -66.7 156.67 85.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 1.5 110.735 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 25.8 Cg_endo -60.9 -28.66 86.7 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.596 2.198 . . . . 0.60999999999999999 112.119 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.33 61.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.70999999999999996 110.599 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.74 -40.1 16.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.846 -0.616 . . . . 2.1699999999999999 110.767 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.7 tpt180 -65.46 -61.37 2.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.5700000000000001 110.876 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.82 -38.43 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 2.6899999999999999 110.844 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -53.54 -59.67 4.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 2.5899999999999999 110.765 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.7 mt -58.56 -44.15 89.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.3 110.718 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -53.53 -29.48 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.94999999999999996 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.3 t -66.79 -38.49 86.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 1.6399999999999999 110.794 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.02 -24.69 24.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 1.6399999999999999 110.882 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.31 16.31 18.76 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.848 -0.691 . . . . 0.81999999999999995 112.732 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.453 ' CE ' HD12 ' A' ' 11' ' ' ILE . 90.7 mmm -91.35 90.52 7.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 2.5499999999999998 111.048 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.6 mp -108.18 161.65 22.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.68999999999999995 110.608 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 91.5 Cg_exo -42.56 109.77 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.43 2.087 . . . . 0.51000000000000001 112.068 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.86 2.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.40000000000000002 112.012 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.2 m -106.87 135.19 48.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.76 0.314 . . . . 0.62 110.904 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.1 m -90.2 148.07 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 1.3 111.199 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.7 p90 -162.77 179.38 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.35999999999999999 110.892 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.29 153.37 43.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 2.9399999999999999 110.812 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.0 t -92.55 141.3 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 1.28 111.187 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 60.6 t -101.75 -44.81 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.54000000000000004 111.303 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -175.71 115.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 2.7999999999999998 110.975 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.7 p -135.71 158.81 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.2 111.148 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -106.78 147.61 35.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.985 -0.552 . . . . 0.81000000000000005 111.085 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 -15.89 34.16 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.586 2.191 . . . . 1.3400000000000001 112.647 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.32 -73.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 2.5099999999999998 111.17 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.24 91.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.859 -0.686 . . . . 0.77000000000000002 112.41 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 7.6 m-20 -137.84 171.38 8.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.646 0.26 . . . . 1.0700000000000001 110.921 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.57 118.01 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.858 2.372 . . . . 0.60999999999999999 111.87 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.4 p -110.13 154.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.569 -0.741 . . . . 0.39000000000000001 110.942 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' VAL . 72.1 m-70 -109.23 133.64 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.688 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 pt -105.02 144.04 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.35999999999999999 111.051 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.21 110.04 20.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 2.1299999999999999 110.644 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 31' ' ' MET . 30.8 p -110.58 -171.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.64000000000000001 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -51.17 95.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 3.04 111.303 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 53.77 24.2 4.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 4.1100000000000003 111.545 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -146.12 115.3 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.035 0.445 . . . . 1.23 111.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -101.39 108.18 19.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.64000000000000001 110.533 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 46.9 tp -99.61 162.47 13.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.954 0.407 . . . . 1.54 111.262 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 9.3 p -117.01 126.47 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.5 110.974 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 65' ' ' LEU . 88.2 mt -119.05 165.95 13.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.96999999999999997 111.158 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.4 ttt180 -139.18 154.59 48.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 3.3199999999999998 110.657 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -46.48 -27.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 4.7000000000000002 111.756 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -79.44 -29.21 41.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 2.2799999999999998 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.12 -33.1 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 2.2999999999999998 110.984 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -76.42 -24.51 54.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.69999999999999996 110.968 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.81 62.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.66000000000000003 111.304 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.6 mt -91.53 -60.65 1.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.33 -0.395 . . . . 0.47999999999999998 110.975 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.405 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 23.7 pt -65.7 151.29 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.42999999999999999 110.925 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.52 146.21 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 2.29 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.41 159.44 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.8500000000000001 110.591 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.81 145.29 30.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.393 -0.367 . . . . 2.2400000000000002 111.084 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.09 163.8 27.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.76000000000000001 111.059 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m -109.82 161.82 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 1.1599999999999999 111.308 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.35 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 2.2799999999999998 111.09 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 5.1299999999999999 110.924 179.914 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.925 0.393 . . . . 5.1699999999999999 111.052 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -138.18 171.28 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.52 . . . . 2.9399999999999999 110.86 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -59.11 99.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 2.25 110.873 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -122.41 153.83 62.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.66000000000000003 111.241 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.05 83.44 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.65000000000000002 112.308 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.11 -42.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 2.6899999999999999 110.641 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.8 m -98.34 165.75 11.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 1.8899999999999999 110.927 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 160.97 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.46999999999999997 111.101 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.5 m95 -139.97 164.86 28.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.68999999999999995 110.798 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' SER . 39.9 ttmt -104.88 138.28 41.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 2.04 111.106 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.0 mt -88.13 132.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.56000000000000005 110.562 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 15.9 m -142.27 52.47 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.21 -0.45 . . . . 0.96999999999999997 110.798 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.22 93.59 0.01 OUTLIER Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.017 -0.611 . . . . 0.45000000000000001 112.848 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.84 101.41 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.777 0.322 . . . . 0.81000000000000005 110.88 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 m -110.48 -176.61 3.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.76000000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.7 mpt_? -74.85 -23.01 58.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -169.42 42.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 2.48 110.746 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.7 tt -46.97 115.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.56999999999999995 111.266 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -71.0 157.38 90.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.55 . . . . 1.5 110.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 24.9 Cg_endo -59.83 -27.37 84.78 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.771 2.314 . . . . 0.60999999999999999 112.141 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -49.36 -44.09 44.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.509 -0.314 . . . . 0.70999999999999996 110.713 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -86.15 -39.02 17.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 2.1699999999999999 111.144 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 17.9 tpp180 -67.91 -56.83 7.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 1.5700000000000001 111.338 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -40.97 -30.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.405 -0.362 . . . . 2.6899999999999999 111.633 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 14.2 mmmm -68.48 -54.77 14.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 2.5899999999999999 110.376 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.7 mt -54.61 -51.82 64.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 1.3 110.641 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -49.4 -43.57 44.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.94999999999999996 111.006 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -54.26 -50.97 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.474 . . . . 1.6399999999999999 110.752 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.96 -23.87 60.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 1.6399999999999999 110.815 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.12 19.03 31.92 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.81999999999999995 112.669 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 mtm -94.33 88.93 5.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.759 0.314 . . . . 2.5499999999999998 111.01 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -92.2 160.61 34.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.68999999999999995 110.531 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.1 104.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.33 2.02 . . . . 0.51000000000000001 112.197 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 50.33 0.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.40000000000000002 112.154 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 48.0 t -117.84 170.85 8.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.277 . . . . 0.62 110.746 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.2 p -118.99 139.4 51.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 1.3 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.9 p90 -148.45 163.13 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.35999999999999999 111.041 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -108.94 151.45 26.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 2.9399999999999999 110.983 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.5 129.26 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.199 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.5 t -99.03 -36.38 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.54000000000000004 111.115 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -175.03 125.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.361 . . . . 2.7999999999999998 111.14 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' CG2' ' A' ' 49' ' ' VAL . 59.0 t -140.86 156.24 22.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 1.2 111.183 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -138.04 128.13 15.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.81000000000000005 110.845 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.6 Cg_exo -57.58 -36.73 98.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.427 2.085 . . . . 1.3400000000000001 112.193 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.9 -45.32 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.925 -0.58 . . . . 2.5099999999999998 111.167 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.69 99.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.77000000000000002 112.234 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 8.9 m-20 -148.26 170.63 7.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.624 0.25 . . . . 1.0700000000000001 111.14 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.37 121.53 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.856 2.371 . . . . 0.60999999999999999 111.51 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.71 156.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.705 -0.68 . . . . 0.39000000000000001 111.03 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.8 m-70 -122.96 130.87 53.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 1.1299999999999999 110.41 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 19.5 pt -103.6 137.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.086 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.01 121.59 44.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 2.1299999999999999 110.733 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 55' ' ' ARG . 56.5 p -124.12 -172.9 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.99 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -49.63 91.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 3.04 111.351 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' THR . 17.8 mmm180 53.43 33.65 16.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 4.1100000000000003 111.463 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.6 t -150.97 104.59 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 1.23 111.307 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -97.52 107.84 20.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.64000000000000001 110.713 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.95 153.64 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 1.54 111.131 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 7.1 p -111.67 129.88 66.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.5 111.052 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.9 135.92 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.96999999999999997 110.906 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.4 mtt180 -103.01 160.36 14.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 3.3199999999999998 111.041 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -42.51 -37.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 4.7000000000000002 111.474 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 18.8 ptmt -64.53 -34.43 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 2.2799999999999998 111.127 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.08 -24.05 35.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 2.2999999999999998 111.067 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -86.18 -21.37 27.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.349 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.5 64.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.66000000000000003 111.377 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.0 mt -91.5 -55.86 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.352 -0.386 . . . . 0.47999999999999998 111.316 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 65' ' ' LEU . 25.7 pt -65.67 150.56 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.42999999999999999 111.092 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -100.42 143.08 31.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 2.29 110.816 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.6 ' N ' HD22 ' A' ' 70' ' ' LEU . 1.9 mm? -116.82 149.5 39.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.8500000000000001 110.779 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -144.21 156.11 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 2.2400000000000002 110.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.93 164.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 0.76000000000000001 111.007 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -95.45 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 1.1599999999999999 111.196 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.7 146.4 40.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 2.2799999999999998 110.754 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 5.1299999999999999 111.061 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.769 0.318 . . . . 5.1699999999999999 110.966 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.48 106.06 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 2.9399999999999999 111.014 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 56.7 m-85 -61.58 99.39 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.475 . . . . 2.25 110.787 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -100.26 145.23 29.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.66000000000000003 111.189 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' HG23 ' A' ' 39' ' ' VAL . 57.3 Cg_endo -70.34 86.85 0.64 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 112.215 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 177.85 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 2.6899999999999999 110.847 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -97.82 146.89 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 9' ' ' TRP . . . -79.81 171.14 15.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.46999999999999997 110.955 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' ALA . 57.5 m95 -156.71 160.94 39.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.68999999999999995 110.78 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 71' ' ' GLU . 59.0 mttp -112.1 134.35 53.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.04 110.801 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.477 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.0 mt -70.92 138.65 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.56000000000000005 111.292 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 9.2 m -146.52 43.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.189 0.519 . . . . 0.96999999999999997 110.484 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.48 90.5 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.45000000000000001 112.824 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -147.09 95.03 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.81000000000000005 110.736 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -99.32 -169.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.76000000000000001 110.928 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.1 mpt_? -83.29 -23.49 32.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 3.5800000000000001 110.93 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.07 37.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.48 110.775 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tt -46.08 116.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.301 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 m -64.25 155.9 77.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 1.5 110.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 33.9 Cg_endo -63.37 -26.79 71.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.565 2.176 . . . . 0.60999999999999999 112.14 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.06 55.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.70999999999999996 110.672 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' OD1' ' A' ' 64' ' ' ASP . 92.8 m-85 -85.84 -39.82 16.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 2.1699999999999999 110.915 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 22.5 tpt180 -65.2 -58.95 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.176 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.0 tt0 -43.8 -28.44 0.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 2.6899999999999999 111.724 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -65.01 -36.59 84.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 2.5899999999999999 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.7 mp -79.39 -45.41 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.3 111.038 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -50.47 -25.16 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.94999999999999996 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.8 m -57.41 -47.81 80.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.6399999999999999 111.042 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.9 mp -86.18 -25.06 25.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 1.6399999999999999 110.899 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 27.88 10.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 0.81999999999999995 112.762 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.2 mmt -95.29 99.45 11.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.7 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.54 159.86 37.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.54 . . . . 0.68999999999999995 110.826 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -42.24 114.59 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.495 2.13 . . . . 0.51000000000000001 112.148 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 25.22 2.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.859 -0.686 . . . . 0.40000000000000002 112.478 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 44.9 t -94.71 174.09 7.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.62 110.57 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.1 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.3 111.097 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.6 p90 -163.84 -173.4 3.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.076 -0.511 . . . . 0.35999999999999999 110.732 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -137.11 159.99 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 2.9399999999999999 110.966 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -100.57 131.46 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 1.28 110.883 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -89.58 -48.06 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.242 -0.436 . . . . 0.54000000000000004 111.568 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -171.39 120.8 0.5 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.732 0.301 . . . . 2.7999999999999998 111.385 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 43' ' ' ALA . 13.2 p -147.77 160.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 1.2 111.088 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -128.84 142.86 46.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 111.025 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 33.9 Cg_exo -59.42 -22.29 65.26 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.474 2.116 . . . . 1.3400000000000001 112.514 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.98 -73.68 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.361 . . . . 2.5099999999999998 111.242 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.41 91.72 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.779 -0.725 . . . . 0.77000000000000002 112.354 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.464 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.8 m-20 -138.39 171.54 8.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.514 0.197 . . . . 1.0700000000000001 110.722 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.71 116.45 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.903 2.402 . . . . 0.60999999999999999 111.95 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 42' ' ' VAL . 2.7 p -111.66 139.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.39000000000000001 111.315 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' VAL . 35.0 m-70 -101.68 130.79 48.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.604 . . . . 1.1299999999999999 110.504 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 57' ' ' SER . 37.8 pt -97.26 147.09 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.35999999999999999 111.008 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.73 119.83 40.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 2.1299999999999999 110.804 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.477 ' HG1' HG13 ' A' ' 56' ' ' VAL . 17.4 p -127.15 -163.19 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.64000000000000001 111.205 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 56' ' ' VAL . 34.5 mmt180 -48.31 97.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.079 0.466 . . . . 3.04 111.867 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 43.57 34.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 4.1100000000000003 112.286 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HG1' ' A' ' 53' ' ' THR . 12.2 p -159.94 125.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.968 0.413 . . . . 1.23 111.197 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 47.0 t -105.94 112.49 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 111.271 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.73 171.13 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.553 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -123.32 132.29 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.41 -0.359 . . . . 0.5 111.198 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -135.75 166.39 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.516 . . . . 0.96999999999999997 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.2 mtt180 -123.54 146.79 47.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 3.3199999999999998 110.601 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.453 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.3 tpmt? -50.01 -25.11 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.368 . . . . 4.7000000000000002 111.021 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.88 -30.0 40.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 2.2799999999999998 110.578 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' OD1' ' CD1' ' A' ' 22' ' ' TYR . 21.2 t70 -81.35 -36.63 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 2.2999999999999998 110.719 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.7 mp -61.69 -22.11 65.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.69999999999999996 110.928 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.13 61.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 111.192 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.66 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.47999999999999998 110.968 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 65' ' ' LEU . 27.6 pt -65.71 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.42999999999999999 110.78 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.8 tt0 -99.04 146.14 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.29 111.109 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -116.52 149.89 38.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 1.8500000000000001 110.681 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.4 tp10 -129.88 150.24 51.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 2.2400000000000002 110.974 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.97 171.57 12.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.76000000000000001 111.23 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.4 m -77.57 176.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.1599999999999999 111.022 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 -52.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 2.2799999999999998 111.034 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 5.1299999999999999 110.916 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.779 0.324 . . . . 5.1699999999999999 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -171.79 -179.05 2.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 2.9399999999999999 110.995 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 13.5 p90 -118.86 128.29 54.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 2.25 111.099 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -100.08 154.89 36.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.66000000000000003 110.908 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 58.0 Cg_endo -71.72 83.54 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.394 2.063 . . . . 0.65000000000000002 112.484 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 13.3 t70 178.71 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 2.6899999999999999 110.897 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 t -90.77 159.35 16.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.8899999999999999 111.11 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.03 169.25 11.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.46999999999999997 111.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 60.6 m95 -151.58 154.82 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.68999999999999995 111.107 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' SER . 31.7 mmmt -95.37 131.33 41.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.982 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 32.4 mt -83.05 125.33 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.56000000000000005 111.242 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 35.7 p -133.09 58.82 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.96999999999999997 110.534 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.26 91.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.742 -0.663 . . . . 0.45000000000000001 112.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.05 94.85 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.81000000000000005 110.344 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -97.89 -172.56 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.76000000000000001 111.247 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -85.73 -24.31 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 3.5800000000000001 110.695 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -158.5 37.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.048 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.15 128.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 0.56999999999999995 111.311 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.3 m -77.61 157.04 80.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 1.5 111.096 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 55.8 Cg_endo -70.36 -26.68 24.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.583 2.188 . . . . 0.60999999999999999 112.491 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.76 -47.11 59.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.351 -0.386 . . . . 0.70999999999999996 110.724 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -86.22 -38.39 17.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.915 -0.584 . . . . 2.1699999999999999 110.954 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 24.1 tpt180 -66.95 -58.19 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 1.5700000000000001 111.405 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -44.82 -30.5 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 2.6899999999999999 111.517 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.36 -40.97 73.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 2.5899999999999999 111.053 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.24 -50.87 19.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 1.3 110.64 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.33 -35.49 60.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.94999999999999996 110.856 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.2 m -78.25 -27.47 47.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 1.6399999999999999 111.038 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.39 -25.06 39.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 1.6399999999999999 110.846 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.07 5.96 43.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.807 -0.711 . . . . 0.81999999999999995 113.103 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -98.74 96.13 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 2.5499999999999998 110.931 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -104.96 158.73 31.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.454 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -39.59 105.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.576 2.184 . . . . 0.51000000000000001 112.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 33.95 0.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.40000000000000002 112.294 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.5 t -106.42 174.44 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.602 0.239 . . . . 0.62 110.525 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 p -129.13 144.98 51.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.866 0.365 . . . . 1.3 111.012 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CE2' HG22 ' A' ' 51' ' ' ILE . 13.5 p90 -152.04 168.41 25.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.35999999999999999 111.021 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -115.56 140.61 49.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 2.9399999999999999 110.517 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 49' ' ' VAL . 48.0 t -80.31 131.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.387 -0.37 . . . . 1.28 111.22 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.07 -39.61 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.428 . . . . 0.54000000000000004 111.324 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 49' ' ' VAL . 37.3 ptt180 -179.73 121.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 2.7999999999999998 110.801 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -145.02 159.5 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 1.2 111.152 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -112.61 155.45 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.81000000000000005 111.02 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.98 -22.23 15.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.584 2.189 . . . . 1.3400000000000001 112.367 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.9 -62.21 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 111.094 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.8 103.13 0.18 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.77000000000000002 112.208 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.457 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.9 m-20 -147.97 170.45 7.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.666 0.269 . . . . 1.0700000000000001 111.039 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -85.17 119.01 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.848 2.366 . . . . 0.60999999999999999 111.587 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' ARG . 2.7 p -115.06 149.35 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.39000000000000001 111.406 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -99.55 146.46 26.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 1.1299999999999999 110.995 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 58' ' ' LEU . 33.6 pt -112.08 138.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.35999999999999999 110.842 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.1 131.44 54.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 2.1299999999999999 110.91 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 p -137.35 -173.05 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.64000000000000001 110.991 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -52.83 91.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 3.04 111.3 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 54.04 39.11 30.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 4.1100000000000003 111.57 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -156.86 111.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 1.23 110.976 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -105.32 107.92 19.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.64000000000000001 111.071 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 58.5 tp -98.95 159.96 14.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.54 111.022 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 8.6 p -113.89 135.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.5 111.009 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.93 141.12 52.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.96999999999999997 110.979 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -106.96 151.61 25.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 3.3199999999999998 110.97 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -47.38 -29.87 2.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 4.7000000000000002 111.463 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 21.1 ptmt -81.34 -25.4 36.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 2.2799999999999998 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 61' ' ' ARG . 12.3 t70 -78.05 -30.69 49.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.48 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.8 mp -75.55 -21.91 57.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.142 -0.481 . . . . 0.69999999999999996 111.124 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.87 71.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.66000000000000003 111.36 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.95 -61.74 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.47999999999999998 111.204 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -65.68 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.031 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 5.8 tp10 -98.49 155.85 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 2.29 110.859 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.1 tp -125.04 157.48 36.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 1.8500000000000001 110.561 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 35.3 tt0 -147.42 149.93 33.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 110.83 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.29 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.35 -174.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.79 113.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 2.2799999999999998 111.298 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 5.1299999999999999 110.639 179.669 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ptp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.828 0.347 . . . . 5.1699999999999999 110.844 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -148.29 117.3 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 2.9399999999999999 110.909 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.44 99.11 12.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 2.25 110.721 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 p -102.43 151.46 38.19 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.66000000000000003 111.338 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.681 ' HA ' HG23 ' A' ' 39' ' ' VAL . 59.0 Cg_endo -71.87 91.06 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.563 2.176 . . . . 0.65000000000000002 112.489 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 176.6 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 2.6899999999999999 110.912 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -106.31 144.14 33.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 1.8899999999999999 110.984 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.33 165.32 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 111.128 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -155.2 153.91 31.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.68999999999999995 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 35' ' ' SER . 49.8 mtmt -113.59 138.68 49.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 2.04 111.25 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' CD1' ' A' ' 37' ' ' PHE . 47.3 mt -79.12 123.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.56000000000000005 111.265 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 57.7 p -131.78 59.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.96999999999999997 110.554 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -51.64 97.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.838 -0.696 . . . . 0.45000000000000001 112.44 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -145.09 96.92 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.371 . . . . 0.81000000000000005 111.125 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -114.12 153.57 29.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.76000000000000001 110.698 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -52.55 -25.01 9.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 3.5800000000000001 110.57 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.3 39.72 0.67 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 2.48 110.783 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.3 tt -42.72 105.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.076 0.465 . . . . 0.56999999999999995 111.468 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -63.42 146.8 96.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.5 110.806 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.3 Cg_endo -58.64 -30.31 91.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.721 2.281 . . . . 0.60999999999999999 112.131 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -45.33 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.70999999999999996 110.937 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 54.0 m-85 -85.39 -42.02 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 2.1699999999999999 111.249 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -60.76 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 1.5700000000000001 111.269 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.3 mm-40 -54.88 -22.12 13.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.34 -0.391 . . . . 2.6899999999999999 111.456 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 22' ' ' TYR . 23.1 ttpp -69.2 -42.93 75.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.331 . . . . 2.5899999999999999 110.823 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.1 mt -52.14 -34.42 44.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.725 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.83 -27.73 44.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.94999999999999996 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -49.0 -38.11 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 1.6399999999999999 111.121 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.1 mm? -107.11 -21.24 13.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.6399999999999999 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.28 29.63 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.737 -0.744 . . . . 0.81999999999999995 112.531 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -88.57 92.71 9.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.749 0.309 . . . . 2.5499999999999998 110.791 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.4 mp -83.04 158.98 63.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.68999999999999995 110.825 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.36 107.27 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.328 2.019 . . . . 0.51000000000000001 112.112 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.71 32.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.855 -0.688 . . . . 0.40000000000000002 112.518 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 10' ' ' LYS . 46.7 t -104.76 174.18 5.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.71 0.291 . . . . 0.62 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -116.04 154.54 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.334 -0.394 . . . . 1.3 111.169 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 11' ' ' ILE . 30.0 p90 -165.04 169.96 15.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.35999999999999999 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 29.3 m80 -124.69 134.55 52.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 2.9399999999999999 111.014 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 5' ' ' PRO . 7.0 m -83.87 132.32 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.28 111.16 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.69 -49.71 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.54000000000000004 111.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 2.7999999999999998 110.892 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.1 t -143.55 159.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.2 111.189 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.26 144.95 52.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.81000000000000005 110.944 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.06 -18.23 31.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.476 2.117 . . . . 1.3400000000000001 112.596 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.42 -55.17 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 2.5099999999999998 111.15 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.68 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.77000000000000002 112.272 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.8 m-20 -143.43 170.66 8.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.67 0.271 . . . . 1.0700000000000001 111.118 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.94 117.14 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.933 2.422 . . . . 0.60999999999999999 111.924 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.62 156.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.39000000000000001 110.935 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -115.58 131.91 56.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 37.5 pt -101.73 142.43 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.097 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 38.0 tt0 -107.33 124.53 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 2.1299999999999999 110.709 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 56' ' ' VAL . 69.6 p -132.1 -173.52 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.64000000000000001 111.278 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 56' ' ' VAL . 38.1 mmt180 -41.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.105 0.409 . . . . 3.04 112.105 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 44.15 51.0 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.906 -0.588 . . . . 4.1100000000000003 111.886 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 56' ' ' VAL . 14.2 p 179.71 119.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 1.23 111.201 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -102.33 112.57 25.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 110.946 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 47.7 tp -92.0 162.77 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 1.54 110.615 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 12.6 p -112.29 145.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.5 111.244 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.03 147.06 41.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.847 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.3 mtt180 -107.65 150.51 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.3199999999999998 110.908 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.89 -25.95 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.919 -0.582 . . . . 4.7000000000000002 111.226 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -81.08 -27.76 35.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 2.2799999999999998 110.826 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.5 -31.59 47.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 2.2999999999999998 110.974 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -72.79 -21.17 61.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.69999999999999996 111.008 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.77 71.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.66000000000000003 111.146 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.38 -61.69 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.47999999999999998 111.042 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.403 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 25.8 pt -66.08 148.98 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.415 . . . . 0.42999999999999999 110.962 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.4 tt0 -102.35 153.81 19.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 2.29 110.733 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -115.96 149.58 38.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.8500000000000001 110.866 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.32 110.72 9.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 2.2400000000000002 110.957 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 155.34 1.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.76000000000000001 111.0 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.81 163.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 1.1599999999999999 111.278 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.17 128.91 35.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 2.2799999999999998 110.908 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 5.1299999999999999 110.956 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.4 mtp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.866 0.365 . . . . 5.1699999999999999 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.47 167.45 18.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 2.9399999999999999 110.902 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.15 104.84 12.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 2.25 110.788 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.4 p -99.88 155.97 35.86 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.66000000000000003 111.143 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 58.6 Cg_endo -72.3 87.27 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.502 2.135 . . . . 0.65000000000000002 112.289 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 t70 177.77 -57.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 2.6899999999999999 110.965 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -77.32 135.9 38.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 1.8899999999999999 110.804 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.42 157.65 28.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.46999999999999997 111.327 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 71.9 m95 -141.37 167.62 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.68999999999999995 110.804 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.1 136.57 51.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 2.04 111.165 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' CD1' ' A' ' 37' ' ' PHE . 50.5 mt -79.47 136.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.56000000000000005 110.742 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 12' ' ' THR . 12.7 m -143.83 46.52 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.96999999999999997 110.825 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.85 90.32 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.881 -0.676 . . . . 0.45000000000000001 112.657 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' THR . 69.3 t80 -146.68 102.69 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.81000000000000005 110.732 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -97.94 -179.12 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.76000000000000001 111.115 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.2 mpt_? -75.25 -24.85 57.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 3.5800000000000001 110.629 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.95 38.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 2.48 110.63 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -42.88 131.7 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.038 -0.528 . . . . 0.56999999999999995 111.737 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.8 m -92.47 157.4 40.27 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.5 110.784 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 24' ' ' GLN . 11.7 Cg_endo -54.44 -32.75 74.5 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.638 2.225 . . . . 0.60999999999999999 112.093 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.08 -46.69 34.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.07 0.462 . . . . 0.70999999999999996 110.771 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -85.95 -49.96 7.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.558 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.48 -61.23 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 1.5700000000000001 111.064 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.4 tt0 -47.51 -32.42 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 2.6899999999999999 111.055 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.66 -55.9 28.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 2.5899999999999999 110.752 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.5 -45.15 92.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 1.3 110.817 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.45 -53.36 37.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.94999999999999996 111.113 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -49.92 -29.91 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 1.6399999999999999 111.085 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HD11 ' A' ' 58' ' ' LEU . 84.2 mt -91.88 -25.42 18.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 1.6399999999999999 110.94 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.06 31.35 9.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.698 -0.763 . . . . 0.81999999999999995 112.874 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.4 mtt -110.3 87.46 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 2.5499999999999998 110.623 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.8 mp -86.95 161.21 47.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.68999999999999995 110.746 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.78 115.13 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.508 2.138 . . . . 0.51000000000000001 112.163 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.4 28.58 2.98 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.786 -0.721 . . . . 0.40000000000000002 112.188 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 37.3 t -96.36 163.16 13.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.638 0.256 . . . . 0.62 110.634 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -110.67 145.3 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 1.3 111.028 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 11' ' ' ILE . 19.1 p90 -158.28 170.33 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.35999999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -120.81 149.75 42.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.107 -0.497 . . . . 2.9399999999999999 110.991 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 5' ' ' PRO . 54.2 t -82.17 132.54 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.072 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.0 -33.51 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.54000000000000004 111.522 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 176.41 130.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 2.7999999999999998 111.22 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 43' ' ' ALA . 51.0 t -139.87 158.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 1.2 111.04 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -114.63 134.35 22.39 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.81000000000000005 110.859 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.3 -26.3 76.36 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.455 2.103 . . . . 1.3400000000000001 112.48 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.2 mp -91.26 -65.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.427 -0.351 . . . . 2.5099999999999998 111.215 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.12 106.94 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.77000000000000002 112.338 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.3 m-20 -148.32 173.21 4.39 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 111.05 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 2.3 Cg_endo -83.52 120.23 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.60999999999999999 111.522 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.486 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.55 156.02 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.629 -0.714 . . . . 0.39000000000000001 111.202 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -120.78 134.26 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 1.1299999999999999 110.525 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 37.3 pt -101.38 137.88 27.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.198 -0.455 . . . . 0.35999999999999999 110.916 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.7 101.32 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.445 . . . . 2.1299999999999999 110.887 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.8 p -99.64 -169.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 110.838 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -56.18 96.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 3.04 111.584 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.3 26.3 8.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 4.1100000000000003 111.629 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -148.53 114.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 1.23 111.257 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -103.24 107.86 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.64000000000000001 110.779 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 64.5 mt -94.77 174.78 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 1.54 111.006 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.99 131.26 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.975 0.416 . . . . 0.5 111.181 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.8 mt -124.06 165.11 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.789 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' HD13 ' A' ' 65' ' ' LEU . 97.5 mtt180 -146.05 162.23 38.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 3.3199999999999998 111.066 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -52.54 -22.33 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 4.7000000000000002 111.545 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE3' ' HD2' ' A' ' 61' ' ' ARG . 23.0 pttp -80.35 -33.67 37.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 2.2799999999999998 110.624 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.27 -42.55 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 2.2999999999999998 110.888 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -60.47 -24.19 65.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.69999999999999996 111.007 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.92 65.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.401 . . . . 0.66000000000000003 111.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.15 -57.26 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.362 . . . . 0.47999999999999998 111.072 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.3 pt -65.94 151.19 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.42999999999999999 111.192 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -103.43 150.51 23.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 2.29 110.722 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.87 142.14 50.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.8500000000000001 111.088 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -124.13 152.72 42.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 2.2400000000000002 110.906 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.21 -178.51 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 111.105 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.9 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 1.1599999999999999 111.084 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.19 -43.21 14.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 2.2799999999999998 111.065 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 5.1299999999999999 110.85 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.774 0.321 . . . . 5.1699999999999999 110.96 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -83.89 144.9 28.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 2.9399999999999999 110.832 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 9' ' ' TRP . 62.9 m-85 57.41 96.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 2.25 110.705 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -114.41 161.09 30.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.66000000000000003 111.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.97 147.55 14.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.65000000000000002 112.345 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 66.4 18.27 10.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 2.6899999999999999 111.647 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.493 ' OG ' HG21 ' A' ' 39' ' ' VAL . 84.5 p -98.74 173.25 6.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.733 0.301 . . . . 1.8899999999999999 110.651 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.07 142.81 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.46999999999999997 111.122 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.559 ' CD2' ' CE2' ' A' ' 3' ' ' PHE . 32.1 m95 -154.02 162.83 40.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.68999999999999995 110.696 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -106.33 138.19 42.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 2.04 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 44.8 mt -77.79 127.4 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.56000000000000005 111.026 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 m -136.05 48.15 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.96999999999999997 110.571 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -46.59 92.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.45000000000000001 113.046 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -147.08 94.9 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.81000000000000005 110.668 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 32.2 t -98.63 -178.76 4.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.896 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.9 mpt_? -79.05 -21.49 46.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 3.5800000000000001 111.001 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.02 37.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.479 -0.328 . . . . 2.48 111.17 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 10.8 tt -45.6 126.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.56999999999999995 111.396 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -85.36 149.29 51.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 1.5 110.964 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 15.6 Cg_endo -56.8 -31.25 87.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.801 2.334 . . . . 0.60999999999999999 112.257 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.56 -47.11 28.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.70999999999999996 110.858 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -85.79 -43.65 13.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 2.1699999999999999 110.904 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.4 tpt180 -60.7 -61.01 2.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 1.5700000000000001 110.967 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' PRO . 52.8 tp60 -48.89 -30.35 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 2.6899999999999999 110.85 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.61 -32.97 73.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 2.5899999999999999 110.849 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.94 -48.04 26.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.837 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.65 -34.05 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.94999999999999996 111.062 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -53.09 -33.27 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.6399999999999999 110.904 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -89.79 -22.95 21.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 1.6399999999999999 110.823 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.74 23.67 30.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 0.81999999999999995 112.495 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 39.8 mtm -101.44 91.01 4.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 2.5499999999999998 110.763 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -92.54 159.3 36.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.68999999999999995 110.879 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.04 106.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.637 2.225 . . . . 0.51000000000000001 112.186 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.18 33.34 0.9 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.798 -0.715 . . . . 0.40000000000000002 112.454 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.4 t -107.49 171.8 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.62 110.829 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -116.05 145.96 42.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 1.3 111.009 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 18.2 p90 -157.62 159.73 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.317 -0.401 . . . . 0.35999999999999999 111.033 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -109.33 151.62 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 2.9399999999999999 110.67 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.493 HG21 ' OG ' ' A' ' 7' ' ' SER . 57.6 t -89.37 140.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 1.28 111.221 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.9 t -103.45 -52.22 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.54000000000000004 111.426 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.33 129.13 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 2.7999999999999998 111.074 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.3 t -143.2 159.2 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.201 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -129.06 145.17 55.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.98 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 33.3 Cg_endo -64.46 -16.97 57.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.568 2.179 . . . . 1.3400000000000001 112.468 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -89.88 -69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.872 0.367 . . . . 2.5099999999999998 110.975 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.52 94.17 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.77000000000000002 112.347 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB2' ' CD ' ' A' ' 48' ' ' PRO . 4.2 p-10 -131.25 178.01 1.95 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.475 0.179 . . . . 1.0700000000000001 110.711 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' CD ' ' HB2' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.25 118.36 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.938 2.425 . . . . 0.60999999999999999 111.557 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.84 157.53 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.39000000000000001 111.293 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.43 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.8 m-70 -117.57 144.92 44.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.642 -0.708 . . . . 1.1299999999999999 110.463 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.2 135.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.35999999999999999 111.222 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -106.94 112.49 25.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 2.1299999999999999 110.651 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -118.13 -174.11 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.64000000000000001 111.128 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -50.71 93.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.04 111.283 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.25 37.71 15.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 4.1100000000000003 111.578 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG11 HD23 ' A' ' 29' ' ' LEU . 89.2 t -152.71 100.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 1.23 110.887 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -97.77 108.42 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.64000000000000001 111.008 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 56.8 tp -108.01 161.26 15.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 1.54 110.935 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 7.4 p -114.59 141.17 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.023 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -126.77 144.11 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.96999999999999997 110.813 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.45 ' O ' HD13 ' A' ' 65' ' ' LEU . 56.9 mtp180 -107.92 152.67 24.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 3.3199999999999998 111.171 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.81 -33.12 9.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 4.7000000000000002 111.713 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.98 -22.88 36.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 2.2799999999999998 111.073 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.96 -23.55 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 2.2999999999999998 110.931 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 61' ' ' ARG . 9.6 mp -79.5 -28.93 41.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.69999999999999996 110.965 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -24.27 52.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.66000000000000003 111.071 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.54 -61.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.47999999999999998 110.917 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 22.4 pt -65.65 151.86 9.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.42999999999999999 110.819 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -105.48 142.54 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 2.29 111.426 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -110.16 125.64 53.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.969 -0.559 . . . . 1.8500000000000001 110.455 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.44 124.01 45.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.2400000000000002 110.72 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.1 152.44 7.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.028 -0.533 . . . . 0.76000000000000001 111.199 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.78 177.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 1.1599999999999999 111.281 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.39 -50.55 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 2.2799999999999998 110.993 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 5.1299999999999999 110.854 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.885 0.374 . . . . 5.1699999999999999 110.968 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -132.72 139.52 47.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 2.9399999999999999 110.852 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.5 ' HB2' ' CE2' ' A' ' 9' ' ' TRP . 37.0 p90 -121.6 112.74 18.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 2.25 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.0 p -81.18 153.1 71.73 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.66000000000000003 111.194 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.0 81.7 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.454 2.103 . . . . 0.65000000000000002 112.013 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -176.58 -42.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 2.6899999999999999 110.94 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -90.18 154.64 19.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.8899999999999999 110.884 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.54 170.12 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.46999999999999997 111.034 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 52.0 m95 -155.63 175.69 13.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.68999999999999995 110.911 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.3 134.02 54.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 2.04 111.094 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG13 ' CD1' ' A' ' 37' ' ' PHE . 58.9 mt -80.74 123.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.56000000000000005 111.028 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 19.5 m -133.89 53.46 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.115 0.484 . . . . 0.96999999999999997 110.509 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.57 88.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.885 -0.598 . . . . 0.45000000000000001 112.826 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' THR . 19.4 t80 -147.21 107.6 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.81000000000000005 111.046 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 m -108.66 164.36 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.76000000000000001 110.842 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -55.17 -22.8 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 3.5800000000000001 110.976 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -164.1 42.45 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.712 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -44.3 134.17 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.56999999999999995 111.558 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 m -84.6 155.81 62.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.5 110.971 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' GLN . 24.9 Cg_endo -62.05 -29.72 81.84 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.605 2.204 . . . . 0.60999999999999999 112.421 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.08 -45.28 64.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.70999999999999996 110.646 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.38 -41.99 14.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 110.798 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -65.51 -61.41 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.5700000000000001 110.999 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' PRO . 12.9 mm100 -52.82 -22.95 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 2.6899999999999999 111.255 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -73.5 -40.41 64.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 2.5899999999999999 110.796 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.5 -44.04 95.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 1.3 110.895 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.56 -25.79 4.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.94999999999999996 110.978 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.6 m -53.59 -35.37 60.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.6399999999999999 111.015 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.8 mm? -94.02 -25.21 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 1.6399999999999999 110.852 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.4 56.16 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.81999999999999995 112.835 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -88.95 98.51 11.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.923 0.392 . . . . 2.5499999999999998 110.687 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.3 mp -83.3 159.66 61.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.544 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.05 149.77 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.47 2.113 . . . . 0.51000000000000001 111.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . 77.65 17.95 78.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.693 -0.765 . . . . 0.40000000000000002 112.342 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.6 t -77.74 174.04 11.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.601 0.239 . . . . 0.62 110.446 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -121.23 136.0 55.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 1.3 110.91 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CD1' HG13 ' A' ' 11' ' ' ILE . 12.8 p90 -151.72 173.65 14.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.35999999999999999 111.085 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -127.75 158.42 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 2.9399999999999999 110.839 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.02 128.59 46.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 1.28 111.248 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.2 -38.63 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.54000000000000004 111.05 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -178.74 123.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 2.7999999999999998 111.003 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.9 p -143.61 160.87 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 1.2 111.218 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -125.16 153.79 71.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.81000000000000005 110.994 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.97 -14.55 9.77 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.592 2.195 . . . . 1.3400000000000001 112.911 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD11 ' OD2' ' A' ' 47' ' ' ASP . 4.4 pp -85.32 -18.95 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.606 -0.27 . . . . 2.5099999999999998 111.287 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 45' ' ' LEU . . . 114.93 88.45 1.56 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.687 -0.768 . . . . 0.77000000000000002 112.297 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.639 ' OD2' HD11 ' A' ' 45' ' ' LEU . 7.3 m-20 -137.52 171.94 7.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.605 0.24 . . . . 1.0700000000000001 110.897 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.4 Cg_endo -84.3 115.94 1.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.832 2.355 . . . . 0.60999999999999999 111.72 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.54 138.44 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.39000000000000001 111.025 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -95.91 136.01 36.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.919 -0.582 . . . . 1.1299999999999999 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.62 134.64 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.35999999999999999 110.962 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.26 120.54 42.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 2.1299999999999999 111.015 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 74.3 p -124.46 -173.65 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.64000000000000001 110.657 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -49.57 92.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 3.04 111.328 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 34.0 mmt180 53.09 40.9 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.808 -0.633 . . . . 4.1100000000000003 111.488 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 55' ' ' ARG . 66.7 t -157.45 105.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 1.23 111.025 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -104.88 107.52 18.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.64000000000000001 110.9 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.7 tp -100.73 160.19 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.644 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.43 142.94 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.5 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' CD2' ' A' ' 65' ' ' LEU . 57.1 tp -137.52 141.92 41.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.96999999999999997 110.82 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.433 ' CZ ' ' HD3' ' A' ' 63' ' ' LYS . 31.3 ptt180 -114.84 179.46 3.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 3.3199999999999998 110.62 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -75.62 -48.85 20.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.521 -0.308 . . . . 4.7000000000000002 111.513 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 61' ' ' ARG . 21.0 ptmt -51.57 -34.44 36.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 2.2799999999999998 110.567 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.52 -25.48 33.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 2.2999999999999998 110.434 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.536 ' CD2' HD21 ' A' ' 60' ' ' LEU . 10.0 mt -74.86 -25.46 58.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.052 -0.522 . . . . 0.69999999999999996 111.038 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.89 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.66000000000000003 111.108 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -84.92 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.254 -0.43 . . . . 0.47999999999999998 110.983 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.97 155.95 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.283 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.7 tp10 -107.72 135.37 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 2.29 110.776 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.8 mm? -105.21 152.32 23.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 1.8500000000000001 111.11 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.98 121.21 10.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 2.2400000000000002 110.707 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.75 166.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.76000000000000001 111.22 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.28 148.64 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 1.1599999999999999 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.83 171.24 7.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 2.2799999999999998 111.122 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 5.1299999999999999 110.961 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.96 0.41 . . . . 5.1699999999999999 110.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -139.26 164.8 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 2.9399999999999999 110.757 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' A' ' 42' ' ' VAL . 28.5 p90 -147.93 111.76 5.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 2.25 110.984 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.0 p -79.39 155.35 76.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.66000000000000003 110.954 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 65.5 Cg_endo -74.08 89.64 1.02 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.488 2.125 . . . . 0.65000000000000002 112.46 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 t70 177.94 -43.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 2.6899999999999999 111.048 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -87.64 144.24 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.8899999999999999 110.914 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 158.59 32.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 111.131 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.435 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 72.5 m95 -145.79 158.11 43.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.68999999999999995 110.877 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -108.85 138.35 45.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 2.04 110.91 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 60.8 mt -80.65 137.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.56000000000000005 111.141 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -141.69 56.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.96999999999999997 110.253 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.22 90.08 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.45000000000000001 112.875 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -146.43 94.69 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.81000000000000005 110.433 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -100.85 150.28 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.76000000000000001 111.204 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' OD2' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -53.55 -22.47 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.616 . . . . 3.5800000000000001 111.067 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 48.5 m-20 -149.0 34.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.782 0.325 . . . . 2.48 111.151 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -43.94 148.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.389 -0.369 . . . . 0.56999999999999995 111.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 m -96.01 155.85 37.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 1.5 110.985 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 38.8 Cg_endo -66.91 -32.25 36.26 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.461 2.108 . . . . 0.60999999999999999 112.093 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.98 -44.97 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 110.433 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 26' ' ' LEU . 96.1 m-85 -85.49 -48.17 9.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 2.1699999999999999 110.325 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 25.6 tpt180 -56.98 -61.35 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 1.5700000000000001 111.022 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 0.8 OUTLIER -51.47 -34.83 37.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.081 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -60.82 -41.17 95.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.366 -0.379 . . . . 2.5899999999999999 111.29 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 22' ' ' TYR . 10.8 mp -74.22 -52.69 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 1.3 111.157 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -46.35 -37.1 7.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.94999999999999996 111.513 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -69.31 -23.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 1.6399999999999999 111.339 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.0 mt -96.87 -24.18 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.438 -0.347 . . . . 1.6399999999999999 111.055 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.75 7.44 53.35 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.68 -0.771 . . . . 0.81999999999999995 113.035 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 31' ' ' MET . 1.1 mpt? -89.97 90.67 8.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.891 0.377 . . . . 2.5499999999999998 110.736 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -94.69 160.55 31.15 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.788 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.5 Cg_exo -45.38 122.76 4.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.266 1.977 . . . . 0.51000000000000001 111.847 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.04 23.8 6.88 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.884 -0.674 . . . . 0.40000000000000002 112.071 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.8 t -87.73 174.05 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.62 110.892 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -123.58 144.97 49.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.009 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' HG22 ' A' ' 51' ' ' ILE . 20.7 p90 -158.98 -177.94 6.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.35999999999999999 110.891 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -131.8 132.5 43.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 2.9399999999999999 111.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 5' ' ' PRO . 7.1 p -78.31 135.62 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 1.28 111.025 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.87 -52.21 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.489 -0.323 . . . . 0.54000000000000004 111.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 20.9 ptp180 -153.84 139.03 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 2.7999999999999998 111.186 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.6 t -148.59 158.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 1.2 111.108 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -126.11 143.34 45.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.81000000000000005 111.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 45.2 Cg_endo -68.33 -21.41 41.25 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.647 2.231 . . . . 1.3400000000000001 112.468 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.8 mm? -89.88 -56.1 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 2.5099999999999998 111.111 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.12 107.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.77000000000000002 112.332 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.0 m-20 -148.17 170.66 7.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.637 0.256 . . . . 1.0700000000000001 111.07 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.72 118.12 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.985 2.456 . . . . 0.60999999999999999 111.77 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.8 p -106.79 160.78 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 0.39000000000000001 110.881 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.494 ' CE1' HG23 ' A' ' 59' ' ' VAL . 93.3 m-70 -123.47 135.74 54.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 1.1299999999999999 110.98 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 37' ' ' PHE . 37.1 pt -102.04 139.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.983 -0.553 . . . . 0.35999999999999999 110.855 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.68 108.88 19.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 2.1299999999999999 111.014 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 61.9 p -111.14 -175.3 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.64000000000000001 110.703 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.7 mmt180 -47.68 91.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.04 111.48 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 32.9 mmt180 53.01 36.06 21.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.046 -0.524 . . . . 4.1100000000000003 111.396 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 54' ' ' ARG . 85.9 t -150.87 112.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 1.23 111.052 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -105.07 107.57 18.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.64000000000000001 110.643 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.72 157.31 17.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.162 -0.472 . . . . 1.54 110.951 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.494 HG23 ' CE1' ' A' ' 50' ' ' HIS . 13.8 p -102.62 143.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.047 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 51' ' ' ILE . 96.5 mt -139.07 117.58 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.96999999999999997 110.777 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -92.48 169.78 10.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 3.3199999999999998 110.797 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -46.94 -27.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 4.7000000000000002 111.338 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -84.25 -42.43 15.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.38 . . . . 2.2799999999999998 111.17 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 -34.35 65.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 2.2999999999999998 110.973 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -81.27 -21.14 39.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.69999999999999996 111.134 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.63 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.66000000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.65 -65.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.47999999999999998 111.378 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.4 pt -65.08 140.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.482 -0.326 . . . . 0.42999999999999999 110.967 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.85 154.96 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 2.29 110.697 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -116.43 158.07 24.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 1.8500000000000001 110.774 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -146.24 154.39 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.2400000000000002 111.083 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.81 169.17 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.76000000000000001 111.122 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 m -98.99 -178.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 1.1599999999999999 110.998 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' CB ' ' OE1' ' A' ' 75' ' ' GLN . . . -133.97 -58.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 2.2799999999999998 111.176 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.424 ' OE1' ' CB ' ' A' ' 74' ' ' ALA . 5.0 pm0 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.359 -0.382 . . . . 5.1299999999999999 110.923 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.898 0.38 . . . . 5.1699999999999999 110.841 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -81.47 171.04 15.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.051 -0.522 . . . . 2.9399999999999999 110.731 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 61.9 m-85 -76.89 106.73 8.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.836 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -118.54 152.39 51.04 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.66000000000000003 111.209 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.07 84.46 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.663 2.242 . . . . 0.65000000000000002 112.34 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -179.97 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.293 -0.412 . . . . 2.6899999999999999 110.901 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 42.1 t -103.07 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 1.8899999999999999 110.629 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.93 169.22 8.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.46999999999999997 111.101 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 78.7 m95 -146.41 168.34 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.68999999999999995 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 54.9 mtpt -124.24 138.05 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 2.04 111.129 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.478 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.1 mt -80.2 118.14 27.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.159 -0.473 . . . . 0.56000000000000005 111.159 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 18.9 m -130.37 53.17 1.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.96999999999999997 110.388 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' HA3' ' NH2' ' A' ' 23' ' ' ARG . . . -48.83 96.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.45000000000000001 112.627 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -145.53 95.95 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.81000000000000005 110.935 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -111.88 158.03 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.013 -0.539 . . . . 0.76000000000000001 110.778 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -51.78 -24.36 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 3.5800000000000001 110.729 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -158.29 42.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.789 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -41.07 128.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.802 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.0 t -80.22 147.38 64.68 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 1.5 110.782 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.3 Cg_endo -62.62 -28.43 76.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.625 2.216 . . . . 0.60999999999999999 112.501 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.02 -43.79 50.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.70999999999999996 111.052 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -85.29 -45.49 11.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 2.1699999999999999 111.2 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' NH2' ' HA3' ' A' ' 13' ' ' GLY . 18.3 tpp180 -67.58 -61.46 1.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.5700000000000001 111.43 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 11.1 mm100 -55.93 -19.59 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 111.629 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -80.25 -36.77 34.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 2.5899999999999999 110.993 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.74 -32.6 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 1.3 110.982 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -57.24 -33.73 67.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.94999999999999996 111.254 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.1 m -64.04 -39.63 94.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 1.6399999999999999 110.997 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.6 mm? -78.01 -23.23 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 1.6399999999999999 111.059 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.79 20.52 10.63 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.771 . . . . 0.81999999999999995 112.593 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.402 ' C ' HD12 ' A' ' 32' ' ' LEU . 1.1 mpt? -98.72 98.24 9.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 2.5499999999999998 110.988 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -102.51 157.93 32.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.68999999999999995 110.675 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' NH1' ' A' ' 23' ' ' ARG . 71.2 Cg_exo -47.46 111.19 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.391 2.061 . . . . 0.51000000000000001 111.803 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 21.39 4.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 0.40000000000000002 112.36 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -88.02 166.26 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.303 . . . . 0.62 110.639 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 49.7 m -121.85 156.92 32.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 1.3 111.044 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 51.9 p90 -166.64 178.82 5.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.488 . . . . 0.35999999999999999 110.831 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -128.3 125.61 39.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 2.9399999999999999 111.098 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' SER . 18.9 m -75.17 134.59 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.263 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.64 -52.09 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.54000000000000004 111.34 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -148.66 133.71 18.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 2.7999999999999998 111.083 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 43' ' ' ALA . 41.4 t -146.0 160.39 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.396 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -154.83 124.4 3.18 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.512 . . . . 0.81000000000000005 110.737 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.05 -24.45 49.12 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.475 2.117 . . . . 1.3400000000000001 112.491 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -63.45 -22.87 67.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 2.5099999999999998 111.067 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.06 73.65 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.572 -0.823 . . . . 0.77000000000000002 112.11 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.1 m-20 -122.4 170.11 8.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.731 0.301 . . . . 1.0700000000000001 111.172 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.93 120.34 2.28 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.975 2.45 . . . . 0.60999999999999999 111.724 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.6 p -106.74 159.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.783 -0.644 . . . . 0.39000000000000001 111.123 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 80.8 m80 -123.32 123.53 40.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 1.1299999999999999 110.804 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 47.7 pt -97.16 141.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.35999999999999999 111.021 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -106.67 120.89 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.342 -0.39 . . . . 2.1299999999999999 110.828 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.549 ' OG1' HG13 ' A' ' 56' ' ' VAL . 27.1 p -122.63 -163.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.884 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -46.45 93.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.067 0.461 . . . . 3.04 111.732 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' THR . 25.7 mmm180 44.44 28.59 0.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.81 -0.632 . . . . 4.1100000000000003 112.121 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -152.55 113.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 1.23 110.838 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -93.84 118.9 32.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.64000000000000001 111.315 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 tp -99.54 150.23 22.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 1.54 110.653 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' HD23 ' A' ' 60' ' ' LEU . 11.4 p -104.83 134.32 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.394 . . . . 0.5 111.296 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB2' HD11 ' A' ' 65' ' ' LEU . 83.7 mt -143.33 155.62 44.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 110.721 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' NH2' ' HD3' ' A' ' 63' ' ' LYS . 70.4 mtm180 -110.63 160.4 16.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.88 0.371 . . . . 3.3199999999999998 110.898 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -44.05 -28.2 0.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 4.7000000000000002 111.585 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 21.8 ptmt -80.73 -35.53 33.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 2.2799999999999998 110.88 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 7.3 m-20 -68.62 -31.49 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 2.2999999999999998 111.134 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 65' ' ' LEU . 5.8 mp -86.42 -25.69 25.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.69999999999999996 111.266 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.63 -58.43 6.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.66000000000000003 111.468 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.93 -59.05 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.47999999999999998 111.188 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.22 151.96 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.411 . . . . 0.42999999999999999 111.47 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 12' ' ' THR . 9.1 tp10 -95.78 136.15 36.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.573 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.5 mm? -110.0 139.71 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 1.8500000000000001 110.991 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.81 118.01 19.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 2.2400000000000002 110.817 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.89 148.16 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.76000000000000001 111.073 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.0 -176.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 1.1599999999999999 111.136 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.19 116.89 8.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 2.2799999999999998 111.187 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 5.1299999999999999 110.882 179.841 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 tpp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.817 0.341 . . . . 5.1699999999999999 110.997 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -76.36 142.36 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 2.9399999999999999 111.046 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -98.44 92.44 5.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 2.25 110.601 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -88.41 154.66 51.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.66000000000000003 111.276 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.567 ' HA ' HG23 ' A' ' 39' ' ' VAL . 60.7 Cg_endo -72.85 92.89 0.78 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.507 2.138 . . . . 0.65000000000000002 112.354 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 176.29 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.535 . . . . 2.6899999999999999 110.702 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -104.41 146.4 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 1.8899999999999999 110.79 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.37 170.21 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.46999999999999997 111.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 35.2 m95 -155.41 160.4 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.68999999999999995 110.797 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -114.65 138.62 50.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 2.04 111.125 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 37' ' ' PHE . 57.3 mt -79.33 129.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.56000000000000005 111.191 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 62.8 p -134.72 58.73 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.96999999999999997 110.508 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.8 96.39 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.665 -0.698 . . . . 0.45000000000000001 112.696 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -147.16 98.55 3.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.81000000000000005 110.875 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.9 m -112.32 161.94 16.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.76000000000000001 110.829 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -22.44 34.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.314 -0.403 . . . . 3.5800000000000001 110.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -162.7 44.4 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 2.48 110.861 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -45.94 128.67 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.494 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -81.61 154.99 71.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 1.5 110.776 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.65 -28.19 69.2 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.615 2.21 . . . . 0.60999999999999999 112.241 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.34 -45.32 45.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.823 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 95.3 m-85 -85.46 -49.24 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 2.1699999999999999 110.503 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -57.74 -61.27 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.5700000000000001 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 27' ' ' LEU . 13.4 mm100 -51.02 -34.13 28.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 2.6899999999999999 110.731 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -51.75 -53.27 41.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 2.5899999999999999 110.949 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.03 -43.4 95.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 1.3 111.088 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 24' ' ' GLN . 84.0 mt -48.78 -26.51 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.94999999999999996 111.186 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.4 t -69.56 -34.03 73.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 1.6399999999999999 110.974 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -94.34 -24.53 17.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.6399999999999999 110.921 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.58 9.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.653 -0.784 . . . . 0.81999999999999995 112.55 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.9 mtt -99.32 91.47 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 111.018 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -92.32 158.02 39.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.561 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.87 118.72 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.481 2.121 . . . . 0.51000000000000001 112.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.11 31.02 3.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.825 -0.702 . . . . 0.40000000000000002 112.398 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.6 t -95.57 173.89 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.62 110.875 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -121.84 148.94 44.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.3 110.943 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 36.1 p90 -162.22 173.1 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.35999999999999999 110.732 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 47.9 m-70 -128.56 130.33 47.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.956 0.408 . . . . 2.9399999999999999 111.233 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 5' ' ' PRO . 19.4 m -80.01 138.38 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.28 110.994 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 48.1 t -99.62 -40.49 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.54000000000000004 111.426 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 38.8 ptt180 -164.67 129.36 2.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.377 -0.374 . . . . 2.7999999999999998 110.913 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG21 ' A' ' 49' ' ' VAL . 10.0 t -138.14 159.15 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 1.2 111.159 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -122.32 146.23 46.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.995 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.06 -14.85 26.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.573 2.182 . . . . 1.3400000000000001 112.592 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -93.6 -50.32 5.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 2.5099999999999998 111.078 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.25 95.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.873 -0.68 . . . . 0.77000000000000002 112.259 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.9 m-20 -136.52 170.2 11.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.791 0.329 . . . . 1.0700000000000001 111.151 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.98 116.6 1.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.01 2.473 . . . . 0.60999999999999999 111.694 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 152.34 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 110.923 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 91.8 m-70 -110.44 131.6 54.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 1.1299999999999999 110.517 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.489 HD11 HD23 ' A' ' 58' ' ' LEU . 30.9 pt -104.65 139.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.35999999999999999 111.227 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 39.3 tt0 -108.14 114.46 28.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.639 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.4 p -113.37 -173.82 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.64000000000000001 111.142 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -52.69 99.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 3.04 111.542 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 52.11 29.42 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 4.1100000000000003 111.651 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.1 t -149.4 128.48 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.23 111.16 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -109.92 107.78 17.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.64000000000000001 110.969 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 HD11 ' A' ' 51' ' ' ILE . 58.6 tp -105.0 156.71 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 1.54 111.235 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.99 132.86 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.182 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 65' ' ' LEU . 74.2 mt -118.18 140.32 49.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.96999999999999997 110.677 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 94.0 mtt180 -107.35 149.21 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 3.3199999999999998 110.959 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -27.93 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.976 -0.556 . . . . 4.7000000000000002 111.498 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -82.17 -29.94 31.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 2.2799999999999998 110.938 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 19.5 t70 -72.47 -30.18 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 2.2999999999999998 110.863 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -79.74 -29.7 40.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.69999999999999996 110.801 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.46 -23.7 10.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.66000000000000003 111.231 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 22' ' ' TYR . 67.7 mt -97.55 -63.75 1.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.438 . . . . 0.47999999999999998 111.146 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 44.6 pt -65.12 152.99 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.42999999999999999 111.081 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.2 tt0 -104.01 153.27 21.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.954 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -112.15 148.59 33.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 1.8500000000000001 110.591 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -131.19 128.67 40.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.331 . . . . 2.2400000000000002 110.853 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 156.27 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 111.288 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -61.81 178.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.079 -0.51 . . . . 1.1599999999999999 111.154 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.69 125.31 49.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 2.2799999999999998 111.28 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 5.1299999999999999 110.824 179.877 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mmm . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.755 0.312 . . . . 5.1699999999999999 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -77.78 -179.44 5.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 2.9399999999999999 110.974 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CE1' HD23 ' A' ' 70' ' ' LEU . 51.8 m-85 -112.66 112.16 23.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 2.25 110.723 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -113.33 155.21 44.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.66000000000000003 111.642 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.96 89.55 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.564 2.176 . . . . 0.65000000000000002 112.024 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -179.98 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 2.6899999999999999 110.631 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -94.07 143.98 25.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 1.8899999999999999 110.729 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.17 160.18 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.46999999999999997 111.157 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 23.3 m95 -149.37 164.1 35.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.68999999999999995 110.674 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -114.2 136.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 2.04 111.12 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.4 mt -78.19 134.42 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 0.56000000000000005 111.045 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 12' ' ' THR . 24.4 m -136.26 57.88 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.96999999999999997 110.614 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.3 87.42 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.45000000000000001 112.937 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.07 94.76 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.376 . . . . 0.81000000000000005 110.713 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.6 m -101.27 -174.93 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -26.67 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 3.5800000000000001 110.947 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.91 29.6 1.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.078 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 18' ' ' ILE . 10.2 tt -43.69 119.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.401 . . . . 0.56999999999999995 111.413 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 p -80.64 156.58 72.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.031 -0.532 . . . . 1.5 110.756 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.9 Cg_endo -58.33 -30.83 92.34 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.593 2.195 . . . . 0.60999999999999999 112.399 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.84 59.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.70999999999999996 110.758 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -85.75 -37.65 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 2.1699999999999999 111.118 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.09 -61.56 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 1.5700000000000001 111.121 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 20' ' ' PRO . 6.3 tp-100 -56.58 -20.59 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.6899999999999999 111.366 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -69.88 -50.43 42.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.842 0.353 . . . . 2.5899999999999999 110.677 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.16 -37.71 80.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 1.3 110.984 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.6 mt -54.24 -25.73 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.94999999999999996 111.317 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -52.42 -45.5 65.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.937 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.4 mm? -96.91 -22.67 16.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 1.6399999999999999 111.103 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.34 23.82 8.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.81999999999999995 112.255 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.446 ' HE3' ' HB2' ' A' ' 31' ' ' MET . 50.4 mtm -84.15 89.81 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 2.5499999999999998 111.149 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -97.39 158.49 33.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.68999999999999995 110.836 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.89 109.32 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.443 2.095 . . . . 0.51000000000000001 111.973 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.16 29.15 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.703 -0.761 . . . . 0.40000000000000002 112.439 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -96.65 174.19 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.62 110.614 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.2 p -121.49 143.59 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 1.3 110.93 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 6.8 p90 -156.81 -176.58 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.35999999999999999 110.946 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -140.09 134.81 31.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 2.9399999999999999 110.985 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 42' ' ' VAL . 59.0 t -64.81 136.48 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 1.28 111.081 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -94.26 -40.74 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.54000000000000004 111.221 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -175.57 124.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.038 0.447 . . . . 2.7999999999999998 111.17 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.619 HG23 ' CG1' ' A' ' 39' ' ' VAL . 21.2 t -137.42 157.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.59 . . . . 1.2 111.131 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -116.91 154.51 49.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.81000000000000005 110.988 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.76 -19.34 18.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.565 2.177 . . . . 1.3400000000000001 112.525 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.47 -67.46 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 2.5099999999999998 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.08 105.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.809 -0.71 . . . . 0.77000000000000002 112.365 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 6.2 m-20 -148.14 171.27 6.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.536 0.207 . . . . 1.0700000000000001 111.228 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.06 120.06 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.74 2.293 . . . . 0.60999999999999999 111.486 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.26 152.79 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.612 -0.722 . . . . 0.39000000000000001 111.013 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.5 m-70 -109.82 135.86 50.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.605 -0.725 . . . . 1.1299999999999999 110.398 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 60' ' ' LEU . 36.9 pt -93.82 145.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.35999999999999999 111.039 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -106.84 109.18 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 2.1299999999999999 110.71 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -114.94 -170.2 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 111.167 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 25.3 tpp180 -48.96 96.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.333 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 35.2 ptt180 45.71 33.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 4.1100000000000003 111.884 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -151.44 116.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 1.23 110.993 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.6 p -103.04 109.99 21.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.64000000000000001 110.907 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.62 170.92 9.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 1.54 111.04 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 7.6 p -114.76 140.92 33.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.07 -0.514 . . . . 0.5 111.206 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 65' ' ' LEU . 91.4 mt -135.39 120.94 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.362 -0.381 . . . . 0.96999999999999997 111.181 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.657 ' O ' HD13 ' A' ' 65' ' ' LEU . 33.6 mmt180 -65.83 -168.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.3199999999999998 110.551 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 2.6 mppt? -81.35 -36.7 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.435 -0.348 . . . . 4.7000000000000002 111.455 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -86.1 -33.27 20.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.2799999999999998 111.377 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.74 -24.54 2.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.2999999999999998 110.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.9 mp -85.35 -22.09 28.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.284 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.38 90.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.444 -0.344 . . . . 0.66000000000000003 111.637 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.1 -59.0 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.47999999999999998 111.127 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 pt -65.6 142.42 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.42999999999999999 111.203 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.06 148.69 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 2.29 110.873 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.9 tp -117.01 159.16 22.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 1.8500000000000001 111.052 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.36 147.65 43.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.34 166.85 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.76000000000000001 111.004 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -76.78 -176.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 1.1599999999999999 111.046 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.2 173.46 7.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.2799999999999998 111.033 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 5.1299999999999999 110.946 179.966 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.588 0.232 . . . . 5.1699999999999999 111.542 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -171.54 126.29 0.62 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.761 0.315 . . . . 2.9399999999999999 110.616 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -121.24 105.7 10.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 2.25 111.066 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -104.74 155.94 36.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.66000000000000003 111.072 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.51 90.83 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.51 2.14 . . . . 0.65000000000000002 112.361 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 p30 176.89 -37.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 2.6899999999999999 110.892 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.0 m -100.96 153.52 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 1.8899999999999999 110.967 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.52 158.5 15.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.46999999999999997 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 45.2 m95 -139.64 178.05 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.68999999999999995 110.756 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -125.17 138.1 54.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 2.04 111.279 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 49.9 mt -75.64 125.81 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.56000000000000005 110.704 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 12' ' ' THR . 9.8 m -139.78 46.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.175 0.512 . . . . 0.96999999999999997 110.837 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.7 86.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.845 -0.693 . . . . 0.45000000000000001 112.598 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' THR . 92.0 t80 -143.14 94.89 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.81000000000000005 110.688 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -97.32 -175.15 3.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.76000000000000001 111.032 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -85.49 -28.77 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 3.5800000000000001 110.788 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -141.03 30.25 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 2.48 110.9 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -41.94 148.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 111.656 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.0 m -107.31 156.54 37.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.122 -0.49 . . . . 1.5 110.87 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 32.9 Cg_endo -63.97 -28.6 66.56 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.216 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -47.08 -46.89 22.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.70999999999999996 110.863 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CD2' ' OD2' ' A' ' 64' ' ' ASP . 75.6 m-85 -86.57 -46.17 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 2.1699999999999999 110.561 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.5 tpt180 -56.4 -58.05 9.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 1.5700000000000001 111.289 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -43.94 -28.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 2.6899999999999999 111.703 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 30.9 mmmt -65.81 -41.08 92.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 2.5899999999999999 111.004 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.7 mm? -72.34 -54.98 7.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.157 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 mt -50.67 -29.1 10.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.94999999999999996 111.162 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.7 m -77.48 -28.89 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 1.6399999999999999 111.099 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -25.4 18.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.6399999999999999 111.205 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.69 23.93 19.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.654 -0.784 . . . . 0.81999999999999995 112.892 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.18 90.48 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 2.5499999999999998 110.623 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -84.47 160.81 55.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.703 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 85.7 Cg_exo -44.85 120.3 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.305 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.52 22.1 5.23 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.873 -0.68 . . . . 0.40000000000000002 112.489 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.8 t -93.56 174.17 7.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.62 110.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -117.25 158.8 23.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 1.3 111.13 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 28.0 p90 -168.43 168.41 11.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.35999999999999999 110.626 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -120.53 152.34 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 2.9399999999999999 110.998 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' CG1' HG23 ' A' ' 42' ' ' VAL . 46.0 t -87.75 136.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 1.28 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.5 -40.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.54000000000000004 111.429 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -169.69 125.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.38 . . . . 2.7999999999999998 110.886 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG23 ' CG1' ' A' ' 39' ' ' VAL . 60.7 t -137.38 158.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.296 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.506 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -145.48 109.78 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.81000000000000005 111.059 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -43.32 -34.1 4.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 1.3400000000000001 112.745 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.18 -26.59 28.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 2.5099999999999998 111.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.2 90.09 1.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.77000000000000002 112.044 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.6 m-20 -143.87 172.01 6.1 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.647 0.26 . . . . 1.0700000000000001 111.04 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.31 121.77 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.769 2.313 . . . . 0.60999999999999999 111.687 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.4 p -106.43 158.96 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.665 -0.698 . . . . 0.39000000000000001 111.007 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 5.3 m80 -114.83 131.41 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.673 . . . . 1.1299999999999999 110.605 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -101.84 141.91 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 110.987 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.02 108.41 19.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.071 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -108.17 -169.59 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.948 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -55.46 96.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 3.04 111.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 52.39 30.55 8.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 4.1100000000000003 111.723 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -151.4 112.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.965 0.412 . . . . 1.23 111.388 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -97.15 109.95 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.637 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 74.6 mt -99.79 163.35 12.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.154 -0.475 . . . . 1.54 111.245 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 12.0 p -121.76 137.96 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.5 110.871 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD13 ' CD1' ' A' ' 68' ' ' ILE . 86.2 mt -127.53 136.27 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.96999999999999997 110.954 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . 99.4 mtt180 -85.83 150.83 24.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 3.3199999999999998 110.915 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -45.64 -30.26 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 4.7000000000000002 111.454 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -83.17 -39.24 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 2.2799999999999998 111.191 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' CD2' ' A' ' 22' ' ' TYR . 9.0 t70 -57.96 -29.56 65.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 2.2999999999999998 111.046 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.1 mp -76.26 -20.25 57.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.69999999999999996 111.281 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.24 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.557 -0.292 . . . . 0.66000000000000003 111.441 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.99 -54.32 3.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.747 0.308 . . . . 0.47999999999999998 111.295 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' CD1' HD13 ' A' ' 60' ' ' LEU . 36.2 pt -65.61 152.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.42999999999999999 111.035 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 7.6 tp10 -105.02 149.29 25.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 2.29 111.014 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -130.51 139.51 50.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.8500000000000001 110.96 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -116.3 129.97 56.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 2.2400000000000002 110.792 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.57 20.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.76000000000000001 111.047 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.85 175.99 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 1.1599999999999999 111.372 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 -177.83 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 2.2799999999999998 111.026 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 5.1299999999999999 110.843 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.854 0.359 . . . . 5.1699999999999999 111.042 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -52.15 150.19 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 2.9399999999999999 111.147 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -141.36 104.03 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 2.25 110.745 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 46.2 p -86.08 156.22 57.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.66000000000000003 111.259 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 73.2 Cg_endo -74.27 90.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.637 2.224 . . . . 0.65000000000000002 112.284 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 178.32 -42.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 110.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.3 m -92.17 141.84 28.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 110.929 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.98 164.17 25.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.46999999999999997 111.089 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 42.5 m95 -147.84 169.53 19.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.68999999999999995 110.645 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' SER . 57.8 mttp -114.87 137.03 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 2.04 111.099 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 42.1 mt -78.34 122.92 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 110.955 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 12' ' ' THR . 32.1 m -136.16 51.45 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.96999999999999997 110.806 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.42 96.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.957 -0.639 . . . . 0.45000000000000001 112.638 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -147.29 94.98 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.81000000000000005 110.813 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 25.6 t -105.29 -172.42 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.76000000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -21.89 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.009 -0.542 . . . . 3.5800000000000001 111.188 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -156.5 33.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.455 -0.339 . . . . 2.48 111.159 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 5.6 tt -46.89 122.61 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.56999999999999995 111.281 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.3 p -76.79 155.58 83.05 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 1.5 110.826 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.77 -29.87 77.41 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.616 2.211 . . . . 0.60999999999999999 112.488 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.22 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.011 0.434 . . . . 0.70999999999999996 110.41 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -85.75 -28.93 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 111.02 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NH1' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -76.04 -61.73 1.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 1.5700000000000001 111.029 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -53.4 -27.64 25.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.347 -0.388 . . . . 2.6899999999999999 110.947 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -50.67 -32.1 18.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 2.5899999999999999 111.153 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.9 mp -84.02 -42.31 16.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 1.3 111.251 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' NH1' ' A' ' 23' ' ' ARG . 73.2 mt -49.03 -25.81 2.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.94999999999999996 111.238 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 29' ' ' LEU . 73.7 p -65.6 -37.54 86.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 1.6399999999999999 110.935 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -91.07 -24.04 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 1.6399999999999999 110.898 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.9 16.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.652 -0.785 . . . . 0.81999999999999995 112.467 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 51.9 mtm -98.43 99.33 10.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 2.5499999999999998 110.795 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.7 mp -95.48 160.94 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.68999999999999995 110.816 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 80.2 Cg_exo -41.11 114.03 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.601 2.201 . . . . 0.51000000000000001 112.282 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.17 33.02 1.56 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.40000000000000002 112.174 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 39.8 t -100.58 174.78 5.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.612 0.244 . . . . 0.62 110.807 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.7 t -120.18 154.7 34.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 1.3 110.876 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.8 p90 -167.62 177.26 5.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.35999999999999999 110.751 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -128.82 155.18 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 2.9399999999999999 111.033 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 42' ' ' VAL . 66.1 t -92.78 134.88 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 1.28 110.906 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.21 -51.44 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.54000000000000004 111.461 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 16.9 ptm180 -155.49 123.79 5.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 2.7999999999999998 111.263 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 49' ' ' VAL . 46.6 t -135.69 158.79 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 1.2 111.025 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.498 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -124.87 152.89 70.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.81000000000000005 111.09 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.25 -30.78 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.8 2.334 . . . . 1.3400000000000001 112.856 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.11 -26.69 39.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 2.5099999999999998 111.129 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 104.13 1.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.723 -0.751 . . . . 0.77000000000000002 112.167 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.3 m-20 -147.86 170.67 7.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.07 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.5 120.71 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.928 2.419 . . . . 0.60999999999999999 111.69 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.96 159.12 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.82 -0.627 . . . . 0.39000000000000001 111.264 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 59' ' ' VAL . 53.2 m-70 -114.35 137.03 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 1.1299999999999999 110.448 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -102.11 141.18 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.35999999999999999 111.63 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.61 107.75 18.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.942 -0.572 . . . . 2.1299999999999999 110.507 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.3 p -113.96 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.64000000000000001 111.094 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.7 mmt180 -49.61 102.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 3.04 111.428 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 29.4 ptt180 44.81 37.01 2.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 4.1100000000000003 112.056 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 54' ' ' ARG . 99.1 t -151.52 126.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 1.23 111.118 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.6 t -109.98 107.73 17.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.64000000000000001 110.666 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 77.9 mt -106.95 156.8 18.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 1.54 111.233 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 8.0 p -112.96 134.71 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.5 110.992 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CB ' HD11 ' A' ' 65' ' ' LEU . 70.5 mt -122.31 134.22 54.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.96999999999999997 110.757 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -97.35 160.68 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.3199999999999998 110.848 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -51.48 -23.52 4.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 4.7000000000000002 110.965 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -85.08 -27.88 26.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 2.2799999999999998 110.815 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.25 -32.75 61.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 2.2999999999999998 110.823 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.7 mp -79.44 -21.69 45.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.69999999999999996 111.075 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.18 62.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.66000000000000003 111.589 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.55 -58.94 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.75 0.31 . . . . 0.47999999999999998 111.353 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.4 pt -65.94 158.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.42999999999999999 111.345 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.4 tp10 -111.53 141.74 44.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.29 110.695 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -117.16 142.27 47.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 1.8500000000000001 111.086 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -128.02 122.94 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 2.2400000000000002 110.718 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.27 175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.76000000000000001 111.327 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.61 -176.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.1599999999999999 111.129 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.96 114.77 1.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 2.2799999999999998 111.088 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 5.1299999999999999 110.804 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.727 0.299 . . . . 5.1699999999999999 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -175.38 -175.2 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 2.9399999999999999 110.804 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m-85 -101.9 117.74 35.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 2.25 110.897 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -112.27 153.86 44.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.66000000000000003 111.203 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . 59.2 Cg_endo -71.74 89.38 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.56 2.173 . . . . 0.65000000000000002 112.437 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t70 176.69 -37.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 2.6899999999999999 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -101.42 144.34 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 1.8899999999999999 110.934 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.16 167.16 21.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.46999999999999997 110.955 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.6 m95 -151.74 174.78 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.95 0.405 . . . . 0.68999999999999995 111.198 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -127.23 135.42 50.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 2.04 110.988 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 64.0 mt -72.92 133.17 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.56000000000000005 111.13 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 12' ' ' THR . 13.9 m -137.45 48.95 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.456 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.8 89.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.856 -0.688 . . . . 0.45000000000000001 112.658 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -147.09 95.42 2.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.81000000000000005 110.866 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -102.14 160.4 14.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.943 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -17.75 62.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 3.5800000000000001 111.232 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -154.06 34.0 0.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.59 0.233 . . . . 2.48 111.415 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 tt -47.36 128.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.598 -0.274 . . . . 0.56999999999999995 111.281 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.9 p -87.76 156.55 52.75 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 1.5 110.84 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -65.44 -28.92 53.93 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.462 2.108 . . . . 0.60999999999999999 112.482 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.05 -48.35 22.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.70999999999999996 110.772 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 52.5 t80 -86.62 -46.08 10.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 2.1699999999999999 110.787 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 18.2 tpt180 -56.05 -56.19 23.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 1.5700000000000001 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -45.73 -34.2 3.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 2.6899999999999999 111.371 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.73 -27.88 67.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 2.5899999999999999 111.106 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.81 -55.12 5.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.3 110.912 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -48.2 -30.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.94999999999999996 111.187 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -75.97 -32.04 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.6399999999999999 111.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CD1' HD22 ' A' ' 58' ' ' LEU . 80.0 mt -90.1 -23.09 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.6399999999999999 111.032 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.72 10.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.81999999999999995 112.358 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.401 ' C ' HD12 ' A' ' 32' ' ' LEU . 65.1 mtt -109.01 91.51 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 2.5499999999999998 110.874 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -104.65 160.24 26.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.68999999999999995 110.83 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 71.1 Cg_exo -46.82 115.26 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.427 2.084 . . . . 0.51000000000000001 112.094 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.9 19.22 8.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.806 -0.712 . . . . 0.40000000000000002 112.612 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 43.7 t -92.94 172.36 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.62 110.787 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.0 m -116.39 153.56 31.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 1.3 111.182 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.3 p90 -164.76 163.02 21.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.35999999999999999 110.52 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -115.72 117.48 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 2.9399999999999999 111.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.66 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.086 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.91 -47.74 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.393 -0.367 . . . . 0.54000000000000004 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 36.9 ptt180 -162.16 138.01 7.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.915 0.388 . . . . 2.7999999999999998 111.228 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' ALA . 19.5 t -145.78 159.31 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.2 111.078 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -121.54 155.86 58.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.81000000000000005 111.123 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.42 -26.99 8.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 1.3400000000000001 112.685 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.9 -52.52 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 2.5099999999999998 111.02 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.98 111.92 0.3 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.734 -0.746 . . . . 0.77000000000000002 112.417 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.1 m-20 -148.16 172.74 4.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.639 0.257 . . . . 1.0700000000000001 111.09 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.9 Cg_endo -84.35 117.24 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.961 2.441 . . . . 0.60999999999999999 111.654 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.4 p -106.79 154.12 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.39000000000000001 111.068 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -119.68 142.2 48.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.606 . . . . 1.1299999999999999 110.805 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 37' ' ' PHE . 38.6 pt -114.72 136.55 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.35999999999999999 111.371 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.08 115.98 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 2.1299999999999999 110.426 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.471 ' OG1' HG13 ' A' ' 56' ' ' VAL . 37.5 p -130.25 -167.76 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.64000000000000001 111.273 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HG12 ' A' ' 56' ' ' VAL . 40.0 mmt180 -41.4 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.973 0.416 . . . . 3.04 112.018 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' THR . 79.8 mtm180 41.37 53.15 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 4.1100000000000003 111.923 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.1 p -171.89 116.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.23 111.449 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -104.65 108.11 19.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 0.64000000000000001 110.515 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' A' ' 29' ' ' LEU . 48.4 tp -100.16 158.44 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 1.54 110.98 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 60' ' ' LEU . 13.3 p -106.82 153.33 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.5 111.118 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 59' ' ' VAL . 97.1 mt -144.81 119.45 9.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.96999999999999997 111.023 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -77.51 -173.11 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 3.3199999999999998 110.91 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -75.1 -28.14 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 4.7000000000000002 111.153 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.44 -35.33 25.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.348 -0.387 . . . . 2.2799999999999998 111.036 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.86 -30.93 71.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 2.2999999999999998 110.754 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 68' ' ' ILE . 26.7 mt -76.5 -24.77 53.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.69999999999999996 111.035 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.06 71.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.66000000000000003 111.341 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.81 -58.16 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.47999999999999998 111.361 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.514 ' CG2' ' CE1' ' A' ' 22' ' ' TYR . 31.3 pt -65.52 149.66 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.42999999999999999 111.256 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' C ' HD22 ' A' ' 70' ' ' LEU . 6.3 tp10 -109.77 151.56 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 2.29 110.635 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -118.91 148.1 43.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 110.675 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.34 145.19 43.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 2.2400000000000002 110.852 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.4 172.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.76000000000000001 110.953 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.6 m -97.03 167.14 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 1.1599999999999999 111.233 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.42 95.62 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 2.2799999999999998 110.878 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 5.1299999999999999 110.939 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.756 0.312 . . . . 5.1699999999999999 110.993 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -104.76 134.37 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 2.9399999999999999 111.047 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -85.91 108.23 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 2.25 110.898 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -114.17 154.19 46.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.66000000000000003 111.204 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.29 89.73 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.531 2.154 . . . . 0.65000000000000002 112.432 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 178.24 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 2.6899999999999999 110.918 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.2 m -106.25 170.21 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.56 169.33 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.46999999999999997 111.044 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CA ' HG13 ' A' ' 73' ' ' VAL . 52.1 m95 -151.1 162.08 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.68999999999999995 110.583 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 5.8 ptpp? -107.61 137.85 44.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 2.04 110.987 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.8 mt -83.1 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.56000000000000005 111.235 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' GLU . 23.6 m -135.92 56.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.96999999999999997 110.286 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.45 96.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.701 -0.682 . . . . 0.45000000000000001 112.745 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -147.14 97.38 2.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.341 . . . . 0.81000000000000005 110.708 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.1 m -108.61 -174.34 2.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.76000000000000001 110.977 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.3 mpt_? -74.78 -27.26 60.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 3.5800000000000001 110.881 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.91 42.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.48 110.81 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 18' ' ' ILE . 5.7 tt -45.7 109.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.277 -0.42 . . . . 0.56999999999999995 111.172 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.0 p -59.63 155.8 37.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 1.5 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 21.8 Cg_endo -61.07 -30.47 89.41 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.60999999999999999 112.101 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.63 -46.25 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.414 . . . . 0.70999999999999996 110.897 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.98 -35.3 20.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.51 . . . . 2.1699999999999999 111.148 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.1 tpt180 -70.94 -61.04 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.524 . . . . 1.5700000000000001 111.612 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -42.75 -34.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.506 -0.316 . . . . 2.6899999999999999 111.839 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.29 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 2.5899999999999999 111.103 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.21 -53.63 55.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 1.3 111.075 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -48.85 -46.23 41.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 0.94999999999999996 111.203 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -55.59 -49.25 73.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 1.6399999999999999 111.05 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 58' ' ' LEU . 73.5 mt -71.75 -25.17 61.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 1.6399999999999999 110.885 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 19.54 27.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 0.81999999999999995 112.774 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.4 mtt -95.03 87.05 4.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.726 0.298 . . . . 2.5499999999999998 110.792 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.7 mp -92.2 159.65 36.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.68999999999999995 110.499 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.96 132.22 17.43 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.298 1.999 . . . . 0.51000000000000001 111.757 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.37 38.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.75 -0.738 . . . . 0.40000000000000002 112.267 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -82.22 174.24 11.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.685 0.278 . . . . 0.62 110.582 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.4 p -125.89 137.83 53.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 1.3 110.733 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 9.6 p90 -150.53 157.64 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 111.003 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -108.51 146.87 32.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.9399999999999999 110.855 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.0 t -84.93 128.32 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 1.28 111.144 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.93 -47.54 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.54000000000000004 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -168.28 129.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 2.7999999999999998 110.814 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG22 ' HB ' ' A' ' 49' ' ' VAL . 39.5 t -141.56 156.56 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.368 . . . . 1.2 111.339 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.88 141.65 41.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.81000000000000005 110.825 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.97 -21.23 37.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.497 2.131 . . . . 1.3400000000000001 112.658 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 mt -85.74 -48.95 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 2.5099999999999998 110.882 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.65 105.61 0.37 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.762 -0.732 . . . . 0.77000000000000002 112.497 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.9 m-20 -148.11 171.06 6.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 110.804 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.48 118.75 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.878 2.385 . . . . 0.60999999999999999 111.788 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.65 161.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 0.39000000000000001 111.123 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.458 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 82.1 m-70 -125.07 148.37 48.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 1.1299999999999999 110.467 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.3 pt -115.56 138.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.35999999999999999 111.446 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.95 112.97 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 2.1299999999999999 110.612 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.533 ' OG1' HG13 ' A' ' 56' ' ' VAL . 41.7 p -126.7 -175.98 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.387 . . . . 0.64000000000000001 111.343 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -41.59 95.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.964 -0.562 . . . . 3.04 112.101 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 43.28 54.79 4.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 4.1100000000000003 112.089 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.4 p -175.78 113.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 1.23 111.29 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -100.49 112.18 24.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 0.64000000000000001 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 29' ' ' LEU . 38.0 tp -105.73 148.58 27.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.797 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.56 140.71 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.315 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' HD11 ' A' ' 65' ' ' LEU . 95.8 mt -140.44 166.12 25.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.96999999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 80.7 mtp180 -130.3 152.82 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 3.3199999999999998 110.896 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.4 tpmt? -50.49 -24.81 3.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.969 -0.56 . . . . 4.7000000000000002 111.523 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.37 -28.67 34.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.894 0.378 . . . . 2.2799999999999998 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.28 -33.08 29.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 2.2999999999999998 111.068 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.8 mp -71.43 -20.7 62.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.69999999999999996 111.267 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.15 84.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.505 -0.316 . . . . 0.66000000000000003 111.468 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.31 -56.59 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.47999999999999998 111.257 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 65' ' ' LEU . 28.7 pt -66.96 151.91 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.42999999999999999 111.102 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 70' ' ' LEU . 33.0 tt0 -100.49 128.96 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.29 110.59 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 69' ' ' GLU . 5.3 mp -118.45 136.14 53.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 1.8500000000000001 111.077 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 38.4 tt0 -130.23 156.53 44.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 2.2400000000000002 110.755 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 133.43 51.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.113 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 9' ' ' TRP . 32.7 m -60.25 167.66 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 111.208 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.08 134.48 50.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 2.2799999999999998 110.98 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 5.1299999999999999 110.816 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.72 0.295 . . . . 2.25 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -108.92 150.05 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.66000000000000003 111.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 85.57 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.562 2.175 . . . . 0.65000000000000002 112.357 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.6 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 2.6899999999999999 110.867 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -84.84 164.27 18.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 1.8899999999999999 110.986 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.7 165.45 11.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.46999999999999997 111.241 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 61.1 m95 -155.07 174.55 15.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.68999999999999995 110.832 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -127.6 134.34 49.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 2.04 111.05 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.451 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.1 mt -74.52 126.09 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.56000000000000005 111.346 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -139.74 48.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.96999999999999997 110.572 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.72 91.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.866 -0.683 . . . . 0.45000000000000001 112.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -147.23 96.97 2.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.64 0.257 . . . . 0.81000000000000005 110.786 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -105.79 -175.79 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.76000000000000001 110.803 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.2 mpt_? -86.31 -21.67 27.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 3.5800000000000001 111.047 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -147.44 28.19 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.463 -0.335 . . . . 2.48 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 18' ' ' ILE . 14.6 tt -46.17 122.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 0.56999999999999995 111.369 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -72.82 155.43 90.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 1.5 110.929 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 24' ' ' GLN . 37.9 Cg_endo -66.42 -27.71 46.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.503 2.136 . . . . 0.60999999999999999 112.268 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.64 -45.15 57.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.70999999999999996 110.83 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -85.78 -37.27 19.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 2.1699999999999999 111.129 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -70.58 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 1.5700000000000001 111.359 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' PRO . 51.8 tt0 -57.88 -18.64 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 2.6899999999999999 111.537 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -75.32 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 2.5899999999999999 111.149 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -50.0 -30.88 11.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.033 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.0 mt -51.57 -34.04 35.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.94999999999999996 111.013 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.4 p -62.88 -29.47 70.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.6399999999999999 111.092 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.33 -24.43 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 1.6399999999999999 111.012 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.92 20.63 59.11 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.81999999999999995 112.465 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.31 91.57 4.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 2.5499999999999998 110.846 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -88.26 160.6 45.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 110.79 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 87.7 Cg_exo -42.37 112.78 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.525 2.15 . . . . 0.51000000000000001 112.417 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 30.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 0.40000000000000002 112.454 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.8 t -102.1 174.1 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.62 110.878 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -119.06 138.95 52.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.467 . . . . 1.3 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.451 ' CD1' HG13 ' A' ' 11' ' ' ILE . 23.7 p90 -153.37 159.89 42.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.35999999999999999 111.018 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 73.3 m80 -114.41 160.76 18.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.426 . . . . 2.9399999999999999 110.82 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.8 t -98.37 134.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 1.28 111.222 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.5 t -94.98 -49.53 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.54000000000000004 111.08 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.77 138.44 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 2.7999999999999998 110.832 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG22 ' CG2' ' A' ' 49' ' ' VAL . 19.7 t -146.16 157.97 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 1.2 111.388 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.58 147.37 52.82 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.81000000000000005 111.065 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.11 -20.47 19.07 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 1.3400000000000001 112.663 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.84 -46.41 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.387 -0.37 . . . . 2.5099999999999998 111.059 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.33 100.3 0.2 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 0.77000000000000002 112.306 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.2 m-20 -139.38 170.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 1.0700000000000001 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.81 117.19 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.942 2.428 . . . . 0.60999999999999999 111.647 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 157.17 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.823 -0.626 . . . . 0.39000000000000001 110.874 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.5 m-70 -121.04 136.45 54.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 1.1299999999999999 110.72 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 58' ' ' LEU . 31.8 pt -102.08 143.84 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.35999999999999999 111.136 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' HIS . 7.7 mm-40 -106.77 110.58 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 2.1299999999999999 110.755 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -112.08 -174.33 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.64000000000000001 111.063 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -52.43 94.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 3.04 111.479 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 53.23 38.19 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 4.1100000000000003 111.691 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -155.44 132.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.713 0.292 . . . . 1.23 111.093 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -112.21 107.83 16.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.64000000000000001 111.148 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 50.4 tp -101.54 154.07 19.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 1.54 110.55 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.52 139.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 0.5 111.183 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.39 166.18 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.96999999999999997 110.756 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HD3' ' NZ ' ' A' ' 63' ' ' LYS . 95.5 mtt180 -124.63 136.43 53.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.79 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.0 tpmt? -45.96 -29.36 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 4.7000000000000002 111.253 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' NZ ' ' HD3' ' A' ' 61' ' ' ARG . 21.3 pttm -84.41 -31.61 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.937 0.399 . . . . 2.2799999999999998 110.393 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ARG . 18.5 t70 -69.49 -35.95 76.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 2.2999999999999998 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -63.0 -23.58 67.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.69999999999999996 110.989 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.17 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.38 . . . . 0.66000000000000003 111.28 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -83.47 -61.03 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.47999999999999998 111.202 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 pt -65.32 144.52 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.42999999999999999 111.183 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.26 154.44 18.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.847 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.46 148.98 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.8500000000000001 111.05 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -134.43 115.31 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 2.2400000000000002 110.738 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.39 53.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.76000000000000001 111.092 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.1599999999999999 111.234 179.806 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 70' ' ' LEU . 83.1 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.84 0.352 . . . . 2.25 110.802 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -112.03 154.85 44.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.66000000000000003 111.173 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.362 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 177.77 -43.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 110.794 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.54 149.31 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.8899999999999999 110.788 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.79 146.83 23.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.445 . . . . 0.46999999999999997 111.18 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 38.8 m95 -133.64 174.06 10.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.68999999999999995 110.671 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -122.1 138.23 54.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.351 -0.386 . . . . 2.04 111.093 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CD1' ' CE ' ' A' ' 31' ' ' MET . 53.5 mt -77.31 138.9 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.56000000000000005 111.14 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 17.7 m -142.48 50.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 110.434 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 91.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.773 -0.648 . . . . 0.45000000000000001 112.9 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 47.3 t80 -147.25 99.22 3.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.81000000000000005 110.693 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -101.84 -172.66 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.409 . . . . 0.76000000000000001 111.075 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.0 mpt_? -77.89 -29.85 50.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 3.5800000000000001 110.911 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.22 40.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 2.48 110.981 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.21 130.73 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.56999999999999995 111.401 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.3 m -80.64 156.73 72.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 1.5 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 18.1 Cg_endo -58.39 -33.03 97.47 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.516 2.144 . . . . 0.60999999999999999 112.166 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.92 -43.52 59.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.70999999999999996 110.326 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -85.67 -43.46 13.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 2.1699999999999999 110.514 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.4 tpt180 -62.56 -61.67 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.5700000000000001 111.041 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' PRO . 89.8 mt-30 -52.2 -32.21 35.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.453 -0.339 . . . . 2.6899999999999999 110.833 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -51.04 -40.68 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 2.5899999999999999 111.021 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.4 mm? -84.5 -38.7 19.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 1.3 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.87 -33.45 23.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.94999999999999996 110.99 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -63.12 -50.73 69.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 1.6399999999999999 110.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.37 -23.82 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 1.6399999999999999 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.06 18.94 25.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 0.81999999999999995 112.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.488 ' CE ' ' CD1' ' A' ' 11' ' ' ILE . 65.4 mtp -91.43 94.77 9.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 2.5499999999999998 110.923 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -103.12 159.7 28.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.857 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.72 111.9 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.569 2.18 . . . . 0.51000000000000001 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.11 25.64 3.49 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.919 -0.657 . . . . 0.40000000000000002 112.302 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.2 t -93.51 163.47 13.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.62 110.709 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -111.01 142.8 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.929 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 11' ' ' ILE . 24.1 p90 -155.1 162.72 40.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.35999999999999999 110.844 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -114.55 148.04 38.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 2.9399999999999999 111.002 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 t -86.88 113.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 1.28 110.868 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.9 t -78.81 -52.38 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.54000000000000004 111.398 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -169.25 121.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 2.7999999999999998 111.107 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -140.32 158.08 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.944 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -113.94 140.32 24.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.81000000000000005 111.407 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.15 -26.81 83.1 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.554 2.169 . . . . 1.3400000000000001 112.351 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -80.41 -65.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 2.5099999999999998 110.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 169.27 100.76 0.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.712 -0.756 . . . . 0.77000000000000002 112.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.3 m-20 -144.48 171.24 6.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.609 0.242 . . . . 1.0700000000000001 111.025 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.63 113.64 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.955 2.437 . . . . 0.60999999999999999 111.677 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.77 140.69 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 111.173 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 44.5 m-70 -99.67 137.63 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.905 -0.589 . . . . 1.1299999999999999 110.611 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -108.67 140.65 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.35999999999999999 111.198 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.29 109.47 21.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 2.1299999999999999 110.81 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.1 p -107.37 -172.85 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.64000000000000001 111.087 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -50.93 96.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.04 111.405 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 52.53 26.24 4.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 4.1100000000000003 111.696 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -146.75 120.68 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.4 . . . . 1.23 111.117 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -104.22 107.93 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.64000000000000001 110.912 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -103.37 160.28 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 1.54 110.669 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.64 138.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.369 . . . . 0.5 111.132 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.15 155.41 50.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.96999999999999997 110.874 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 64' ' ' ASP . 75.2 mtp180 -122.12 155.62 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 3.3199999999999998 111.058 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 5.6 mmpt? -44.2 -28.93 0.56 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.078 -0.51 . . . . 4.7000000000000002 111.486 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 pttt -76.43 -36.09 58.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.281 -0.418 . . . . 2.2799999999999998 110.874 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' ARG . 13.2 m-20 -74.41 -34.47 63.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.825 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.1 mp -74.58 -26.57 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.69999999999999996 110.937 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.24 -25.33 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.66000000000000003 111.163 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.6 -58.47 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.47999999999999998 111.124 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.0 pt -67.64 154.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.42999999999999999 110.904 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 8.3 tp10 -102.88 155.74 18.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 2.29 110.974 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 92.1 mt -128.84 165.66 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.082 -0.508 . . . . 1.8500000000000001 110.753 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.51 149.08 30.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 2.2400000000000002 111.023 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -174.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 110.903 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 1.1599999999999999 111.023 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.783 0.325 . . . . 2.25 110.957 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -116.23 156.26 47.3 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.66000000000000003 111.381 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.81 141.61 27.77 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.724 2.283 . . . . 0.65000000000000002 112.396 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.24 21.02 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 2.6899999999999999 111.518 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.6 p -88.17 159.79 18.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.8899999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.19 135.44 53.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.46999999999999997 111.06 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 54.1 m95 -151.42 157.22 42.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.68999999999999995 110.572 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' SER . 62.7 mttp -99.52 135.09 41.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 2.04 110.745 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.496 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.9 mt -77.3 132.39 32.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.039 -0.528 . . . . 0.56000000000000005 111.328 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.2 m -139.51 44.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.009 -0.541 . . . . 0.96999999999999997 110.391 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.21 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.917 -0.659 . . . . 0.45000000000000001 112.581 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 89.9 t80 -147.7 94.89 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.81000000000000005 110.828 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m -100.39 161.86 13.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.857 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -58.77 -19.15 38.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.5800000000000001 111.369 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -165.55 42.26 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 2.48 111.401 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.45 139.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.347 -0.388 . . . . 0.56999999999999995 111.325 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -88.41 156.37 50.98 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 1.5 110.895 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.45 -30.39 90.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.621 2.214 . . . . 0.60999999999999999 112.347 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.71 -46.61 50.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.078 0.466 . . . . 0.70999999999999996 110.665 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -86.45 -43.4 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 2.1699999999999999 110.806 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -62.09 -58.84 6.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 1.5700000000000001 111.38 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.06 -48.19 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.499 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 28' ' ' SER . 61.1 mttp -51.16 -47.77 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.404 -0.362 . . . . 2.5899999999999999 111.152 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.95 -57.13 12.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 1.3 111.025 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.7 mt -48.86 -26.48 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.94999999999999996 111.176 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 38.5 t -66.09 -37.05 84.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 1.6399999999999999 111.087 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.59 -25.26 38.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.376 -0.375 . . . . 1.6399999999999999 111.073 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.15 7.67 55.95 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.716 -0.754 . . . . 0.81999999999999995 113.04 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -91.97 103.06 15.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.969 0.385 . . . . 2.5499999999999998 111.05 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -90.58 160.38 39.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.614 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.23 127.15 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.277 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.21 27.39 6.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.727 -0.749 . . . . 0.40000000000000002 112.323 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 46.5 t -94.31 174.23 7.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.649 0.261 . . . . 0.62 110.788 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -123.97 148.81 46.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 1.3 110.946 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' A' ' 11' ' ' ILE . 6.8 p90 -161.43 179.53 8.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.35999999999999999 110.853 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -132.21 152.22 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 2.9399999999999999 110.844 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 49' ' ' VAL . 60.5 t -91.23 141.09 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 1.28 111.051 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -95.96 -39.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 111.342 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.8 ptm180 179.73 126.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 2.7999999999999998 110.982 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 43' ' ' ALA . 9.2 p -148.66 159.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.2 111.153 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.505 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -114.15 155.75 45.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.81000000000000005 111.066 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.29 -18.44 23.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.676 2.25 . . . . 1.3400000000000001 112.586 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 tp -89.65 -65.8 0.98 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 2.5099999999999998 110.938 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 170.84 107.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.77000000000000002 112.434 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.0 m-20 -147.72 172.26 5.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.58 0.229 . . . . 1.0700000000000001 110.712 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.19 110.87 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.755 2.303 . . . . 0.60999999999999999 111.526 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' CG2' HG13 ' A' ' 39' ' ' VAL . 3.7 p -106.57 140.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 111.199 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 68.6 m80 -101.43 131.03 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.845 -0.616 . . . . 1.1299999999999999 110.804 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 60' ' ' LEU . 44.2 pt -96.63 139.62 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 110.831 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -106.83 97.09 6.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 2.1299999999999999 110.888 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.2 -172.68 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.64000000000000001 111.002 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HB2' ' CE ' ' A' ' 31' ' ' MET . 41.3 mmt180 -51.47 96.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 3.04 111.451 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 51.89 30.08 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 4.1100000000000003 111.541 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 54' ' ' ARG . 79.7 t -149.75 117.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 1.23 111.33 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -100.87 107.76 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.64000000000000001 110.751 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' A' ' 51' ' ' ILE . 32.0 tp -102.9 158.17 16.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.988 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -104.55 138.96 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.5 110.911 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD1' HD13 ' A' ' 51' ' ' ILE . 90.2 mt -144.08 143.13 31.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.931 0.396 . . . . 0.96999999999999997 111.104 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 32.4 ttm180 -112.12 162.3 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 3.3199999999999998 110.683 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 mmpt? -47.18 -26.92 1.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 4.7000000000000002 111.218 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.1 -30.09 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 2.2799999999999998 110.912 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.85 -31.93 40.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 2.2999999999999998 111.027 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.3 mp -81.6 -18.5 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.69 -27.03 68.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.766 0.317 . . . . 0.66000000000000003 111.499 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.67 -57.69 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.47999999999999998 111.119 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.2 pt -66.04 154.81 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.42999999999999999 111.338 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 12' ' ' THR . 9.0 tp10 -104.93 147.78 27.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.186 -0.461 . . . . 2.29 110.475 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.7 mm? -121.43 153.63 37.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 1.8500000000000001 111.097 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.01 147.08 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 2.2400000000000002 110.787 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 165.94 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.76000000000000001 111.18 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.1599999999999999 111.023 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CE1' HD23 ' A' ' 70' ' ' LEU . 38.7 m-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.764 0.316 . . . . 2.25 110.715 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 41.2 p -113.82 156.25 44.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.66000000000000003 111.253 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 62.0 Cg_endo -72.92 90.12 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.58 2.187 . . . . 0.65000000000000002 112.313 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 178.32 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 110.828 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 1.8899999999999999 110.784 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.89 168.68 8.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 110.93 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.512 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 69.3 m95 -149.75 173.45 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.68999999999999995 110.872 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.435 ' O ' HD12 ' A' ' 70' ' ' LEU . 31.2 mmmt -107.06 126.99 53.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.88 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.9 mt -77.21 126.78 38.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.56000000000000005 111.118 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 23.0 m -132.65 56.88 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.393 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' NH1' ' A' ' 23' ' ' ARG . . . -58.59 85.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.971 -0.633 . . . . 0.45000000000000001 113.004 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -147.11 95.98 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.81000000000000005 110.632 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -95.05 -174.26 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.985 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -86.18 -26.01 25.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.581 . . . . 3.5800000000000001 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -150.29 34.23 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 2.48 111.414 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 tt -48.63 143.18 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 111.253 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -94.63 147.93 34.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.5 110.88 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 17.2 Cg_endo -57.29 -32.02 92.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.712 2.274 . . . . 0.60999999999999999 112.124 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.03 -47.05 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.025 0.44 . . . . 0.70999999999999996 110.711 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.69 -43.39 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.646 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.2 tpt180 -60.25 -61.26 2.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 1.5700000000000001 110.98 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' PRO . 91.5 mt-30 -49.98 -41.71 47.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 2.6899999999999999 110.843 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -53.69 -25.77 19.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 2.5899999999999999 110.972 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.29 -46.62 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 1.3 110.594 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -50.77 -33.6 23.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.94999999999999996 111.048 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.9 p -69.23 -42.21 75.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.979 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.3 -25.34 65.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 1.6399999999999999 110.979 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.14 16.16 39.08 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.81999999999999995 112.835 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 ptm -104.0 103.94 13.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.983 0.42 . . . . 2.5499999999999998 110.883 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -105.03 159.81 28.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.443 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.0 Cg_exo -42.11 109.4 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.521 2.147 . . . . 0.51000000000000001 112.152 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 31.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.40000000000000002 112.166 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 t -101.35 174.18 6.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.623 0.249 . . . . 0.62 110.57 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -119.99 143.35 48.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 1.3 111.071 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' TRP . 4.0 p90 -150.45 175.36 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.35999999999999999 110.824 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -130.71 129.03 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 2.9399999999999999 110.988 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 140.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 1.28 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.4 t -99.06 -35.48 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54000000000000004 111.125 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -179.61 139.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 2.7999999999999998 111.088 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.5 t -146.92 160.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.122 -0.49 . . . . 1.2 111.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.56 132.0 24.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.81000000000000005 110.83 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.46 -21.19 44.24 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 1.3400000000000001 112.503 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -89.82 -66.33 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 2.5099999999999998 111.229 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.96 105.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.77000000000000002 112.263 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.455 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.0 m-20 -148.12 172.13 5.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.562 0.22 . . . . 1.0700000000000001 111.056 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.19 119.47 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 0.60999999999999999 111.487 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.53 148.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.39000000000000001 110.964 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' VAL . 36.4 m-70 -112.98 135.85 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.779 -0.646 . . . . 1.1299999999999999 110.745 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 60' ' ' LEU . 47.0 pt -98.55 145.83 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.35999999999999999 111.16 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -109.34 100.81 9.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 2.1299999999999999 110.742 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 p -103.92 -173.14 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.64000000000000001 111.185 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.0 mmt180 -50.94 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 3.04 111.531 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 48.62 30.13 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 4.1100000000000003 111.698 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' ARG . 89.0 t -147.8 113.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.981 0.419 . . . . 1.23 111.139 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -100.03 107.74 19.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.64000000000000001 110.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.13 160.36 14.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.54 111.305 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.55 137.01 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.031 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' CG2' ' A' ' 51' ' ' ILE . 91.0 mt -130.44 161.43 31.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.96999999999999997 111.059 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.8 mtp180 -130.68 147.7 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 3.3199999999999998 110.473 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -47.98 -25.9 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 4.7000000000000002 111.08 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -75.82 -33.43 60.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 2.2799999999999998 110.7 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.87 -34.86 44.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 2.2999999999999998 111.044 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.5 mp -67.76 -20.74 65.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.288 -0.415 . . . . 0.69999999999999996 111.076 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.29 -28.61 68.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.369 -0.378 . . . . 0.66000000000000003 111.083 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.94 -56.53 3.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.47999999999999998 110.968 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.3 pt -65.09 166.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.005 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 12' ' ' THR . 12.3 tt0 -114.47 153.54 29.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 2.29 111.195 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.469 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.5 tp -129.91 158.09 40.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 110.664 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.71 147.18 31.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 2.2400000000000002 110.876 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.53 169.84 2.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.76000000000000001 110.993 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 1.1599999999999999 111.248 -179.847 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CD2' HG11 ' A' ' 42' ' ' VAL . 21.5 p90 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.892 0.377 . . . . 2.25 110.887 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -121.44 156.35 58.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.66000000000000003 111.147 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.65 87.84 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.48 2.12 . . . . 0.65000000000000002 112.298 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 177.96 -36.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 2.6899999999999999 110.772 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 t -99.51 170.9 8.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 1.8899999999999999 110.96 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.26 165.33 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.46999999999999997 110.94 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 3' ' ' PHE . 54.0 m95 -154.61 163.5 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.68999999999999995 110.616 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.77 127.03 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 2.04 111.185 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.2 mt -74.38 142.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.56000000000000005 111.122 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -142.31 52.11 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.688 -0.687 . . . . 0.96999999999999997 110.155 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -50.7 95.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.45000000000000001 112.89 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -147.5 94.74 2.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.378 . . . . 0.81000000000000005 110.565 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 m -104.19 -174.64 2.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.76000000000000001 110.946 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 9.2 mpt_? -86.24 -23.27 26.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 3.5800000000000001 111.002 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.86 32.04 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 2.48 111.504 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.8 tt -47.21 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.974 0.416 . . . . 0.56999999999999995 111.058 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.5 m -66.7 156.67 85.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 1.5 110.735 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 25.8 Cg_endo -60.9 -28.66 86.7 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.596 2.198 . . . . 0.60999999999999999 112.119 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.33 61.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.70999999999999996 110.599 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.74 -40.1 16.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.846 -0.616 . . . . 2.1699999999999999 110.767 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.7 tpt180 -65.46 -61.37 2.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.5700000000000001 110.876 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.82 -38.43 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 2.6899999999999999 110.844 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -53.54 -59.67 4.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 2.5899999999999999 110.765 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.7 mt -58.56 -44.15 89.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.3 110.718 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -53.53 -29.48 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.94999999999999996 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.3 t -66.79 -38.49 86.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 1.6399999999999999 110.794 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.02 -24.69 24.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 1.6399999999999999 110.882 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.31 16.31 18.76 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.848 -0.691 . . . . 0.81999999999999995 112.732 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.453 ' CE ' HD12 ' A' ' 11' ' ' ILE . 90.7 mmm -91.35 90.52 7.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 2.5499999999999998 111.048 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.6 mp -108.18 161.65 22.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.68999999999999995 110.608 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 91.5 Cg_exo -42.56 109.77 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.43 2.087 . . . . 0.51000000000000001 112.068 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.86 2.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.40000000000000002 112.012 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.2 m -106.87 135.19 48.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.76 0.314 . . . . 0.62 110.904 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.1 m -90.2 148.07 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 1.3 111.199 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.7 p90 -162.77 179.38 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.35999999999999999 110.892 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.29 153.37 43.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 2.9399999999999999 110.812 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.0 t -92.55 141.3 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 1.28 111.187 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 60.6 t -101.75 -44.81 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.54000000000000004 111.303 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -175.71 115.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 2.7999999999999998 110.975 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.7 p -135.71 158.81 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.2 111.148 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -106.78 147.61 35.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.985 -0.552 . . . . 0.81000000000000005 111.085 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 -15.89 34.16 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.586 2.191 . . . . 1.3400000000000001 112.647 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.32 -73.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 2.5099999999999998 111.17 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.24 91.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.859 -0.686 . . . . 0.77000000000000002 112.41 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 7.6 m-20 -137.84 171.38 8.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.646 0.26 . . . . 1.0700000000000001 110.921 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.57 118.01 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.858 2.372 . . . . 0.60999999999999999 111.87 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.416 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.4 p -110.13 154.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.569 -0.741 . . . . 0.39000000000000001 110.942 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.411 ' CD2' ' HB ' ' A' ' 59' ' ' VAL . 76.1 m80 -109.23 133.64 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.688 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 pt -105.02 144.04 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.35999999999999999 111.051 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.21 110.04 20.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 2.1299999999999999 110.644 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 31' ' ' MET . 30.8 p -110.58 -171.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.64000000000000001 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -51.17 95.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 3.04 111.303 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 53.77 24.2 4.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 4.1100000000000003 111.545 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -146.12 115.3 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.035 0.445 . . . . 1.23 111.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -101.39 108.18 19.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.64000000000000001 110.533 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 46.9 tp -99.61 162.47 13.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.954 0.407 . . . . 1.54 111.262 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 9.3 p -117.01 126.47 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.5 110.974 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 65' ' ' LEU . 88.2 mt -119.05 165.95 13.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.96999999999999997 111.158 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.4 ttt180 -139.18 154.59 48.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 3.3199999999999998 110.657 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -46.48 -27.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 4.7000000000000002 111.756 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -79.44 -29.21 41.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 2.2799999999999998 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.12 -33.1 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 2.2999999999999998 110.984 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -76.42 -24.51 54.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.69999999999999996 110.968 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.81 62.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.66000000000000003 111.304 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.6 mt -91.53 -60.65 1.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.33 -0.395 . . . . 0.47999999999999998 110.975 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.405 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 23.7 pt -65.7 151.29 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.42999999999999999 110.925 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.52 146.21 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 2.29 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.41 159.44 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.8500000000000001 110.591 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.81 145.29 30.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.393 -0.367 . . . . 2.2400000000000002 111.084 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.09 163.8 27.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.76000000000000001 111.059 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 1.1599999999999999 111.308 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.8 0.333 . . . . 2.25 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -122.41 153.83 62.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.66000000000000003 111.241 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.05 83.44 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.65000000000000002 112.308 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.11 -42.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 2.6899999999999999 110.641 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.8 m -98.34 165.75 11.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 1.8899999999999999 110.927 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 160.97 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.46999999999999997 111.101 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.5 m95 -139.97 164.86 28.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.68999999999999995 110.798 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' SER . 39.9 ttmt -104.88 138.28 41.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 2.04 111.106 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.0 mt -88.13 132.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.56000000000000005 110.562 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 15.9 m -142.27 52.47 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.21 -0.45 . . . . 0.96999999999999997 110.798 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.22 93.59 0.01 OUTLIER Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.017 -0.611 . . . . 0.45000000000000001 112.848 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.84 101.41 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.777 0.322 . . . . 0.81000000000000005 110.88 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 m -110.48 -176.61 3.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.76000000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.7 mpt_? -74.85 -23.01 58.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -169.42 42.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 2.48 110.746 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.7 tt -46.97 115.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.56999999999999995 111.266 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -71.0 157.38 90.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.55 . . . . 1.5 110.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 24.9 Cg_endo -59.83 -27.37 84.78 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.771 2.314 . . . . 0.60999999999999999 112.141 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -49.36 -44.09 44.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.509 -0.314 . . . . 0.70999999999999996 110.713 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -86.15 -39.02 17.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 2.1699999999999999 111.144 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 17.9 tpp180 -67.91 -56.83 7.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 1.5700000000000001 111.338 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -40.97 -30.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.405 -0.362 . . . . 2.6899999999999999 111.633 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 14.2 mmmm -68.48 -54.77 14.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 2.5899999999999999 110.376 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.7 mt -54.61 -51.82 64.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 1.3 110.641 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -49.4 -43.57 44.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.94999999999999996 111.006 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -54.26 -50.97 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.474 . . . . 1.6399999999999999 110.752 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.96 -23.87 60.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 1.6399999999999999 110.815 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.12 19.03 31.92 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.81999999999999995 112.669 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 mtm -94.33 88.93 5.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.759 0.314 . . . . 2.5499999999999998 111.01 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -92.2 160.61 34.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.68999999999999995 110.531 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.1 104.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.33 2.02 . . . . 0.51000000000000001 112.197 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 50.33 0.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.40000000000000002 112.154 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 48.0 t -117.84 170.85 8.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.277 . . . . 0.62 110.746 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.2 p -118.99 139.4 51.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 1.3 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.9 p90 -148.45 163.13 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.35999999999999999 111.041 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 38.0 t60 -108.94 151.45 26.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 2.9399999999999999 110.983 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' O ' ' CD2' ' A' ' 38' ' ' HIS . 59.4 t -92.5 129.26 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.199 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.5 t -99.03 -36.38 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.54000000000000004 111.115 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -175.03 125.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.361 . . . . 2.7999999999999998 111.14 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' CG2' ' A' ' 49' ' ' VAL . 59.0 t -140.86 156.24 22.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 1.2 111.183 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -138.04 128.13 15.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.81000000000000005 110.845 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.6 Cg_exo -57.58 -36.73 98.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.427 2.085 . . . . 1.3400000000000001 112.193 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.9 -45.32 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.925 -0.58 . . . . 2.5099999999999998 111.167 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.69 99.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.77000000000000002 112.234 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 8.9 m-20 -148.26 170.63 7.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.624 0.25 . . . . 1.0700000000000001 111.14 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.37 121.53 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.856 2.371 . . . . 0.60999999999999999 111.51 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.71 156.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.705 -0.68 . . . . 0.39000000000000001 111.03 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.8 m-70 -122.96 130.87 53.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 1.1299999999999999 110.41 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 19.5 pt -103.6 137.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.086 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.01 121.59 44.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 2.1299999999999999 110.733 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 55' ' ' ARG . 56.5 p -124.12 -172.9 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.99 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -49.63 91.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 3.04 111.351 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' THR . 17.8 mmm180 53.43 33.65 16.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 4.1100000000000003 111.463 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.6 t -150.97 104.59 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 1.23 111.307 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -97.52 107.84 20.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.64000000000000001 110.713 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.95 153.64 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 1.54 111.131 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 7.1 p -111.67 129.88 66.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.5 111.052 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.9 135.92 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.96999999999999997 110.906 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.4 mtt180 -103.01 160.36 14.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 3.3199999999999998 111.041 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -42.51 -37.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 4.7000000000000002 111.474 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 18.8 ptmt -64.53 -34.43 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 2.2799999999999998 111.127 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.08 -24.05 35.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 2.2999999999999998 111.067 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -86.18 -21.37 27.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.349 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.5 64.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.66000000000000003 111.377 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.0 mt -91.5 -55.86 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.352 -0.386 . . . . 0.47999999999999998 111.316 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 65' ' ' LEU . 25.7 pt -65.67 150.56 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.42999999999999999 111.092 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -100.42 143.08 31.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 2.29 110.816 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.6 ' N ' HD22 ' A' ' 70' ' ' LEU . 1.9 mm? -116.82 149.5 39.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.8500000000000001 110.779 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -144.21 156.11 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 2.2400000000000002 110.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.93 164.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 0.76000000000000001 111.007 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 1.1599999999999999 111.196 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.424 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 56.7 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.848 0.356 . . . . 2.25 110.787 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -100.26 145.23 29.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.66000000000000003 111.189 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' HG23 ' A' ' 39' ' ' VAL . 57.3 Cg_endo -70.34 86.85 0.64 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 112.215 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 177.85 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 2.6899999999999999 110.847 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -97.82 146.89 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 9' ' ' TRP . . . -79.81 171.14 15.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.46999999999999997 110.955 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' ALA . 57.5 m95 -156.71 160.94 39.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.68999999999999995 110.78 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 71' ' ' GLU . 59.0 mttp -112.1 134.35 53.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.04 110.801 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.477 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.0 mt -70.92 138.65 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.56000000000000005 111.292 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 9.2 m -146.52 43.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.189 0.519 . . . . 0.96999999999999997 110.484 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.48 90.5 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.45000000000000001 112.824 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -147.09 95.03 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.81000000000000005 110.736 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -99.32 -169.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.76000000000000001 110.928 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.1 mpt_? -83.29 -23.49 32.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 3.5800000000000001 110.93 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.07 37.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.48 110.775 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tt -46.08 116.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.301 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 m -64.25 155.9 77.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 1.5 110.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 33.9 Cg_endo -63.37 -26.79 71.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.565 2.176 . . . . 0.60999999999999999 112.14 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.06 55.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.70999999999999996 110.672 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' OD1' ' A' ' 64' ' ' ASP . 92.8 m-85 -85.84 -39.82 16.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 2.1699999999999999 110.915 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 22.5 tpt180 -65.2 -58.95 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.176 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.0 tt0 -43.8 -28.44 0.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 2.6899999999999999 111.724 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -65.01 -36.59 84.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 2.5899999999999999 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.7 mp -79.39 -45.41 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.3 111.038 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -50.47 -25.16 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.94999999999999996 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.8 m -57.41 -47.81 80.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.6399999999999999 111.042 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.9 mp -86.18 -25.06 25.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 1.6399999999999999 110.899 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 27.88 10.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 0.81999999999999995 112.762 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.2 mmt -95.29 99.45 11.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.7 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.54 159.86 37.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.54 . . . . 0.68999999999999995 110.826 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -42.24 114.59 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.495 2.13 . . . . 0.51000000000000001 112.148 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 25.22 2.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.859 -0.686 . . . . 0.40000000000000002 112.478 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 44.9 t -94.71 174.09 7.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.62 110.57 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.1 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.3 111.097 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.6 p90 -163.84 -173.4 3.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.076 -0.511 . . . . 0.35999999999999999 110.732 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.11 159.99 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 2.9399999999999999 110.966 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -100.57 131.46 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 1.28 110.883 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -89.58 -48.06 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.242 -0.436 . . . . 0.54000000000000004 111.568 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -171.39 120.8 0.5 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.732 0.301 . . . . 2.7999999999999998 111.385 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 43' ' ' ALA . 13.2 p -147.77 160.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 1.2 111.088 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -128.84 142.86 46.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 111.025 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 33.9 Cg_exo -59.42 -22.29 65.26 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.474 2.116 . . . . 1.3400000000000001 112.514 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.98 -73.68 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.361 . . . . 2.5099999999999998 111.242 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.41 91.72 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.779 -0.725 . . . . 0.77000000000000002 112.354 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.464 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.8 m-20 -138.39 171.54 8.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.514 0.197 . . . . 1.0700000000000001 110.722 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.71 116.45 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.903 2.402 . . . . 0.60999999999999999 111.95 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 42' ' ' VAL . 2.7 p -111.66 139.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.39000000000000001 111.315 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' VAL . 35.0 m-70 -101.68 130.79 48.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.604 . . . . 1.1299999999999999 110.504 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 57' ' ' SER . 37.8 pt -97.26 147.09 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.35999999999999999 111.008 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.73 119.83 40.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 2.1299999999999999 110.804 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.477 ' HG1' HG13 ' A' ' 56' ' ' VAL . 17.4 p -127.15 -163.19 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.64000000000000001 111.205 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 56' ' ' VAL . 34.5 mmt180 -48.31 97.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.079 0.466 . . . . 3.04 111.867 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 43.57 34.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 4.1100000000000003 112.286 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HG1' ' A' ' 53' ' ' THR . 12.2 p -159.94 125.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.968 0.413 . . . . 1.23 111.197 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 47.0 t -105.94 112.49 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 111.271 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.73 171.13 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.553 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -123.32 132.29 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.41 -0.359 . . . . 0.5 111.198 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -135.75 166.39 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.516 . . . . 0.96999999999999997 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.2 mtt180 -123.54 146.79 47.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 3.3199999999999998 110.601 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.453 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.3 tpmt? -50.01 -25.11 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.368 . . . . 4.7000000000000002 111.021 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.88 -30.0 40.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 2.2799999999999998 110.578 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.463 ' OD1' ' CD1' ' A' ' 22' ' ' TYR . 21.2 t70 -81.35 -36.63 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 2.2999999999999998 110.719 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.7 mp -61.69 -22.11 65.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.69999999999999996 110.928 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.13 61.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 111.192 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.66 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.47999999999999998 110.968 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 65' ' ' LEU . 27.6 pt -65.71 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.42999999999999999 110.78 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.8 tt0 -99.04 146.14 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.29 111.109 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -116.52 149.89 38.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 1.8500000000000001 110.681 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.4 tp10 -129.88 150.24 51.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 2.2400000000000002 110.974 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.97 171.57 12.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.76000000000000001 111.23 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.1599999999999999 111.022 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 13.5 p90 . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.973 0.416 . . . . 2.25 111.099 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -100.08 154.89 36.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.66000000000000003 110.908 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 58.0 Cg_endo -71.72 83.54 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.394 2.063 . . . . 0.65000000000000002 112.484 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 13.3 t70 178.71 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 2.6899999999999999 110.897 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 t -90.77 159.35 16.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.8899999999999999 111.11 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.03 169.25 11.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.46999999999999997 111.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 60.6 m95 -151.58 154.82 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.68999999999999995 111.107 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' SER . 31.7 mmmt -95.37 131.33 41.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.982 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 32.4 mt -83.05 125.33 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.56000000000000005 111.242 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 35.7 p -133.09 58.82 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.96999999999999997 110.534 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.26 91.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.742 -0.663 . . . . 0.45000000000000001 112.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.05 94.85 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.81000000000000005 110.344 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -97.89 -172.56 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.76000000000000001 111.247 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -85.73 -24.31 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 3.5800000000000001 110.695 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -158.5 37.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.048 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.15 128.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 0.56999999999999995 111.311 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.3 m -77.61 157.04 80.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 1.5 111.096 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 55.8 Cg_endo -70.36 -26.68 24.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.583 2.188 . . . . 0.60999999999999999 112.491 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.76 -47.11 59.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.351 -0.386 . . . . 0.70999999999999996 110.724 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -86.22 -38.39 17.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.915 -0.584 . . . . 2.1699999999999999 110.954 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 24.1 tpt180 -66.95 -58.19 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 1.5700000000000001 111.405 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -44.82 -30.5 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 2.6899999999999999 111.517 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.36 -40.97 73.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 2.5899999999999999 111.053 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.24 -50.87 19.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 1.3 110.64 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.33 -35.49 60.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.94999999999999996 110.856 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.2 m -78.25 -27.47 47.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 1.6399999999999999 111.038 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.39 -25.06 39.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 1.6399999999999999 110.846 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.07 5.96 43.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.807 -0.711 . . . . 0.81999999999999995 113.103 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -98.74 96.13 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 2.5499999999999998 110.931 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -104.96 158.73 31.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.454 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -39.59 105.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.576 2.184 . . . . 0.51000000000000001 112.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 33.95 0.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.40000000000000002 112.294 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.5 t -106.42 174.44 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.602 0.239 . . . . 0.62 110.525 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 p -129.13 144.98 51.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.866 0.365 . . . . 1.3 111.012 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CE2' HG22 ' A' ' 51' ' ' ILE . 13.5 p90 -152.04 168.41 25.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.35999999999999999 111.021 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -115.56 140.61 49.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 2.9399999999999999 110.517 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 49' ' ' VAL . 48.0 t -80.31 131.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.387 -0.37 . . . . 1.28 111.22 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.07 -39.61 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.428 . . . . 0.54000000000000004 111.324 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 49' ' ' VAL . 37.3 ptt180 -179.73 121.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 2.7999999999999998 110.801 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -145.02 159.5 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 1.2 111.152 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -112.61 155.45 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.81000000000000005 111.02 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.98 -22.23 15.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.584 2.189 . . . . 1.3400000000000001 112.367 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.9 -62.21 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 111.094 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.8 103.13 0.18 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.77000000000000002 112.208 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.457 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.9 m-20 -147.97 170.45 7.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.666 0.269 . . . . 1.0700000000000001 111.039 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -85.17 119.01 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.848 2.366 . . . . 0.60999999999999999 111.587 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' ARG . 2.7 p -115.06 149.35 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.39000000000000001 111.406 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -99.55 146.46 26.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 1.1299999999999999 110.995 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 58' ' ' LEU . 33.6 pt -112.08 138.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.35999999999999999 110.842 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.1 131.44 54.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 2.1299999999999999 110.91 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 p -137.35 -173.05 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.64000000000000001 110.991 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -52.83 91.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 3.04 111.3 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 54.04 39.11 30.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 4.1100000000000003 111.57 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -156.86 111.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 1.23 110.976 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -105.32 107.92 19.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.64000000000000001 111.071 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 58.5 tp -98.95 159.96 14.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.54 111.022 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 8.6 p -113.89 135.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.5 111.009 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.93 141.12 52.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.96999999999999997 110.979 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -106.96 151.61 25.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 3.3199999999999998 110.97 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -47.38 -29.87 2.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 4.7000000000000002 111.463 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 21.1 ptmt -81.34 -25.4 36.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 2.2799999999999998 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 61' ' ' ARG . 12.3 t70 -78.05 -30.69 49.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.48 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.8 mp -75.55 -21.91 57.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.142 -0.481 . . . . 0.69999999999999996 111.124 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.87 71.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.66000000000000003 111.36 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.95 -61.74 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.47999999999999998 111.204 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -65.68 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.031 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 5.8 tp10 -98.49 155.85 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 2.29 110.859 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.1 tp -125.04 157.48 36.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 1.8500000000000001 110.561 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 35.3 tt0 -147.42 149.93 33.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 110.83 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.29 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 111.086 179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 2.25 110.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 p -102.43 151.46 38.19 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.66000000000000003 111.338 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.681 ' HA ' HG23 ' A' ' 39' ' ' VAL . 59.0 Cg_endo -71.87 91.06 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.563 2.176 . . . . 0.65000000000000002 112.489 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 176.6 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 2.6899999999999999 110.912 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -106.31 144.14 33.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 1.8899999999999999 110.984 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.33 165.32 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 111.128 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -155.2 153.91 31.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.68999999999999995 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 35' ' ' SER . 49.8 mtmt -113.59 138.68 49.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 2.04 111.25 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' CD1' ' A' ' 37' ' ' PHE . 47.3 mt -79.12 123.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.56000000000000005 111.265 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 57.7 p -131.78 59.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.96999999999999997 110.554 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -51.64 97.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.838 -0.696 . . . . 0.45000000000000001 112.44 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -145.09 96.92 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.371 . . . . 0.81000000000000005 111.125 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -114.12 153.57 29.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.76000000000000001 110.698 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -52.55 -25.01 9.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 3.5800000000000001 110.57 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.3 39.72 0.67 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 2.48 110.783 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.3 tt -42.72 105.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.076 0.465 . . . . 0.56999999999999995 111.468 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -63.42 146.8 96.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.5 110.806 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.3 Cg_endo -58.64 -30.31 91.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.721 2.281 . . . . 0.60999999999999999 112.131 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -45.33 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.70999999999999996 110.937 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 54.0 m-85 -85.39 -42.02 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 2.1699999999999999 111.249 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -60.76 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 1.5700000000000001 111.269 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.3 mm-40 -54.88 -22.12 13.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.34 -0.391 . . . . 2.6899999999999999 111.456 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 22' ' ' TYR . 23.1 ttpp -69.2 -42.93 75.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.331 . . . . 2.5899999999999999 110.823 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.1 mt -52.14 -34.42 44.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.725 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.83 -27.73 44.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.94999999999999996 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -49.0 -38.11 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 1.6399999999999999 111.121 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.1 mm? -107.11 -21.24 13.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.6399999999999999 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.28 29.63 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.737 -0.744 . . . . 0.81999999999999995 112.531 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -88.57 92.71 9.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.749 0.309 . . . . 2.5499999999999998 110.791 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.4 mp -83.04 158.98 63.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.68999999999999995 110.825 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.36 107.27 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.328 2.019 . . . . 0.51000000000000001 112.112 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.71 32.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.855 -0.688 . . . . 0.40000000000000002 112.518 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 10' ' ' LYS . 46.7 t -104.76 174.18 5.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.71 0.291 . . . . 0.62 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -116.04 154.54 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.334 -0.394 . . . . 1.3 111.169 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 11' ' ' ILE . 30.0 p90 -165.04 169.96 15.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.35999999999999999 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 29.3 m80 -124.69 134.55 52.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 2.9399999999999999 111.014 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 5' ' ' PRO . 7.0 m -83.87 132.32 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.28 111.16 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.69 -49.71 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.54000000000000004 111.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 2.7999999999999998 110.892 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.1 t -143.55 159.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.2 111.189 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.26 144.95 52.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.81000000000000005 110.944 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.06 -18.23 31.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.476 2.117 . . . . 1.3400000000000001 112.596 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.42 -55.17 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 2.5099999999999998 111.15 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.68 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.77000000000000002 112.272 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.8 m-20 -143.43 170.66 8.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.67 0.271 . . . . 1.0700000000000001 111.118 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.94 117.14 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.933 2.422 . . . . 0.60999999999999999 111.924 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.62 156.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.39000000000000001 110.935 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -115.58 131.91 56.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 37.5 pt -101.73 142.43 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.097 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 38.0 tt0 -107.33 124.53 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 2.1299999999999999 110.709 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 56' ' ' VAL . 69.6 p -132.1 -173.52 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.64000000000000001 111.278 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 56' ' ' VAL . 38.1 mmt180 -41.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.105 0.409 . . . . 3.04 112.105 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 44.15 51.0 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.906 -0.588 . . . . 4.1100000000000003 111.886 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 56' ' ' VAL . 14.2 p 179.71 119.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 1.23 111.201 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -102.33 112.57 25.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 110.946 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 47.7 tp -92.0 162.77 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 1.54 110.615 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 12.6 p -112.29 145.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.5 111.244 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.03 147.06 41.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.847 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.3 mtt180 -107.65 150.51 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.3199999999999998 110.908 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.89 -25.95 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.919 -0.582 . . . . 4.7000000000000002 111.226 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -81.08 -27.76 35.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 2.2799999999999998 110.826 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.5 -31.59 47.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 2.2999999999999998 110.974 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -72.79 -21.17 61.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.69999999999999996 111.008 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.77 71.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.66000000000000003 111.146 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.38 -61.69 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.47999999999999998 111.042 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.403 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 25.8 pt -66.08 148.98 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.415 . . . . 0.42999999999999999 110.962 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.4 tt0 -102.35 153.81 19.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 2.29 110.733 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -115.96 149.58 38.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.8500000000000001 110.866 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.32 110.72 9.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 2.2400000000000002 110.957 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 155.34 1.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.76000000000000001 111.0 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 1.1599999999999999 111.278 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.941 0.401 . . . . 2.25 110.788 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.4 p -99.88 155.97 35.86 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.66000000000000003 111.143 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 58.6 Cg_endo -72.3 87.27 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.502 2.135 . . . . 0.65000000000000002 112.289 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 t70 177.77 -57.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 2.6899999999999999 110.965 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -77.32 135.9 38.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 1.8899999999999999 110.804 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.42 157.65 28.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.46999999999999997 111.327 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 71.9 m95 -141.37 167.62 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.68999999999999995 110.804 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.1 136.57 51.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 2.04 111.165 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' CD1' ' A' ' 37' ' ' PHE . 50.5 mt -79.47 136.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.56000000000000005 110.742 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 12' ' ' THR . 12.7 m -143.83 46.52 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.96999999999999997 110.825 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.85 90.32 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.881 -0.676 . . . . 0.45000000000000001 112.657 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' THR . 69.3 t80 -146.68 102.69 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.81000000000000005 110.732 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -97.94 -179.12 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.76000000000000001 111.115 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.2 mpt_? -75.25 -24.85 57.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 3.5800000000000001 110.629 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.95 38.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 2.48 110.63 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -42.88 131.7 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.038 -0.528 . . . . 0.56999999999999995 111.737 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.8 m -92.47 157.4 40.27 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.5 110.784 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 24' ' ' GLN . 11.7 Cg_endo -54.44 -32.75 74.5 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.638 2.225 . . . . 0.60999999999999999 112.093 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.08 -46.69 34.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.07 0.462 . . . . 0.70999999999999996 110.771 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -85.95 -49.96 7.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.558 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.48 -61.23 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 1.5700000000000001 111.064 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.4 tt0 -47.51 -32.42 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 2.6899999999999999 111.055 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.66 -55.9 28.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 2.5899999999999999 110.752 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.5 -45.15 92.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 1.3 110.817 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.45 -53.36 37.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.94999999999999996 111.113 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -49.92 -29.91 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 1.6399999999999999 111.085 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HD11 ' A' ' 58' ' ' LEU . 84.2 mt -91.88 -25.42 18.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 1.6399999999999999 110.94 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.06 31.35 9.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.698 -0.763 . . . . 0.81999999999999995 112.874 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.4 mtt -110.3 87.46 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 2.5499999999999998 110.623 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.8 mp -86.95 161.21 47.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.68999999999999995 110.746 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.78 115.13 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.508 2.138 . . . . 0.51000000000000001 112.163 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.4 28.58 2.98 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.786 -0.721 . . . . 0.40000000000000002 112.188 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 37.3 t -96.36 163.16 13.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.638 0.256 . . . . 0.62 110.634 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -110.67 145.3 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 1.3 111.028 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 11' ' ' ILE . 19.1 p90 -158.28 170.33 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.35999999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -120.81 149.75 42.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.107 -0.497 . . . . 2.9399999999999999 110.991 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 5' ' ' PRO . 54.2 t -82.17 132.54 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.072 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.0 -33.51 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.54000000000000004 111.522 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 176.41 130.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 2.7999999999999998 111.22 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 43' ' ' ALA . 51.0 t -139.87 158.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 1.2 111.04 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -114.63 134.35 22.39 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.81000000000000005 110.859 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.3 -26.3 76.36 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.455 2.103 . . . . 1.3400000000000001 112.48 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.2 mp -91.26 -65.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.427 -0.351 . . . . 2.5099999999999998 111.215 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.12 106.94 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.77000000000000002 112.338 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.3 m-20 -148.32 173.21 4.39 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 111.05 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.467 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 2.3 Cg_endo -83.52 120.23 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.60999999999999999 111.522 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.486 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.55 156.02 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.629 -0.714 . . . . 0.39000000000000001 111.202 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -120.78 134.26 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 1.1299999999999999 110.525 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 37.3 pt -101.38 137.88 27.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.198 -0.455 . . . . 0.35999999999999999 110.916 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.7 101.32 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.445 . . . . 2.1299999999999999 110.887 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.8 p -99.64 -169.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 110.838 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -56.18 96.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 3.04 111.584 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.3 26.3 8.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 4.1100000000000003 111.629 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -148.53 114.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 1.23 111.257 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -103.24 107.86 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.64000000000000001 110.779 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 64.5 mt -94.77 174.78 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 1.54 111.006 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.99 131.26 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.975 0.416 . . . . 0.5 111.181 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.8 mt -124.06 165.11 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.789 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' HD13 ' A' ' 65' ' ' LEU . 97.5 mtt180 -146.05 162.23 38.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 3.3199999999999998 111.066 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -52.54 -22.33 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 4.7000000000000002 111.545 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE3' ' HD2' ' A' ' 61' ' ' ARG . 23.0 pttp -80.35 -33.67 37.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 2.2799999999999998 110.624 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.27 -42.55 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 2.2999999999999998 110.888 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -60.47 -24.19 65.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.69999999999999996 111.007 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.92 65.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.401 . . . . 0.66000000000000003 111.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.15 -57.26 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.362 . . . . 0.47999999999999998 111.072 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.3 pt -65.94 151.19 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.42999999999999999 111.192 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -103.43 150.51 23.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 2.29 110.722 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.87 142.14 50.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.8500000000000001 111.088 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -124.13 152.72 42.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 2.2400000000000002 110.906 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.21 -178.51 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 111.105 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 1.1599999999999999 111.084 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 9' ' ' TRP . 62.9 m-85 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.832 0.349 . . . . 2.25 110.705 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -114.41 161.09 30.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.66000000000000003 111.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.97 147.55 14.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.65000000000000002 112.345 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 66.4 18.27 10.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 2.6899999999999999 111.647 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.493 ' OG ' HG21 ' A' ' 39' ' ' VAL . 84.5 p -98.74 173.25 6.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.733 0.301 . . . . 1.8899999999999999 110.651 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.07 142.81 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.46999999999999997 111.122 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.559 ' CD2' ' CE2' ' A' ' 3' ' ' PHE . 32.1 m95 -154.02 162.83 40.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.68999999999999995 110.696 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -106.33 138.19 42.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 2.04 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 44.8 mt -77.79 127.4 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.56000000000000005 111.026 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 m -136.05 48.15 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.96999999999999997 110.571 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -46.59 92.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.45000000000000001 113.046 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -147.08 94.9 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.81000000000000005 110.668 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 32.2 t -98.63 -178.76 4.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.896 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.9 mpt_? -79.05 -21.49 46.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 3.5800000000000001 111.001 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.02 37.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.479 -0.328 . . . . 2.48 111.17 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 10.8 tt -45.6 126.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.56999999999999995 111.396 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -85.36 149.29 51.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 1.5 110.964 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 15.6 Cg_endo -56.8 -31.25 87.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.801 2.334 . . . . 0.60999999999999999 112.257 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.56 -47.11 28.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.70999999999999996 110.858 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -85.79 -43.65 13.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 2.1699999999999999 110.904 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.4 tpt180 -60.7 -61.01 2.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 1.5700000000000001 110.967 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' PRO . 7.7 tp-100 -48.89 -30.35 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 2.6899999999999999 110.85 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.61 -32.97 73.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 2.5899999999999999 110.849 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.94 -48.04 26.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.837 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.65 -34.05 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.94999999999999996 111.062 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -53.09 -33.27 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.6399999999999999 110.904 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -89.79 -22.95 21.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 1.6399999999999999 110.823 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.74 23.67 30.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 0.81999999999999995 112.495 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 39.8 mtm -101.44 91.01 4.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 2.5499999999999998 110.763 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -92.54 159.3 36.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.68999999999999995 110.879 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.04 106.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.637 2.225 . . . . 0.51000000000000001 112.186 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.18 33.34 0.9 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.798 -0.715 . . . . 0.40000000000000002 112.454 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.4 t -107.49 171.8 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.62 110.829 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -116.05 145.96 42.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 1.3 111.009 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 18.2 p90 -157.62 159.73 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.317 -0.401 . . . . 0.35999999999999999 111.033 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -109.33 151.62 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 2.9399999999999999 110.67 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.493 HG21 ' OG ' ' A' ' 7' ' ' SER . 57.6 t -89.37 140.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 1.28 111.221 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.9 t -103.45 -52.22 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.54000000000000004 111.426 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.33 129.13 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 2.7999999999999998 111.074 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.3 t -143.2 159.2 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.201 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -129.06 145.17 55.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.98 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 33.3 Cg_endo -64.46 -16.97 57.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.568 2.179 . . . . 1.3400000000000001 112.468 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -89.88 -69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.872 0.367 . . . . 2.5099999999999998 110.975 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.52 94.17 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.77000000000000002 112.347 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB2' ' CD ' ' A' ' 48' ' ' PRO . 4.2 p-10 -131.25 178.01 1.95 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.475 0.179 . . . . 1.0700000000000001 110.711 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' CD ' ' HB2' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.25 118.36 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.938 2.425 . . . . 0.60999999999999999 111.557 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.84 157.53 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.39000000000000001 111.293 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.43 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.8 m-70 -117.57 144.92 44.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.642 -0.708 . . . . 1.1299999999999999 110.463 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.2 135.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.35999999999999999 111.222 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -106.94 112.49 25.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 2.1299999999999999 110.651 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -118.13 -174.11 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.64000000000000001 111.128 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -50.71 93.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.04 111.283 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.25 37.71 15.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 4.1100000000000003 111.578 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG11 HD23 ' A' ' 29' ' ' LEU . 89.2 t -152.71 100.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 1.23 110.887 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -97.77 108.42 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.64000000000000001 111.008 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 56.8 tp -108.01 161.26 15.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 1.54 110.935 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 7.4 p -114.59 141.17 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.023 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -126.77 144.11 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.96999999999999997 110.813 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.45 ' O ' HD13 ' A' ' 65' ' ' LEU . 56.9 mtp180 -107.92 152.67 24.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 3.3199999999999998 111.171 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.81 -33.12 9.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 4.7000000000000002 111.713 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.98 -22.88 36.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 2.2799999999999998 111.073 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.96 -23.55 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 2.2999999999999998 110.931 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 61' ' ' ARG . 9.6 mp -79.5 -28.93 41.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.69999999999999996 110.965 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -24.27 52.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.66000000000000003 111.071 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.54 -61.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.47999999999999998 110.917 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 22.4 pt -65.65 151.86 9.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.42999999999999999 110.819 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -105.48 142.54 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 2.29 111.426 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -110.16 125.64 53.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.969 -0.559 . . . . 1.8500000000000001 110.455 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.44 124.01 45.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.2400000000000002 110.72 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.1 152.44 7.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.028 -0.533 . . . . 0.76000000000000001 111.199 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 1.1599999999999999 111.281 179.91 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.5 ' HB2' ' CE2' ' A' ' 9' ' ' TRP . 37.0 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.792 0.33 . . . . 2.25 110.969 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.0 p -81.18 153.1 71.73 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.66000000000000003 111.194 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.0 81.7 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.454 2.103 . . . . 0.65000000000000002 112.013 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -176.58 -42.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 2.6899999999999999 110.94 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -90.18 154.64 19.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.8899999999999999 110.884 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.54 170.12 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.46999999999999997 111.034 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 52.0 m95 -155.63 175.69 13.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.68999999999999995 110.911 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.3 134.02 54.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 2.04 111.094 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.501 HG13 ' CD1' ' A' ' 37' ' ' PHE . 58.9 mt -80.74 123.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.56000000000000005 111.028 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 19.5 m -133.89 53.46 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.115 0.484 . . . . 0.96999999999999997 110.509 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.57 88.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.885 -0.598 . . . . 0.45000000000000001 112.826 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' THR . 19.4 t80 -147.21 107.6 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.81000000000000005 111.046 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 m -108.66 164.36 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.76000000000000001 110.842 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.448 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -55.17 -22.8 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 3.5800000000000001 110.976 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -164.1 42.45 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.712 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -44.3 134.17 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.56999999999999995 111.558 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 m -84.6 155.81 62.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.5 110.971 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' GLN . 24.9 Cg_endo -62.05 -29.72 81.84 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.605 2.204 . . . . 0.60999999999999999 112.421 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.08 -45.28 64.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.70999999999999996 110.646 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.38 -41.99 14.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 110.798 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -65.51 -61.41 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.5700000000000001 110.999 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' PRO . 12.9 mm100 -52.82 -22.95 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 2.6899999999999999 111.255 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -73.5 -40.41 64.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 2.5899999999999999 110.796 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.5 -44.04 95.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 1.3 110.895 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.56 -25.79 4.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.94999999999999996 110.978 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.6 m -53.59 -35.37 60.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.6399999999999999 111.015 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.8 mm? -94.02 -25.21 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 1.6399999999999999 110.852 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.4 56.16 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.81999999999999995 112.835 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -88.95 98.51 11.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.923 0.392 . . . . 2.5499999999999998 110.687 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.3 mp -83.3 159.66 61.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.544 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.05 149.77 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.47 2.113 . . . . 0.51000000000000001 111.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . 77.65 17.95 78.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.693 -0.765 . . . . 0.40000000000000002 112.342 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.6 t -77.74 174.04 11.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.601 0.239 . . . . 0.62 110.446 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -121.23 136.0 55.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 1.3 110.91 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CD1' HG13 ' A' ' 11' ' ' ILE . 12.8 p90 -151.72 173.65 14.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.35999999999999999 111.085 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -127.75 158.42 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 2.9399999999999999 110.839 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.02 128.59 46.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 1.28 111.248 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.2 -38.63 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.54000000000000004 111.05 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -178.74 123.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 2.7999999999999998 111.003 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.9 p -143.61 160.87 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 1.2 111.218 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -125.16 153.79 71.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.81000000000000005 110.994 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.97 -14.55 9.77 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.592 2.195 . . . . 1.3400000000000001 112.911 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.639 HD11 ' OD2' ' A' ' 47' ' ' ASP . 4.4 pp -85.32 -18.95 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.606 -0.27 . . . . 2.5099999999999998 111.287 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 45' ' ' LEU . . . 114.93 88.45 1.56 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.687 -0.768 . . . . 0.77000000000000002 112.297 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.639 ' OD2' HD11 ' A' ' 45' ' ' LEU . 7.3 m-20 -137.52 171.94 7.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.605 0.24 . . . . 1.0700000000000001 110.897 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.4 Cg_endo -84.3 115.94 1.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.832 2.355 . . . . 0.60999999999999999 111.72 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.54 138.44 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.39000000000000001 111.025 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -95.91 136.01 36.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.919 -0.582 . . . . 1.1299999999999999 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.62 134.64 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.35999999999999999 110.962 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.26 120.54 42.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 2.1299999999999999 111.015 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 74.3 p -124.46 -173.65 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.64000000000000001 110.657 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -49.57 92.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 3.04 111.328 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 34.0 mmt180 53.09 40.9 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.808 -0.633 . . . . 4.1100000000000003 111.488 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 55' ' ' ARG . 66.7 t -157.45 105.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 1.23 111.025 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -104.88 107.52 18.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.64000000000000001 110.9 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.7 tp -100.73 160.19 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.644 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.43 142.94 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.5 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' CD2' ' A' ' 65' ' ' LEU . 57.1 tp -137.52 141.92 41.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.96999999999999997 110.82 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.433 ' CZ ' ' HD3' ' A' ' 63' ' ' LYS . 31.3 ptt180 -114.84 179.46 3.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 3.3199999999999998 110.62 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -75.62 -48.85 20.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.521 -0.308 . . . . 4.7000000000000002 111.513 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 61' ' ' ARG . 21.0 ptmt -51.57 -34.44 36.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 2.2799999999999998 110.567 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.52 -25.48 33.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 2.2999999999999998 110.434 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.536 ' CD2' HD21 ' A' ' 60' ' ' LEU . 10.0 mt -74.86 -25.46 58.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.052 -0.522 . . . . 0.69999999999999996 111.038 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.89 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.66000000000000003 111.108 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -84.92 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.254 -0.43 . . . . 0.47999999999999998 110.983 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.97 155.95 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.283 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.7 tp10 -107.72 135.37 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 2.29 110.776 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.8 mm? -105.21 152.32 23.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 1.8500000000000001 111.11 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.98 121.21 10.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 2.2400000000000002 110.707 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.75 166.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.76000000000000001 111.22 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 1.1599999999999999 111.135 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' A' ' 42' ' ' VAL . 28.5 p90 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.816 0.341 . . . . 2.25 110.984 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.0 p -79.39 155.35 76.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.66000000000000003 110.954 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 65.5 Cg_endo -74.08 89.64 1.02 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.488 2.125 . . . . 0.65000000000000002 112.46 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 t70 177.94 -43.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 2.6899999999999999 111.048 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -87.64 144.24 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.8899999999999999 110.914 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 158.59 32.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 111.131 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.435 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 72.5 m95 -145.79 158.11 43.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.68999999999999995 110.877 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -108.85 138.35 45.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 2.04 110.91 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 60.8 mt -80.65 137.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.56000000000000005 111.141 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -141.69 56.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.96999999999999997 110.253 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.22 90.08 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.45000000000000001 112.875 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -146.43 94.69 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.81000000000000005 110.433 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -100.85 150.28 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.76000000000000001 111.204 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' OD2' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -53.55 -22.47 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.616 . . . . 3.5800000000000001 111.067 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 48.5 m-20 -149.0 34.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.782 0.325 . . . . 2.48 111.151 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -43.94 148.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.389 -0.369 . . . . 0.56999999999999995 111.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 m -96.01 155.85 37.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 1.5 110.985 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 38.8 Cg_endo -66.91 -32.25 36.26 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.461 2.108 . . . . 0.60999999999999999 112.093 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.98 -44.97 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 110.433 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 26' ' ' LEU . 96.1 m-85 -85.49 -48.17 9.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 2.1699999999999999 110.325 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 25.6 tpt180 -56.98 -61.35 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 1.5700000000000001 111.022 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -51.47 -34.83 37.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.081 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -60.82 -41.17 95.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.366 -0.379 . . . . 2.5899999999999999 111.29 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 22' ' ' TYR . 10.8 mp -74.22 -52.69 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 1.3 111.157 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -46.35 -37.1 7.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.94999999999999996 111.513 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -69.31 -23.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 1.6399999999999999 111.339 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.0 mt -96.87 -24.18 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.438 -0.347 . . . . 1.6399999999999999 111.055 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.75 7.44 53.35 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.68 -0.771 . . . . 0.81999999999999995 113.035 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 31' ' ' MET . 1.1 mpt? -89.97 90.67 8.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.891 0.377 . . . . 2.5499999999999998 110.736 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -94.69 160.55 31.15 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.788 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.5 Cg_exo -45.38 122.76 4.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.266 1.977 . . . . 0.51000000000000001 111.847 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.04 23.8 6.88 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.884 -0.674 . . . . 0.40000000000000002 112.071 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.8 t -87.73 174.05 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.62 110.892 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -123.58 144.97 49.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.009 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' HG22 ' A' ' 51' ' ' ILE . 20.7 p90 -158.98 -177.94 6.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.35999999999999999 110.891 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -131.8 132.5 43.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 2.9399999999999999 111.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 5' ' ' PRO . 7.1 p -78.31 135.62 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 1.28 111.025 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.87 -52.21 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.489 -0.323 . . . . 0.54000000000000004 111.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 20.9 ptp180 -153.84 139.03 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 2.7999999999999998 111.186 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.6 t -148.59 158.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 1.2 111.108 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -126.11 143.34 45.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.81000000000000005 111.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 45.2 Cg_endo -68.33 -21.41 41.25 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.647 2.231 . . . . 1.3400000000000001 112.468 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.8 mm? -89.88 -56.1 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 2.5099999999999998 111.111 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.12 107.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.77000000000000002 112.332 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.0 m-20 -148.17 170.66 7.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.637 0.256 . . . . 1.0700000000000001 111.07 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.72 118.12 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.985 2.456 . . . . 0.60999999999999999 111.77 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.8 p -106.79 160.78 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 0.39000000000000001 110.881 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 57.4 m80 -123.47 135.74 54.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 1.1299999999999999 110.98 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 37' ' ' PHE . 37.1 pt -102.04 139.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.983 -0.553 . . . . 0.35999999999999999 110.855 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.68 108.88 19.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 2.1299999999999999 111.014 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 61.9 p -111.14 -175.3 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.64000000000000001 110.703 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.7 mmt180 -47.68 91.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.04 111.48 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 32.9 mmt180 53.01 36.06 21.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.046 -0.524 . . . . 4.1100000000000003 111.396 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 54' ' ' ARG . 85.9 t -150.87 112.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 1.23 111.052 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -105.07 107.57 18.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.64000000000000001 110.643 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.72 157.31 17.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.162 -0.472 . . . . 1.54 110.951 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 50' ' ' HIS . 13.8 p -102.62 143.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.047 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 51' ' ' ILE . 96.5 mt -139.07 117.58 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.96999999999999997 110.777 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -92.48 169.78 10.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 3.3199999999999998 110.797 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -46.94 -27.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 4.7000000000000002 111.338 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -84.25 -42.43 15.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.38 . . . . 2.2799999999999998 111.17 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 -34.35 65.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 2.2999999999999998 110.973 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -81.27 -21.14 39.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.69999999999999996 111.134 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.63 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.66000000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.65 -65.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.47999999999999998 111.378 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.4 pt -65.08 140.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.482 -0.326 . . . . 0.42999999999999999 110.967 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.85 154.96 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 2.29 110.697 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -116.43 158.07 24.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 1.8500000000000001 110.774 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -146.24 154.39 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.2400000000000002 111.083 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.81 169.17 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.76000000000000001 111.122 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 1.1599999999999999 110.998 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 61.9 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.883 0.373 . . . . 2.25 110.836 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -118.54 152.39 51.04 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.66000000000000003 111.209 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.07 84.46 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.663 2.242 . . . . 0.65000000000000002 112.34 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -179.97 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.293 -0.412 . . . . 2.6899999999999999 110.901 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 42.1 t -103.07 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 1.8899999999999999 110.629 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.93 169.22 8.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.46999999999999997 111.101 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 78.7 m95 -146.41 168.34 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.68999999999999995 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 54.9 mtpt -124.24 138.05 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 2.04 111.129 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.478 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.1 mt -80.2 118.14 27.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.159 -0.473 . . . . 0.56000000000000005 111.159 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 18.9 m -130.37 53.17 1.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.96999999999999997 110.388 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' HA3' ' NH2' ' A' ' 23' ' ' ARG . . . -48.83 96.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.45000000000000001 112.627 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -145.53 95.95 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.81000000000000005 110.935 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -111.88 158.03 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.013 -0.539 . . . . 0.76000000000000001 110.778 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -51.78 -24.36 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 3.5800000000000001 110.729 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -158.29 42.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.789 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -41.07 128.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.802 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.0 t -80.22 147.38 64.68 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 1.5 110.782 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.3 Cg_endo -62.62 -28.43 76.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.625 2.216 . . . . 0.60999999999999999 112.501 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.02 -43.79 50.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.70999999999999996 111.052 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -85.29 -45.49 11.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 2.1699999999999999 111.2 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' NH2' ' HA3' ' A' ' 13' ' ' GLY . 18.3 tpp180 -67.58 -61.46 1.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.5700000000000001 111.43 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 11.1 mm100 -55.93 -19.59 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 111.629 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -80.25 -36.77 34.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 2.5899999999999999 110.993 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.74 -32.6 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 1.3 110.982 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -57.24 -33.73 67.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.94999999999999996 111.254 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.1 m -64.04 -39.63 94.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 1.6399999999999999 110.997 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.6 mm? -78.01 -23.23 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 1.6399999999999999 111.059 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.79 20.52 10.63 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.771 . . . . 0.81999999999999995 112.593 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.402 ' C ' HD12 ' A' ' 32' ' ' LEU . 1.1 mpt? -98.72 98.24 9.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 2.5499999999999998 110.988 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -102.51 157.93 32.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.68999999999999995 110.675 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' NH1' ' A' ' 23' ' ' ARG . 71.2 Cg_exo -47.46 111.19 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.391 2.061 . . . . 0.51000000000000001 111.803 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 21.39 4.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 0.40000000000000002 112.36 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -88.02 166.26 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.303 . . . . 0.62 110.639 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 49.7 m -121.85 156.92 32.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 1.3 111.044 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 51.9 p90 -166.64 178.82 5.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.488 . . . . 0.35999999999999999 110.831 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -128.3 125.61 39.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 2.9399999999999999 111.098 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' SER . 18.9 m -75.17 134.59 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.263 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.64 -52.09 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.54000000000000004 111.34 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -148.66 133.71 18.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 2.7999999999999998 111.083 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 43' ' ' ALA . 41.4 t -146.0 160.39 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.396 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -154.83 124.4 3.18 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.512 . . . . 0.81000000000000005 110.737 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.05 -24.45 49.12 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.475 2.117 . . . . 1.3400000000000001 112.491 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -63.45 -22.87 67.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 2.5099999999999998 111.067 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.06 73.65 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.572 -0.823 . . . . 0.77000000000000002 112.11 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.1 m-20 -122.4 170.11 8.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.731 0.301 . . . . 1.0700000000000001 111.172 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.93 120.34 2.28 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.975 2.45 . . . . 0.60999999999999999 111.724 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.6 p -106.74 159.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.783 -0.644 . . . . 0.39000000000000001 111.123 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 80.8 m80 -123.32 123.53 40.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 1.1299999999999999 110.804 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 47.7 pt -97.16 141.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.35999999999999999 111.021 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -106.67 120.89 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.342 -0.39 . . . . 2.1299999999999999 110.828 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.549 ' OG1' HG13 ' A' ' 56' ' ' VAL . 27.1 p -122.63 -163.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.884 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -46.45 93.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.067 0.461 . . . . 3.04 111.732 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' THR . 25.7 mmm180 44.44 28.59 0.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.81 -0.632 . . . . 4.1100000000000003 112.121 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -152.55 113.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 1.23 110.838 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -93.84 118.9 32.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.64000000000000001 111.315 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 tp -99.54 150.23 22.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 1.54 110.653 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' HD23 ' A' ' 60' ' ' LEU . 11.4 p -104.83 134.32 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.394 . . . . 0.5 111.296 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB2' HD11 ' A' ' 65' ' ' LEU . 83.7 mt -143.33 155.62 44.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 110.721 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' NH2' ' HD3' ' A' ' 63' ' ' LYS . 70.4 mtm180 -110.63 160.4 16.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.88 0.371 . . . . 3.3199999999999998 110.898 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -44.05 -28.2 0.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 4.7000000000000002 111.585 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 21.8 ptmt -80.73 -35.53 33.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 2.2799999999999998 110.88 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 7.3 m-20 -68.62 -31.49 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 2.2999999999999998 111.134 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 65' ' ' LEU . 5.8 mp -86.42 -25.69 25.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.69999999999999996 111.266 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.63 -58.43 6.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.66000000000000003 111.468 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.93 -59.05 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.47999999999999998 111.188 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.22 151.96 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.411 . . . . 0.42999999999999999 111.47 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 12' ' ' THR . 9.1 tp10 -95.78 136.15 36.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.573 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.5 mm? -110.0 139.71 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 1.8500000000000001 110.991 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.81 118.01 19.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 2.2400000000000002 110.817 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.89 148.16 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.76000000000000001 111.073 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 1.1599999999999999 111.136 -179.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.841 0.353 . . . . 2.25 110.601 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -88.41 154.66 51.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.66000000000000003 111.276 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.567 ' HA ' HG23 ' A' ' 39' ' ' VAL . 60.7 Cg_endo -72.85 92.89 0.78 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.507 2.138 . . . . 0.65000000000000002 112.354 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 176.29 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.535 . . . . 2.6899999999999999 110.702 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -104.41 146.4 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 1.8899999999999999 110.79 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.37 170.21 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.46999999999999997 111.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 35.2 m95 -155.41 160.4 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.68999999999999995 110.797 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -114.65 138.62 50.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 2.04 111.125 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 37' ' ' PHE . 57.3 mt -79.33 129.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.56000000000000005 111.191 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 62.8 p -134.72 58.73 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.96999999999999997 110.508 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.8 96.39 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.665 -0.698 . . . . 0.45000000000000001 112.696 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -147.16 98.55 3.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.81000000000000005 110.875 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.9 m -112.32 161.94 16.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.76000000000000001 110.829 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -22.44 34.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.314 -0.403 . . . . 3.5800000000000001 110.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -162.7 44.4 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 2.48 110.861 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -45.94 128.67 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.494 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -81.61 154.99 71.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 1.5 110.776 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.65 -28.19 69.2 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.615 2.21 . . . . 0.60999999999999999 112.241 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.34 -45.32 45.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.823 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 95.3 m-85 -85.46 -49.24 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 2.1699999999999999 110.503 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -57.74 -61.27 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.5700000000000001 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.481 ' NE2' HD12 ' A' ' 27' ' ' LEU . 27.9 mm-40 -51.02 -34.13 28.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 2.6899999999999999 110.731 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -51.75 -53.27 41.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 2.5899999999999999 110.949 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.03 -43.4 95.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 1.3 111.088 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.481 HD12 ' NE2' ' A' ' 24' ' ' GLN . 84.0 mt -48.78 -26.51 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.94999999999999996 111.186 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.4 t -69.56 -34.03 73.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 1.6399999999999999 110.974 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -94.34 -24.53 17.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.6399999999999999 110.921 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.58 9.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.653 -0.784 . . . . 0.81999999999999995 112.55 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.9 mtt -99.32 91.47 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 111.018 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -92.32 158.02 39.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.561 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.87 118.72 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.481 2.121 . . . . 0.51000000000000001 112.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.11 31.02 3.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.825 -0.702 . . . . 0.40000000000000002 112.398 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.6 t -95.57 173.89 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.62 110.875 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -121.84 148.94 44.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.3 110.943 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 36.1 p90 -162.22 173.1 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.35999999999999999 110.732 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 47.9 m-70 -128.56 130.33 47.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.956 0.408 . . . . 2.9399999999999999 111.233 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 5' ' ' PRO . 19.4 m -80.01 138.38 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.28 110.994 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 48.1 t -99.62 -40.49 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.54000000000000004 111.426 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 38.8 ptt180 -164.67 129.36 2.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.377 -0.374 . . . . 2.7999999999999998 110.913 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG21 ' A' ' 49' ' ' VAL . 10.0 t -138.14 159.15 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 1.2 111.159 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -122.32 146.23 46.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.995 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.06 -14.85 26.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.573 2.182 . . . . 1.3400000000000001 112.592 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -93.6 -50.32 5.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 2.5099999999999998 111.078 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.25 95.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.873 -0.68 . . . . 0.77000000000000002 112.259 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.9 m-20 -136.52 170.2 11.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.791 0.329 . . . . 1.0700000000000001 111.151 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.98 116.6 1.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.01 2.473 . . . . 0.60999999999999999 111.694 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 152.34 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 110.923 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 73.1 m80 -110.44 131.6 54.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 1.1299999999999999 110.517 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.489 HD11 HD23 ' A' ' 58' ' ' LEU . 30.9 pt -104.65 139.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.35999999999999999 111.227 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 39.3 tt0 -108.14 114.46 28.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.639 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.4 p -113.37 -173.82 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.64000000000000001 111.142 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -52.69 99.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 3.04 111.542 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 52.11 29.42 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 4.1100000000000003 111.651 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.1 t -149.4 128.48 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.23 111.16 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -109.92 107.78 17.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.64000000000000001 110.969 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 HD11 ' A' ' 51' ' ' ILE . 58.6 tp -105.0 156.71 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 1.54 111.235 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.99 132.86 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.182 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 65' ' ' LEU . 74.2 mt -118.18 140.32 49.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.96999999999999997 110.677 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 94.0 mtt180 -107.35 149.21 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 3.3199999999999998 110.959 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -27.93 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.976 -0.556 . . . . 4.7000000000000002 111.498 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -82.17 -29.94 31.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 2.2799999999999998 110.938 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 19.5 t70 -72.47 -30.18 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 2.2999999999999998 110.863 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -79.74 -29.7 40.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.69999999999999996 110.801 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.46 -23.7 10.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.66000000000000003 111.231 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 22' ' ' TYR . 67.7 mt -97.55 -63.75 1.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.438 . . . . 0.47999999999999998 111.146 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 44.6 pt -65.12 152.99 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.42999999999999999 111.081 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.2 tt0 -104.01 153.27 21.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.954 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -112.15 148.59 33.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 1.8500000000000001 110.591 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -131.19 128.67 40.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.331 . . . . 2.2400000000000002 110.853 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 156.27 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 111.288 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.079 -0.51 . . . . 1.1599999999999999 111.154 179.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CE1' HD23 ' A' ' 70' ' ' LEU . 51.8 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.745 0.307 . . . . 2.25 110.723 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -113.33 155.21 44.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.66000000000000003 111.642 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.96 89.55 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.564 2.176 . . . . 0.65000000000000002 112.024 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -179.98 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 2.6899999999999999 110.631 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -94.07 143.98 25.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 1.8899999999999999 110.729 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.17 160.18 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.46999999999999997 111.157 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 23.3 m95 -149.37 164.1 35.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.68999999999999995 110.674 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -114.2 136.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 2.04 111.12 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.4 mt -78.19 134.42 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 0.56000000000000005 111.045 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 12' ' ' THR . 24.4 m -136.26 57.88 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.96999999999999997 110.614 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.3 87.42 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.45000000000000001 112.937 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.07 94.76 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.376 . . . . 0.81000000000000005 110.713 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.6 m -101.27 -174.93 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -26.67 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 3.5800000000000001 110.947 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.91 29.6 1.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.078 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 18' ' ' ILE . 10.2 tt -43.69 119.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.401 . . . . 0.56999999999999995 111.413 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 p -80.64 156.58 72.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.031 -0.532 . . . . 1.5 110.756 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.9 Cg_endo -58.33 -30.83 92.34 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.593 2.195 . . . . 0.60999999999999999 112.399 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.84 59.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.70999999999999996 110.758 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -85.75 -37.65 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 2.1699999999999999 111.118 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.09 -61.56 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 1.5700000000000001 111.121 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 20' ' ' PRO . 6.3 tp-100 -56.58 -20.59 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.6899999999999999 111.366 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -69.88 -50.43 42.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.842 0.353 . . . . 2.5899999999999999 110.677 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.16 -37.71 80.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 1.3 110.984 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.6 mt -54.24 -25.73 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.94999999999999996 111.317 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -52.42 -45.5 65.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.937 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.4 mm? -96.91 -22.67 16.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 1.6399999999999999 111.103 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.34 23.82 8.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.81999999999999995 112.255 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.446 ' HE3' ' HB2' ' A' ' 31' ' ' MET . 50.4 mtm -84.15 89.81 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 2.5499999999999998 111.149 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -97.39 158.49 33.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.68999999999999995 110.836 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.89 109.32 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.443 2.095 . . . . 0.51000000000000001 111.973 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.16 29.15 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.703 -0.761 . . . . 0.40000000000000002 112.439 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -96.65 174.19 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.62 110.614 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.2 p -121.49 143.59 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 1.3 110.93 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 6.8 p90 -156.81 -176.58 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.35999999999999999 110.946 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -140.09 134.81 31.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 2.9399999999999999 110.985 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 42' ' ' VAL . 59.0 t -64.81 136.48 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 1.28 111.081 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -94.26 -40.74 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.54000000000000004 111.221 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -175.57 124.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.038 0.447 . . . . 2.7999999999999998 111.17 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.619 HG23 ' CG1' ' A' ' 39' ' ' VAL . 21.2 t -137.42 157.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.59 . . . . 1.2 111.131 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -116.91 154.51 49.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.81000000000000005 110.988 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.76 -19.34 18.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.565 2.177 . . . . 1.3400000000000001 112.525 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.47 -67.46 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 2.5099999999999998 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.08 105.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.809 -0.71 . . . . 0.77000000000000002 112.365 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 6.2 m-20 -148.14 171.27 6.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.536 0.207 . . . . 1.0700000000000001 111.228 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.06 120.06 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.74 2.293 . . . . 0.60999999999999999 111.486 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.26 152.79 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.612 -0.722 . . . . 0.39000000000000001 111.013 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.5 m-70 -109.82 135.86 50.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.605 -0.725 . . . . 1.1299999999999999 110.398 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 60' ' ' LEU . 36.9 pt -93.82 145.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.35999999999999999 111.039 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -106.84 109.18 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 2.1299999999999999 110.71 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -114.94 -170.2 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 111.167 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 25.3 tpp180 -48.96 96.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.333 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 35.2 ptt180 45.71 33.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 4.1100000000000003 111.884 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -151.44 116.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 1.23 110.993 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.6 p -103.04 109.99 21.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.64000000000000001 110.907 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.62 170.92 9.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 1.54 111.04 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 7.6 p -114.76 140.92 33.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.07 -0.514 . . . . 0.5 111.206 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 65' ' ' LEU . 91.4 mt -135.39 120.94 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.362 -0.381 . . . . 0.96999999999999997 111.181 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.657 ' O ' HD13 ' A' ' 65' ' ' LEU . 33.6 mmt180 -65.83 -168.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.3199999999999998 110.551 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 2.6 mppt? -81.35 -36.7 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.435 -0.348 . . . . 4.7000000000000002 111.455 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -86.1 -33.27 20.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.2799999999999998 111.377 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.74 -24.54 2.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.2999999999999998 110.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.9 mp -85.35 -22.09 28.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.284 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.38 90.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.444 -0.344 . . . . 0.66000000000000003 111.637 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.1 -59.0 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.47999999999999998 111.127 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 pt -65.6 142.42 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.42999999999999999 111.203 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.06 148.69 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 2.29 110.873 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.9 tp -117.01 159.16 22.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 1.8500000000000001 111.052 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.36 147.65 43.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.34 166.85 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.76000000000000001 111.004 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 1.1599999999999999 111.046 179.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.756 0.312 . . . . 2.25 111.066 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -104.74 155.94 36.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.66000000000000003 111.072 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.51 90.83 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.51 2.14 . . . . 0.65000000000000002 112.361 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 p30 176.89 -37.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 2.6899999999999999 110.892 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.0 m -100.96 153.52 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 1.8899999999999999 110.967 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.52 158.5 15.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.46999999999999997 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 45.2 m95 -139.64 178.05 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.68999999999999995 110.756 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -125.17 138.1 54.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 2.04 111.279 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 49.9 mt -75.64 125.81 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.56000000000000005 110.704 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 12' ' ' THR . 9.8 m -139.78 46.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.175 0.512 . . . . 0.96999999999999997 110.837 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.7 86.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.845 -0.693 . . . . 0.45000000000000001 112.598 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' THR . 92.0 t80 -143.14 94.89 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.81000000000000005 110.688 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -97.32 -175.15 3.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.76000000000000001 111.032 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -85.49 -28.77 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 3.5800000000000001 110.788 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -141.03 30.25 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 2.48 110.9 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -41.94 148.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 111.656 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.0 m -107.31 156.54 37.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.122 -0.49 . . . . 1.5 110.87 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 32.9 Cg_endo -63.97 -28.6 66.56 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.216 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -47.08 -46.89 22.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.70999999999999996 110.863 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CD2' ' OD2' ' A' ' 64' ' ' ASP . 75.6 m-85 -86.57 -46.17 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 2.1699999999999999 110.561 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.5 tpt180 -56.4 -58.05 9.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 1.5700000000000001 111.289 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -43.94 -28.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 2.6899999999999999 111.703 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 30.9 mmmt -65.81 -41.08 92.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 2.5899999999999999 111.004 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.7 mm? -72.34 -54.98 7.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.157 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 mt -50.67 -29.1 10.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.94999999999999996 111.162 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.7 m -77.48 -28.89 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 1.6399999999999999 111.099 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -25.4 18.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.6399999999999999 111.205 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.69 23.93 19.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.654 -0.784 . . . . 0.81999999999999995 112.892 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.18 90.48 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 2.5499999999999998 110.623 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -84.47 160.81 55.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.703 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 85.7 Cg_exo -44.85 120.3 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.305 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.52 22.1 5.23 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.873 -0.68 . . . . 0.40000000000000002 112.489 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.8 t -93.56 174.17 7.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.62 110.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -117.25 158.8 23.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 1.3 111.13 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 28.0 p90 -168.43 168.41 11.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.35999999999999999 110.626 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -120.53 152.34 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 2.9399999999999999 110.998 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' CG1' HG23 ' A' ' 42' ' ' VAL . 46.0 t -87.75 136.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 1.28 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.5 -40.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.54000000000000004 111.429 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -169.69 125.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.38 . . . . 2.7999999999999998 110.886 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG23 ' CG1' ' A' ' 39' ' ' VAL . 60.7 t -137.38 158.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.296 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.506 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -145.48 109.78 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.81000000000000005 111.059 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -43.32 -34.1 4.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 1.3400000000000001 112.745 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.18 -26.59 28.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 2.5099999999999998 111.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.2 90.09 1.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.77000000000000002 112.044 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.6 m-20 -143.87 172.01 6.1 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.647 0.26 . . . . 1.0700000000000001 111.04 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.31 121.77 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.769 2.313 . . . . 0.60999999999999999 111.687 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.4 p -106.43 158.96 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.665 -0.698 . . . . 0.39000000000000001 111.007 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 12.5 m-70 -114.83 131.41 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.673 . . . . 1.1299999999999999 110.605 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -101.84 141.91 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 110.987 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.02 108.41 19.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.071 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -108.17 -169.59 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.948 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -55.46 96.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 3.04 111.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 52.39 30.55 8.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 4.1100000000000003 111.723 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -151.4 112.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.965 0.412 . . . . 1.23 111.388 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -97.15 109.95 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.637 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 74.6 mt -99.79 163.35 12.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.154 -0.475 . . . . 1.54 111.245 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 12.0 p -121.76 137.96 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.5 110.871 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD13 ' CD1' ' A' ' 68' ' ' ILE . 86.2 mt -127.53 136.27 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.96999999999999997 110.954 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . 99.4 mtt180 -85.83 150.83 24.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 3.3199999999999998 110.915 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -45.64 -30.26 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 4.7000000000000002 111.454 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -83.17 -39.24 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 2.2799999999999998 111.191 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' CD2' ' A' ' 22' ' ' TYR . 9.0 t70 -57.96 -29.56 65.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 2.2999999999999998 111.046 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.1 mp -76.26 -20.25 57.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.69999999999999996 111.281 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.24 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.557 -0.292 . . . . 0.66000000000000003 111.441 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.99 -54.32 3.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.747 0.308 . . . . 0.47999999999999998 111.295 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' CD1' HD13 ' A' ' 60' ' ' LEU . 36.2 pt -65.61 152.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.42999999999999999 111.035 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 7.6 tp10 -105.02 149.29 25.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 2.29 111.014 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -130.51 139.51 50.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.8500000000000001 110.96 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -116.3 129.97 56.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 2.2400000000000002 110.792 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.57 20.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.76000000000000001 111.047 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 1.1599999999999999 111.372 -179.703 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.3 p90 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.894 0.378 . . . . 2.25 110.745 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 46.2 p -86.08 156.22 57.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.66000000000000003 111.259 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 73.2 Cg_endo -74.27 90.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.637 2.224 . . . . 0.65000000000000002 112.284 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 178.32 -42.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 110.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.3 m -92.17 141.84 28.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 110.929 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.98 164.17 25.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.46999999999999997 111.089 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 42.5 m95 -147.84 169.53 19.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.68999999999999995 110.645 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' SER . 57.8 mttp -114.87 137.03 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 2.04 111.099 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 42.1 mt -78.34 122.92 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 110.955 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 12' ' ' THR . 32.1 m -136.16 51.45 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.96999999999999997 110.806 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.42 96.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.957 -0.639 . . . . 0.45000000000000001 112.638 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -147.29 94.98 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.81000000000000005 110.813 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 25.6 t -105.29 -172.42 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.76000000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -21.89 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.009 -0.542 . . . . 3.5800000000000001 111.188 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -156.5 33.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.455 -0.339 . . . . 2.48 111.159 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 5.6 tt -46.89 122.61 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.56999999999999995 111.281 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.3 p -76.79 155.58 83.05 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 1.5 110.826 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.77 -29.87 77.41 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.616 2.211 . . . . 0.60999999999999999 112.488 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.22 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.011 0.434 . . . . 0.70999999999999996 110.41 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -85.75 -28.93 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 111.02 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NH1' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -76.04 -61.73 1.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 1.5700000000000001 111.029 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -53.4 -27.64 25.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.347 -0.388 . . . . 2.6899999999999999 110.947 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -50.67 -32.1 18.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 2.5899999999999999 111.153 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.9 mp -84.02 -42.31 16.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 1.3 111.251 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' NH1' ' A' ' 23' ' ' ARG . 73.2 mt -49.03 -25.81 2.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.94999999999999996 111.238 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 29' ' ' LEU . 73.7 p -65.6 -37.54 86.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 1.6399999999999999 110.935 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -91.07 -24.04 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 1.6399999999999999 110.898 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.9 16.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.652 -0.785 . . . . 0.81999999999999995 112.467 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 51.9 mtm -98.43 99.33 10.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 2.5499999999999998 110.795 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.7 mp -95.48 160.94 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.68999999999999995 110.816 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 80.2 Cg_exo -41.11 114.03 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.601 2.201 . . . . 0.51000000000000001 112.282 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.17 33.02 1.56 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.40000000000000002 112.174 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 39.8 t -100.58 174.78 5.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.612 0.244 . . . . 0.62 110.807 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.7 t -120.18 154.7 34.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 1.3 110.876 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.8 p90 -167.62 177.26 5.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.35999999999999999 110.751 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 76.6 t60 -128.82 155.18 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 2.9399999999999999 111.033 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 42' ' ' VAL . 66.1 t -92.78 134.88 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 1.28 110.906 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.21 -51.44 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.54000000000000004 111.461 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 16.9 ptm180 -155.49 123.79 5.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 2.7999999999999998 111.263 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 49' ' ' VAL . 46.6 t -135.69 158.79 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 1.2 111.025 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.498 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -124.87 152.89 70.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.81000000000000005 111.09 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.25 -30.78 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.8 2.334 . . . . 1.3400000000000001 112.856 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.11 -26.69 39.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 2.5099999999999998 111.129 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 104.13 1.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.723 -0.751 . . . . 0.77000000000000002 112.167 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.3 m-20 -147.86 170.67 7.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.07 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.5 120.71 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.928 2.419 . . . . 0.60999999999999999 111.69 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.96 159.12 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.82 -0.627 . . . . 0.39000000000000001 111.264 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 59' ' ' VAL . 53.2 m-70 -114.35 137.03 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 1.1299999999999999 110.448 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -102.11 141.18 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.35999999999999999 111.63 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.61 107.75 18.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.942 -0.572 . . . . 2.1299999999999999 110.507 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.3 p -113.96 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.64000000000000001 111.094 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.7 mmt180 -49.61 102.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 3.04 111.428 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 29.4 ptt180 44.81 37.01 2.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 4.1100000000000003 112.056 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 54' ' ' ARG . 99.1 t -151.52 126.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 1.23 111.118 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.6 t -109.98 107.73 17.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.64000000000000001 110.666 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 77.9 mt -106.95 156.8 18.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 1.54 111.233 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 8.0 p -112.96 134.71 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.5 110.992 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CB ' HD11 ' A' ' 65' ' ' LEU . 70.5 mt -122.31 134.22 54.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.96999999999999997 110.757 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -97.35 160.68 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.3199999999999998 110.848 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -51.48 -23.52 4.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 4.7000000000000002 110.965 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -85.08 -27.88 26.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 2.2799999999999998 110.815 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.25 -32.75 61.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 2.2999999999999998 110.823 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.7 mp -79.44 -21.69 45.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.69999999999999996 111.075 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.18 62.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.66000000000000003 111.589 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.55 -58.94 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.75 0.31 . . . . 0.47999999999999998 111.353 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.4 pt -65.94 158.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.42999999999999999 111.345 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.4 tp10 -111.53 141.74 44.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.29 110.695 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -117.16 142.27 47.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 1.8500000000000001 111.086 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -128.02 122.94 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 2.2400000000000002 110.718 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.27 175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.76000000000000001 111.327 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.1599999999999999 111.129 179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m-85 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.78 0.324 . . . . 2.25 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -112.27 153.86 44.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.66000000000000003 111.203 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . 59.2 Cg_endo -71.74 89.38 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.56 2.173 . . . . 0.65000000000000002 112.437 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t70 176.69 -37.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 2.6899999999999999 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -101.42 144.34 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 1.8899999999999999 110.934 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.16 167.16 21.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.46999999999999997 110.955 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.6 m95 -151.74 174.78 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.95 0.405 . . . . 0.68999999999999995 111.198 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -127.23 135.42 50.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 2.04 110.988 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 64.0 mt -72.92 133.17 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.56000000000000005 111.13 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 12' ' ' THR . 13.9 m -137.45 48.95 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.456 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.8 89.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.856 -0.688 . . . . 0.45000000000000001 112.658 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -147.09 95.42 2.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.81000000000000005 110.866 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -102.14 160.4 14.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.943 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -17.75 62.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 3.5800000000000001 111.232 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -154.06 34.0 0.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.59 0.233 . . . . 2.48 111.415 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 tt -47.36 128.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.598 -0.274 . . . . 0.56999999999999995 111.281 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.9 p -87.76 156.55 52.75 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 1.5 110.84 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -65.44 -28.92 53.93 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.462 2.108 . . . . 0.60999999999999999 112.482 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.05 -48.35 22.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.70999999999999996 110.772 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 52.5 t80 -86.62 -46.08 10.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 2.1699999999999999 110.787 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 18.2 tpt180 -56.05 -56.19 23.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 1.5700000000000001 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -45.73 -34.2 3.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 2.6899999999999999 111.371 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.73 -27.88 67.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 2.5899999999999999 111.106 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.81 -55.12 5.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.3 110.912 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -48.2 -30.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.94999999999999996 111.187 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -75.97 -32.04 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.6399999999999999 111.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CD1' HD22 ' A' ' 58' ' ' LEU . 80.0 mt -90.1 -23.09 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.6399999999999999 111.032 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.72 10.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.81999999999999995 112.358 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.401 ' C ' HD12 ' A' ' 32' ' ' LEU . 65.1 mtt -109.01 91.51 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 2.5499999999999998 110.874 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -104.65 160.24 26.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.68999999999999995 110.83 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 71.1 Cg_exo -46.82 115.26 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.427 2.084 . . . . 0.51000000000000001 112.094 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.9 19.22 8.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.806 -0.712 . . . . 0.40000000000000002 112.612 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 43.7 t -92.94 172.36 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.62 110.787 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.0 m -116.39 153.56 31.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 1.3 111.182 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.3 p90 -164.76 163.02 21.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.35999999999999999 110.52 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -115.72 117.48 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 2.9399999999999999 111.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.66 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.086 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.91 -47.74 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.393 -0.367 . . . . 0.54000000000000004 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 36.9 ptt180 -162.16 138.01 7.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.915 0.388 . . . . 2.7999999999999998 111.228 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' ALA . 19.5 t -145.78 159.31 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.2 111.078 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -121.54 155.86 58.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.81000000000000005 111.123 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.42 -26.99 8.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 1.3400000000000001 112.685 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.9 -52.52 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 2.5099999999999998 111.02 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.98 111.92 0.3 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.734 -0.746 . . . . 0.77000000000000002 112.417 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.1 m-20 -148.16 172.74 4.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.639 0.257 . . . . 1.0700000000000001 111.09 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.9 Cg_endo -84.35 117.24 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.961 2.441 . . . . 0.60999999999999999 111.654 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.4 p -106.79 154.12 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.39000000000000001 111.068 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -119.68 142.2 48.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.606 . . . . 1.1299999999999999 110.805 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 37' ' ' PHE . 38.6 pt -114.72 136.55 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.35999999999999999 111.371 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.08 115.98 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 2.1299999999999999 110.426 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.471 ' OG1' HG13 ' A' ' 56' ' ' VAL . 37.5 p -130.25 -167.76 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.64000000000000001 111.273 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HG12 ' A' ' 56' ' ' VAL . 40.0 mmt180 -41.4 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.973 0.416 . . . . 3.04 112.018 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' THR . 79.8 mtm180 41.37 53.15 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 4.1100000000000003 111.923 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.1 p -171.89 116.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.23 111.449 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -104.65 108.11 19.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 0.64000000000000001 110.515 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' A' ' 29' ' ' LEU . 48.4 tp -100.16 158.44 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 1.54 110.98 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 60' ' ' LEU . 13.3 p -106.82 153.33 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.5 111.118 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 59' ' ' VAL . 97.1 mt -144.81 119.45 9.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.96999999999999997 111.023 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -77.51 -173.11 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 3.3199999999999998 110.91 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -75.1 -28.14 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 4.7000000000000002 111.153 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.44 -35.33 25.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.348 -0.387 . . . . 2.2799999999999998 111.036 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.86 -30.93 71.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 2.2999999999999998 110.754 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 68' ' ' ILE . 26.7 mt -76.5 -24.77 53.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.69999999999999996 111.035 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.06 71.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.66000000000000003 111.341 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.81 -58.16 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.47999999999999998 111.361 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.514 ' CG2' ' CE1' ' A' ' 22' ' ' TYR . 31.3 pt -65.52 149.66 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.42999999999999999 111.256 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' C ' HD22 ' A' ' 70' ' ' LEU . 6.3 tp10 -109.77 151.56 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 2.29 110.635 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -118.91 148.1 43.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 110.675 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.34 145.19 43.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 2.2400000000000002 110.852 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.4 172.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.76000000000000001 110.953 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 1.1599999999999999 111.233 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.817 0.341 . . . . 2.25 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -114.17 154.19 46.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.66000000000000003 111.204 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.29 89.73 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.531 2.154 . . . . 0.65000000000000002 112.432 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 178.24 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 2.6899999999999999 110.918 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.2 m -106.25 170.21 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.56 169.33 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.46999999999999997 111.044 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CA ' HG13 ' A' ' 73' ' ' VAL . 52.1 m95 -151.1 162.08 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.68999999999999995 110.583 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 5.8 ptpp? -107.61 137.85 44.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 2.04 110.987 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.8 mt -83.1 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.56000000000000005 111.235 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' GLU . 23.6 m -135.92 56.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.96999999999999997 110.286 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.45 96.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.701 -0.682 . . . . 0.45000000000000001 112.745 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -147.14 97.38 2.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.341 . . . . 0.81000000000000005 110.708 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.1 m -108.61 -174.34 2.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.76000000000000001 110.977 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.3 mpt_? -74.78 -27.26 60.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 3.5800000000000001 110.881 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.91 42.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.48 110.81 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 18' ' ' ILE . 5.7 tt -45.7 109.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.277 -0.42 . . . . 0.56999999999999995 111.172 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.0 p -59.63 155.8 37.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 1.5 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 21.8 Cg_endo -61.07 -30.47 89.41 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.60999999999999999 112.101 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.63 -46.25 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.414 . . . . 0.70999999999999996 110.897 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.98 -35.3 20.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.51 . . . . 2.1699999999999999 111.148 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.1 tpt180 -70.94 -61.04 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.524 . . . . 1.5700000000000001 111.612 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -42.75 -34.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.506 -0.316 . . . . 2.6899999999999999 111.839 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.29 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 2.5899999999999999 111.103 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.21 -53.63 55.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 1.3 111.075 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -48.85 -46.23 41.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 0.94999999999999996 111.203 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -55.59 -49.25 73.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 1.6399999999999999 111.05 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 58' ' ' LEU . 73.5 mt -71.75 -25.17 61.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 1.6399999999999999 110.885 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 19.54 27.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 0.81999999999999995 112.774 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.4 mtt -95.03 87.05 4.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.726 0.298 . . . . 2.5499999999999998 110.792 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.7 mp -92.2 159.65 36.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.68999999999999995 110.499 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.96 132.22 17.43 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.298 1.999 . . . . 0.51000000000000001 111.757 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.37 38.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.75 -0.738 . . . . 0.40000000000000002 112.267 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -82.22 174.24 11.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.685 0.278 . . . . 0.62 110.582 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.4 p -125.89 137.83 53.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 1.3 110.733 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 9.6 p90 -150.53 157.64 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 111.003 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -108.51 146.87 32.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.9399999999999999 110.855 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.0 t -84.93 128.32 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 1.28 111.144 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.93 -47.54 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.54000000000000004 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -168.28 129.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 2.7999999999999998 110.814 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG22 ' HB ' ' A' ' 49' ' ' VAL . 39.5 t -141.56 156.56 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.368 . . . . 1.2 111.339 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.88 141.65 41.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.81000000000000005 110.825 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.97 -21.23 37.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.497 2.131 . . . . 1.3400000000000001 112.658 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 mt -85.74 -48.95 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 2.5099999999999998 110.882 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.65 105.61 0.37 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.762 -0.732 . . . . 0.77000000000000002 112.497 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.9 m-20 -148.11 171.06 6.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 110.804 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.48 118.75 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.878 2.385 . . . . 0.60999999999999999 111.788 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.65 161.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 0.39000000000000001 111.123 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.458 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 79.2 m80 -125.07 148.37 48.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 1.1299999999999999 110.467 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.3 pt -115.56 138.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.35999999999999999 111.446 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.95 112.97 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 2.1299999999999999 110.612 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.533 ' OG1' HG13 ' A' ' 56' ' ' VAL . 41.7 p -126.7 -175.98 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.387 . . . . 0.64000000000000001 111.343 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -41.59 95.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.964 -0.562 . . . . 3.04 112.101 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 43.28 54.79 4.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 4.1100000000000003 112.089 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.4 p -175.78 113.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 1.23 111.29 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -100.49 112.18 24.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 0.64000000000000001 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 29' ' ' LEU . 38.0 tp -105.73 148.58 27.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.797 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HB ' ' CD2' ' A' ' 50' ' ' HIS . 8.8 p -99.56 140.71 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.315 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' HD11 ' A' ' 65' ' ' LEU . 95.8 mt -140.44 166.12 25.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.96999999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 80.7 mtp180 -130.3 152.82 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 3.3199999999999998 110.896 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.4 tpmt? -50.49 -24.81 3.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.969 -0.56 . . . . 4.7000000000000002 111.523 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.37 -28.67 34.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.894 0.378 . . . . 2.2799999999999998 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.28 -33.08 29.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 2.2999999999999998 111.068 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.8 mp -71.43 -20.7 62.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.69999999999999996 111.267 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.15 84.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.505 -0.316 . . . . 0.66000000000000003 111.468 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.31 -56.59 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.47999999999999998 111.257 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 65' ' ' LEU . 28.7 pt -66.96 151.91 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.42999999999999999 111.102 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 70' ' ' LEU . 33.0 tt0 -100.49 128.96 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.29 110.59 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 69' ' ' GLU . 5.3 mp -118.45 136.14 53.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 1.8500000000000001 111.077 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 38.4 tt0 -130.23 156.53 44.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 2.2400000000000002 110.755 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 133.43 51.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.113 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 9' ' ' TRP . 32.7 m . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.735 0.302 . . . . 5.1699999999999999 110.98 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -85.92 163.98 17.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 2.9399999999999999 111.011 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -111.43 110.73 21.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 2.25 110.805 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.8 p -108.92 150.05 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.66000000000000003 111.466 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 85.57 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.562 2.175 . . . . 0.65000000000000002 112.357 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.6 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 2.6899999999999999 110.867 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -84.84 164.27 18.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 1.8899999999999999 110.986 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.7 165.45 11.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.46999999999999997 111.241 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 61.1 m95 -155.07 174.55 15.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.68999999999999995 110.832 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -127.6 134.34 49.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 2.04 111.05 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.451 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.1 mt -74.52 126.09 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.56000000000000005 111.346 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -139.74 48.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.826 -0.625 . . . . 0.96999999999999997 110.572 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.72 91.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.866 -0.683 . . . . 0.45000000000000001 112.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -147.23 96.97 2.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.64 0.257 . . . . 0.81000000000000005 110.786 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -105.79 -175.79 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.76000000000000001 110.803 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.2 mpt_? -86.31 -21.67 27.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 3.5800000000000001 111.047 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -147.44 28.19 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.463 -0.335 . . . . 2.48 111.178 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 18' ' ' ILE . 14.6 tt -46.17 122.66 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 0.56999999999999995 111.369 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -72.82 155.43 90.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 1.5 110.929 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 24' ' ' GLN . 37.9 Cg_endo -66.42 -27.71 46.87 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.503 2.136 . . . . 0.60999999999999999 112.268 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.64 -45.15 57.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.70999999999999996 110.83 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -85.78 -37.27 19.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.992 -0.549 . . . . 2.1699999999999999 111.129 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -70.58 -61.34 1.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 1.5700000000000001 111.359 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' PRO . 51.8 tt0 -57.88 -18.64 23.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 2.6899999999999999 111.537 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -75.32 -57.56 3.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 2.5899999999999999 111.149 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -50.0 -30.88 11.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.033 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.0 mt -51.57 -34.04 35.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.94999999999999996 111.013 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.4 p -62.88 -29.47 70.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.6399999999999999 111.092 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.33 -24.43 24.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 1.6399999999999999 111.012 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.92 20.63 59.11 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.671 -0.776 . . . . 0.81999999999999995 112.465 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.4 mmt -102.31 91.57 4.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 2.5499999999999998 110.846 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -88.26 160.6 45.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.02 -0.536 . . . . 0.68999999999999995 110.79 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 87.7 Cg_exo -42.37 112.78 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.525 2.15 . . . . 0.51000000000000001 112.417 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 30.34 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 0.40000000000000002 112.454 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.8 t -102.1 174.1 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.62 110.878 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -119.06 138.95 52.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.467 . . . . 1.3 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.451 ' CD1' HG13 ' A' ' 11' ' ' ILE . 23.7 p90 -153.37 159.89 42.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.35999999999999999 111.018 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 52' ' ' GLU . 73.3 m80 -114.41 160.76 18.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.426 . . . . 2.9399999999999999 110.82 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.8 t -98.37 134.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 1.28 111.222 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.5 t -94.98 -49.53 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.54000000000000004 111.08 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.77 138.44 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 2.7999999999999998 110.832 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.474 HG22 ' CG2' ' A' ' 49' ' ' VAL . 19.7 t -146.16 157.97 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 1.2 111.388 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.58 147.37 52.82 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.81000000000000005 111.065 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.11 -20.47 19.07 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.657 2.238 . . . . 1.3400000000000001 112.663 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 tp -92.84 -46.41 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.387 -0.37 . . . . 2.5099999999999998 111.059 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.33 100.3 0.2 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 0.77000000000000002 112.306 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.2 m-20 -139.38 170.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.671 0.272 . . . . 1.0700000000000001 111.018 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.81 117.19 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.942 2.428 . . . . 0.60999999999999999 111.647 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 157.17 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.823 -0.626 . . . . 0.39000000000000001 110.874 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.416 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.5 m-70 -121.04 136.45 54.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 1.1299999999999999 110.72 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 58' ' ' LEU . 31.8 pt -102.08 143.84 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.35999999999999999 111.136 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' HIS . 7.7 mm-40 -106.77 110.58 22.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 2.1299999999999999 110.755 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.1 p -112.08 -174.33 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.068 -0.515 . . . . 0.64000000000000001 111.063 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -52.43 94.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 3.04 111.479 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 53.23 38.19 27.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 4.1100000000000003 111.691 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.8 t -155.44 132.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.713 0.292 . . . . 1.23 111.093 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 t -112.21 107.83 16.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.64000000000000001 111.148 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 51' ' ' ILE . 50.4 tp -101.54 154.07 19.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.15 -0.477 . . . . 1.54 110.55 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.52 139.11 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 0.5 111.183 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.39 166.18 20.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.512 . . . . 0.96999999999999997 110.756 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HD3' ' NZ ' ' A' ' 63' ' ' LYS . 95.5 mtt180 -124.63 136.43 53.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 3.3199999999999998 110.79 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.0 tpmt? -45.96 -29.36 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 4.7000000000000002 111.253 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' NZ ' ' HD3' ' A' ' 61' ' ' ARG . 21.3 pttm -84.41 -31.61 24.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.937 0.399 . . . . 2.2799999999999998 110.393 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ARG . 18.5 t70 -69.49 -35.95 76.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 2.2999999999999998 110.617 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -63.0 -23.58 67.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.69999999999999996 110.989 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.17 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.38 . . . . 0.66000000000000003 111.28 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -83.47 -61.03 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.464 -0.334 . . . . 0.47999999999999998 111.202 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 pt -65.32 144.52 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.42999999999999999 111.183 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -93.26 154.44 18.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 2.29 110.847 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.46 148.98 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 1.8500000000000001 111.05 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -134.43 115.31 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 2.2400000000000002 110.738 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.39 53.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.76000000000000001 111.092 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.4 -178.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.1599999999999999 111.234 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.94 101.82 14.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 2.2799999999999998 111.2 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 5.1299999999999999 110.856 179.757 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.782 0.325 . . . . 5.1699999999999999 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -135.62 -176.52 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 2.9399999999999999 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 70' ' ' LEU . 83.1 m-85 -99.65 105.34 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 2.25 110.802 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.0 p -112.03 154.85 44.09 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.66000000000000003 111.173 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.527 2.151 . . . . 0.65000000000000002 112.362 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 177.77 -43.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 110.794 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 m -89.54 149.31 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.8899999999999999 110.788 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.79 146.83 23.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.222 -0.445 . . . . 0.46999999999999997 111.18 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 38.8 m95 -133.64 174.06 10.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.68999999999999995 110.671 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -122.1 138.23 54.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.351 -0.386 . . . . 2.04 111.093 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CD1' ' CE ' ' A' ' 31' ' ' MET . 53.5 mt -77.31 138.9 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.56000000000000005 111.14 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 17.7 m -142.48 50.47 1.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.933 -0.576 . . . . 0.96999999999999997 110.434 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.08 91.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.773 -0.648 . . . . 0.45000000000000001 112.9 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 47.3 t80 -147.25 99.22 3.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.81000000000000005 110.693 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -101.84 -172.66 2.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.409 . . . . 0.76000000000000001 111.075 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.0 mpt_? -77.89 -29.85 50.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.078 -0.51 . . . . 3.5800000000000001 110.911 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.22 40.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 2.48 110.981 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.21 130.73 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.335 -0.393 . . . . 0.56999999999999995 111.401 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.3 m -80.64 156.73 72.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 1.5 110.906 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 18.1 Cg_endo -58.39 -33.03 97.47 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.516 2.144 . . . . 0.60999999999999999 112.166 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.92 -43.52 59.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.104 0.478 . . . . 0.70999999999999996 110.326 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -85.67 -43.46 13.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.71 -0.677 . . . . 2.1699999999999999 110.514 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.4 tpt180 -62.56 -61.67 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 1.5700000000000001 111.041 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 20' ' ' PRO . 89.8 mt-30 -52.2 -32.21 35.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.453 -0.339 . . . . 2.6899999999999999 110.833 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -51.04 -40.68 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 2.5899999999999999 111.021 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.4 mm? -84.5 -38.7 19.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 1.3 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.87 -33.45 23.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.94999999999999996 110.99 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -63.12 -50.73 69.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.133 -0.485 . . . . 1.6399999999999999 110.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.37 -23.82 60.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 1.6399999999999999 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.06 18.94 25.41 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.761 -0.733 . . . . 0.81999999999999995 112.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.488 ' CE ' ' CD1' ' A' ' 11' ' ' ILE . 65.4 mtp -91.43 94.77 9.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.876 0.37 . . . . 2.5499999999999998 110.923 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -103.12 159.7 28.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.857 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.72 111.9 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.569 2.18 . . . . 0.51000000000000001 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.11 25.64 3.49 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.919 -0.657 . . . . 0.40000000000000002 112.302 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.2 t -93.51 163.47 13.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.62 110.709 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.7 m -111.01 142.8 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.929 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 11' ' ' ILE . 24.1 p90 -155.1 162.72 40.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.35999999999999999 110.844 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -114.55 148.04 38.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 2.9399999999999999 111.002 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 t -86.88 113.1 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 1.28 110.868 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.9 t -78.81 -52.38 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.54000000000000004 111.398 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -169.25 121.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 2.7999999999999998 111.107 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -140.32 158.08 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.2 110.944 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -113.94 140.32 24.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.81000000000000005 111.407 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.15 -26.81 83.1 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.554 2.169 . . . . 1.3400000000000001 112.351 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -80.41 -65.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.324 -0.398 . . . . 2.5099999999999998 110.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 169.27 100.76 0.14 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.712 -0.756 . . . . 0.77000000000000002 112.334 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.3 m-20 -144.48 171.24 6.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.609 0.242 . . . . 1.0700000000000001 111.025 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.63 113.64 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.955 2.437 . . . . 0.60999999999999999 111.677 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.77 140.69 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 111.173 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 44.5 m-70 -99.67 137.63 37.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.905 -0.589 . . . . 1.1299999999999999 110.611 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -108.67 140.65 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.35999999999999999 111.198 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -107.29 109.47 21.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 2.1299999999999999 110.81 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.1 p -107.37 -172.85 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.64000000000000001 111.087 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -50.93 96.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.04 111.405 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 52.53 26.24 4.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 4.1100000000000003 111.696 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -146.75 120.68 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.4 . . . . 1.23 111.117 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -104.22 107.93 19.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.64000000000000001 110.912 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -103.37 160.28 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 1.54 110.669 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.64 138.3 48.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.369 . . . . 0.5 111.132 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.15 155.41 50.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.96999999999999997 110.874 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 64' ' ' ASP . 75.2 mtp180 -122.12 155.62 35.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 3.3199999999999998 111.058 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 5.6 mmpt? -44.2 -28.93 0.56 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.078 -0.51 . . . . 4.7000000000000002 111.486 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 pttt -76.43 -36.09 58.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.281 -0.418 . . . . 2.2799999999999998 110.874 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' ARG . 13.2 m-20 -74.41 -34.47 63.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.825 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.1 mp -74.58 -26.57 60.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.69999999999999996 110.937 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.24 -25.33 63.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.66000000000000003 111.163 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.6 -58.47 2.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.47999999999999998 111.124 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.0 pt -67.64 154.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.42999999999999999 110.904 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 12' ' ' THR . 8.3 tp10 -102.88 155.74 18.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 2.29 110.974 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 92.1 mt -128.84 165.66 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.082 -0.508 . . . . 1.8500000000000001 110.753 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.51 149.08 30.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 2.2400000000000002 111.023 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.47 -174.41 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 110.903 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 m -131.43 -177.78 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 1.1599999999999999 111.023 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.74 135.64 57.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.2799999999999998 111.189 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.037 -0.529 . . . . 5.1299999999999999 110.732 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mtp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.862 0.363 . . . . 5.1699999999999999 110.95 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -67.7 141.96 56.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 2.9399999999999999 110.934 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -66.23 106.71 1.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 2.25 110.957 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -116.23 156.26 47.3 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.66000000000000003 111.381 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.81 141.61 27.77 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.724 2.283 . . . . 0.65000000000000002 112.396 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 66.24 21.02 11.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 2.6899999999999999 111.518 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.6 p -88.17 159.79 18.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.8899999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.19 135.44 53.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 0.46999999999999997 111.06 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 54.1 m95 -151.42 157.22 42.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.68999999999999995 110.572 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' SER . 62.7 mttp -99.52 135.09 41.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.313 -0.403 . . . . 2.04 110.745 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.496 HG13 ' CD1' ' A' ' 37' ' ' PHE . 54.9 mt -77.3 132.39 32.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.039 -0.528 . . . . 0.56000000000000005 111.328 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' PHE . 9.2 m -139.51 44.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.009 -0.541 . . . . 0.96999999999999997 110.391 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.21 89.74 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.917 -0.659 . . . . 0.45000000000000001 112.581 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' THR . 89.9 t80 -147.7 94.89 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.81000000000000005 110.828 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 m -100.39 161.86 13.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.76000000000000001 110.857 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -58.77 -19.15 38.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.5800000000000001 111.369 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -165.55 42.26 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.69 0.281 . . . . 2.48 111.401 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.45 139.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.347 -0.388 . . . . 0.56999999999999995 111.325 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.5 p -88.41 156.37 50.98 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 1.5 110.895 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.45 -30.39 90.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.621 2.214 . . . . 0.60999999999999999 112.347 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.71 -46.61 50.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.078 0.466 . . . . 0.70999999999999996 110.665 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -86.45 -43.4 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 2.1699999999999999 110.806 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -62.09 -58.84 6.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 1.5700000000000001 111.38 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -46.06 -48.19 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.499 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 28' ' ' SER . 61.1 mttp -51.16 -47.77 62.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.404 -0.362 . . . . 2.5899999999999999 111.152 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.95 -57.13 12.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 1.3 111.025 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.7 mt -48.86 -26.48 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 0.94999999999999996 111.176 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 38.5 t -66.09 -37.05 84.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 1.6399999999999999 111.087 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.59 -25.26 38.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.376 -0.375 . . . . 1.6399999999999999 111.073 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.15 7.67 55.95 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.716 -0.754 . . . . 0.81999999999999995 113.04 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -91.97 103.06 15.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.969 0.385 . . . . 2.5499999999999998 111.05 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -90.58 160.38 39.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.614 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.23 127.15 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.277 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.21 27.39 6.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.727 -0.749 . . . . 0.40000000000000002 112.323 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 46.5 t -94.31 174.23 7.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.649 0.261 . . . . 0.62 110.788 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.9 t -123.97 148.81 46.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 1.3 110.946 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' A' ' 11' ' ' ILE . 6.8 p90 -161.43 179.53 8.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.253 -0.43 . . . . 0.35999999999999999 110.853 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -132.21 152.22 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 2.9399999999999999 110.844 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG13 ' CG2' ' A' ' 49' ' ' VAL . 60.5 t -91.23 141.09 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 1.28 111.051 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -95.96 -39.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.54000000000000004 111.342 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 49' ' ' VAL . 16.8 ptm180 179.73 126.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 2.7999999999999998 110.982 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 43' ' ' ALA . 9.2 p -148.66 159.28 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.2 111.153 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.505 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -114.15 155.75 45.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.81000000000000005 111.066 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.29 -18.44 23.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.676 2.25 . . . . 1.3400000000000001 112.586 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.7 tp -89.65 -65.8 0.98 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 2.5099999999999998 110.938 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' HG3' ' A' ' 62' ' ' LYS . . . 170.84 107.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.77000000000000002 112.434 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.0 m-20 -147.72 172.26 5.39 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.58 0.229 . . . . 1.0700000000000001 110.712 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.19 110.87 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.755 2.303 . . . . 0.60999999999999999 111.526 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' CG2' HG13 ' A' ' 39' ' ' VAL . 3.7 p -106.57 140.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 111.199 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 40' ' ' VAL . 68.6 m80 -101.43 131.03 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.845 -0.616 . . . . 1.1299999999999999 110.804 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 60' ' ' LEU . 44.2 pt -96.63 139.62 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.35999999999999999 110.831 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -106.83 97.09 6.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 2.1299999999999999 110.888 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.2 -172.68 2.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.64000000000000001 111.002 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HB2' ' CE ' ' A' ' 31' ' ' MET . 41.3 mmt180 -51.47 96.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 3.04 111.451 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 51.89 30.08 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 4.1100000000000003 111.541 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 54' ' ' ARG . 79.7 t -149.75 117.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 1.23 111.33 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.5 t -100.87 107.76 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.64000000000000001 110.751 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' A' ' 51' ' ' ILE . 32.0 tp -102.9 158.17 16.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.988 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -104.55 138.96 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.5 110.911 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD1' HD13 ' A' ' 51' ' ' ILE . 90.2 mt -144.08 143.13 31.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.931 0.396 . . . . 0.96999999999999997 111.104 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 62' ' ' LYS . 32.4 ttm180 -112.12 162.3 15.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 3.3199999999999998 110.683 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 mmpt? -47.18 -26.92 1.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 4.7000000000000002 111.218 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.1 -30.09 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 2.2799999999999998 110.912 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.85 -31.93 40.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.148 -0.478 . . . . 2.2999999999999998 111.027 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.3 mp -81.6 -18.5 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.69 -27.03 68.04 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.766 0.317 . . . . 0.66000000000000003 111.499 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.67 -57.69 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.47999999999999998 111.119 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.2 pt -66.04 154.81 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.42999999999999999 111.338 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 12' ' ' THR . 9.0 tp10 -104.93 147.78 27.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.186 -0.461 . . . . 2.29 110.475 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.7 mm? -121.43 153.63 37.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.419 . . . . 1.8500000000000001 111.097 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -132.01 147.08 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 2.2400000000000002 110.787 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 165.94 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.76000000000000001 111.18 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.1 m -103.03 162.71 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.1599999999999999 111.023 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.41 128.35 36.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.2799999999999998 111.122 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.128 -0.487 . . . . 5.1299999999999999 110.872 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.781 0.324 . . . . 5.1699999999999999 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.53 167.35 10.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 2.9399999999999999 110.774 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.469 ' CE1' HD23 ' A' ' 70' ' ' LEU . 38.7 m-85 -72.06 92.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 2.25 110.715 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 41.2 p -113.82 156.25 44.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.66000000000000003 111.253 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 4' ' ' THR . 62.0 Cg_endo -72.92 90.12 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.58 2.187 . . . . 0.65000000000000002 112.313 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.6 t70 178.32 -37.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 2.6899999999999999 110.828 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.8 m -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 1.8899999999999999 110.784 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.89 168.68 8.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.46999999999999997 110.93 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.512 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 69.3 m95 -149.75 173.45 13.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.68999999999999995 110.872 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' O ' HD12 ' A' ' 70' ' ' LEU . 31.2 mmmt -107.06 126.99 53.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.88 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.9 mt -77.21 126.78 38.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.56000000000000005 111.118 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 23.0 m -132.65 56.88 1.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.393 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' O ' ' NH1' ' A' ' 23' ' ' ARG . . . -58.59 85.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.971 -0.633 . . . . 0.45000000000000001 113.004 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -147.11 95.98 2.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.81000000000000005 110.632 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.4 m -95.05 -174.26 3.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.082 -0.508 . . . . 0.76000000000000001 110.985 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -86.18 -26.01 25.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.581 . . . . 3.5800000000000001 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -150.29 34.23 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 2.48 111.414 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 tt -48.63 143.18 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.56999999999999995 111.253 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -94.63 147.93 34.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.5 110.88 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 17.2 Cg_endo -57.29 -32.02 92.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.712 2.274 . . . . 0.60999999999999999 112.124 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.03 -47.05 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.025 0.44 . . . . 0.70999999999999996 110.711 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.69 -43.39 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.646 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 20.2 tpt180 -60.25 -61.26 2.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 1.5700000000000001 110.98 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' PRO . 91.5 mt-30 -49.98 -41.71 47.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 2.6899999999999999 110.843 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -53.69 -25.77 19.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 2.5899999999999999 110.972 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.29 -46.62 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 1.3 110.594 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -50.77 -33.6 23.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.94999999999999996 111.048 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.9 p -69.23 -42.21 75.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.979 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.3 -25.34 65.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 1.6399999999999999 110.979 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.14 16.16 39.08 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.81999999999999995 112.835 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.6 ptm -104.0 103.94 13.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.983 0.42 . . . . 2.5499999999999998 110.883 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -105.03 159.81 28.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.443 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.0 Cg_exo -42.11 109.4 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.521 2.147 . . . . 0.51000000000000001 112.152 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.55 31.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.40000000000000002 112.166 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 t -101.35 174.18 6.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.623 0.249 . . . . 0.62 110.57 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -119.99 143.35 48.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 1.3 111.071 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' TRP . 4.0 p90 -150.45 175.36 11.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.35999999999999999 110.824 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -130.71 129.03 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 2.9399999999999999 110.988 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 140.25 19.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 1.28 111.161 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 62.4 t -99.06 -35.48 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54000000000000004 111.125 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -179.61 139.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 2.7999999999999998 111.088 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.5 t -146.92 160.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.122 -0.49 . . . . 1.2 111.143 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -123.56 132.0 24.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.81000000000000005 110.83 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.46 -21.19 44.24 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.404 2.069 . . . . 1.3400000000000001 112.503 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -89.82 -66.33 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 2.5099999999999998 111.229 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.96 105.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 0.77000000000000002 112.263 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.455 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.0 m-20 -148.12 172.13 5.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.562 0.22 . . . . 1.0700000000000001 111.056 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.19 119.47 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 0.60999999999999999 111.487 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.53 148.36 11.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.39000000000000001 110.964 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' VAL . 36.4 m-70 -112.98 135.85 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.779 -0.646 . . . . 1.1299999999999999 110.745 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' CG2' HD12 ' A' ' 60' ' ' LEU . 47.0 pt -98.55 145.83 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.35999999999999999 111.16 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -109.34 100.81 9.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 2.1299999999999999 110.742 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.0 p -103.92 -173.14 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.156 -0.475 . . . . 0.64000000000000001 111.185 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.0 mmt180 -50.94 98.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 3.04 111.531 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 48.62 30.13 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 4.1100000000000003 111.698 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' ARG . 89.0 t -147.8 113.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.981 0.419 . . . . 1.23 111.139 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -100.03 107.74 19.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.64000000000000001 110.611 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.13 160.36 14.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 1.54 111.305 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.55 137.01 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.5 111.031 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD12 ' CG2' ' A' ' 51' ' ' ILE . 91.0 mt -130.44 161.43 31.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.96999999999999997 111.059 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.8 mtp180 -130.68 147.7 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 3.3199999999999998 110.473 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -47.98 -25.9 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 4.7000000000000002 111.08 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -75.82 -33.43 60.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 2.2799999999999998 110.7 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -78.87 -34.86 44.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.092 -0.504 . . . . 2.2999999999999998 111.044 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.5 mp -67.76 -20.74 65.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.288 -0.415 . . . . 0.69999999999999996 111.076 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.29 -28.61 68.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.369 -0.378 . . . . 0.66000000000000003 111.083 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.94 -56.53 3.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.47999999999999998 110.968 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.3 pt -65.09 166.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.005 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 12' ' ' THR . 12.3 tt0 -114.47 153.54 29.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 2.29 111.195 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.469 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.5 tp -129.91 158.09 40.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 1.8500000000000001 110.664 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.71 147.18 31.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 2.2400000000000002 110.876 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.53 169.84 2.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.76000000000000001 110.993 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.7 m -89.02 178.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 1.1599999999999999 111.248 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.59 134.52 44.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 2.2799999999999998 111.094 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 5.1299999999999999 110.876 179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.821 0.343 . . . . 5.1699999999999999 110.851 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -120.36 135.99 54.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 2.9399999999999999 110.922 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.479 ' CD2' HG11 ' A' ' 42' ' ' VAL . 21.5 p90 -113.27 140.23 48.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.25 110.887 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.5 p -121.44 156.35 58.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.66000000000000003 111.147 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.65 87.84 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.48 2.12 . . . . 0.65000000000000002 112.298 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 177.96 -36.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 2.6899999999999999 110.772 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 t -99.51 170.9 8.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 1.8899999999999999 110.96 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.26 165.33 11.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.46999999999999997 110.94 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 3' ' ' PHE . 54.0 m95 -154.61 163.5 40.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.68999999999999995 110.616 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.77 127.03 53.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 2.04 111.185 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 40.2 mt -74.38 142.97 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.56000000000000005 111.122 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -142.31 52.11 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.688 -0.687 . . . . 0.96999999999999997 110.155 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -50.7 95.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.819 -0.628 . . . . 0.45000000000000001 112.89 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -147.5 94.74 2.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.378 . . . . 0.81000000000000005 110.565 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.0 m -104.19 -174.64 2.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.76000000000000001 110.946 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 9.2 mpt_? -86.24 -23.27 26.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 3.5800000000000001 111.002 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -150.86 32.04 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 2.48 111.504 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.8 tt -47.21 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.974 0.416 . . . . 0.56999999999999995 111.058 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.5 m -66.7 156.67 85.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 1.5 110.735 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.45 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 25.8 Cg_endo -60.9 -28.66 86.7 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.596 2.198 . . . . 0.60999999999999999 112.119 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.33 61.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.70999999999999996 110.599 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -85.74 -40.1 16.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.846 -0.616 . . . . 2.1699999999999999 110.767 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.7 tpt180 -65.46 -61.37 2.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.189 -0.46 . . . . 1.5700000000000001 110.876 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.82 -38.43 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 2.6899999999999999 110.844 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -53.54 -59.67 4.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 2.5899999999999999 110.765 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.7 mt -58.56 -44.15 89.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.3 110.718 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -53.53 -29.48 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.94999999999999996 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.3 t -66.79 -38.49 86.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 1.6399999999999999 110.794 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.02 -24.69 24.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 1.6399999999999999 110.882 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.31 16.31 18.76 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.848 -0.691 . . . . 0.81999999999999995 112.732 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.453 ' CE ' HD12 ' A' ' 11' ' ' ILE . 90.7 mmm -91.35 90.52 7.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 2.5499999999999998 111.048 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.6 mp -108.18 161.65 22.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.68999999999999995 110.608 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 91.5 Cg_exo -42.56 109.77 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.43 2.087 . . . . 0.51000000000000001 112.068 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.86 2.57 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.40000000000000002 112.012 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.2 m -106.87 135.19 48.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.76 0.314 . . . . 0.62 110.904 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.1 m -90.2 148.07 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 1.3 111.199 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.7 p90 -162.77 179.38 7.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.35999999999999999 110.892 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -125.29 153.37 43.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 2.9399999999999999 110.812 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.0 t -92.55 141.3 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 1.28 111.187 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 50' ' ' HIS . 60.6 t -101.75 -44.81 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.54000000000000004 111.303 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -175.71 115.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 2.7999999999999998 110.975 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.7 p -135.71 158.81 39.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 1.2 111.148 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -106.78 147.61 35.35 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.985 -0.552 . . . . 0.81000000000000005 111.085 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 -15.89 34.16 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.586 2.191 . . . . 1.3400000000000001 112.647 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.32 -73.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 2.5099999999999998 111.17 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.24 91.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.859 -0.686 . . . . 0.77000000000000002 112.41 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 7.6 m-20 -137.84 171.38 8.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.646 0.26 . . . . 1.0700000000000001 110.921 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.57 118.01 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.858 2.372 . . . . 0.60999999999999999 111.87 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.4 p -110.13 154.29 11.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.569 -0.741 . . . . 0.39000000000000001 110.942 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.411 ' CD2' ' HB ' ' A' ' 59' ' ' VAL . 76.1 m80 -109.23 133.64 52.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.688 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 pt -105.02 144.04 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.35999999999999999 111.051 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.21 110.04 20.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 2.1299999999999999 110.644 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 31' ' ' MET . 30.8 p -110.58 -171.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.64000000000000001 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -51.17 95.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.525 . . . . 3.04 111.303 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 53.77 24.2 4.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.068 -0.515 . . . . 4.1100000000000003 111.545 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -146.12 115.3 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.035 0.445 . . . . 1.23 111.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -101.39 108.18 19.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.64000000000000001 110.533 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 46.9 tp -99.61 162.47 13.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.954 0.407 . . . . 1.54 111.262 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 9.3 p -117.01 126.47 74.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.5 110.974 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB3' HD11 ' A' ' 65' ' ' LEU . 88.2 mt -119.05 165.95 13.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.96999999999999997 111.158 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 73.4 ttt180 -139.18 154.59 48.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 3.3199999999999998 110.657 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -46.48 -27.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 4.7000000000000002 111.756 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -79.44 -29.21 41.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.692 0.282 . . . . 2.2799999999999998 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -82.12 -33.1 29.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.256 -0.429 . . . . 2.2999999999999998 110.984 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -76.42 -24.51 54.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 0.69999999999999996 110.968 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.43 -25.81 62.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.66000000000000003 111.304 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.6 mt -91.53 -60.65 1.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.33 -0.395 . . . . 0.47999999999999998 110.975 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.405 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 23.7 pt -65.7 151.29 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.42999999999999999 110.925 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.52 146.21 27.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 2.29 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.41 159.44 18.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.261 -0.427 . . . . 1.8500000000000001 110.591 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.81 145.29 30.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.393 -0.367 . . . . 2.2400000000000002 111.084 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.09 163.8 27.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.76000000000000001 111.059 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m -109.82 161.82 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 1.1599999999999999 111.308 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.35 -178.87 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 2.2799999999999998 111.09 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 5.1299999999999999 110.924 179.914 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.925 0.393 . . . . 5.1699999999999999 111.052 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -138.18 171.28 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.52 . . . . 2.9399999999999999 110.86 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -59.11 99.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 2.25 110.873 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -122.41 153.83 62.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.66000000000000003 111.241 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.05 83.44 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.578 2.185 . . . . 0.65000000000000002 112.308 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.11 -42.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 2.6899999999999999 110.641 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.8 m -98.34 165.75 11.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 1.8899999999999999 110.927 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 160.97 14.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.46999999999999997 111.101 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.5 m95 -139.97 164.86 28.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.68999999999999995 110.798 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' SER . 39.9 ttmt -104.88 138.28 41.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 2.04 111.106 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.0 mt -88.13 132.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.56000000000000005 110.562 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 15.9 m -142.27 52.47 1.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.21 -0.45 . . . . 0.96999999999999997 110.798 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -45.22 93.59 0.01 OUTLIER Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.017 -0.611 . . . . 0.45000000000000001 112.848 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.84 101.41 3.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.777 0.322 . . . . 0.81000000000000005 110.88 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 m -110.48 -176.61 3.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.76000000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.7 mpt_? -74.85 -23.01 58.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 111.148 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -169.42 42.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 2.48 110.746 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.7 tt -46.97 115.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.56999999999999995 111.266 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 m -71.0 157.38 90.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.989 -0.55 . . . . 1.5 110.859 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 24.9 Cg_endo -59.83 -27.37 84.78 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.771 2.314 . . . . 0.60999999999999999 112.141 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -49.36 -44.09 44.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.509 -0.314 . . . . 0.70999999999999996 110.713 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -86.15 -39.02 17.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 2.1699999999999999 111.144 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 17.9 tpp180 -67.91 -56.83 7.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 1.5700000000000001 111.338 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -40.97 -30.79 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.405 -0.362 . . . . 2.6899999999999999 111.633 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 14.2 mmmm -68.48 -54.77 14.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 2.5899999999999999 110.376 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.7 mt -54.61 -51.82 64.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 1.3 110.641 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.8 mt -49.4 -43.57 44.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.94999999999999996 111.006 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -54.26 -50.97 65.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.474 . . . . 1.6399999999999999 110.752 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.96 -23.87 60.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 1.6399999999999999 110.815 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.12 19.03 31.92 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.727 . . . . 0.81999999999999995 112.669 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 mtm -94.33 88.93 5.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.759 0.314 . . . . 2.5499999999999998 111.01 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -92.2 160.61 34.98 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.68999999999999995 110.531 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -45.1 104.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.33 2.02 . . . . 0.51000000000000001 112.197 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 50.33 0.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.40000000000000002 112.154 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 48.0 t -117.84 170.85 8.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.277 . . . . 0.62 110.746 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.2 p -118.99 139.4 51.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 1.3 110.928 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 12.9 p90 -148.45 163.13 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.35999999999999999 111.041 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 38.0 t60 -108.94 151.45 26.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.081 -0.509 . . . . 2.9399999999999999 110.983 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' O ' ' CD2' ' A' ' 38' ' ' HIS . 59.4 t -92.5 129.26 43.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 1.28 111.199 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.5 t -99.03 -36.38 5.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.54000000000000004 111.115 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -175.03 125.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.361 . . . . 2.7999999999999998 111.14 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' CG2' ' A' ' 49' ' ' VAL . 59.0 t -140.86 156.24 22.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 1.2 111.183 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -138.04 128.13 15.24 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.81000000000000005 110.845 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 36.6 Cg_exo -57.58 -36.73 98.53 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.427 2.085 . . . . 1.3400000000000001 112.193 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.9 -45.32 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.925 -0.58 . . . . 2.5099999999999998 111.167 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.69 99.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.77000000000000002 112.234 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 8.9 m-20 -148.26 170.63 7.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.624 0.25 . . . . 1.0700000000000001 111.14 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.37 121.53 2.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.856 2.371 . . . . 0.60999999999999999 111.51 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.555 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.71 156.7 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.705 -0.68 . . . . 0.39000000000000001 111.03 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.8 m-70 -122.96 130.87 53.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 1.1299999999999999 110.41 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 19.5 pt -103.6 137.19 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.086 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.01 121.59 44.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 2.1299999999999999 110.733 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 55' ' ' ARG . 56.5 p -124.12 -172.9 2.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.99 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -49.63 91.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 3.04 111.351 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' THR . 17.8 mmm180 53.43 33.65 16.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 4.1100000000000003 111.463 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.6 t -150.97 104.59 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 1.23 111.307 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -97.52 107.84 20.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.64000000000000001 110.713 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.9 tp -102.95 153.64 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 1.54 111.131 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 7.1 p -111.67 129.88 66.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.5 111.052 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.9 135.92 48.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.96999999999999997 110.906 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.4 mtt180 -103.01 160.36 14.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.258 -0.428 . . . . 3.3199999999999998 111.041 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -42.51 -37.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.872 -0.604 . . . . 4.7000000000000002 111.474 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 18.8 ptmt -64.53 -34.43 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 2.2799999999999998 111.127 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.08 -24.05 35.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 2.2999999999999998 111.067 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -86.18 -21.37 27.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.349 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.64 -24.5 64.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.811 0.338 . . . . 0.66000000000000003 111.377 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.0 mt -91.5 -55.86 3.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.352 -0.386 . . . . 0.47999999999999998 111.316 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.412 HG12 ' HA ' ' A' ' 65' ' ' LEU . 25.7 pt -65.67 150.56 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.42999999999999999 111.092 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -100.42 143.08 31.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.432 . . . . 2.29 110.816 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.6 ' N ' HD22 ' A' ' 70' ' ' LEU . 1.9 mm? -116.82 149.5 39.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.306 -0.406 . . . . 1.8500000000000001 110.779 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -144.21 156.11 44.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 2.2400000000000002 110.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.93 164.34 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 0.76000000000000001 111.007 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -95.45 157.09 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 1.1599999999999999 111.196 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.7 146.4 40.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 2.2799999999999998 110.754 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 5.1299999999999999 111.061 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.769 0.318 . . . . 5.1699999999999999 110.966 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -52.48 106.06 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 2.9399999999999999 111.014 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.424 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 56.7 m-85 -61.58 99.39 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.475 . . . . 2.25 110.787 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -100.26 145.23 29.89 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.66000000000000003 111.189 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' HG23 ' A' ' 39' ' ' VAL . 57.3 Cg_endo -70.34 86.85 0.64 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.608 2.206 . . . . 0.65000000000000002 112.215 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 177.85 -37.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 2.6899999999999999 110.847 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -97.82 146.89 24.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 110.906 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' C ' ' CD1' ' A' ' 9' ' ' TRP . . . -79.81 171.14 15.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.46999999999999997 110.955 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' ALA . 57.5 m95 -156.71 160.94 39.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.68999999999999995 110.78 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 71' ' ' GLU . 59.0 mttp -112.1 134.35 53.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.04 110.801 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.477 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.0 mt -70.92 138.65 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.56000000000000005 111.292 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 9.2 m -146.52 43.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.189 0.519 . . . . 0.96999999999999997 110.484 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.48 90.5 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.45000000000000001 112.824 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -147.09 95.03 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.821 0.343 . . . . 0.81000000000000005 110.736 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -99.32 -169.61 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.76000000000000001 110.928 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' N ' ' CD ' ' A' ' 16' ' ' ARG . 9.1 mpt_? -83.29 -23.49 32.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 3.5800000000000001 110.93 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -164.07 37.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.48 110.775 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tt -46.08 116.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.225 -0.443 . . . . 0.56999999999999995 111.301 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 51.1 m -64.25 155.9 77.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 1.5 110.573 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 33.9 Cg_endo -63.37 -26.79 71.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.565 2.176 . . . . 0.60999999999999999 112.14 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.06 55.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.70999999999999996 110.672 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.463 ' CD1' ' OD1' ' A' ' 64' ' ' ASP . 92.8 m-85 -85.84 -39.82 16.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 2.1699999999999999 110.915 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 22.5 tpt180 -65.2 -58.95 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 1.5700000000000001 111.176 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.0 tt0 -43.8 -28.44 0.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 2.6899999999999999 111.724 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -65.01 -36.59 84.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.474 -0.33 . . . . 2.5899999999999999 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.7 mp -79.39 -45.41 19.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.3 111.038 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -50.47 -25.16 3.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.94999999999999996 111.112 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.8 m -57.41 -47.81 80.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.6399999999999999 111.042 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.9 mp -86.18 -25.06 25.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 1.6399999999999999 110.899 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.83 27.88 10.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.694 -0.765 . . . . 0.81999999999999995 112.762 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.2 mmt -95.29 99.45 11.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.7 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.54 159.86 37.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.54 . . . . 0.68999999999999995 110.826 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -42.24 114.59 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.495 2.13 . . . . 0.51000000000000001 112.148 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 25.22 2.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.859 -0.686 . . . . 0.40000000000000002 112.478 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 44.9 t -94.71 174.09 7.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.62 110.57 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.1 m -118.94 146.96 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 1.3 111.097 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD1' HG13 ' A' ' 11' ' ' ILE . 15.6 p90 -163.84 -173.4 3.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.076 -0.511 . . . . 0.35999999999999999 110.732 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -137.11 159.99 40.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 2.9399999999999999 110.966 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -100.57 131.46 48.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 1.28 110.883 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 50' ' ' HIS . 67.0 t -89.58 -48.06 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.242 -0.436 . . . . 0.54000000000000004 111.568 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -171.39 120.8 0.5 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.732 0.301 . . . . 2.7999999999999998 111.385 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 43' ' ' ALA . 13.2 p -147.77 160.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 1.2 111.088 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -128.84 142.86 46.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 0.81000000000000005 111.025 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 33.9 Cg_exo -59.42 -22.29 65.26 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.474 2.116 . . . . 1.3400000000000001 112.514 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.98 -73.68 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.361 . . . . 2.5099999999999998 111.242 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.41 91.72 0.08 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.779 -0.725 . . . . 0.77000000000000002 112.354 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.464 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 5.8 m-20 -138.39 171.54 8.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.514 0.197 . . . . 1.0700000000000001 110.722 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -84.71 116.45 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.903 2.402 . . . . 0.60999999999999999 111.95 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.415 ' CG2' ' HB ' ' A' ' 42' ' ' VAL . 2.7 p -111.66 139.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.765 -0.652 . . . . 0.39000000000000001 111.315 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' VAL . 35.0 m-70 -101.68 130.79 48.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.604 . . . . 1.1299999999999999 110.504 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 57' ' ' SER . 37.8 pt -97.26 147.09 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.35999999999999999 111.008 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.73 119.83 40.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 2.1299999999999999 110.804 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.477 ' HG1' HG13 ' A' ' 56' ' ' VAL . 17.4 p -127.15 -163.19 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.64000000000000001 111.205 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 56' ' ' VAL . 34.5 mmt180 -48.31 97.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.079 0.466 . . . . 3.04 111.867 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 43.57 34.79 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 4.1100000000000003 112.286 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HG1' ' A' ' 53' ' ' THR . 12.2 p -159.94 125.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.968 0.413 . . . . 1.23 111.197 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 47.0 t -105.94 112.49 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 111.271 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.73 171.13 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.553 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -123.32 132.29 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.41 -0.359 . . . . 0.5 111.198 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.5 mt -135.75 166.39 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.516 . . . . 0.96999999999999997 110.901 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.2 mtt180 -123.54 146.79 47.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 3.3199999999999998 110.601 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.453 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.3 tpmt? -50.01 -25.11 3.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.389 -0.368 . . . . 4.7000000000000002 111.021 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -79.88 -30.0 40.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 2.2799999999999998 110.578 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.463 ' OD1' ' CD1' ' A' ' 22' ' ' TYR . 21.2 t70 -81.35 -36.63 29.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 2.2999999999999998 110.719 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 8.7 mp -61.69 -22.11 65.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.405 . . . . 0.69999999999999996 110.928 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.13 61.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 111.192 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.66 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.47999999999999998 110.968 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 65' ' ' LEU . 27.6 pt -65.71 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.42999999999999999 110.78 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.8 tt0 -99.04 146.14 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.29 111.109 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -116.52 149.89 38.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 1.8500000000000001 110.681 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 9.4 tp10 -129.88 150.24 51.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.341 -0.39 . . . . 2.2400000000000002 110.974 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.97 171.57 12.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.76000000000000001 111.23 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.4 m -77.57 176.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.1599999999999999 111.022 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 -52.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 2.2799999999999998 111.034 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 5.1299999999999999 110.916 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.779 0.324 . . . . 5.1699999999999999 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -171.79 -179.05 2.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 2.9399999999999999 110.995 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 13.5 p90 -118.86 128.29 54.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.975 -0.557 . . . . 2.25 111.099 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -100.08 154.89 36.98 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.66000000000000003 110.908 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 58.0 Cg_endo -71.72 83.54 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.394 2.063 . . . . 0.65000000000000002 112.484 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 13.3 t70 178.71 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 2.6899999999999999 110.897 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 t -90.77 159.35 16.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.8899999999999999 111.11 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.03 169.25 11.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.46999999999999997 111.064 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 3' ' ' PHE . 60.6 m95 -151.58 154.82 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.68999999999999995 111.107 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' SER . 31.7 mmmt -95.37 131.33 41.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.982 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 32.4 mt -83.05 125.33 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.56000000000000005 111.242 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 35.7 p -133.09 58.82 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.96999999999999997 110.534 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.26 91.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.742 -0.663 . . . . 0.45000000000000001 112.879 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.05 94.85 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.917 0.389 . . . . 0.81000000000000005 110.344 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -97.89 -172.56 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.06 -0.518 . . . . 0.76000000000000001 111.247 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -85.73 -24.31 26.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 3.5800000000000001 110.695 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -158.5 37.53 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 2.48 111.048 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tt -46.15 128.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.942 0.401 . . . . 0.56999999999999995 111.311 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.3 m -77.61 157.04 80.32 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 1.5 111.096 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 55.8 Cg_endo -70.36 -26.68 24.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.583 2.188 . . . . 0.60999999999999999 112.491 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.76 -47.11 59.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.351 -0.386 . . . . 0.70999999999999996 110.724 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -86.22 -38.39 17.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.915 -0.584 . . . . 2.1699999999999999 110.954 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 24.1 tpt180 -66.95 -58.19 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.999 -0.546 . . . . 1.5700000000000001 111.405 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -44.82 -30.5 0.98 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 2.6899999999999999 111.517 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.36 -40.97 73.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 2.5899999999999999 111.053 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.24 -50.87 19.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 1.3 110.64 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.33 -35.49 60.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.94999999999999996 110.856 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.2 m -78.25 -27.47 47.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 1.6399999999999999 111.038 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.39 -25.06 39.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 1.6399999999999999 110.846 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.07 5.96 43.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.807 -0.711 . . . . 0.81999999999999995 113.103 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -98.74 96.13 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.402 . . . . 2.5499999999999998 110.931 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -104.96 158.73 31.4 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.454 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -39.59 105.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.576 2.184 . . . . 0.51000000000000001 112.387 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.45 33.95 0.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.925 -0.655 . . . . 0.40000000000000002 112.294 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.5 t -106.42 174.44 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.602 0.239 . . . . 0.62 110.525 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 p -129.13 144.98 51.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.866 0.365 . . . . 1.3 111.012 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CE2' HG22 ' A' ' 51' ' ' ILE . 13.5 p90 -152.04 168.41 25.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.35999999999999999 111.021 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -115.56 140.61 49.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 2.9399999999999999 110.517 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 49' ' ' VAL . 48.0 t -80.31 131.83 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.387 -0.37 . . . . 1.28 111.22 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.6 t -92.07 -39.61 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.428 . . . . 0.54000000000000004 111.324 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 49' ' ' VAL . 37.3 ptt180 -179.73 121.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 2.7999999999999998 110.801 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 43' ' ' ALA . 7.1 p -145.02 159.5 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 1.2 111.152 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -112.61 155.45 43.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.81000000000000005 111.02 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.98 -22.23 15.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.584 2.189 . . . . 1.3400000000000001 112.367 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -80.9 -62.21 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 111.094 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.8 103.13 0.18 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.77000000000000002 112.208 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.457 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.9 m-20 -147.97 170.45 7.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.666 0.269 . . . . 1.0700000000000001 111.039 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -85.17 119.01 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.848 2.366 . . . . 0.60999999999999999 111.587 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 41' ' ' ARG . 2.7 p -115.06 149.35 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.996 -0.547 . . . . 0.39000000000000001 111.406 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -99.55 146.46 26.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 1.1299999999999999 110.995 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 58' ' ' LEU . 33.6 pt -112.08 138.24 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.35999999999999999 110.842 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.1 131.44 54.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.429 -0.35 . . . . 2.1299999999999999 110.91 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 p -137.35 -173.05 3.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.64000000000000001 110.991 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -52.83 91.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 3.04 111.3 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 54.04 39.11 30.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 4.1100000000000003 111.57 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -156.86 111.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 1.23 110.976 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.7 t -105.32 107.92 19.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.64000000000000001 111.071 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 58.5 tp -98.95 159.96 14.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.54 111.022 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 8.6 p -113.89 135.95 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.5 111.009 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.93 141.12 52.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.96999999999999997 110.979 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -106.96 151.61 25.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 3.3199999999999998 110.97 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -47.38 -29.87 2.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.19 -0.459 . . . . 4.7000000000000002 111.463 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 21.1 ptmt -81.34 -25.4 36.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 2.2799999999999998 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 61' ' ' ARG . 12.3 t70 -78.05 -30.69 49.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 2.2999999999999998 110.48 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.8 mp -75.55 -21.91 57.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.142 -0.481 . . . . 0.69999999999999996 111.124 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.87 71.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.416 -0.356 . . . . 0.66000000000000003 111.36 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.95 -61.74 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.47999999999999998 111.204 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -65.68 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.031 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 5.8 tp10 -98.49 155.85 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 2.29 110.859 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.1 tp -125.04 157.48 36.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 1.8500000000000001 110.561 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 35.3 tt0 -147.42 149.93 33.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.2400000000000002 110.83 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.29 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.35 -174.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 111.086 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.79 113.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 2.2799999999999998 111.298 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 5.1299999999999999 110.639 179.669 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ptp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.828 0.347 . . . . 5.1699999999999999 110.844 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -148.29 117.3 6.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 2.9399999999999999 110.909 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.44 99.11 12.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 2.25 110.721 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.2 p -102.43 151.46 38.19 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.66000000000000003 111.338 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.681 ' HA ' HG23 ' A' ' 39' ' ' VAL . 59.0 Cg_endo -71.87 91.06 0.72 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.563 2.176 . . . . 0.65000000000000002 112.489 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 176.6 -34.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 2.6899999999999999 110.912 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -106.31 144.14 33.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.34 -0.391 . . . . 1.8899999999999999 110.984 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.33 165.32 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 111.128 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -155.2 153.91 31.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.182 -0.463 . . . . 0.68999999999999995 110.715 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 35' ' ' SER . 49.8 mtmt -113.59 138.68 49.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 2.04 111.25 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' CD1' ' A' ' 37' ' ' PHE . 47.3 mt -79.12 123.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.56000000000000005 111.265 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 57.7 p -131.78 59.56 1.7 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.96999999999999997 110.554 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -51.64 97.71 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.838 -0.696 . . . . 0.45000000000000001 112.44 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -145.09 96.92 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.371 . . . . 0.81000000000000005 111.125 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 m -114.12 153.57 29.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.76000000000000001 110.698 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -52.55 -25.01 9.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 3.5800000000000001 110.57 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.3 39.72 0.67 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.113 -0.494 . . . . 2.48 110.783 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.3 tt -42.72 105.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.076 0.465 . . . . 0.56999999999999995 111.468 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.6 t -63.42 146.8 96.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.5 110.806 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.3 Cg_endo -58.64 -30.31 91.79 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.721 2.281 . . . . 0.60999999999999999 112.131 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -45.33 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.70999999999999996 110.937 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 54.0 m-85 -85.39 -42.02 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.511 . . . . 2.1699999999999999 111.249 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -60.76 2.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 1.5700000000000001 111.269 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.3 mm-40 -54.88 -22.12 13.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.34 -0.391 . . . . 2.6899999999999999 111.456 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 22' ' ' TYR . 23.1 ttpp -69.2 -42.93 75.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.331 . . . . 2.5899999999999999 110.823 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.1 mt -52.14 -34.42 44.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 1.3 110.725 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.0 mt -54.83 -27.73 44.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.94999999999999996 111.075 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -49.0 -38.11 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 1.6399999999999999 111.121 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.1 mm? -107.11 -21.24 13.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.6399999999999999 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.82 19.28 29.63 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.737 -0.744 . . . . 0.81999999999999995 112.531 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.2 mtm -88.57 92.71 9.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.749 0.309 . . . . 2.5499999999999998 110.791 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.4 mp -83.04 158.98 63.69 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.436 . . . . 0.68999999999999995 110.825 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.36 107.27 0.13 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.328 2.019 . . . . 0.51000000000000001 112.112 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.71 32.81 0.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.855 -0.688 . . . . 0.40000000000000002 112.518 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 10' ' ' LYS . 46.7 t -104.76 174.18 5.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.71 0.291 . . . . 0.62 110.812 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 t -116.04 154.54 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.334 -0.394 . . . . 1.3 111.169 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.511 ' CD1' HG13 ' A' ' 11' ' ' ILE . 30.0 p90 -165.04 169.96 15.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.079 -0.509 . . . . 0.35999999999999999 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 29.3 m80 -124.69 134.55 52.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 2.9399999999999999 111.014 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG23 ' HA ' ' A' ' 5' ' ' PRO . 7.0 m -83.87 132.32 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.28 111.16 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.6 t -91.69 -49.71 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.54000000000000004 111.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 2.7999999999999998 110.892 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.1 t -143.55 159.87 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.2 111.189 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.475 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.26 144.95 52.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.81000000000000005 110.944 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.06 -18.23 31.14 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.476 2.117 . . . . 1.3400000000000001 112.596 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.42 -55.17 3.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.431 -0.349 . . . . 2.5099999999999998 111.15 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.68 102.06 0.19 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.77000000000000002 112.272 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.8 m-20 -143.43 170.66 8.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.67 0.271 . . . . 1.0700000000000001 111.118 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.94 117.14 1.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.933 2.422 . . . . 0.60999999999999999 111.924 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.46 HG21 HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.62 156.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.801 -0.636 . . . . 0.39000000000000001 110.935 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -115.58 131.91 56.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.846 -0.616 . . . . 1.1299999999999999 110.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.444 ' CG2' ' CD2' ' A' ' 37' ' ' PHE . 37.5 pt -101.73 142.43 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.35999999999999999 111.097 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 38.0 tt0 -107.33 124.53 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 2.1299999999999999 110.709 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 56' ' ' VAL . 69.6 p -132.1 -173.52 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.64000000000000001 111.278 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' HG12 ' A' ' 56' ' ' VAL . 38.1 mmt180 -41.35 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.105 0.409 . . . . 3.04 112.105 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 44.15 51.0 7.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.906 -0.588 . . . . 4.1100000000000003 111.886 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 56' ' ' VAL . 14.2 p 179.71 119.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 1.23 111.201 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -102.33 112.57 25.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 110.946 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 47.7 tp -92.0 162.77 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 1.54 110.615 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 12.6 p -112.29 145.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.5 111.244 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.03 147.06 41.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.847 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 99.3 mtt180 -107.65 150.51 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 3.3199999999999998 110.908 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.89 -25.95 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.919 -0.582 . . . . 4.7000000000000002 111.226 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -81.08 -27.76 35.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 2.2799999999999998 110.826 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.5 -31.59 47.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 2.2999999999999998 110.974 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.3 mp -72.79 -21.17 61.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.69999999999999996 111.008 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.77 71.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.66000000000000003 111.146 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.38 -61.69 1.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.47999999999999998 111.042 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.403 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 25.8 pt -66.08 148.98 11.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.415 . . . . 0.42999999999999999 110.962 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.4 tt0 -102.35 153.81 19.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 2.29 110.733 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -115.96 149.58 38.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.8500000000000001 110.866 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.32 110.72 9.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 2.2400000000000002 110.957 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.32 155.34 1.44 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.76000000000000001 111.0 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.81 163.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 1.1599999999999999 111.278 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.17 128.91 35.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 2.2799999999999998 110.908 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 5.1299999999999999 110.956 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.4 mtp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.866 0.365 . . . . 5.1699999999999999 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.47 167.45 18.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 2.9399999999999999 110.902 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.15 104.84 12.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 2.25 110.788 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.4 p -99.88 155.97 35.86 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.526 . . . . 0.66000000000000003 111.143 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 58.6 Cg_endo -72.3 87.27 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.502 2.135 . . . . 0.65000000000000002 112.289 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.1 t70 177.77 -57.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.036 -0.529 . . . . 2.6899999999999999 110.965 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -77.32 135.9 38.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 1.8899999999999999 110.804 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.42 157.65 28.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.46999999999999997 111.327 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 71.9 m95 -141.37 167.62 21.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.68999999999999995 110.804 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.1 136.57 51.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 2.04 111.165 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG13 ' CD1' ' A' ' 37' ' ' PHE . 50.5 mt -79.47 136.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.56000000000000005 110.742 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 12' ' ' THR . 12.7 m -143.83 46.52 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.96999999999999997 110.825 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.85 90.32 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.881 -0.676 . . . . 0.45000000000000001 112.657 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' THR . 69.3 t80 -146.68 102.69 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.81000000000000005 110.732 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -97.94 -179.12 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.76000000000000001 111.115 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.2 mpt_? -75.25 -24.85 57.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 3.5800000000000001 110.629 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.95 38.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 2.48 110.63 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -42.88 131.7 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.038 -0.528 . . . . 0.56999999999999995 111.737 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.8 m -92.47 157.4 40.27 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.5 110.784 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 24' ' ' GLN . 11.7 Cg_endo -54.44 -32.75 74.5 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.638 2.225 . . . . 0.60999999999999999 112.093 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.08 -46.69 34.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.07 0.462 . . . . 0.70999999999999996 110.771 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -85.95 -49.96 7.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.558 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.48 -61.23 2.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.029 -0.532 . . . . 1.5700000000000001 111.064 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' PRO . 29.4 tt0 -47.51 -32.42 5.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 2.6899999999999999 111.055 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.66 -55.9 28.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 2.5899999999999999 110.752 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.5 -45.15 92.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 1.3 110.817 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.45 -53.36 37.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.037 -0.529 . . . . 0.94999999999999996 111.113 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -49.92 -29.91 9.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 1.6399999999999999 111.085 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HD11 ' A' ' 58' ' ' LEU . 84.2 mt -91.88 -25.42 18.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 1.6399999999999999 110.94 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.06 31.35 9.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.698 -0.763 . . . . 0.81999999999999995 112.874 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.4 mtt -110.3 87.46 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 2.5499999999999998 110.623 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.8 mp -86.95 161.21 47.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.68999999999999995 110.746 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.78 115.13 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.508 2.138 . . . . 0.51000000000000001 112.163 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.4 28.58 2.98 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.786 -0.721 . . . . 0.40000000000000002 112.188 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 37.3 t -96.36 163.16 13.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.638 0.256 . . . . 0.62 110.634 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.1 p -110.67 145.3 38.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.874 0.369 . . . . 1.3 111.028 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 11' ' ' ILE . 19.1 p90 -158.28 170.33 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.35999999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -120.81 149.75 42.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.107 -0.497 . . . . 2.9399999999999999 110.991 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 5' ' ' PRO . 54.2 t -82.17 132.54 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.072 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.0 -33.51 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.54000000000000004 111.522 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 176.41 130.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 2.7999999999999998 111.22 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 43' ' ' ALA . 51.0 t -139.87 158.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.219 -0.446 . . . . 1.2 111.04 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -114.63 134.35 22.39 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.81000000000000005 110.859 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.3 -26.3 76.36 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.455 2.103 . . . . 1.3400000000000001 112.48 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.2 mp -91.26 -65.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.427 -0.351 . . . . 2.5099999999999998 111.215 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.12 106.94 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.77000000000000002 112.338 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.3 m-20 -148.32 173.21 4.39 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 111.05 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 2.3 Cg_endo -83.52 120.23 2.78 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.809 2.339 . . . . 0.60999999999999999 111.522 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.486 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.55 156.02 7.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.629 -0.714 . . . . 0.39000000000000001 111.202 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -120.78 134.26 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 1.1299999999999999 110.525 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 37.3 pt -101.38 137.88 27.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.198 -0.455 . . . . 0.35999999999999999 110.916 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.7 101.32 10.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.222 -0.445 . . . . 2.1299999999999999 110.887 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.8 p -99.64 -169.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 110.838 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -56.18 96.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 3.04 111.584 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.3 26.3 8.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 4.1100000000000003 111.629 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.0 t -148.53 114.88 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.318 . . . . 1.23 111.257 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -103.24 107.86 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.64000000000000001 110.779 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 64.5 mt -94.77 174.78 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 1.54 111.006 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.99 131.26 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.975 0.416 . . . . 0.5 111.181 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.8 mt -124.06 165.11 18.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.107 -0.497 . . . . 0.96999999999999997 110.789 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' O ' HD13 ' A' ' 65' ' ' LEU . 97.5 mtt180 -146.05 162.23 38.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 3.3199999999999998 111.066 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -52.54 -22.33 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 4.7000000000000002 111.545 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HE3' ' HD2' ' A' ' 61' ' ' ARG . 23.0 pttp -80.35 -33.67 37.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.877 0.37 . . . . 2.2799999999999998 110.624 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.27 -42.55 18.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 2.2999999999999998 110.888 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.9 mp -60.47 -24.19 65.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 0.69999999999999996 111.007 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.92 65.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.319 -0.401 . . . . 0.66000000000000003 111.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.15 -57.26 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.861 0.362 . . . . 0.47999999999999998 111.072 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.3 pt -65.94 151.19 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.42999999999999999 111.192 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' THR . 32.7 tt0 -103.43 150.51 23.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.442 . . . . 2.29 110.722 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -129.87 142.14 50.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.8500000000000001 111.088 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -124.13 152.72 42.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 2.2400000000000002 110.906 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.21 -178.51 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.76000000000000001 111.105 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.9 175.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.104 -0.498 . . . . 1.1599999999999999 111.084 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.19 -43.21 14.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 2.2799999999999998 111.065 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 5.1299999999999999 110.85 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.774 0.321 . . . . 5.1699999999999999 110.96 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -83.89 144.9 28.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.283 -0.417 . . . . 2.9399999999999999 110.832 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 9' ' ' TRP . 62.9 m-85 57.41 96.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 2.25 110.705 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -114.41 161.09 30.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.66000000000000003 111.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.97 147.55 14.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.591 2.194 . . . . 0.65000000000000002 112.345 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 66.4 18.27 10.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 2.6899999999999999 111.647 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.493 ' OG ' HG21 ' A' ' 39' ' ' VAL . 84.5 p -98.74 173.25 6.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.733 0.301 . . . . 1.8899999999999999 110.651 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.07 142.81 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.46999999999999997 111.122 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.559 ' CD2' ' CE2' ' A' ' 3' ' ' PHE . 32.1 m95 -154.02 162.83 40.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.68999999999999995 110.696 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -106.33 138.19 42.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 2.04 110.945 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 44.8 mt -77.79 127.4 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.56000000000000005 111.026 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 m -136.05 48.15 2.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.96999999999999997 110.571 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 68' ' ' ILE . . . -46.59 92.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.45000000000000001 113.046 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -147.08 94.9 2.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.81000000000000005 110.668 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 32.2 t -98.63 -178.76 4.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.76000000000000001 110.896 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 8.9 mpt_? -79.05 -21.49 46.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 3.5800000000000001 111.001 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.02 37.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.479 -0.328 . . . . 2.48 111.17 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 10.8 tt -45.6 126.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.913 0.387 . . . . 0.56999999999999995 111.396 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -85.36 149.29 51.83 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 1.5 110.964 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 15.6 Cg_endo -56.8 -31.25 87.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.801 2.334 . . . . 0.60999999999999999 112.257 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.56 -47.11 28.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.70999999999999996 110.858 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -85.79 -43.65 13.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 2.1699999999999999 110.904 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.4 tpt180 -60.7 -61.01 2.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.114 -0.494 . . . . 1.5700000000000001 110.967 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 20' ' ' PRO . 7.7 tp-100 -48.89 -30.35 5.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 2.6899999999999999 110.85 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -68.61 -32.97 73.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 2.5899999999999999 110.849 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.94 -48.04 26.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 1.3 110.837 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.3 mt -49.65 -34.05 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.94999999999999996 111.062 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -53.09 -33.27 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.6399999999999999 110.904 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -89.79 -22.95 21.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 1.6399999999999999 110.823 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.74 23.67 30.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 0.81999999999999995 112.495 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 39.8 mtm -101.44 91.01 4.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 2.5499999999999998 110.763 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -92.54 159.3 36.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.68999999999999995 110.879 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -43.04 106.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.637 2.225 . . . . 0.51000000000000001 112.186 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.18 33.34 0.9 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.798 -0.715 . . . . 0.40000000000000002 112.454 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.4 t -107.49 171.8 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.62 110.829 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.6 t -116.05 145.96 42.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 1.3 111.009 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 18.2 p90 -157.62 159.73 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.317 -0.401 . . . . 0.35999999999999999 111.033 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -109.33 151.62 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 2.9399999999999999 110.67 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.493 HG21 ' OG ' ' A' ' 7' ' ' SER . 57.6 t -89.37 140.51 15.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 1.28 111.221 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 50' ' ' HIS . 58.9 t -103.45 -52.22 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.54000000000000004 111.426 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -155.33 129.13 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 2.7999999999999998 111.074 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 43' ' ' ALA . 13.3 t -143.2 159.2 17.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.201 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -129.06 145.17 55.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.98 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 33.3 Cg_endo -64.46 -16.97 57.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.568 2.179 . . . . 1.3400000000000001 112.468 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.0 mm? -89.88 -69.51 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.872 0.367 . . . . 2.5099999999999998 110.975 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.52 94.17 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.69 -0.767 . . . . 0.77000000000000002 112.347 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB2' ' CD ' ' A' ' 48' ' ' PRO . 4.2 p-10 -131.25 178.01 1.95 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.475 0.179 . . . . 1.0700000000000001 110.711 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' CD ' ' HB2' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.25 118.36 2.27 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.938 2.425 . . . . 0.60999999999999999 111.557 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.0 p -106.84 157.53 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.39000000000000001 111.293 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.43 ' O ' HG23 ' A' ' 40' ' ' VAL . 31.8 m-70 -117.57 144.92 44.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.642 -0.708 . . . . 1.1299999999999999 110.463 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.2 135.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.35999999999999999 111.222 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -106.94 112.49 25.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 2.1299999999999999 110.651 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -118.13 -174.11 2.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.64000000000000001 111.128 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -50.71 93.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.04 111.283 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.25 37.71 15.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 4.1100000000000003 111.578 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG11 HD23 ' A' ' 29' ' ' LEU . 89.2 t -152.71 100.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.907 0.384 . . . . 1.23 110.887 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -97.77 108.42 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.64000000000000001 111.008 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 59' ' ' VAL . 56.8 tp -108.01 161.26 15.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 1.54 110.935 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 7.4 p -114.59 141.17 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.023 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.1 mt -126.77 144.11 51.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.96999999999999997 110.813 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.45 ' O ' HD13 ' A' ' 65' ' ' LEU . 56.9 mtp180 -107.92 152.67 24.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 3.3199999999999998 111.171 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -48.81 -33.12 9.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.029 -0.532 . . . . 4.7000000000000002 111.713 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.98 -22.88 36.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.446 -0.343 . . . . 2.2799999999999998 111.073 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -80.96 -23.55 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 2.2999999999999998 110.931 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 61' ' ' ARG . 9.6 mp -79.5 -28.93 41.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.69999999999999996 110.965 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.12 -24.27 52.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.66000000000000003 111.071 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.54 -61.61 1.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.47999999999999998 110.917 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 13' ' ' GLY . 22.4 pt -65.65 151.86 9.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.42999999999999999 110.819 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -105.48 142.54 35.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 2.29 111.426 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -110.16 125.64 53.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.969 -0.559 . . . . 1.8500000000000001 110.455 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -100.44 124.01 45.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.2400000000000002 110.72 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.1 152.44 7.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.028 -0.533 . . . . 0.76000000000000001 111.199 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -86.78 177.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 1.1599999999999999 111.281 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.39 -50.55 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 2.2799999999999998 110.993 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 5.1299999999999999 110.854 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.885 0.374 . . . . 5.1699999999999999 110.968 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -132.72 139.52 47.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 2.9399999999999999 110.852 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.5 ' HB2' ' CE2' ' A' ' 9' ' ' TRP . 37.0 p90 -121.6 112.74 18.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 2.25 110.969 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.0 p -81.18 153.1 71.73 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 0.66000000000000003 111.194 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.0 81.7 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.454 2.103 . . . . 0.65000000000000002 112.013 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -176.58 -42.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 2.6899999999999999 110.94 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 t -90.18 154.64 19.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 1.8899999999999999 110.884 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.54 170.12 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.46999999999999997 111.034 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.5 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 52.0 m95 -155.63 175.69 13.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.265 -0.425 . . . . 0.68999999999999995 110.911 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.3 134.02 54.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 2.04 111.094 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG13 ' CD1' ' A' ' 37' ' ' PHE . 58.9 mt -80.74 123.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.56000000000000005 111.028 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' THR . 19.5 m -133.89 53.46 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.115 0.484 . . . . 0.96999999999999997 110.509 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.57 88.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.885 -0.598 . . . . 0.45000000000000001 112.826 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' THR . 19.4 t80 -147.21 107.6 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.81000000000000005 111.046 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 m -108.66 164.36 12.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.76000000000000001 110.842 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' HD3' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -55.17 -22.8 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 3.5800000000000001 110.976 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -164.1 42.45 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.712 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 tt -44.3 134.17 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.268 -0.424 . . . . 0.56999999999999995 111.558 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.6 m -84.6 155.81 62.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.5 110.971 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 24' ' ' GLN . 24.9 Cg_endo -62.05 -29.72 81.84 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.605 2.204 . . . . 0.60999999999999999 112.421 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.08 -45.28 64.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 0.70999999999999996 110.646 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.38 -41.99 14.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 110.798 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -65.51 -61.41 2.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 1.5700000000000001 110.999 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' PRO . 12.9 mm100 -52.82 -22.95 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.525 . . . . 2.6899999999999999 111.255 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -73.5 -40.41 64.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 2.5899999999999999 110.796 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.5 -44.04 95.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 1.3 110.895 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.56 -25.79 4.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.94999999999999996 110.978 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.6 m -53.59 -35.37 60.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.6399999999999999 111.015 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.8 mm? -94.02 -25.21 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 1.6399999999999999 110.852 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.4 56.16 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.735 -0.745 . . . . 0.81999999999999995 112.835 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.6 mtt -88.95 98.51 11.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.923 0.392 . . . . 2.5499999999999998 110.687 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.3 mp -83.3 159.66 61.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.544 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.05 149.77 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.47 2.113 . . . . 0.51000000000000001 111.986 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . 77.65 17.95 78.16 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.693 -0.765 . . . . 0.40000000000000002 112.342 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.434 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.6 t -77.74 174.04 11.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.601 0.239 . . . . 0.62 110.446 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.5 t -121.23 136.0 55.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 1.3 110.91 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CD1' HG13 ' A' ' 11' ' ' ILE . 12.8 p90 -151.72 173.65 14.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.35999999999999999 111.085 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -127.75 158.42 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 2.9399999999999999 110.839 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.4 t -95.02 128.59 46.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 1.28 111.248 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.2 -38.63 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.54000000000000004 111.05 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -178.74 123.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 2.7999999999999998 111.003 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 43' ' ' ALA . 14.9 p -143.61 160.87 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 1.2 111.218 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -125.16 153.79 71.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.81000000000000005 110.994 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.97 -14.55 9.77 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.592 2.195 . . . . 1.3400000000000001 112.911 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.639 HD11 ' OD2' ' A' ' 47' ' ' ASP . 4.4 pp -85.32 -18.95 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.606 -0.27 . . . . 2.5099999999999998 111.287 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 45' ' ' LEU . . . 114.93 88.45 1.56 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.687 -0.768 . . . . 0.77000000000000002 112.297 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.639 ' OD2' HD11 ' A' ' 45' ' ' LEU . 7.3 m-20 -137.52 171.94 7.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.605 0.24 . . . . 1.0700000000000001 110.897 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.4 Cg_endo -84.3 115.94 1.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.832 2.355 . . . . 0.60999999999999999 111.72 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.54 138.44 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.39000000000000001 111.025 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -95.91 136.01 36.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.919 -0.582 . . . . 1.1299999999999999 110.882 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 pt -100.62 134.64 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.35999999999999999 110.962 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -110.26 120.54 42.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 2.1299999999999999 111.015 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 74.3 p -124.46 -173.65 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.64000000000000001 110.657 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -49.57 92.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 3.04 111.328 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 34.0 mmt180 53.09 40.9 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.808 -0.633 . . . . 4.1100000000000003 111.488 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 55' ' ' ARG . 66.7 t -157.45 105.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 1.23 111.025 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.6 t -104.88 107.52 18.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.64000000000000001 110.9 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.7 tp -100.73 160.19 14.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.521 . . . . 1.54 110.644 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -96.43 142.94 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.5 111.205 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 ' CD2' ' A' ' 65' ' ' LEU . 57.1 tp -137.52 141.92 41.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.96999999999999997 110.82 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.433 ' CZ ' ' HD3' ' A' ' 63' ' ' LYS . 31.3 ptt180 -114.84 179.46 3.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 3.3199999999999998 110.62 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.2 tpmt? -75.62 -48.85 20.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.521 -0.308 . . . . 4.7000000000000002 111.513 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 61' ' ' ARG . 21.0 ptmt -51.57 -34.44 36.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.896 0.379 . . . . 2.2799999999999998 110.567 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -82.52 -25.48 33.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 2.2999999999999998 110.434 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.536 ' CD2' HD21 ' A' ' 60' ' ' LEU . 10.0 mt -74.86 -25.46 58.98 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.052 -0.522 . . . . 0.69999999999999996 111.038 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.89 60.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.66000000000000003 111.108 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -84.92 -55.91 3.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.254 -0.43 . . . . 0.47999999999999998 110.983 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.4 pt -65.97 155.95 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 0.42999999999999999 111.283 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.7 tp10 -107.72 135.37 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 2.29 110.776 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.8 mm? -105.21 152.32 23.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 1.8500000000000001 111.11 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.98 121.21 10.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.112 -0.495 . . . . 2.2400000000000002 110.707 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.75 166.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.76000000000000001 111.22 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.28 148.64 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 1.1599999999999999 111.135 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.83 171.24 7.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 2.2799999999999998 111.122 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.437 ' N ' ' NE2' ' A' ' 75' ' ' GLN . 1.3 mp0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 5.1299999999999999 110.961 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.96 0.41 . . . . 5.1699999999999999 110.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -139.26 164.8 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 2.9399999999999999 110.757 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' A' ' 42' ' ' VAL . 28.5 p90 -147.93 111.76 5.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 2.25 110.984 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.0 p -79.39 155.35 76.63 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.66000000000000003 110.954 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG13 ' A' ' 39' ' ' VAL . 65.5 Cg_endo -74.08 89.64 1.02 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.488 2.125 . . . . 0.65000000000000002 112.46 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.0 t70 177.94 -43.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 2.6899999999999999 111.048 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m -87.64 144.24 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.385 . . . . 1.8899999999999999 110.914 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.02 158.59 32.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 111.131 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.435 ' CE2' ' HB2' ' A' ' 3' ' ' PHE . 72.5 m95 -145.79 158.11 43.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.68999999999999995 110.877 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -108.85 138.35 45.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 2.04 110.91 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.499 HG13 ' CD1' ' A' ' 37' ' ' PHE . 60.8 mt -80.65 137.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.56000000000000005 111.141 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -141.69 56.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.939 -0.573 . . . . 0.96999999999999997 110.253 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.22 90.08 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.68 -0.691 . . . . 0.45000000000000001 112.875 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -146.43 94.69 2.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.854 0.359 . . . . 0.81000000000000005 110.433 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.9 m -100.85 150.28 22.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.76000000000000001 111.204 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HG2' ' OD2' ' A' ' 17' ' ' ASP . 0.1 OUTLIER -53.55 -22.47 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.616 . . . . 3.5800000000000001 111.067 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 16' ' ' ARG . 48.5 m-20 -149.0 34.54 0.75 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.782 0.325 . . . . 2.48 111.151 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -43.94 148.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.389 -0.369 . . . . 0.56999999999999995 111.485 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 m -96.01 155.85 37.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 1.5 110.985 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 38.8 Cg_endo -66.91 -32.25 36.26 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.461 2.108 . . . . 0.60999999999999999 112.093 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.98 -44.97 41.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 110.433 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 26' ' ' LEU . 96.1 m-85 -85.49 -48.17 9.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.767 -0.651 . . . . 2.1699999999999999 110.325 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 25.6 tpt180 -56.98 -61.35 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 1.5700000000000001 111.022 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -51.47 -34.83 37.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 2.6899999999999999 111.081 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -60.82 -41.17 95.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.366 -0.379 . . . . 2.5899999999999999 111.29 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 22' ' ' TYR . 10.8 mp -74.22 -52.69 11.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.795 0.331 . . . . 1.3 111.157 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -46.35 -37.1 7.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.285 -0.416 . . . . 0.94999999999999996 111.513 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.1 p -69.31 -23.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 1.6399999999999999 111.339 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.0 mt -96.87 -24.18 16.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.438 -0.347 . . . . 1.6399999999999999 111.055 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.75 7.44 53.35 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.68 -0.771 . . . . 0.81999999999999995 113.035 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 31' ' ' MET . 1.1 mpt? -89.97 90.67 8.25 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.891 0.377 . . . . 2.5499999999999998 110.736 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.7 mp -94.69 160.55 31.15 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.788 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 83.5 Cg_exo -45.38 122.76 4.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.266 1.977 . . . . 0.51000000000000001 111.847 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.04 23.8 6.88 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.884 -0.674 . . . . 0.40000000000000002 112.071 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 47.8 t -87.73 174.05 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.711 0.291 . . . . 0.62 110.892 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -123.58 144.97 49.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.009 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CE2' HG22 ' A' ' 51' ' ' ILE . 20.7 p90 -158.98 -177.94 6.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.35999999999999999 110.891 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -131.8 132.5 43.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 2.9399999999999999 111.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 5' ' ' PRO . 7.1 p -78.31 135.62 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 1.28 111.025 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.87 -52.21 10.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.489 -0.323 . . . . 0.54000000000000004 111.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 20.9 ptp180 -153.84 139.03 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 2.7999999999999998 111.186 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 43' ' ' ALA . 20.6 t -148.59 158.34 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.347 -0.388 . . . . 1.2 111.108 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -126.11 143.34 45.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.81000000000000005 111.215 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 45' ' ' LEU . 45.2 Cg_endo -68.33 -21.41 41.25 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.647 2.231 . . . . 1.3400000000000001 112.468 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.8 mm? -89.88 -56.1 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 2.5099999999999998 111.111 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.12 107.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.77000000000000002 112.332 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.0 m-20 -148.17 170.66 7.34 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.637 0.256 . . . . 1.0700000000000001 111.07 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.72 118.12 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.985 2.456 . . . . 0.60999999999999999 111.77 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 50' ' ' HIS . 1.8 p -106.79 160.78 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 0.39000000000000001 110.881 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.451 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 57.4 m80 -123.47 135.74 54.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.806 -0.634 . . . . 1.1299999999999999 110.98 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 37' ' ' PHE . 37.1 pt -102.04 139.26 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.983 -0.553 . . . . 0.35999999999999999 110.855 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -108.68 108.88 19.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 2.1299999999999999 111.014 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' ARG . 61.9 p -111.14 -175.3 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.64000000000000001 110.703 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.7 mmt180 -47.68 91.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 3.04 111.48 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' THR . 32.9 mmt180 53.01 36.06 21.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.046 -0.524 . . . . 4.1100000000000003 111.396 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 54' ' ' ARG . 85.9 t -150.87 112.6 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.359 . . . . 1.23 111.052 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -105.07 107.57 18.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.64000000000000001 110.643 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.72 157.31 17.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.162 -0.472 . . . . 1.54 110.951 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 50' ' ' HIS . 13.8 p -102.62 143.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.047 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 51' ' ' ILE . 96.5 mt -139.07 117.58 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.96999999999999997 110.777 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -92.48 169.78 10.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 3.3199999999999998 110.797 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -46.94 -27.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.948 -0.569 . . . . 4.7000000000000002 111.338 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -84.25 -42.43 15.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.38 . . . . 2.2799999999999998 111.17 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 -34.35 65.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 2.2999999999999998 110.973 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -81.27 -21.14 39.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.69999999999999996 111.134 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.14 -25.63 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.66000000000000003 111.263 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.65 -65.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.47999999999999998 111.378 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.4 pt -65.08 140.77 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.482 -0.326 . . . . 0.42999999999999999 110.967 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -92.85 154.96 17.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 2.29 110.697 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.9 tp -116.43 158.07 24.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 1.8500000000000001 110.774 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -146.24 154.39 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.2400000000000002 111.083 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.81 169.17 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.76000000000000001 111.122 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 m -98.99 -178.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 1.1599999999999999 110.998 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' CB ' ' OE1' ' A' ' 75' ' ' GLN . . . -133.97 -58.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.336 -0.393 . . . . 2.2799999999999998 111.176 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.424 ' OE1' ' CB ' ' A' ' 74' ' ' ALA . 5.0 pm0 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.359 -0.382 . . . . 5.1299999999999999 110.923 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.898 0.38 . . . . 5.1699999999999999 110.841 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -81.47 171.04 15.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.051 -0.522 . . . . 2.9399999999999999 110.731 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 9' ' ' TRP . 61.9 m-85 -76.89 106.73 8.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.836 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -118.54 152.39 51.04 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.66000000000000003 111.209 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.07 84.46 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.663 2.242 . . . . 0.65000000000000002 112.34 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -179.97 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.293 -0.412 . . . . 2.6899999999999999 110.901 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.41 ' O ' HG22 ' A' ' 39' ' ' VAL . 42.1 t -103.07 173.43 6.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.351 -0.386 . . . . 1.8899999999999999 110.629 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.93 169.22 8.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.46999999999999997 111.101 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 78.7 m95 -146.41 168.34 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.68999999999999995 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 54.9 mtpt -124.24 138.05 54.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 2.04 111.129 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.478 HG13 ' CD1' ' A' ' 37' ' ' PHE . 52.1 mt -80.2 118.14 27.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.159 -0.473 . . . . 0.56000000000000005 111.159 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 18.9 m -130.37 53.17 1.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.96999999999999997 110.388 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' HA3' ' NH2' ' A' ' 23' ' ' ARG . . . -48.83 96.49 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.45000000000000001 112.627 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -145.53 95.95 2.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.81000000000000005 110.935 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -111.88 158.03 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.013 -0.539 . . . . 0.76000000000000001 110.778 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -51.78 -24.36 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 3.5800000000000001 110.729 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -158.29 42.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 2.48 110.789 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -41.07 128.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.56999999999999995 111.802 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.0 t -80.22 147.38 64.68 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 1.5 110.782 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' GLN . 31.3 Cg_endo -62.62 -28.43 76.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.625 2.216 . . . . 0.60999999999999999 112.501 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.02 -43.79 50.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.70999999999999996 111.052 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -85.29 -45.49 11.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 2.1699999999999999 111.2 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' NH2' ' HA3' ' A' ' 13' ' ' GLY . 18.3 tpp180 -67.58 -61.46 1.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 1.5700000000000001 111.43 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 20' ' ' PRO . 11.1 mm100 -55.93 -19.59 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 111.629 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -80.25 -36.77 34.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 2.5899999999999999 110.993 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.74 -32.6 60.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 1.3 110.982 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -57.24 -33.73 67.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.94999999999999996 111.254 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.1 m -64.04 -39.63 94.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 1.6399999999999999 110.997 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.6 mm? -78.01 -23.23 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 1.6399999999999999 111.059 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.79 20.52 10.63 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.682 -0.771 . . . . 0.81999999999999995 112.593 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.402 ' C ' HD12 ' A' ' 32' ' ' LEU . 1.1 mpt? -98.72 98.24 9.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 2.5499999999999998 110.988 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -102.51 157.93 32.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.68999999999999995 110.675 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' NH1' ' A' ' 23' ' ' ARG . 71.2 Cg_exo -47.46 111.19 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.391 2.061 . . . . 0.51000000000000001 111.803 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 21.39 4.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 0.40000000000000002 112.36 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -88.02 166.26 14.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.303 . . . . 0.62 110.639 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 49.7 m -121.85 156.92 32.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 1.3 111.044 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 51.9 p90 -166.64 178.82 5.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.125 -0.488 . . . . 0.35999999999999999 110.831 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -128.3 125.61 39.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 2.9399999999999999 111.098 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 7' ' ' SER . 18.9 m -75.17 134.59 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.263 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.64 -52.09 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.54000000000000004 111.34 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -148.66 133.71 18.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 2.7999999999999998 111.083 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 43' ' ' ALA . 41.4 t -146.0 160.39 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.396 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -154.83 124.4 3.18 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.512 . . . . 0.81000000000000005 110.737 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.05 -24.45 49.12 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.475 2.117 . . . . 1.3400000000000001 112.491 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -63.45 -22.87 67.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 2.5099999999999998 111.067 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.06 73.65 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.572 -0.823 . . . . 0.77000000000000002 112.11 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.1 m-20 -122.4 170.11 8.48 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.731 0.301 . . . . 1.0700000000000001 111.172 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -84.93 120.34 2.28 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.975 2.45 . . . . 0.60999999999999999 111.724 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.6 p -106.74 159.95 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.783 -0.644 . . . . 0.39000000000000001 111.123 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 80.8 m80 -123.32 123.53 40.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.689 -0.687 . . . . 1.1299999999999999 110.804 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 37' ' ' PHE . 47.7 pt -97.16 141.1 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.35999999999999999 111.021 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -106.67 120.89 43.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.342 -0.39 . . . . 2.1299999999999999 110.828 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.549 ' OG1' HG13 ' A' ' 56' ' ' VAL . 27.1 p -122.63 -163.99 1.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.884 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -46.45 93.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.067 0.461 . . . . 3.04 111.732 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 53' ' ' THR . 25.7 mmm180 44.44 28.59 0.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.81 -0.632 . . . . 4.1100000000000003 112.121 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.9 p -152.55 113.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 1.23 110.838 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -93.84 118.9 32.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.64000000000000001 111.315 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.9 tp -99.54 150.23 22.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 1.54 110.653 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' O ' HD23 ' A' ' 60' ' ' LEU . 11.4 p -104.83 134.32 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.394 . . . . 0.5 111.296 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB2' HD11 ' A' ' 65' ' ' LEU . 83.7 mt -143.33 155.62 44.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 110.721 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' NH2' ' HD3' ' A' ' 63' ' ' LYS . 70.4 mtm180 -110.63 160.4 16.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.88 0.371 . . . . 3.3199999999999998 110.898 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -44.05 -28.2 0.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.517 . . . . 4.7000000000000002 111.585 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 21.8 ptmt -80.73 -35.53 33.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 2.2799999999999998 110.88 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 7.3 m-20 -68.62 -31.49 70.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 2.2999999999999998 111.134 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 65' ' ' LEU . 5.8 mp -86.42 -25.69 25.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 0.69999999999999996 111.266 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.63 -58.43 6.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.66000000000000003 111.468 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.93 -59.05 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.47999999999999998 111.188 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -66.22 151.96 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.411 . . . . 0.42999999999999999 111.47 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 12' ' ' THR . 9.1 tp10 -95.78 136.15 36.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 2.29 110.573 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 70' ' ' LEU . 2.5 mm? -110.0 139.71 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 1.8500000000000001 110.991 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -131.81 118.01 19.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 2.2400000000000002 110.817 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.89 148.16 10.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.76000000000000001 111.073 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.0 -176.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 1.1599999999999999 111.136 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.19 116.89 8.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 2.2799999999999998 111.187 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 5.1299999999999999 110.882 179.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 tpp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.817 0.341 . . . . 5.1699999999999999 110.997 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -76.36 142.36 41.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 2.9399999999999999 111.046 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -98.44 92.44 5.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.025 -0.534 . . . . 2.25 110.601 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.8 p -88.41 154.66 51.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.66000000000000003 111.276 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.567 ' HA ' HG23 ' A' ' 39' ' ' VAL . 60.7 Cg_endo -72.85 92.89 0.78 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.507 2.138 . . . . 0.65000000000000002 112.354 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 176.29 -35.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.535 . . . . 2.6899999999999999 110.702 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -104.41 146.4 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.049 -0.523 . . . . 1.8899999999999999 110.79 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.37 170.21 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.46999999999999997 111.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 35.2 m95 -155.41 160.4 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.68999999999999995 110.797 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -114.65 138.62 50.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 2.04 111.125 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 37' ' ' PHE . 57.3 mt -79.33 129.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.56000000000000005 111.191 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 69' ' ' GLU . 62.8 p -134.72 58.73 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.96999999999999997 110.508 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 68' ' ' ILE . . . -53.8 96.39 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.665 -0.698 . . . . 0.45000000000000001 112.696 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -147.16 98.55 3.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.81000000000000005 110.875 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.9 m -112.32 161.94 16.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.76000000000000001 110.829 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -22.44 34.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.314 -0.403 . . . . 3.5800000000000001 110.865 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -162.7 44.4 0.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.353 -0.385 . . . . 2.48 110.861 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -45.94 128.67 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.56999999999999995 111.494 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.9 p -81.61 154.99 71.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 1.5 110.776 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.65 -28.19 69.2 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.615 2.21 . . . . 0.60999999999999999 112.241 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.34 -45.32 45.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.995 0.426 . . . . 0.70999999999999996 110.823 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 67' ' ' LEU . 95.3 m-85 -85.46 -49.24 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.945 -0.57 . . . . 2.1699999999999999 110.503 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -57.74 -61.27 2.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.52 . . . . 1.5700000000000001 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.481 ' NE2' HD12 ' A' ' 27' ' ' LEU . 27.9 mm-40 -51.02 -34.13 28.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 2.6899999999999999 110.731 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -51.75 -53.27 41.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 2.5899999999999999 110.949 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.03 -43.4 95.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 1.3 111.088 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.481 HD12 ' NE2' ' A' ' 24' ' ' GLN . 84.0 mt -48.78 -26.51 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.94999999999999996 111.186 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.4 t -69.56 -34.03 73.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 1.6399999999999999 110.974 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.0 mt -94.34 -24.53 17.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.265 -0.425 . . . . 1.6399999999999999 110.921 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.76 23.58 9.25 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.653 -0.784 . . . . 0.81999999999999995 112.55 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 64.9 mtt -99.32 91.47 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 111.018 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -92.32 158.02 39.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.68999999999999995 110.561 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.87 118.72 1.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.481 2.121 . . . . 0.51000000000000001 112.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.11 31.02 3.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.825 -0.702 . . . . 0.40000000000000002 112.398 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.6 t -95.57 173.89 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.762 0.315 . . . . 0.62 110.875 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -121.84 148.94 44.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 1.3 110.943 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 36.1 p90 -162.22 173.1 14.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.35999999999999999 110.732 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 52' ' ' GLU . 47.9 m-70 -128.56 130.33 47.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.956 0.408 . . . . 2.9399999999999999 111.233 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 5' ' ' PRO . 19.4 m -80.01 138.38 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.015 -0.539 . . . . 1.28 110.994 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 50' ' ' HIS . 48.1 t -99.62 -40.49 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.54000000000000004 111.426 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 38.8 ptt180 -164.67 129.36 2.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.377 -0.374 . . . . 2.7999999999999998 110.913 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG21 ' A' ' 49' ' ' VAL . 10.0 t -138.14 159.15 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 1.2 111.159 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -122.32 146.23 46.5 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.81000000000000005 110.995 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.06 -14.85 26.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.573 2.182 . . . . 1.3400000000000001 112.592 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -93.6 -50.32 5.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 2.5099999999999998 111.078 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.25 95.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.873 -0.68 . . . . 0.77000000000000002 112.259 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.9 m-20 -136.52 170.2 11.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.791 0.329 . . . . 1.0700000000000001 111.151 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.7 Cg_endo -84.98 116.6 1.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.01 2.473 . . . . 0.60999999999999999 111.694 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 42' ' ' VAL . 2.1 p -106.54 152.34 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 110.923 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 40' ' ' VAL . 73.1 m80 -110.44 131.6 54.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.621 -0.718 . . . . 1.1299999999999999 110.517 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.489 HD11 HD23 ' A' ' 58' ' ' LEU . 30.9 pt -104.65 139.71 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.35999999999999999 111.227 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 38' ' ' HIS . 39.3 tt0 -108.14 114.46 28.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 2.1299999999999999 110.639 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.4 p -113.37 -173.82 2.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.64000000000000001 111.142 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -52.69 99.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 3.04 111.542 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 52.11 29.42 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 4.1100000000000003 111.651 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 64.1 t -149.4 128.48 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 1.23 111.16 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -109.92 107.78 17.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.64000000000000001 110.969 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 HD11 ' A' ' 51' ' ' ILE . 58.6 tp -105.0 156.71 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 1.54 111.235 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.99 132.86 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.182 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 65' ' ' LEU . 74.2 mt -118.18 140.32 49.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.96999999999999997 110.677 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 64' ' ' ASP . 94.0 mtt180 -107.35 149.21 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 3.3199999999999998 110.959 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -27.93 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.976 -0.556 . . . . 4.7000000000000002 111.498 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -82.17 -29.94 31.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 2.2799999999999998 110.938 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' ARG . 19.5 t70 -72.47 -30.18 64.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 2.2999999999999998 110.863 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 65' ' ' LEU . 6.7 mp -79.74 -29.7 40.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.69999999999999996 110.801 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.46 -23.7 10.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.66000000000000003 111.231 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CD1' ' CE2' ' A' ' 22' ' ' TYR . 67.7 mt -97.55 -63.75 1.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.438 . . . . 0.47999999999999998 111.146 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 44.6 pt -65.12 152.99 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.42999999999999999 111.081 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' C ' ' HG1' ' A' ' 12' ' ' THR . 33.2 tt0 -104.01 153.27 21.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.954 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.0 mm? -112.15 148.59 33.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 1.8500000000000001 110.591 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -131.19 128.67 40.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.331 . . . . 2.2400000000000002 110.853 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 156.27 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.76000000000000001 111.288 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -61.81 178.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.079 -0.51 . . . . 1.1599999999999999 111.154 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.69 125.31 49.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 2.2799999999999998 111.28 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 5.1299999999999999 110.824 179.877 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mmm . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.755 0.312 . . . . 5.1699999999999999 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -77.78 -179.44 5.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 2.9399999999999999 110.974 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CE1' HD23 ' A' ' 70' ' ' LEU . 51.8 m-85 -112.66 112.16 23.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 2.25 110.723 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.6 p -113.33 155.21 44.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.66000000000000003 111.642 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.96 89.55 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.564 2.176 . . . . 0.65000000000000002 112.024 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -179.98 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 2.6899999999999999 110.631 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -94.07 143.98 25.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 1.8899999999999999 110.729 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.17 160.18 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.46999999999999997 111.157 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 23.3 m95 -149.37 164.1 35.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.68999999999999995 110.674 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -114.2 136.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 2.04 111.12 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.4 mt -78.19 134.42 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 0.56000000000000005 111.045 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 12' ' ' THR . 24.4 m -136.26 57.88 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.96999999999999997 110.614 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.3 87.42 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.826 -0.624 . . . . 0.45000000000000001 112.937 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.07 94.76 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.376 . . . . 0.81000000000000005 110.713 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.6 m -101.27 -174.93 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.76000000000000001 110.886 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -26.67 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.006 -0.543 . . . . 3.5800000000000001 110.947 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.91 29.6 1.5 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.078 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 18' ' ' ILE . 10.2 tt -43.69 119.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.401 . . . . 0.56999999999999995 111.413 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 74.6 p -80.64 156.58 72.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.031 -0.532 . . . . 1.5 110.756 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 24' ' ' GLN . 18.9 Cg_endo -58.33 -30.83 92.34 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.593 2.195 . . . . 0.60999999999999999 112.399 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.84 59.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.882 0.372 . . . . 0.70999999999999996 110.758 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -85.75 -37.65 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 2.1699999999999999 111.118 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -70.09 -61.56 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 1.5700000000000001 111.121 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 20' ' ' PRO . 6.3 tp-100 -56.58 -20.59 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.6899999999999999 111.366 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -69.88 -50.43 42.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.842 0.353 . . . . 2.5899999999999999 110.677 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.16 -37.71 80.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 1.3 110.984 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.6 mt -54.24 -25.73 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.94999999999999996 111.317 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 m -52.42 -45.5 65.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 1.6399999999999999 110.937 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.4 mm? -96.91 -22.67 16.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 1.6399999999999999 111.103 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.34 23.82 8.76 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.81999999999999995 112.255 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.446 ' HE3' ' HB2' ' A' ' 31' ' ' MET . 50.4 mtm -84.15 89.81 7.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.799 0.333 . . . . 2.5499999999999998 111.149 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -97.39 158.49 33.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.68999999999999995 110.836 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.89 109.32 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.443 2.095 . . . . 0.51000000000000001 111.973 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.16 29.15 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.703 -0.761 . . . . 0.40000000000000002 112.439 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -96.65 174.19 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.62 110.614 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.2 p -121.49 143.59 49.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 1.3 110.93 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 6.8 p90 -156.81 -176.58 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.35999999999999999 110.946 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -140.09 134.81 31.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 2.9399999999999999 110.985 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.619 ' CG1' HG23 ' A' ' 42' ' ' VAL . 59.0 t -64.81 136.48 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.441 . . . . 1.28 111.081 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -94.26 -40.74 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.54000000000000004 111.221 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -175.57 124.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.038 0.447 . . . . 2.7999999999999998 111.17 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.619 HG23 ' CG1' ' A' ' 39' ' ' VAL . 21.2 t -137.42 157.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.59 . . . . 1.2 111.131 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -116.91 154.51 49.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.81000000000000005 110.988 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.76 -19.34 18.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.565 2.177 . . . . 1.3400000000000001 112.525 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.47 -67.46 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 2.5099999999999998 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.08 105.76 0.19 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.809 -0.71 . . . . 0.77000000000000002 112.365 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 6.2 m-20 -148.14 171.27 6.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.536 0.207 . . . . 1.0700000000000001 111.228 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.3 Cg_endo -84.06 120.06 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.74 2.293 . . . . 0.60999999999999999 111.486 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.596 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.8 p -106.26 152.79 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.612 -0.722 . . . . 0.39000000000000001 111.013 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 40' ' ' VAL . 37.5 m-70 -109.82 135.86 50.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.605 -0.725 . . . . 1.1299999999999999 110.398 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 60' ' ' LEU . 36.9 pt -93.82 145.19 8.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.35999999999999999 111.039 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -106.84 109.18 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 2.1299999999999999 110.71 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -114.94 -170.2 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.64000000000000001 111.167 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 25.3 tpp180 -48.96 96.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.333 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 35.2 ptt180 45.71 33.03 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.952 -0.567 . . . . 4.1100000000000003 111.884 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.6 t -151.44 116.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 1.23 110.993 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.6 p -103.04 109.99 21.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.64000000000000001 110.907 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.8 mt -95.62 170.92 9.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 1.54 111.04 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 7.6 p -114.76 140.92 33.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.07 -0.514 . . . . 0.5 111.206 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.664 ' HB3' HD11 ' A' ' 65' ' ' LEU . 91.4 mt -135.39 120.94 19.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.362 -0.381 . . . . 0.96999999999999997 111.181 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.657 ' O ' HD13 ' A' ' 65' ' ' LEU . 33.6 mmt180 -65.83 -168.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.3199999999999998 110.551 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 2.6 mppt? -81.35 -36.7 29.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.435 -0.348 . . . . 4.7000000000000002 111.455 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -86.1 -33.27 20.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.2799999999999998 111.377 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.74 -24.54 2.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.2999999999999998 110.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 60' ' ' LEU . 5.9 mp -85.35 -22.09 28.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.69999999999999996 111.284 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -42.38 90.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.444 -0.344 . . . . 0.66000000000000003 111.637 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.1 -59.0 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.47999999999999998 111.127 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.2 pt -65.6 142.42 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.42999999999999999 111.203 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.06 148.69 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 2.29 110.873 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.486 HD23 ' CE1' ' A' ' 3' ' ' PHE . 22.9 tp -117.01 159.16 22.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 1.8500000000000001 111.052 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -138.36 147.65 43.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 2.2400000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.34 166.85 13.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.76000000000000001 111.004 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -76.78 -176.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 1.1599999999999999 111.046 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.2 173.46 7.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 2.2799999999999998 111.033 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 5.1299999999999999 110.946 179.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.588 0.232 . . . . 5.1699999999999999 111.542 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -171.54 126.29 0.62 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.761 0.315 . . . . 2.9399999999999999 110.616 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -121.24 105.7 10.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 2.25 111.066 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -104.74 155.94 36.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.66000000000000003 111.072 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.51 90.83 1.0 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.51 2.14 . . . . 0.65000000000000002 112.361 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 p30 176.89 -37.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 2.6899999999999999 110.892 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.0 m -100.96 153.52 19.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 1.8899999999999999 110.967 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.52 158.5 15.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.46999999999999997 110.915 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 45.2 m95 -139.64 178.05 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.68999999999999995 110.756 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -125.17 138.1 54.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 2.04 111.279 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 49.9 mt -75.64 125.81 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.56000000000000005 110.704 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 12' ' ' THR . 9.8 m -139.78 46.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.175 0.512 . . . . 0.96999999999999997 110.837 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.7 86.66 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.845 -0.693 . . . . 0.45000000000000001 112.598 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' THR . 92.0 t80 -143.14 94.89 2.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.81000000000000005 110.688 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -97.32 -175.15 3.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.76000000000000001 111.032 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -85.49 -28.77 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 3.5800000000000001 110.788 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -141.03 30.25 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 2.48 110.9 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 tt -41.94 148.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.25 -0.432 . . . . 0.56999999999999995 111.656 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.0 m -107.31 156.54 37.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.122 -0.49 . . . . 1.5 110.87 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 32.9 Cg_endo -63.97 -28.6 66.56 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.216 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -47.08 -46.89 22.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 0.70999999999999996 110.863 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' CD2' ' OD2' ' A' ' 64' ' ' ASP . 75.6 m-85 -86.57 -46.17 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.985 -0.552 . . . . 2.1699999999999999 110.561 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 19.5 tpt180 -56.4 -58.05 9.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 1.5700000000000001 111.289 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -43.94 -28.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.362 -0.381 . . . . 2.6899999999999999 111.703 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 30.9 mmmt -65.81 -41.08 92.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.472 -0.331 . . . . 2.5899999999999999 111.004 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.7 mm? -72.34 -54.98 7.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.3 111.157 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.4 mt -50.67 -29.1 10.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.94999999999999996 111.162 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.7 m -77.48 -28.89 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 1.6399999999999999 111.099 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -25.4 18.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 1.6399999999999999 111.205 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.69 23.93 19.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.654 -0.784 . . . . 0.81999999999999995 112.892 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -109.18 90.48 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 2.5499999999999998 110.623 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -84.47 160.81 55.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.68999999999999995 110.703 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 85.7 Cg_exo -44.85 120.3 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.51000000000000001 112.305 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.52 22.1 5.23 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.873 -0.68 . . . . 0.40000000000000002 112.489 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 34.8 t -93.56 174.17 7.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.543 0.211 . . . . 0.62 110.539 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -117.25 158.8 23.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 1.3 111.13 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 28.0 p90 -168.43 168.41 11.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.075 -0.512 . . . . 0.35999999999999999 110.626 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -120.53 152.34 38.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 2.9399999999999999 110.998 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' CG1' HG23 ' A' ' 42' ' ' VAL . 46.0 t -87.75 136.32 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 1.28 110.933 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.5 -40.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.54000000000000004 111.429 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -169.69 125.96 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.363 -0.38 . . . . 2.7999999999999998 110.886 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG23 ' CG1' ' A' ' 39' ' ' VAL . 60.7 t -137.38 158.72 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.306 -0.406 . . . . 1.2 111.296 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.506 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -145.48 109.78 4.53 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.81000000000000005 111.059 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -43.32 -34.1 4.42 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.543 2.162 . . . . 1.3400000000000001 112.745 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -54.18 -26.59 28.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 2.5099999999999998 111.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.2 90.09 1.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.77000000000000002 112.044 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 3.6 m-20 -143.87 172.01 6.1 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.647 0.26 . . . . 1.0700000000000001 111.04 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.31 121.77 2.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.769 2.313 . . . . 0.60999999999999999 111.687 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 42' ' ' VAL . 1.4 p -106.43 158.96 6.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.665 -0.698 . . . . 0.39000000000000001 111.007 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 12.5 m-70 -114.83 131.41 56.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.718 -0.673 . . . . 1.1299999999999999 110.605 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -101.84 141.91 17.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 110.987 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.02 108.41 19.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.071 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -108.17 -169.59 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.64000000000000001 110.948 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -55.46 96.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 3.04 111.429 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 52.39 30.55 8.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 4.1100000000000003 111.723 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.5 t -151.4 112.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.965 0.412 . . . . 1.23 111.388 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -97.15 109.95 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.64000000000000001 110.637 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 74.6 mt -99.79 163.35 12.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.154 -0.475 . . . . 1.54 111.245 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 50' ' ' HIS . 12.0 p -121.76 137.96 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.5 110.871 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD13 ' CD1' ' A' ' 68' ' ' ILE . 86.2 mt -127.53 136.27 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.96999999999999997 110.954 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . 99.4 mtt180 -85.83 150.83 24.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 3.3199999999999998 110.915 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -45.64 -30.26 1.48 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.049 -0.523 . . . . 4.7000000000000002 111.454 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -83.17 -39.24 21.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 2.2799999999999998 111.191 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' CD2' ' A' ' 22' ' ' TYR . 9.0 t70 -57.96 -29.56 65.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 2.2999999999999998 111.046 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 61' ' ' ARG . 8.1 mp -76.26 -20.25 57.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.69999999999999996 111.281 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.24 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.557 -0.292 . . . . 0.66000000000000003 111.441 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.0 mt -97.99 -54.32 3.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.747 0.308 . . . . 0.47999999999999998 111.295 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' CD1' HD13 ' A' ' 60' ' ' LEU . 36.2 pt -65.61 152.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.373 -0.376 . . . . 0.42999999999999999 111.035 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 12' ' ' THR . 7.6 tp10 -105.02 149.29 25.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 2.29 111.014 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.7 mt -130.51 139.51 50.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 1.8500000000000001 110.96 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -116.3 129.97 56.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 2.2400000000000002 110.792 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.57 20.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.76000000000000001 111.047 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.85 175.99 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 1.1599999999999999 111.372 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 -177.83 3.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 2.2799999999999998 111.026 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 5.1299999999999999 110.843 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.854 0.359 . . . . 5.1699999999999999 111.042 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -52.15 150.19 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 2.9399999999999999 111.147 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -141.36 104.03 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.025 -0.534 . . . . 2.25 110.745 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 46.2 p -86.08 156.22 57.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.66000000000000003 111.259 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 73.2 Cg_endo -74.27 90.71 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.637 2.224 . . . . 0.65000000000000002 112.284 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 178.32 -42.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 110.763 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.3 m -92.17 141.84 28.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 110.929 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.98 164.17 25.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.436 . . . . 0.46999999999999997 111.089 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 42.5 m95 -147.84 169.53 19.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.68999999999999995 110.645 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' SER . 57.8 mttp -114.87 137.03 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 2.04 111.099 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 42.1 mt -78.34 122.92 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 110.955 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 12' ' ' THR . 32.1 m -136.16 51.45 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.96999999999999997 110.806 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.42 96.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.957 -0.639 . . . . 0.45000000000000001 112.638 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -147.29 94.98 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.81000000000000005 110.813 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . 25.6 t -105.29 -172.42 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.429 . . . . 0.76000000000000001 110.878 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.0 mpt_? -86.12 -21.89 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.009 -0.542 . . . . 3.5800000000000001 111.188 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -156.5 33.71 0.32 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.455 -0.339 . . . . 2.48 111.159 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 15' ' ' SER . 5.6 tt -46.89 122.61 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.56999999999999995 111.281 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 78.3 p -76.79 155.58 83.05 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 1.5 110.826 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.77 -29.87 77.41 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.616 2.211 . . . . 0.60999999999999999 112.488 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.22 66.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.011 0.434 . . . . 0.70999999999999996 110.41 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -85.75 -28.93 24.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.888 -0.596 . . . . 2.1699999999999999 111.02 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NH1' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -76.04 -61.73 1.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 1.5700000000000001 111.029 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -53.4 -27.64 25.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.347 -0.388 . . . . 2.6899999999999999 110.947 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -50.67 -32.1 18.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 2.5899999999999999 111.153 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 26' ' ' LEU . 5.9 mp -84.02 -42.31 16.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 1.3 111.251 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' NH1' ' A' ' 23' ' ' ARG . 73.2 mt -49.03 -25.81 2.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.94999999999999996 111.238 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 29' ' ' LEU . 73.7 p -65.6 -37.54 86.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 1.6399999999999999 110.935 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -91.07 -24.04 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 1.6399999999999999 110.898 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.9 16.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.652 -0.785 . . . . 0.81999999999999995 112.467 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 51.9 mtm -98.43 99.33 10.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 2.5499999999999998 110.795 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.7 mp -95.48 160.94 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.023 -0.535 . . . . 0.68999999999999995 110.816 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' LEU . 80.2 Cg_exo -41.11 114.03 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.601 2.201 . . . . 0.51000000000000001 112.282 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.17 33.02 1.56 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.809 -0.71 . . . . 0.40000000000000002 112.174 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 39.8 t -100.58 174.78 5.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.612 0.244 . . . . 0.62 110.807 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.7 t -120.18 154.7 34.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 1.3 110.876 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.8 p90 -167.62 177.26 5.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.35999999999999999 110.751 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 76.6 t60 -128.82 155.18 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 2.9399999999999999 111.033 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' HG23 ' A' ' 42' ' ' VAL . 66.1 t -92.78 134.88 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.526 . . . . 1.28 110.906 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -99.21 -51.44 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.32 -0.4 . . . . 0.54000000000000004 111.461 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 16.9 ptm180 -155.49 123.79 5.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 2.7999999999999998 111.263 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 49' ' ' VAL . 46.6 t -135.69 158.79 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 1.2 111.025 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.498 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -124.87 152.89 70.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.81000000000000005 111.09 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.25 -30.78 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.8 2.334 . . . . 1.3400000000000001 112.856 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.11 -26.69 39.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.277 -0.42 . . . . 2.5099999999999998 111.129 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 104.13 1.44 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.723 -0.751 . . . . 0.77000000000000002 112.167 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 4.3 m-20 -147.86 170.67 7.34 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.673 0.273 . . . . 1.0700000000000001 111.07 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.1 Cg_endo -84.5 120.71 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.928 2.419 . . . . 0.60999999999999999 111.69 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 1.5 p -106.96 159.12 6.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.82 -0.627 . . . . 0.39000000000000001 111.264 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 59' ' ' VAL . 53.2 m-70 -114.35 137.03 52.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 1.1299999999999999 110.448 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 26.2 pt -102.11 141.18 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.936 0.398 . . . . 0.35999999999999999 111.63 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -107.61 107.75 18.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.942 -0.572 . . . . 2.1299999999999999 110.507 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.3 p -113.96 -175.47 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.64000000000000001 111.094 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . 39.7 mmt180 -49.61 102.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 3.04 111.428 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 29.4 ptt180 44.81 37.01 2.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.018 -0.537 . . . . 4.1100000000000003 112.056 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 54' ' ' ARG . 99.1 t -151.52 126.73 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 1.23 111.118 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.6 t -109.98 107.73 17.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.64000000000000001 110.666 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HB2' ' CG1' ' A' ' 51' ' ' ILE . 77.9 mt -106.95 156.8 18.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 1.54 111.233 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HB ' ' CE1' ' A' ' 50' ' ' HIS . 8.0 p -112.96 134.71 54.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.997 -0.547 . . . . 0.5 110.992 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' CB ' HD11 ' A' ' 65' ' ' LEU . 70.5 mt -122.31 134.22 54.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.96999999999999997 110.757 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -97.35 160.68 14.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.3199999999999998 110.848 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -51.48 -23.52 4.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 4.7000000000000002 110.965 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -85.08 -27.88 26.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.39 -0.368 . . . . 2.2799999999999998 110.815 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.25 -32.75 61.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 2.2999999999999998 110.823 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 65' ' ' LEU . 7.7 mp -79.44 -21.69 45.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.69999999999999996 111.075 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.18 62.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.66000000000000003 111.589 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.55 -58.94 1.81 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.75 0.31 . . . . 0.47999999999999998 111.353 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.4 pt -65.94 158.44 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.42999999999999999 111.345 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' C ' HD22 ' A' ' 70' ' ' LEU . 8.4 tp10 -111.53 141.74 44.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.29 110.695 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.1 mm? -117.16 142.27 47.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.406 -0.361 . . . . 1.8500000000000001 111.086 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -128.02 122.94 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 2.2400000000000002 110.718 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.27 175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.76000000000000001 111.327 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.61 -176.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 1.1599999999999999 111.129 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.96 114.77 1.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 2.2799999999999998 111.088 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 5.1299999999999999 110.804 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.727 0.299 . . . . 5.1699999999999999 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -175.38 -175.2 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 2.9399999999999999 110.804 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 70' ' ' LEU . 20.5 m-85 -101.9 117.74 35.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 2.25 110.897 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.1 p -112.27 153.86 44.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.66000000000000003 111.203 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . 59.2 Cg_endo -71.74 89.38 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.56 2.173 . . . . 0.65000000000000002 112.437 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t70 176.69 -37.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 2.6899999999999999 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -101.42 144.34 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 1.8899999999999999 110.934 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.16 167.16 21.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.46999999999999997 110.955 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 64.6 m95 -151.74 174.78 13.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.95 0.405 . . . . 0.68999999999999995 111.198 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -127.23 135.42 50.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 2.04 110.988 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 35' ' ' SER . 64.0 mt -72.92 133.17 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.291 -0.413 . . . . 0.56000000000000005 111.13 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 12' ' ' THR . 13.9 m -137.45 48.95 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 0.96999999999999997 110.456 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.8 89.51 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.856 -0.688 . . . . 0.45000000000000001 112.658 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -147.09 95.42 2.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.81000000000000005 110.866 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -102.14 160.4 14.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.405 -0.361 . . . . 0.76000000000000001 110.943 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -17.75 62.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 3.5800000000000001 111.232 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -154.06 34.0 0.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.59 0.233 . . . . 2.48 111.415 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.2 tt -47.36 128.95 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.598 -0.274 . . . . 0.56999999999999995 111.281 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.9 p -87.76 156.55 52.75 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 1.5 110.84 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -65.44 -28.92 53.93 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.462 2.108 . . . . 0.60999999999999999 112.482 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.05 -48.35 22.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.941 0.4 . . . . 0.70999999999999996 110.772 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.514 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 52.5 t80 -86.62 -46.08 10.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 2.1699999999999999 110.787 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 18.2 tpt180 -56.05 -56.19 23.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 1.5700000000000001 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -45.73 -34.2 3.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.283 -0.417 . . . . 2.6899999999999999 111.371 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.73 -27.88 67.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 2.5899999999999999 111.106 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.1 mt -77.81 -55.12 5.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.3 110.912 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -48.2 -30.22 4.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.94999999999999996 111.187 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.2 p -75.97 -32.04 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.6399999999999999 111.159 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' CD1' HD22 ' A' ' 58' ' ' LEU . 80.0 mt -90.1 -23.09 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 1.6399999999999999 111.032 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.72 10.18 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.769 -0.729 . . . . 0.81999999999999995 112.358 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.401 ' C ' HD12 ' A' ' 32' ' ' LEU . 65.1 mtt -109.01 91.51 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 2.5499999999999998 110.874 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -104.65 160.24 26.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.68999999999999995 110.83 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 71.1 Cg_exo -46.82 115.26 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.427 2.084 . . . . 0.51000000000000001 112.094 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.9 19.22 8.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.806 -0.712 . . . . 0.40000000000000002 112.612 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 43.7 t -92.94 172.36 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.62 110.787 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.0 m -116.39 153.56 31.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.368 . . . . 1.3 111.182 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 9' ' ' TRP . 23.3 p90 -164.76 163.02 21.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.35999999999999999 110.52 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -115.72 117.48 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 2.9399999999999999 111.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.66 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 1.28 111.086 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -97.91 -47.74 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.393 -0.367 . . . . 0.54000000000000004 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 36.9 ptt180 -162.16 138.01 7.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.915 0.388 . . . . 2.7999999999999998 111.228 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 43' ' ' ALA . 19.5 t -145.78 159.31 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 1.2 111.078 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -121.54 155.86 58.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.81000000000000005 111.123 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.42 -26.99 8.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 1.3400000000000001 112.685 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -90.9 -52.52 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 2.5099999999999998 111.02 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.98 111.92 0.3 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.734 -0.746 . . . . 0.77000000000000002 112.417 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.1 m-20 -148.16 172.74 4.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.639 0.257 . . . . 1.0700000000000001 111.09 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.9 Cg_endo -84.35 117.24 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.961 2.441 . . . . 0.60999999999999999 111.654 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 42' ' ' VAL . 2.4 p -106.79 154.12 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.39000000000000001 111.068 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -119.68 142.2 48.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.606 . . . . 1.1299999999999999 110.805 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.446 HG22 ' CD2' ' A' ' 37' ' ' PHE . 38.6 pt -114.72 136.55 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.35999999999999999 111.371 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -109.08 115.98 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 2.1299999999999999 110.426 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.471 ' OG1' HG13 ' A' ' 56' ' ' VAL . 37.5 p -130.25 -167.76 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.64000000000000001 111.273 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HG12 ' A' ' 56' ' ' VAL . 40.0 mmt180 -41.4 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.973 0.416 . . . . 3.04 112.018 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' THR . 79.8 mtm180 41.37 53.15 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 4.1100000000000003 111.923 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 56' ' ' VAL . 12.1 p -171.89 116.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 1.23 111.449 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -104.65 108.11 19.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 0.64000000000000001 110.515 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' A' ' 29' ' ' LEU . 48.4 tp -100.16 158.44 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 1.54 110.98 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 60' ' ' LEU . 13.3 p -106.82 153.33 8.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.5 111.118 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 59' ' ' VAL . 97.1 mt -144.81 119.45 9.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.441 . . . . 0.96999999999999997 111.023 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -77.51 -173.11 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 3.3199999999999998 110.91 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -75.1 -28.14 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 4.7000000000000002 111.153 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.44 -35.33 25.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.348 -0.387 . . . . 2.2799999999999998 111.036 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.86 -30.93 71.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 2.2999999999999998 110.754 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 68' ' ' ILE . 26.7 mt -76.5 -24.77 53.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.055 -0.521 . . . . 0.69999999999999996 111.035 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.06 71.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.66000000000000003 111.341 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.81 -58.16 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.47999999999999998 111.361 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.514 ' CG2' ' CE1' ' A' ' 22' ' ' TYR . 31.3 pt -65.52 149.66 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.381 . . . . 0.42999999999999999 111.256 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' C ' HD22 ' A' ' 70' ' ' LEU . 6.3 tp10 -109.77 151.56 26.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 2.29 110.635 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.2 mm? -118.91 148.1 43.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 1.8500000000000001 110.675 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.34 145.19 43.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 2.2400000000000002 110.852 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.4 172.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.76000000000000001 110.953 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.6 m -97.03 167.14 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.329 -0.396 . . . . 1.1599999999999999 111.233 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.42 95.62 2.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 2.2799999999999998 110.878 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 5.1299999999999999 110.939 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.756 0.312 . . . . 5.1699999999999999 110.993 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -104.76 134.37 48.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 2.9399999999999999 111.047 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -85.91 108.23 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 2.25 110.898 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -114.17 154.19 46.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.66000000000000003 111.204 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.29 89.73 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.531 2.154 . . . . 0.65000000000000002 112.432 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 178.24 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 2.6899999999999999 110.918 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.2 m -106.25 170.21 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 110.9 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.56 169.33 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.46999999999999997 111.044 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.422 ' CA ' HG13 ' A' ' 73' ' ' VAL . 52.1 m95 -151.1 162.08 41.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.68999999999999995 110.583 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 5.8 ptpp? -107.61 137.85 44.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 2.04 110.987 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 37' ' ' PHE . 53.8 mt -83.1 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.56000000000000005 111.235 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' GLU . 23.6 m -135.92 56.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.96999999999999997 110.286 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.45 96.18 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.701 -0.682 . . . . 0.45000000000000001 112.745 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -147.14 97.38 2.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.815 0.341 . . . . 0.81000000000000005 110.708 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.1 m -108.61 -174.34 2.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.76000000000000001 110.977 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 10.3 mpt_? -74.78 -27.26 60.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 3.5800000000000001 110.881 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.91 42.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.48 110.81 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 18' ' ' ILE . 5.7 tt -45.7 109.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.277 -0.42 . . . . 0.56999999999999995 111.172 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.0 p -59.63 155.8 37.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 1.5 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 21.8 Cg_endo -61.07 -30.47 89.41 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.60999999999999999 112.101 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.63 -46.25 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.414 . . . . 0.70999999999999996 110.897 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -85.98 -35.3 20.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.51 . . . . 2.1699999999999999 111.148 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 31.1 tpt180 -70.94 -61.04 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.524 . . . . 1.5700000000000001 111.612 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -42.75 -34.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.506 -0.316 . . . . 2.6899999999999999 111.839 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.29 -49.33 78.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.441 -0.345 . . . . 2.5899999999999999 111.103 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.21 -53.63 55.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 1.3 111.075 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -48.85 -46.23 41.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.396 -0.366 . . . . 0.94999999999999996 111.203 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -55.59 -49.25 73.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 1.6399999999999999 111.05 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 58' ' ' LEU . 73.5 mt -71.75 -25.17 61.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 1.6399999999999999 110.885 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.38 19.54 27.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.747 -0.739 . . . . 0.81999999999999995 112.774 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.4 mtt -95.03 87.05 4.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.726 0.298 . . . . 2.5499999999999998 110.792 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.7 mp -92.2 159.65 36.94 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.68999999999999995 110.499 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.96 132.22 17.43 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.298 1.999 . . . . 0.51000000000000001 111.757 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 17.37 38.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.75 -0.738 . . . . 0.40000000000000002 112.267 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 t -82.22 174.24 11.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.685 0.278 . . . . 0.62 110.582 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.4 p -125.89 137.83 53.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.377 -0.374 . . . . 1.3 110.733 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 11' ' ' ILE . 9.6 p90 -150.53 157.64 43.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.35999999999999999 111.003 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -108.51 146.87 32.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.9399999999999999 110.855 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 42' ' ' VAL . 58.0 t -84.93 128.32 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 1.28 111.144 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.93 -47.54 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.54000000000000004 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -168.28 129.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 2.7999999999999998 110.814 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG22 ' HB ' ' A' ' 49' ' ' VAL . 39.5 t -141.56 156.56 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.368 . . . . 1.2 111.339 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -127.88 141.65 41.8 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.81000000000000005 110.825 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.97 -21.23 37.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.497 2.131 . . . . 1.3400000000000001 112.658 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 mt -85.74 -48.95 8.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.363 -0.38 . . . . 2.5099999999999998 110.882 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.65 105.61 0.37 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.762 -0.732 . . . . 0.77000000000000002 112.497 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.9 m-20 -148.11 171.06 6.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.619 0.247 . . . . 1.0700000000000001 110.804 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 47' ' ' ASP . 1.2 Cg_endo -84.48 118.75 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.878 2.385 . . . . 0.60999999999999999 111.788 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' HB ' HG22 ' A' ' 42' ' ' VAL . 1.9 p -106.65 161.83 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 0.39000000000000001 111.123 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.458 ' N ' ' CG2' ' A' ' 49' ' ' VAL . 79.2 m80 -125.07 148.37 48.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 1.1299999999999999 110.467 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.3 pt -115.56 138.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.386 -0.37 . . . . 0.35999999999999999 111.446 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.95 112.97 26.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 2.1299999999999999 110.612 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.533 ' OG1' HG13 ' A' ' 56' ' ' VAL . 41.7 p -126.7 -175.98 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.912 0.387 . . . . 0.64000000000000001 111.343 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -41.59 95.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.964 -0.562 . . . . 3.04 112.101 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 43.28 54.79 4.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 4.1100000000000003 112.089 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.4 p -175.78 113.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 1.23 111.29 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -100.49 112.18 24.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 0.64000000000000001 110.852 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 29' ' ' LEU . 38.0 tp -105.73 148.58 27.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.797 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' HB ' ' CD2' ' A' ' 50' ' ' HIS . 8.8 p -99.56 140.71 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.5 111.315 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' HD11 ' A' ' 65' ' ' LEU . 95.8 mt -140.44 166.12 25.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.96999999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 80.7 mtp180 -130.3 152.82 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 3.3199999999999998 110.896 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' CE ' ' A' ' 62' ' ' LYS . 2.4 tpmt? -50.49 -24.81 3.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.969 -0.56 . . . . 4.7000000000000002 111.523 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -81.37 -28.67 34.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.894 0.378 . . . . 2.2799999999999998 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.28 -33.08 29.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 2.2999999999999998 111.068 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.8 mp -71.43 -20.7 62.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.69999999999999996 111.267 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.15 84.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.505 -0.316 . . . . 0.66000000000000003 111.468 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.31 -56.59 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.47999999999999998 111.257 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 65' ' ' LEU . 28.7 pt -66.96 151.91 10.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.42999999999999999 111.102 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' O ' HD12 ' A' ' 70' ' ' LEU . 33.0 tt0 -100.49 128.96 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 2.29 110.59 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 69' ' ' GLU . 5.3 mp -118.45 136.14 53.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.276 -0.42 . . . . 1.8500000000000001 111.077 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 38.4 tt0 -130.23 156.53 44.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 2.2400000000000002 110.755 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.02 133.43 51.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 0.76000000000000001 111.113 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.422 HG13 ' CA ' ' A' ' 9' ' ' TRP . 32.7 m -60.25 167.66 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 111.208 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.08 134.48 50.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 2.2799999999999998 110.98 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 5.1299999999999999 110.816 -179.933 . . . . . . . . 0 0 . 1 stop_ save_